Print
Articles
Actavis, the world’s third-largest generic pharmaceutical company, has reached a deal to buy Forest Laboratories for $25 billion in cash and stock, bolstering its geographic reach and expanding its portfolio of generic and over-the-counter pharmaceuticals. Read More
DEALMAKING:
Actavis to Buy Forest Labs for $25 BillionCombination would create a company with combined annual revenues of $15 billion.
Actavis, the world’s third-largest generic pharmaceutical company, has reached a deal to buy Forest Laboratories for $25 billion in cash and stock, bolstering its geographic reach and expanding its portfolio of generic and over-the-counter pharmaceuticals. Read More
- Actavis to Buy Forest Labs for $25 Billion
Combination would create a company with combined annual revenues of $15 billion.
February 23, 2014 - MICHAEL FITZHUGH - Business - Dealmaking - Cell Therapy Shows Promise in Leukemia Battle
Genetically modified T cells induced complete remissions.
February 23, 2014 - MICHAEL FITZHUGH - Tech/Innovation - Cancer - NBA Taps Wearable Tech to Track Player Vitals
League is turning to technology to fine-tune player performance.
February 23, 2014 - MICHAEL FITZHUGH - Health - Digital Health - The Case for Megamergers
Podcast: February 24, 2014
February 21, 2014 - Finance - Mergers and Acquisitions - Novimmune Banks $66M to Advance Pipeline
Swiss biotech targets inflammatory and autoimmune diseases.
February 21, 2014 - MARIE DAGHLIAN - Finance - Venture Capital - Life Sciences IPOs Keep On Coming
Equity offerings top $1 billion in the week.
February 17, 2014 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Partners to Leverage $117M for Antibiotic Discovery
Six-year program will focus on finding novel antibiotics against gram-negative bacteria.
February 16, 2014 - MICHAEL FITZHUGH - Health - Drug Delivery - FDA approves BioMarin's Vimizim for enzyme disorder
New drug is the first to receive a rare pediatric disease priority review voucher from the agency.
February 16, 2014 - MICHAEL FITZHUGH - Law/Policy - Innovation - Mallinckrodt Pays $1.3B for Cadence Pharma
Buyout of pain drug company expected to increase Mallinckrodt's access to hospital customers.
February 16, 2014 - MICHAEL FITZHUGH - Business - Dealmaking - What 2014 Looks Like for Drug Launches
Podcast: February 17, 2014
February 10, 2014 - Tech/Innovation - Drug Development - BIO Argues for Unique Biosimilar Naming
As drugmakers and industry trade groups meet in Washington, naming debate continues.
February 07, 2014 - MICHAEL FITZHUGH - Law/Policy - Generics and Biosimilars - Banner Week for Biotech IPOs in U.S.
Eight companies go public in one week, most since February 2000.
February 07, 2014 - MARIE DAGHLIAN - Finance - Initial Public Offerings - NIH's Collins Discusses Partnership with Industry
Podcast: February 10, 2014
February 06, 2014 - Tech/Innovation - Drug Development - Merck Inks Collaborations with Amgen, Incyte, and Pfizer
Companies will evaluate promising experimental cancer therapy in combination with other medicines.
February 06, 2014 - MICHAEL FITZHUGH - Business - Drug Development - The Game is On
Cancer Research UK harnesses the keen eyes of mobile gamers to speed the analysis of genetic data.
February 06, 2014 - MICHAEL FITZHUGH - Tech/Innovation - Genomics - Five More Biotechs Go Public
Auspex, Genocea, Biocept, and UniQure complete IPOs in U.S., Acucela goes public in Japan.
February 05, 2014 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Breakthrough Designation Proves Elusive
FDA seeks to encourage therapeutic advances, but may need to educate drugmakers better about what it’s looking for.
January 31, 2014 - MICHAEL FITZHUGH - Tech/Innovation - Drug Development - Biotech IPOs Off and Running
Five drug developers price in busy week, Dicerna and UltraGenyx soar in debut.
January 31, 2014 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Ensuring Results Are Reproducible
Podcast: February 3, 2014
January 30, 2014 - Law/Policy - Research - DioGenix Reports Positive Results for Next-Gen MS Test
Diagnostic gives doctors ability to rapidly diagnose multiple sclerosis and get patients on treatment sooner.
January 27, 2014 - MARIE DAGHLIAN - Business - Diagnostics - Non-profit Inks MS Deal with NIH
Myelin Repair Foundation finds expertise and backing in cooperative research agreement with government.
January 27, 2014 - MICHAEL FITZHUGH - Business - Drug Development - Reaching a Personalized Medicine Milestone
Podcast: January 27, 2014
January 24, 2014 - Tech/Innovation - Personalized Medicine - Janssen Puts Focus on Global Public Health
New group sharpens engagement in global markets with unified policy and R&D; agenda.
January 24, 2014 - MICHAEL FITZHUGH - Health - Global Health - U.S. Public Biotechs Raise Almost One Billion in Equity and Debt
Biotech’s strong start in new year spurs opportunity to raise money.
January 24, 2014 - MARIE DAGHLIAN - Finance - Capital Markets - Vigilance Called for as FDA Speeds Approvals
Study calls for closer monitoring of new drugs and better communication about risks and benefits.
January 23, 2014 - MICHAEL FITZHUGH - Law/Policy - Regulatory - IMS Urges Big Pharma to Dive into Social Media
Just half of big drugmakers have active presence in social channels.
January 22, 2014 - MICHAEL FITZHUGH - Business - Business Strategy - Regeneron and Geisinger to Sequence 100k Genomes
Project aims to improve patient care and accelerate innovation in drug discovery and development.
January 18, 2014 - MICHAEL FITZHUGH - Tech/Innovation - Genomics - Sanofi Invests $700M in Rare Disease Specialist Alnylam
Deal gives Sanofi new options following failure to win FDA approval for MS drug.
January 17, 2014 - MICHAEL FITZHUGH - Finance - Deals - FDA Issues Draft Social Media Guidance
Despite offering drugmakers advice, plenty of issues remain to be addressed.
January 17, 2014 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Moderna Signs Rare Disease Pact with Alexion and Launches Onkaido
Newco will develop cancer treatments while Alexion pays $100M for 10 product options.
January 17, 2014 - MARIE DAGHLIAN - Finance - Deals - Regenerative Medicine Gets Ready for Prime Time
Podcast: January 20, 2014
January 16, 2014 - Business - Regenerative Medicine / Stem Cells - Thermo Fisher Sells Assets to GE Healthcare for $1.1B
Sale will satisfy European Commission concerns about its $13.6B Life Tech buy.
January 10, 2014 - MICHAEL FITZHUGH - Business - Business Strategy - Forest Laboratories to Acquire Aptalis for $2.9B
Deal will diversify Forest's product portfolio, says CEO.
January 10, 2014 - MICHAEL FITZHUGH AND MARIE DAGHLIAN - Finance - Deals - FDA Reviewer Flunks Chelsea’s Fainting Drug Ahead of Advisory Meeting, Shares Tank
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 10, 2014 - Business - Trials and Tribulations - New Clues as to How Bacteria Evade Antibiotics
Bacterial “persisters” can cause recurrent infections.
January 10, 2014 - Tech/Innovation - Research - Why We Need Sleep
UW researchers say it is the price we pay for learning.
January 10, 2014 - Health - Wellness - Johnson & Johnson Looks to Israel for Innovation
Biopharma companies sign flurry of deals ahead of JP Morgan Healthcare Conference.
January 10, 2014 - MARIE DAGHLIAN - Finance - Deals - Big Pharma Faces Tougher M&A; Landscape
Podcast: January 13, 2014
January 10, 2014 - Finance - Mergers and Acquisitions - Global Life Sciences M&A; Deal Values Hit $131.8B in 2013
Big Pharma takes a breather from M&A.;
January 06, 2014 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Asia’s Share of Biomedical R&D; Investment Grows
With lure of lower cost labor and subsidies, industry appears to be shifting investments East.
January 03, 2014 - MICHAEL FITZHUGH - Tech/Innovation - Funding Innovation - Drugmakers Launch Data-sharing Site
New patient-level data will open avenues for further research of approved medicines.
January 03, 2014 - MICHAEL FITZHUGH - Law/Policy - Clinical Trial Transparency - A Look at 2013, the J.P. Morgan Conference, and Beyond
Podcast: January 6, 2014
January 02, 2014 - Business - Capital Markets - FDA Rebuffs Genzyme’s Lemtrada for Relapsing MS
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 02, 2014 - Business - Trials and Tribulations - Banner Year for Life Sciences IPOs
More than three quarters of the 52 companies that went public ended the year above their initial offering price.
December 29, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Buyout Firm Acquires Majority Stake in Ikaria
Critical therapy company will pursue international expansion while spinning out part of pipeline.
December 27, 2013 - MICHAEL FITZHUGH and MARIE DAGHLIAN - Business - Business Strategy - Tesaro Reports Positive Results, but Not Good Enough as Investors Sink Shares
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 27, 2013 - Business - Trials and Tribulations - Fighting Cancer with Gene Therapy
Podcast: December 30, 2013
December 26, 2013 - Tech/Innovation - Gene Therapy - Alzheimer’s Disease Unraveled
Researchers clarify where it starts, why it starts there, and how it spreads.
December 26, 2013 - Tech/Innovation - Aging - Merck Launches New Weight Management Business
Partnership with Health Management Resources seeks to lower healthcare costs, minimize chronic disease risks.
December 26, 2013 - MICHAEL FITZHUGH - Health - Obesity - AstraZeneca Banks on Diabetes
Pharma will pay up to $4.3 billion to acquire Bristol-Myers’ stake in joint venture.
December 23, 2013 - MARIE DAGHLIAN - Finance - Deals - UCSF Chancellor Leaving to Head Gates Foundation
Desmond-Hellmann will bring extensive drug-development and administrative experience to foundation.
December 20, 2013 - MICHAEL FITZHUGH - Health - Global Health - Fixing the Life Sciences with the
Lean Startup
Podcast: December 23, 2013
December 19, 2013 - Business - Business Strategy - Biotech Visionary G. Steven Burrill Offers Predictions for 2014
Sees sector maintaining momentum in the new year, but at a slower pace as valuations return to normal
December 19, 2013 - Business - Commentary - Targacept Ends Another Program, Shares Tumble
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 19, 2013 - Business - Trials and Tribulations - Biogen and Samsung to Market Biosimilars in Europe
Agreement advances joint venture’s pursuit of potentially lucrative market.
December 18, 2013 - MICHAEL FITZHUGH - Business - Business Strategy - Covidien Buys Given Imaging for $860M
Israeli GI diagnostics maker’s novel PillCam lets doctors see the digestive tract less invasively.
December 15, 2013 - MARIE DAGHLIAN - Business - Dealmaking - Roche Taps Prothena for Parkinson’s Drug
Collaboration for early-stage therapy worth up to $600 million for Irish biotech.
December 15, 2013 - MARIE DAGHLIAN - Finance - Deals - Avanir Falls as MS Drug Misses Primary Endpoint in Mid-Stage Trial
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 15, 2013 - Business - Trials and Tribulations Why Standards Are Needed to Fix Life Sciences Research
Podcast: December 16, 2013
December 13, 2013 - Law/Policy - Research- Scientists Create Drug Response Biosensor
Modular system could move continuous monitoring beyond diabetics to wider range of applications.
December 13, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Personalized Medicine - Making the U.S. More Competitive
Small business forum discusses public policies to encourage investment in innovative R&D; companies.
December 13, 2013 - Law/Policy - Taxes - Global R&D; Spending to Grow 3.8 Percent in 2014
Big Pharma tops list of R&D; spenders in life sciences.
December 13, 2013 - Tech/Innovation - Funding Innovation - G8 Seeks Dementia Cure by 2025
Health ministers commit to millions in new funding to manage accelerating mental health crisis.
December 12, 2013 - MICHAEL FITZHUGH - Health - Neurodegeneration - 23andMe Suspends Health-Related Gene Tests
Company responds to FDA demand and says will submit offering to regulatory review.
December 08, 2013 - MARIE DAGHLIAN - Law/Policy - Regulatory - FDA Approves Breakthrough Therapy for Hepatitis C
Gilead’s oral pill will make treating the chronic condition easier.
December 08, 2013 - MARIE DAGHLIAN - Health - Drug Development - Cancer Research Centers Partner to Launch Juno with $120M Series A
Startup will focus on immunotherapies.
December 08, 2013 - MARIE DAGHLIAN - Finance - Early-Stage Finance - Three Biotechs Secure Billion Dollar Partnerships
OncoMed, Molecular Partners, and Genmab could earn up to $6.3 billion if all the milestones are achieved.
December 06, 2013 - MARIE DAGHLIAN - Finance - Deals - Pharma Faces Shrinking Returns
from Innovation
Podcast: December 9, 2013
December 05, 2013 - Business - Drug Development - Lilly Discontinues Development of Experimental Drug for Major Depressive Disorder
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 05, 2013 - Business - Trials and Tribulations - FDA Warns 23andMe to Stop Selling its DNA Tests
Agency says the DTC genetic testing firm needs its approval to market its kit and service.
December 01, 2013 - MARIE DAGHLIAN - Law/Policy - Regulatory - Editas Medicine Launches with $43M in Funding
Biotech will use genome editing to develop new class of therapeutics.
November 30, 2013 - MARIE DAGHLIAN - Finance - Early-Stage Finance - Egalet Teams with Shionogi in $425M Deal
Partners will develop abuse-resistant pain pills.
November 29, 2013 - MARIE DAGHLIAN - Finance - Deals - Why Pharma Companies Are Looking More Like Biotechs
Podcast: December 2, 2013
November 28, 2013 - Business - Drug Development - Global Drug Spending to Reach $1 Trillion in 2014
Growth fueled by greater access by expanding middle class, improving economies.
November 24, 2013 - MARIE DAGHLIAN - Health - Drug Spending - FDA Approves First Next-Gen Sequencer as Diagnostic
Agency believes marketing authorization will speed up clinical use of genetic information.
November 22, 2013 - MARIE DAGHLIAN - Tech/Innovation - Personalized Medicine - Clovis Oncology Acquires Ethical Oncology Science for Up to $420M
Gains rights to targeted experimental cancer therapeutic lucitanib.
November 22, 2013 - MARIE DAGHLIAN - Business - Personalized Medicine - Royal DSM and JLL Create $2.6B CMO
Dutch food and chemicals company spins off pharma services unit into joint venture.
November 22, 2013 - MARIE DAGHLIAN - Business - Dealmaking - VCs Launch Two Biotechs Focused on the Gut
Flagship Ventures’ Seres Health will explore the microbiome while Avalon Ventures’ and GSK’s Sitera will tackle celiac disease.
November 22, 2013 - MARIE DAGHLIAN - Finance - Early-Stage Finance - Sanofi Discontinues Development of Fedratinib
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 22, 2013 - Business - Trials and Tribulations - A Common Ground for
Discussing Healthcare
Podcast: November 25, 2013
November 21, 2013 - Law/Policy - Healthcare Reform - Shire to Buy ViroPharma for $4.2B
Deal, the fourth acquisition for the company this year, boosts rare disease portfolio.
November 15, 2013 - MARIE DAGHLIAN - Business - Dealmaking - Sarepta Plummets after FDA says NDA Filing for Eteplirsen Premature
The weekly roundup of failed trials, missed targets, and other business mishaps.
November 15, 2013 - The Burrill Report - Business - Trials and Tribulations - Global Diabetes Pandemic Shows No Sign of Abating
A surge in the chronic condition hits every nation.
November 15, 2013 - MARIE DAGHLIAN - Health - Diabetes - FDA Gives OK for Imbruvica to Treat Rare Blood Cancer
Pharmacyclics’ and J&J;’s ibrutinib is second Breakthrough Therapy drug to gain approval.
November 15, 2013 - MARIE DAGHLIAN - Law/Policy - Regulatory - Life Sciences IPO Fever Cools
Tandem Diabetes Care and Relypsa go public, while several others postpone offerings.
November 15, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Immatics and Roche Sign Cancer Deal Worth Up to $1B
Strategic collaboration focuses on cancer vaccines and immunotherapies.
November 15, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Fixing a $30 Billion a Year
Healthcare Problem
Podcast: November 18, 2013
November 14, 2013 - Tech/Innovation - Global - Salix to pay $2.6B for Santaris
Deal strengthens its GI focus and gives it new colitis drug.
November 08, 2013 - MARIE DAGHLIAN - Finance - Deals - Robust Pace of Financings Continues
Companies raise $53B in first three quarters of 2013.
November 08, 2013 - MARIE DAGHLIAN - Finance - Deals - New Senate Bill Could Be Boon to Biotechs
Start-up Jobs and Innovation Act would stimulate R&D; investment at emerging growth companies.
November 08, 2013 - MARIE DAGHLIAN - Law/Policy - Regulatory - U.K. Caps Government Drug Spend
Pharmaceutical companies agree to cover remaining costs under new drug pricing deal.
November 08, 2013 - MARIE DAGHLIAN - Law/Policy - Drug Prices - Cytori Attracts Strategic Investment from Asia Partner
Podcast: November 11, 2013
November 07, 2013 - Business - Dealmaking - FDA Looks to Eliminate Trans Fats from Food
Agency says move could prevent thousands of heart attacks and deaths.
November 07, 2013 - MARIE DAGHLIAN - Health - Drug Delivery - Roche Enters Antibiotics Partnership with Polyphor
Deal worth up to $548M for experimental drug targeting superbugs.
November 05, 2013 - MARIE DAGHLIAN - Business - Partnering - Life Sciences Companies Up 41 Percent Since IPOs in 2013
Veracyte IPO brings the total to 45 new public companies so far this year, with another 17 in the queue.
November 01, 2013 - MARIE DAGHLIAN - Finance - Deals - Payers Target Rising Specialty Drug Spend
Strategies focus on creating patient-centered models to improve health and economic outcomes.
November 01, 2013 - MARIE DAGHLIAN - Health - Healthcare Delivery - Paying for Outcomes Extends to Drugs
Agreements can be difficult to administrate, but as payers refine efforts, simplified structures appear to have some staying power.
October 31, 2013 - DANIEL S. LEVINE - Business - Business Strategy - Why a Tiny Canadian Biotech Suddenly has Big Ambitions
Podcast: November 4, 2013
October 31, 2013 - Business - Drug Development - Mixed Results for Payer-Pharma Collaborations
HealthCore and Humana don’t see the same return on investment.
October 30, 2013 - SHERYL P. DENKER - Business - Drug Development - Employers Push Workers toward Healthier Choices
Companies control healthcare costs by changing employee behaviors with new tools.
October 30, 2013 - MICHAEL FITZHUGH - Health - Healthcare Economics - Study Finds Neglected Diseases Remain So
Report warns of a “fatal imbalance in medical R&D.;”
October 30, 2013 - DANIEL S. LEVINE - Health - Global Health - Customer Excellence: Business Model Innovation for MedTechs
Podcast: October 29, 2013
October 29, 2013 - Business - Sponsored Content - Glooko Awaits FDA Nod to Expand Diabetes Data Service
By making blood glucose data collection easier, company seeks to improve care management for diabetics.
October 25, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Get it on the Record
Indian Supreme Court orders recording of patient consent for new clinical trials.
October 25, 2013 - Law/Policy - Emerging Markets - Locking in Early-Stage Assets
Sideris Pharma launches with $32 million and potential acquirer.
October 25, 2013 - MARIE DAGHLIAN - Finance - Deals - Spark Therapeutics Launched with $50M to Advance Gene Therapy Trials
Children's Hospital of Philadelphia backs company to commercialize its technology.
October 24, 2013 - SHERYL P. DENKER - Finance - Spin-Outs - Why You Shouldn't Bank on Wall Street's Drug Forecasts
Podcast: October 28, 1013
October 24, 2013 - Business - Drug Sales - Epirus Biopharma to Develop Biosimilars in Brazil
Deal with Orygen Biotechnologia could earn the biotech up to $275 million.
October 24, 2013 - MARIE DAGHLIAN - Business - Emerging Markets - SEC Issues Proposed Crowdfunding Rules
Calls for $1 million limit in 12 month period for companies using process.
October 24, 2013 - Finance - Early-Stage Finance - The Most Common Genetic Mutation in Alzheimer’s Disease is Double Trouble
Findings help clear murky waters of drug discovery for Alzheimer’s therapeutics.
October 23, 2013 - SHERYL P. DENKER - Tech/Innovation - Neurodegeneration - IBM and Cleveland Clinic Put Watson to Work
Partners unveil new projects that put artificial intelligence to work in teaching and making sense of EMRs.
October 18, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Technology - Witty Calls on U.K. to Invest in Innovation through Universities
Report recommends government invest $1.6 billion in projects to boost economy and global competitiveness.
October 18, 2013 - DANIEL S. LEVINE - Tech/Innovation - Global - What the Surging IPO Market Means for Venture Investment
Podcast: October 21, 2013
October 17, 2013 - Finance - Venture Capital - AstraZeneca’s MedImmune Acquires Spirogen for Up to $440 Million
Deal adds antibody drug conjugate technology to an expanding oncology portfolio.
October 17, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - PureTech Ventures Teams with Non-Profit JDRF
Stakeholders seek new treatments for type 1 diabetes.
October 16, 2013 - SHERYL P. DENKER - Finance - Early-Stage Finance - E.U. Cancer Costs Differ Substantially Between Countries
Understanding allocation of funds for cancer could illuminate best steps to dealing with its toll, researchers suggest.
October 15, 2013 - MICHAEL FITZHUGH - Health - Cancer - St. Jude Medical Acquires NanoStim for at least $123.5M
Deal expands St. Jude portfolio with leadless pacemaker, just approved for use in Europe.
October 14, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - California Governor Vetoes Biosimilar Bill
With billions in potential savings at stake, battle continues state-by-state.
October 14, 2013 - MICHAEL FITZHUGH - Law/Policy - Legislation - Why Drug Development Is No Longer Just for Pharma
Podcast: October 14, 2013
October 11, 2013 - Tech/Innovation - Drug Development - New Drug and Device Reviews Still on Hold at FDA
While the agency funds ongoing reviews with user fees, negotiations continue on Capitol Hill.
October 11, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Green Shoots of Productivity
Early signs of improvement at Big Pharma, but too early to say problem solved.
October 10, 2013 - DANIEL S. LEVINE - Business - Business Development - German Watchdog Wants Trials Data Made Public
Reliable assessment of drugs is only possible with full access to clinical study reports, institute says.
October 10, 2013 - MICHAEL FITZHUGH - Law/Policy - Research - Diversify and De-risk
Sialix eyes a faster path to revenue.
October 10, 2013 - SHERYL P. DENKER - Business - Business Strategy - Clinical Trials Results Move the Market
Shares in Ariad, GTX, and Acadia Pharmaceuticals swing on clinical trial results.
October 10, 2013 - SHERYL P. DENKER - Business - Markets - LDR Holding Raises $75M in IPO
Maker of surgical implants for spinal disorders prices shares at midpoint of range.
October 09, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - UK Pursues Large-Scale Genomic Sequencing Project
Public-private effort will dive deep into data on rare diseases, cancers, and infectious diseases.
October 08, 2013 - MICHAEL FITZHUGH - Health - Genomics - Mitokyne Partners with Astellas in $730M Deal
R&D; collaboration will pursue mitochondria-related disease therapeutics.
October 08, 2013 - MARIE DAGHLIAN - Finance - Deals - Geisinger Allies with Genomics Researchers To Fight Liver Disease
Biopsy archive and sequencing power deliver results.
October 04, 2013 - SHERYL P. DENKER - Health - Diagnostics - Device Tax Foes Seize Opportunity in Budget Impasse
Bipartisan support exists for repeal, but only if it doesn't impede implementation of the Affordable Care Act.
October 04, 2013 - SHERYL P. DENKER - Law/Policy - Taxes - Big Data Comes to the Farm
Monsanto will pay $930 million for Climate Corp.’s weather-mining analytics and crop insurance services.
October 04, 2013 - MARIE DAGHLIAN - Tech/Innovation - Industrial Bio/Ag Bio - Princess Di, Faked Moon Landings, and the Denial of Science
Study finds people who believe in conspiracy theories more likely to reject science.
October 04, 2013 - DANIEL S. LEVINE - Law/Policy - Regulatory - Intrexon Invests in Consumer-Focused “Living Art” Company
BioPop creates products using microorganisms for toys, novelty items, paintings.
October 04, 2013 - MARIE DAGHLIAN - Finance - Deals - Wearable Health Tech Revenue Trends Toward $6B by 2018
Hot market is still fitness oriented, but lines are blurring as consumer demands evolve.
October 04, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Fate Therapeutics’ IPO Comes in Below Initial Target
Biotech slashes price, increases shares offered to raise $40.2M.
October 04, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Funding a Personalized Immunotherapy for MS
Podcast: October 7, 2013
October 03, 2013 - Business - Drug Development - What Winners Do to Beat the M&A; Odds
Podcast: October 2013
October 03, 2013 - Partner Content - Partner Content - Lilly Still Plans on Meeting 2014 Goals
Company faces challenges, but is banking on new approvals and cost cutting.
October 03, 2013 - DANIEL S. LEVINE - Business - Drug Sales - Merck Makes Global Cuts to Save $2.5B
Effort to slash operational expenses includes 8,500 job cuts.
October 03, 2013 - MICHAEL FITZHUGH - Business - Trials and Tribulations - The October 2013 Issue of
The Burrill Report
September 29, 2013 - The Burrill Report - Monthly - Lessons for the Newly Insured
What we can learn from Papa Smurf, a superfluous nose, and the unkindest cut of all.
September 27, 2013 - DANIEL S. LEVINE - Health - Drug Delivery - AbbVie Invests $45M in Expanded Galapagos Partnership
Global alliance diffuses development risks, shifts late-stage development costs to AbbVie.
September 27, 2013 - MICHAEL FITZHUGH - Business - Partnering - Separating a Boom from a Bubble
Podcast: September 30, 2013
September 26, 2013 - Finance - Capital Markets - Roche Teams with PacBio In Deal Worth Up To $75M
Next-gen DNA sequencing firm will develop systems for use in clinical diagnostics.
September 26, 2013 - MARIE DAGHLIAN - Business - Dealmaking - JPMorgan, Gates to Create Investment Fund for Late-Stage Global Health Technologies
Total of $94 million committed by group of investors to new fund.
September 26, 2013 - DANIEL S. LEVINE - Finance - Initial Public Offerings - Three Biotech IPOs Raise $298 M
Two of the offerings—Foundation Medicine and Ophthotech—price above range in upsized deals and rocket in market debut.
September 25, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - FDA Finalizes Mobile Medical Apps Guidance
Agency outlines current thinking, with big step toward narrowly tailored rules.
September 23, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Ablynx Scores $175M Upfront in Licensing Deal with AbbVie
Agreement for up to $840 million is focused on rheumatoid arthritis and systemic lupus.
September 23, 2013 - MARIE DAGHLIAN - Business - Dealmaking - Regado CEO sees IPO as a Success
Despite discounted offering, investors warm to biotech as it starts pivotal trial ahead of schedule.
September 20, 2013 - MARIE DAGHLIAN - Finance - Deals - Drug Ads Often Misleading
Study shows television commercials rife with opinion and lifestyle associations but short on factual claims.
September 19, 2013 - DANIEL S. LEVINE - Health - Public Health - Acceleron Prices Upsized IPO at Top of Range
Acceleron Pharma raised $84 million in the second life sciences initial public offering this week and continuing the surge for life sciences IPOs.
September 19, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Google Takes on Aging with Former CEO of Genentech
Long-term bet will pit technology against the ravages of aging.
September 19, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Aging - Building a Better Cancer Drug
Podcast: September 23, 2013
September 19, 2013 - Tech/Innovation - Global - From Field To Bench
Scientists at The Scripps Research Institute develop new approach to modify a long-used drug with potential to improve an entire class of cancer drugs.
September 19, 2013 - SHERYL P. DENKER - Tech/Innovation - Research - Five Prime Therapeutics IPO
Raises $62M
Biotech upsizes offering, prices within the range.
September 18, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Progress Against Cancer Tempered by Challenge
Aging population will send a swell of cases worldwide as advocates call for renewed federal funding efforts.
September 18, 2013 - DANIEL S. LEVINE - Health - Cancer - Teva and Cancer Research Technology Form R&D; Alliance
Partnership will focus on drugs that target cancer DNA damage response.
September 18, 2013 - MARIE DAGHLIAN - Business - Drug Development - CDC Issues Call to Arms on Drug-Resistant Bugs
Center ranks threats and proposes actions.
September 18, 2013 - MICHAEL FITZHUGH - Health - Drug Development - FDA Blocks Imports from Ranbaxy Facilities
Third time the generic drugmaker told its manufacturing fails to meet guidelines.
September 17, 2013 - SHERYL P. DENKER - Law/Policy - Regulatory - Long-Term Care Advisors See
More Work Ahead
With little time to solve tough problems, committee comes up short of financing solutions.
September 16, 2013 - MICHAEL FITZHUGH - Law/Policy - Aging - Paying Docs for Performance Improves Outcomes
Incentivized care program produced better results in comparison to traditional fee-for-service arrangement.
September 13, 2013 - DANIEL S. LEVINE - Health - Healthcare Outcomes - Theranos to Offer Lab Tests through Walgreens
Deal expands drugstore chain’s push to provide primary care services to consumers.
September 13, 2013 - DANIEL S. LEVINE - Business - Business Strategy - Lilly Brings $500M Arbitration Claim Against Canada
Action brought under NAFTA could have broad impacts on how intellectual property treaties are enforced.
September 13, 2013 - DANIEL S. LEVINE - Law/Policy - Patents - Developing Vaccines for the Deadliest Diseases
Podcast: September 16, 2013
September 12, 2013 - Tech/Innovation - Vaccines - Gilead Seeks Approval for its First Cancer Therapy
Company files new drug application for first in a new class of treatment for non-Hodgkin's lymphoma.
September 12, 2013 - MICHAEL FITZHUGH - Business - Drug Development OvaScience Tussles with FDA Over Trial
With regulatory status of experimental in-vitro fertilization product in questions, company seeks resolution.
September 12, 2013 - SHERYL P. DECKER - Law/Policy - Regulatory- Hospira Gains First Biosimilar Approval in EU
Therapeutic developed with Celltrion will compete with Remicade.
September 10, 2013 - MICHAEL FITZHUGH - Business - Biosimilars - Biogen Expands Antisense Bet with $100M Isis Deal
New long-term partnership deepens research ties and defines exclusive relationship.
September 10, 2013 - MICHAEL FITZHUGH - Business - Dealmaking - Otsuka Buys Astex for $886 Million
Drug discovery and development platform will support oncology pipeline expansion.
September 06, 2013 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - NIH Grants $20 Million to Sequence Infant Genomes
Projects will examine accuracy, usefulness, and ethical concerns of obtained genetic data.
September 06, 2013 - SHERYL P. DENKER - Health - Genomics - UltraGenyx Collaborates with Kyowa Hakko Kirin
Partners will develop antibody for rare bone disease.
September 06, 2013 - MARIE DAGHLIAN - Business - Partnering - Cytokinetics Heart Failure Drug Misses Mark
Amgen, exclusive licensor of the drug, is waiting for more data before advancing to late-stage trial.
September 05, 2013 - MICHAEL FITZHUGH - Business - Drug Development - Baxter and Coherus Collaborate on Biosimilars
Exclusive agreement is worth up to $246 million.
September 05, 2013 - DANIEL S. LEVINE - Business - Biosimilars - BioMérieux to Buy BioFire Diagnostics for $450 M
French diagnostic firm acquires U.S. maker of infectious disease diagnostics.
September 05, 2013 - MARIE DAGHLIAN - Business - Diagnostics - Bringing Personalized Medicine to Ovarian Cancer
Podcast: September 9, 2013
September 04, 2013 - Tech/Innovation - Personalized Medicine - Sangamo Makes Strategic Gene Therapy Buy
Podcast: September 2, 2013
August 31, 2013 - Finance - Mergers and Acquisitions - The September 2013 Issue of
The Burrill Report
August 30, 2013 - The Burrill Report - Monthly - Increased Longevity Comes at a Price
Study in mice suggests that the whole body ages differently than each individual organ.
August 30, 2013 - SHERYL P. DENKER - Health - Aging - Lilly and Humana Collaborate to Improve Outcomes
Evidence-based research will initially focus on type 2 diabetes.
August 30, 2013 - DANIEL S. LEVINE - Health - Healthcare Outcomes - AstraZeneca’s MedImmune to Buy Amplimmune for up to $500M
Deal will strengthen pharma’s cancer immunotherapy portfolio.
August 30, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - CIRM Tries to Be Friendlier to Business
Stem cell agency board approves changes to IP rules and plan for industry collaborations.
August 30, 2013 - DANIEL S. LEVINE - Law/Policy - Regenerative Medicine - California Law Could Constrain Biosimilar Substitutions
National battle is unfolding state-by-state, pitting payers against biotech innovators.
August 30, 2013 - MICHAEL FITZHUGH - Law/Policy - Generics and Biosimilars - J&J; Targets Dengue Fever
Janssen, University of Leuven, and the Wellcome Trust aim to stop sometimes deadly virus in its tracks.
August 30, 2013 - MARIE DAGHLIAN - Finance - Deals - Food for Thought
Lab-grown brains may provide a new understanding of neurological diseases and forestall the zombie apocalypse.
August 29, 2013 - DANIEL S. LEVINE - Tech/Innovation - Research - Australia Unveils $250M Medical Innovation Fund
Government responds to domestic call to back domestic research.
August 26, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Regenerative Medicine - Amgen to Acquire Onyx for $10.4 Billion
The $125 per share deal gives biotech giant multiple myeloma drug Kyprolis, strengthens oncology pipeline.
August 25, 2013 - DANIEL S. LEVINE - Finance - Mergers and Acquisitions - Immune Pharmaceuticals and EpiCept Combine
Israeli biotech takes reverse merger route to U.S. public listing.
August 23, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Building a Profitable Biotech
Adimab strikes deals with Celgene and Innovent.
August 23, 2013 - MARIE DAGHLIAN - Business - Business Development - Curing Cancer with the Wisdom and Money of Crowds
Podcast: August 26, 2013
August 22, 2013 - Tech/Innovation - Drug Development - Novartis Gains Third Breakthrough Designation
Experimental rare disease therapy positioned to address multiple indications.
August 22, 2013 - MICHAEL FITZHUGH - Business - Drug Development - St. Jude Medical Acquires Endosense for up to $331 million
Proprietary technology can improve safety and effectiveness of heart procedure.
August 22, 2013 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Employer-Sponsored Family Health Premiums Rise 4 Percent
Costs grow to an average of more than $16,000 per family as workers pay nearly $4,600.
August 22, 2013 - DANIEL S. LEVINE - Health - Healthcare Reform - TransCelerate Biopharma Launches Comparator Network
Direct purchase drug program will reduce counterfeits and save struggling research programs.
August 22, 2013 - SHERYL P. DENKER - Tech/Innovation - Clinical Trials - VCs Buy into Royalty Stream
Two firms partner with Royalty Pharma to share in potential revenue stream.
August 16, 2013 - MARIE DAGHLIAN - Finance - Deals - Seattle BioMed Receives $16.6M for TB Research
Funds will support collaboration between experts in infectious disease, engineering, and computer science.
August 16, 2013 - SHERYL P. DENKER - Health - Public Health - Early-Stage Funding Gets a Boost
BioMotiv and Torrey Pines partner to accelerate promising ideas toward proof-of-concept.
August 15, 2013 - MARIE DAGHLIAN - Finance - Early-Stage Finance - VC Exits Grow, But Funds Dwindle
Podcast: August 19, 2013
August 15, 2013 - Finance - Mergers and Acquisitions - FDA Backs “Organs-on-Chip” with $5.6 Million Grant
Harvard’s Wyss Institute will use funds to use microdevices to test effects of lethal radiation and possible therapies.
August 15, 2013 - DANIEL S. LEVINE - Tech/Innovation - Drug Development - Pharmstandard to Acquire Bever Pharmaceutical for $590M
Russian drugmaker will buy its Singaporean supplier ahead of spinning off its OTC business.
August 14, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - FDA Approves Viiv Healthcare’s New HIV Drug
Once-daily pill could improve patient compliance compared to twice-daily treatment regime.
August 13, 2013 - SHERYL P. DENKER - Business - Drug Development - Cloud-based Continuous Heart Monitor Wins CE Mark
WEB Biotech’s remote device approved for sale in Europe.
August 12, 2013 - MARIE DAGHLIAN - Tech/Innovation - Digital Health - Medtronic Buys Cardiocom for $200M
Deal will help medical device giant push beyond implants, deepen sales channel.
August 12, 2013 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Vical Suffers Drubbing After Late-Stage Failure
Company will focus resources on infectious disease vaccine program.
August 12, 2013 - DANIEL S. LEVINE - Business - Drug Development - Measuring Pharma Innovation
Podcast: August 12, 2013
August 09, 2013 - Tech/Innovation - Drug Development - Better to Burn Out than to Fade Away
Survey finds Americans don’t want to live decades longer.
August 09, 2013 - DANIEL S. LEVINE - Health - Aging - GE and UW Partner to Develop On-Demand Diagnostics
Paper-based device can be taken anywhere to diagnose infectious disease instantaneously.
August 09, 2013 - MARIE DAGHLIAN - Finance - Deals - Faster, Cheaper, Earlier Diabetes Test Gets $7M Boost
Freedom Meditech’s eye scan for diabetes promises to catch developing disease and reduced healthcare costs.
August 09, 2013 - SHERYL P. DENKER - Tech/Innovation - Diabetes - Array Cuts 20 Percent of Workforce
Decision comes at same time as Amgen terminates type 2 diabetes collaboration.
August 08, 2013 - MARIE DAGHLIAN - Business - Downsizing - Test Sees HIV Early, Fast
FDA approves rapid test for infection, hoping it will shorten time to diagnosis and care.
August 08, 2013 - MICHAEL FITZHUGH - Health - HIV/AIDS - GSK Launches $50M Fund Targeting Bioeletronics
First investment made in developer of implantable device for treating inflammatory disease.
August 08, 2013 - DANIEL S. LEVINE - Finance - Venture Capital - Top Health IT Coordinator Departing HHS
Mostashari says he’s leaving public service, but not what he’s doing next.
August 07, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Compugen Strikes $540M Cancer Pact with Bayer
Deal focuses on two novel immunotherapy targets discovered through Israeli biotech’s computational biology platform.
August 07, 2013 - MARIE DAGHLIAN - Business - Partnering - Novartis Breast Cancer Drug Fails Trial
Failure scrubs company’s hope of expanding Afinitor's use in common liver cancer.
August 07, 2013 - SHERYL P. DENKER - Business - Trials and Tribulations - FDA Updates ‘Plug-and-Play’ Standards
Medical device makers get new guidelines to making devices work better together.
August 07, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Intrexon Surges 54.6 Percent on IPO Debut
Synthetic biology company prices upsized offering at top of target range.
August 07, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - One Served
A lab-grown burger that posits a biotech revolution at the meat counter.
August 06, 2013 - DANIEL S. LEVINE - Tech/Innovation - Global - Duane Roth, California Industry Leader, dies at 63
Biking accident cuts short life of Connect CEO and CIRM vice chairman.
August 04, 2013 - DANIEL S. LEVINE - Business - Economic Development - California to Create Network of Stem Cell Clinics for Trials
Podcast: August 5, 2013
August 02, 2013 - Law/Policy - Regenerative Medicine - Summer Heatwave for IPOs
Month bolstered by biggest week for new life sciences issues in 13 years as sector’s offerings outpace IPOs in all other categories.
August 02, 2013 - Finance - Initial Public Offerings - When Cancer Is Not Cancer
NCI group recommends ways to reduce disease’s burden.
August 02, 2013 - SHERYL P. DENKER - Health - Cancer - Cubist to Buy Optimer and Trius for more than $1.6 billion
Deals strengthen Cubist's position in acute care market.
August 02, 2013 - Finance - Deals - Sequestration Cuts $4M From Long-term Heart Disease Study
The weekly round-up of failed trials, missed targets, and other business mishaps.
August 02, 2013 - Business - Trials and Tribulations - Pfizer Pays $491 Million in Off-label Marketing Settlement
Settlement ends two lawsuits for illegal promotion of drug to prevent rejection of kidney transplants.
July 31, 2013 - SHERYL P. DENKER - Business - Trials and Tribulations - Celgene Takes $100M Option on Acetylon
Three-drug deal sets up shareholders for potential $1.1 billion payout over time.
July 30, 2013 - MICHAEL FITZHUGH - Finance - Deals - Pfizer Chases Rejuvenation with Reorg
In three-way split, company hopes to optimize operations, agility, and sales.
July 29, 2013 - MICHAEL FITZHUGH - Business - Business Strategy - Perrigo to Acquire Elan in $8.6 Billion Deal
Over-the-counter drugmaker gains platform for international expansion, tax advantages.
July 29, 2013 - DANIEL S. LEVINE - Finance - Mergers and Acquisitions - Telegraph Hill Partners Raises $310 Million Fund
Firm will invests in commercial-stage life science, medical technology, and healthcare companies.
July 29, 2013 - Finance - Venture Capital - GSK Says China Scandal Will Impact Earnings
With 18 employees arrested, company says it is cooperating with investigation.
July 27, 2013 - MICHAEL FITZHUGH - Business - Markets - Researchers Identify New Drug Target for Parkinson’s Disease
Cell survival protein implicated in blood cell cancer also plays a role in neurons.
July 26, 2013 - SHERYL P. DENKER - Tech/Innovation - Research - GSK Reaches $229 Million Settlment with Eight States
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 26, 2013 - Business - Trials and Tribulations - Adimab Licenses Technology to GSK and Biogen Idec
After a string of pharma partnerships, the deals are the biotech’s first licensing agreements.
July 26, 2013 - MARIE DAGHLIAN - Finance - Deals - Industry Groups Outline Principles for Transparency
Advocates of clinical trials data sharing blast proposal as “window dressing.”
July 26, 2013 - DANIEL S. LEVINE - Law/Policy - Regulatory - Five Biotech IPOs Debut in Busy Week
Total of 20 initial public offerings in the sector completed in past three months.
July 26, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - A Measles Outbreak, Vaccination, and the Persistence of Fear
Podcast: July 25, 2013
July 25, 2013 - Health - Vaccines - The August 2013 Issue of
The Burrill Report
July 25, 2013 - The Burrill Report - Monthly - Venture Capital Dollars Move Back to Biotech
Funding for privately held healthcare biotechs up 38.7 percent in first half of 2013.
July 25, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings South Korea Promises $9B for New Drugs
Government pushes drugmakers to ramp up R&D; with cash and other incentives.
July 25, 2013 - MICHAEL FITZHUGH - Law/Policy - Economic Development- Gene Therapy Startup Audentes Therapeutics Raises $30M
Biotech is focused on treatments for rare but debilitating muscle diseases.
July 20, 2013 - SHERYL P. DENKER - Finance - Early-Stage Finance - Biotech Sizzles in Public Markets
Investors flock not only to IPOs, but to follow-on offerings as well.
July 19, 2013 - MARIE DAGHLIAN - Finance - Deals - Avastin As Good As Lucentis for Wet AMD at a Tenth of the Price
Researchers say UK’s National Health Service could save $129 million a year from switching.
July 19, 2013 - DANIEL S. LEVINE - Law/Policy - Comparative Effectiveness - Symplmed Sees Value in Being Direct
Podcast: July 22, 2013
July 18, 2013 - Business - Business Strategy - National Institute of Health Cancels Clinical Trials in India
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 18, 2013 - Business - Trials and Tribulations - Researchers Gain Understanding of Obesity Gene
One mutation affects both food intake and feeling of satisfaction after eating.
July 17, 2013 - SHERYL P. DENKER - Health - Obesity - Ayasdi Raises $30.6 million for Big Data Platform
Funding will be used to speed the discovery of insights from complex information in seconds.
July 17, 2013 - MARIE DAGHLIAN - Finance - Venture Capital - National Cancer Institute Opens Database of Genetic Variation of Cancer
Catalog is largest of its kind and expected to help researchers understand drug response and resistance.
July 17, 2013 - DANIEL S. LEVINE - Tech/Innovation - Cancer - Ipsen Acquires Syntaxin, Strikes R&D; Deal with Harvard
French pharma targets Botulinum toxin for therapeutic candidates.
July 17, 2013 - MARIE DAGHLIAN - Business - Dealmaking - Crescendo Personalizes Rheumatoid Arthritis Disease Management
Podcast: July15, 2013
July 12, 2013 - Business - Personalized Medicine - Bio-based Industries to Get $5 Billion Boost from European Commission
EU Initiative is part of $28.7 billion investment to create high-tech jobs and growth over next seven years.
July 12, 2013 - MARIE DAGHLIAN - Law/Policy - Economic Development - China Arrests GSK Employees for Alleged Bribery and Tax Violations
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 12, 2013 - Business - Trials and Tribulations - Loxo Oncology Strikes $434 M Cancer Deal with Array BioPharma
Collaboration focuses on small molecule therapies for genetically defined patient populations.
July 12, 2013 - MARIE DAGHLIAN - Finance - Deals - Fighting the Flu without Vaccines
Systems biology approach points to drug targets for influenza.
July 12, 2013 - SHERYL P. DENKER - Health - Drug Development - FDA Plans to Give Generic Drugmakers Power to Change Labels
Consumer advocates hail move that could improve safety for patients and create liability for companies.
July 11, 2013 - DANIEL S. LEVINE - Law/Policy - Regulatory - Italian Pharma Backs UniQure’s Gene Therapy
Rights deal will cover Glybera development costs, fuel progress on pipeline.
July 11, 2013 - MICHAEL FITZHUGH - Finance - Deals - Forma Therapeutics Teams with Cancer Research Technology
Deal is part of broader translational medicine initiative based on company’s asset discovery and development company model.
July 11, 2013 - MARIE DAGHLIAN - Business - Drug Development - Senate Seeks to Grow NIH Budget for Fiscal 2014
Expanded spending plan could ease some sequester-driven cuts.
July 10, 2013 - MICHAEL FITZHUGH - Law/Policy - Research - Novartis Strikes Vaccines Deal with Biological E
Through WHO, companies target typhoid and paratyphoid in emerging markets.
July 09, 2013 - MICHAEL FITZHUGH - Business - Finance - Immunocore Signs Deal with GSK Potentially Worth More Than $500M
Research and licensing agreement advances unique T cell receptor-based therapies.
July 09, 2013 - SHERYL P. DENKER - Business - Drug Development - Will Harlem Be the Next Hotspot for Innovation?
Podcast: July 8, 2013
July 08, 2013 - Business - Economic Development - Cardio3 BioSciences Goes Public
Belgian biotech’s IPO brings to 30 the number of completed life sciences initial public offerings so far in 2013.
July 05, 2013 - MARIE DAGHLIAN - Finance - Deals - California Life Sciences Companies Lead in Venture Financings
Golden State startups account for 38 percent of total raised in first half of 2013.
July 05, 2013 - MARIE DAGHLIAN - Finance - Venture Capital - SEC Investigates Call Options Trading of Onyx Pharmaceuticals Stock
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 05, 2013 - Business - Trials and Tribulations - Biogen licenses Myelin Repair Foundation Tech in Fight Against MS
MRF mouse model provides unique characteristics for development of wide range of therapeutics.
July 03, 2013 - MARIE DAGHLIAN - Tech/Innovation - Neurodegeneration - Genentech Strikes Immunotherapy Deal with Immunocore
Biotech’s platform generates modified T-cell receptors as drugs that target cancer and viral infection.
July 03, 2013 - SHERYL P. DENKER - Business - Drug Development - FDA Gives Antibacterial Drug Developers New Guidance
To address growing drug resistance, agency seeks new mechanisms of action, ability to neutralize resistance.
July 03, 2013 - MICHAEL FITZHUGH - Health - Drug Development - Eisai Suspends Sales of Anti-epileptic Drug Fycompa In Germany
Japanese drugmaker says assessment falls short of recognizing its product's value.
July 02, 2013 - MICHAEL FITZHUGH - Law/Policy - Value Based Pricing - Unique Treatment for Type 1 Diabetes Shows Promise
Novel reverse DNA vaccine improves pancreas function.
July 02, 2013 - SHERYL P. DENKER - Tech/Innovation - Diabetes - SECA Presntation
June 29, 2013 - The Burrill Report - Monthly Returning to Growth
Podcast: July 1, 2013
June 28, 2013 - Business - Drug Development- The July 2013 Issue of
The Burrill Report
June 28, 2013 - The Burrill Report - Monthly - Biggest Advancers and Decliners First Half of 2013
Life sciences stocks that began the year with a minimum price of $1 per share.
June 28, 2013 - Data Center - Data Center - IPO Performance First Half of 2013
Life sciences companies that completed intial public offerings through June 28.
June 28, 2013 - Data Center - Data Center - Viehbacher Threatens to Cut Sanofi R&D; Spending in Europe
CEO says pessure to open trials data and lower drug prices will push drugmakers to seek more business-friendly environments.
June 28, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Resverlogix Tanks Following Failure of Lead Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 28, 2013 - Business - Trials and Tribulations - Prosensa IPO Hits the Market Running
Offering tops busy week with four life sciences issues debuting on the Nasdaq.
June 28, 2013 - MARIE DAGHLIAN - Finance - Deals - Astellas Provides New Muscle to Cytokinetics with Collaboration
Deal worth up to $490 million.
June 28, 2013 - SHERYL P. DENKER - Business - Dealmaking - Monsanto Taps Nimbus Discovery in Crop Protection Pact
Companies will collaborate to develop novel fungicides.
June 28, 2013 - MARIE DAGHLIAN - Tech/Innovation - Industrial Bio/Ag Bio - Decision Misprision
SCOTUS ruling a set back to addressing quality concerns in generic drugs.
June 28, 2013 - PETER J. PITTS - Law/Policy - Commentary - Roche and AstraZeneca to Share Early-Stage Data
Consortium is latest effort among pharmaceutical companies to cut development costs through cooperation.
June 27, 2013 - DANIEL S. LEVINE - Business - Drug Development - Sandoz Advances Enbrel Biosimilar
Drug company lays the groundwork for seeking approval from U.S. and E.U. regulators.
June 26, 2013 - MICHAEL FITZHUGH - Business - Drug Development - SCOTUS Decision Limits Liability for Generic Drugmakers
Court in 5-4 decision says these companies can’t be held responsible for design defects.
June 26, 2013 - DANIEL S. LEVINE - Law/Policy - Court Rulings - How Innovative Have Drugmakers Really Been?
Podcast: June 24, 2013
June 21, 2013 - Business - Drug Development - Bluebird Bio Soars in Market Debut
Gene therapy biotech upsizes IPO and prices above target range.
June 21, 2013 - MARIE DAGHLIAN - Finance - Deals - Illumina Ordered to Pay $115 Million Plus Interest For Patent Infringement
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 21, 2013 - Business - Trials and Tribulations - Improper Use of Drugs Wastes More than $200 Billion a Year
Avoidable cost enough to insure 24 Million people.
June 21, 2013 - SHERYL P. DENKER - Health - Medical Practice - Breakthrough Therapies
Experimental therapies granted breakthrough designation status from the U.S. Food and Drug Administration.
June 21, 2013 - Law/Policy - Regulatory - SCOTUS Rules Pay-For-Delay Settlements Can Violate Antitrust Laws
Orders lower court to allow FTC to proceed with case.
June 19, 2013 - DANIEL S. LEVINE - Law/Policy - Patents - EU Commission Fines Drugmakers $194M Over Pay-for-Delay
Lundbeck agreement on antidepressant called anticompetitive.
June 19, 2013 - MICHAEL FITZHUGH - Law/Policy - Drug Prices - NGM Partners with MedImmune
Companies will work together to discover new treatments for diabetes and obesity.
June 19, 2013 - MARIE DAGHLIAN - Business - Dealmaking - NIH Expands Repurposing Efforts with New Grants
Institute awards $12.7 million total to nine academic groups.
June 18, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Drug Development - AMA Says Obesity Is a Disease
Vote at annual convention overrides committee recommendation
June 18, 2013 - DANIEL S. LEVINE - Health - Obesity - J&J; Bets up to $1 Billion in Aragon Buy
Prostate cancer therapy sold while breast cancer therapy is spun into new company.
June 17, 2013 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Elan Shareholders Vote to Nix Royalty Pharma Takeover
Share buyback plan approved, but $1 billion Theravance royalty stream buy rejected.
June 17, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Cigna Deal Bulks up Catamaran's Muscle
Podcast: June 17, 2013
June 14, 2013 - Business - Dealmaking - Amgen Invests $25 Million to Expand Cytokinetics Agreement
Deal includes $10 million equity purchase.
June 14, 2013 - DANIEL S. LEVINE - Finance - Deals - Pfizer Reaches $2.15B Patent Dispute with Teva and Sun
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 14, 2013 - Business - Trials and Tribulations - Cocktail of Generics as Good as Enbrel for Rheumatoid Arthritis
Study compared combination of disease-modifying anti-rheumatic drugs and methotrexate against high-priced biologic.
June 13, 2013 - DANIEL S. LEVINE - Health - Comparative Effectiveness - SCOTUS Rules Genes Can’t Be Patented
Decision upholds parts of Myriad’s Patents
June 13, 2013 - DANIEL S. LEVINE - Law/Policy - Patents - G8 Science Ministers Spotlight Antibiotics Resistance
Group commits to greater cooperation and research to combat growing problem.
June 13, 2013 - MICHAEL FITZHUGH - Health - Public Health - U.S. Enjoys a Near $1 Trillion Payoff from Human Genome Project
Report says government’s investment continues to produce significant economic returns.
June 12, 2013 - DANIEL S. LEVINE - Tech/Innovation - Genomics - AstraZeneca to Buy Pearl for up to $1.15B
Deal will strengthen pharma’s respiratory portfolio.
June 11, 2013 - MARIE DAGHLIAN - Business - Dealmaking - BioLineRx Partners with Chinese Pharma on Hepatitis C Drug
Deal reflects strategic approach to sharing development and commercialization risks.
June 11, 2013 - MICHAEL FITZHUGH - Finance - Deals - GE Healthcare to Invest $2 Billion in Software Development over Five Years
Plan seeks to create common platform to improve efficiency and care.
June 11, 2013 - MICHAEL FITZHUGH - Business - Digital Health - Burrill & Company Indices
June 10, 2013 - Indices - Burrill Indices - Sourcing Innovation
Podcast: June 10, 2013
June 07, 2013 - Tech/Innovation - Drug Development - Maxygen to Dissolve
Without options for its sole product, board says best decision is to distribute cash to shareholders.
June 07, 2013 - MICHAEL FITZHUGH - Business - Downsizing - Pfizer Taps CytomX’s ADC Technology in Cancer
Biotech’s probodies are activated in tumor tissue but remain inert in healthy tissue.
June 07, 2013 - MARIE DAGHLIAN - Finance - Deals - Supreme Court Backs DNA Collection in Arrests
Cheek swabs and addition to a national DNA database will become common, Scalia warns.
June 07, 2013 - MICHAEL FITZHUGH - Law/Policy - Court Rulings - International Alliance Seeks to Share Genomic and Clinical Data
Groups hope to seize “extraordinary opportunity” and avoid balkanization of information.
June 07, 2013 - DANIEL S. LEVINE - Tech/Innovation - Genetics - Sanofi’s Possible PARP-1 Inhibitor Fails Late-Stage Trial
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 07, 2013 - Business - Trials and Tribulations - New Class of Antibiotics on the Horizon
At least one compound identified that interferes with protein synthesis quality control.
June 06, 2013 - SHERYL P. DENKER - Health - Drug Development - Bill Gates Leads Investment in Open Science Initiative
ResearchGate Raises total of $35 Million for Social Network for researchers.
June 05, 2013 - MARIE DAGHLIAN - Finance - Research and Development - AstraZeneca Ends Development of
Rigel's RA Drug
Termination is a blow to biotech with no other near-term pipeline candidates.
June 05, 2013 - MARIE DAGHLIAN - Business - Drug Development - With ASCO Underway, Cancer Results in the News
A list of trial news updated throughout the conference.
June 04, 2013 - THE BURRILL REPORT STAFF - Business - Drug Development - GSK Licenses MorphoSys Anti-Inflammatory for $29.4 Million
CEO calls transaction a “major milestone” for the company.
June 03, 2013 - MICHAEL FITZHUGH - Business - Drug Development - Epizyme Offering Makes May Biggest Month for Biotech IPOs in 13 Years
Eight companies debut as queue grows to 17.
May 31, 2013 - DANIEL S. LEVINE - Finance - Initial Public Offerings - Valeant Buys Bausch + Lomb for $8.7 Billion
Deal provides Valeant with global brand, low reimbursement risk.
May 31, 2013 - MICHAEL FITZHUGH - Business - Dealmaking - QB3 Lands More Big Pharma Muscle to Launch Startups
Podcast: June 3, 2013
May 31, 2013 - Tech/Innovation - Funding Innovation - Biomarker For Pancreatic Cancer Identified
Modification of routine endoscopy procedure could transform patient outcomes.
May 31, 2013 - SHERYL P. DENKER - Health - Diagnostics - CIRM Chief to Seek Funding for Stem Cell Clinics
Trounson will ask board for $70 million to create network of sites for trials and treatments.
May 31, 2013 - DANIEL S. LEVINE - Law/Policy - Regenerative Medicine - Ophthotech Raises $175 million for Eye Therapy
Money will be used to fund late-stage combo trial of its investigational anti-VEGF therapy.
May 31, 2013 - MARIE DAGHLIAN - Finance - Deals - AstraZeneca Snaps Up Omthera for as Much as $443 Million
Specialty pharma’s prize is late-stage lipid lowering therapy that may be offered in combination with the statin Crestor.
May 31, 2013 - MARIE DAGHLIAN - Business - Dealmaking - GSK Preps Next-Generation Vaccines with $325M Okairos Acquisition
Genetic Technology shows promise for both protection and treatment.
May 31, 2013 - MICHAEL FITZHUGH - Business - Dealmaking - The June 2013 Issue of
The Burrill Report
May 30, 2013 - The Burrill Report - Monthly - Amgen Allies with Astellas in Japan
Deal positions partners for long-haul collaboration, with Amgen taking full control in 2020.
May 30, 2013 - MICHAEL FITZHUGH - Business - Drug Development - Allon Therapeutics, Satori Pharmaceuticals, and Predictive Biosciences to Close Shop
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 30, 2013 - Business - Trials and Tribulations - Actavis Buys Warner Chilcott
Combination will create a tax-advantaged global specialty pharma.
May 24, 2013 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Gates Foundation Helps Repurpose Exubera Technology
Monash Institute of Pharmaceutical Sciences receives more than $1 million for drug delivery development.
May 24, 2013 - SHERYL P. DENKER - Tech/Innovation - Drug Delivery - Industry Advocates Ally to Lobby for Tax Reforms
New group draws together BIO, AdvaMed, and others seeking tax code changes.
May 24, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Elan Strikes More Deals, Rejects Sweetened Royalty Pharma Bid
Pharma moves to acquire two companies, spin out a program, and issue debt.
May 24, 2013 - MARIE DAGHLIAN - Finance - Deals - What Wall Street's Watching at ASCO
Podcast: May 28, 2013
May 23, 2013 - Business - Drug Development - Stem Cell Policy Group Folds Tent
Coalition for the Advancement of Medical Research transfers mission and assets to Alliance for Regenerative Medicine.
May 23, 2013 - DANIEL S. LEVINE - Law/Policy - Regenerative Medicine - GSK and BARDA Collaborate to Develop New Antibiotics
The $200M deal seeks to create a pipeline of new drugs.
May 23, 2013 - MARIE DAGHLIAN - Business - Partnering - Pfizer Drug Fails Three Late-stage Trials
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 22, 2013 - Business - Trials and Tribulations - Obama Administration Offers $1 Billion for Healthcare Innovation
HHS awards designed to transform delivery and payment systems.
May 17, 2013 - DANIEL S. LEVINE - Law/Policy - Innovation - Pharma to Support Early-Stage Biotechs
Roche and Bayer team with QB3 while Atlas Ventures rounds up Amgen and Novartis.
May 17, 2013 - MARIE DAGHLIAN - Finance - Deals - Scientists Report Human Stem Cell Cloning Success
Caffeine and healthy cytoplasm promote growth following nuclear transfer.
May 17, 2013 - SHERYL P. DENKER - Tech/Innovation - Stem Cells - Supreme Court Rules Unanimously in Favor of Monsanto
Judges find Indiana farmer violated company’s patent when he reproduced its biotech seed.
May 16, 2013 - MARIE DAGHLIAN - Law/Policy - Court Rulings Saving Normal
Podcast: May 20, 2013
May 16, 2013 - Health - Mental Health- AbbVie Options Alvine Celiac Drug for $70 Million
Collaboration could broaden pharma’s autoimmune pipeline.
May 15, 2013 - MICHAEL FITZHUGH - Business - Dealmaking - Elan Buys Stake in Theravance Royalties on Drugs
Deal gives Irish company a 21 percent stake in future payments associated with four respiratory programs.
May 15, 2013 - DANIEL S. LEVINE - Finance - Business Models - Carmat to Implant its Artificial Heart in Human Patients
First use of bioprosthetic will take place in four countries.
May 15, 2013 - MARIE DAGHLIAN - Tech/Innovation - Medical Devices - Lack of Intestinal Bacteria Linked to Obesity
Mice fed a mucus-loving microbe lost weight.
May 15, 2013 - SHERYL P. DENKER - Tech/Innovation - Obesity - Astellas to Consolidate R&D;
Japanese pharma plans to outsource some functions while bringing others closer to its headquarters.
May 15, 2013 - MICHAEL FITZHUGH - Business - Business Strategy - Drug Recalls Up Over Last Year
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 15, 2013 - Business - Trials and Tribulations - Synthetic Bio Research Courted with $20 Million Call
European group seeks to strengthen research community and create sustainable advancements.
May 14, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Funding Innovation - Readmission Rates in Europe
Using remote monitoring to contain costs
May 13, 2013 - White Paper - White Paper - U.S. Trade Representative Puts Focus on Indian IP Issues
Following a challenging year for Big Pharma, U.S. urges India to protect innovators.
May 10, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - First Tracheal Implant Performed in the United States
Advances in stem cells and tissue scaffolds bring bioengineered windpipe to the youngest patient ever.
May 10, 2013 - SHERYL P. DENKER - Tech/Innovation - Regenerative Medicine - Already an Internet Favorite, Pfizer Takes Viagra Sales Online
Move intended to combat sites that peddle counterfeit versions of the drug.
May 10, 2013 - DANIEL S. LEVINE - Business - Business Strategy - Lilly’s Late-Stage Lymphoma Drug Fails
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 10, 2013 - Business - Trials and Tribulations - Patent Expirations Help Cut Drug Spending in 2012
The 3.5 percent decline is first drop ever.
May 10, 2013 - DANIEL S. LEVINE - Business - Drug Sales - Baxter Alzheimer’s Late-Stage Candidate Fails
Company will complete analysis of data, but won’t continue development.
May 10, 2013 - MICHAEL FITZHUGH - Business - Drug Development - Florida Eases the Way for Biosimilars
State-by-state, legislators are considering balance between ease of access and safety.
May 10, 2013 - MICHAEL FITZHUGH - Law/Policy - Generics and Biosimilars - Life Sciences IPOs Accelerate
Quintiles upsizes offering to $947 million.
May 10, 2013 - MARIE DAGHLIAN - Finance - Deals - What Transparency Means for Healthcare
Podcast: May 13, 2013
May 09, 2013 - Law/Policy - Healthcare Reform - Healthcare Spending Projections May Be Overstated by $770B
Health Affairs study suggests structural rather than cyclical changes cutting long-term growth in spending.
May 07, 2013 - DANIEL S. LEVINE - Health - Healthcare Economics - Celgene Strikes A Deal with Concert
Big Biotech’s $300 million tie up with Concert Pharmaceuticals is the fourth such deal in past two months.
May 07, 2013 - MARIE DAGHLIAN - Business - Dealmaking - Spate of Life Science IPOs Ready to Debut
Quintiles $750 million offering could cap a busy week.
May 07, 2013 - DANIEL S. LEVINE - Finance - Initial Public Offerings - Why Gene Therapy Is Coming of Age
Podcast: May 6, 2013
May 04, 2013 - Business - Interview - Aveo and Astellas Trial Fails to Impress Advisory Panel
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 03, 2013 - Business - Trials and Tribulations - European Court Enjoins EMA from Releasing AbbVie, InterMune Data
Decision heats up the battle over pharmaceutical data transparency.
May 03, 2013 - DANIEL S. LEVINE - Law/Policy - Litigation - Ambrx Strikes Deal with Bristol-Myers for ADC Technology
Biotech’s new agreement is third collaboration in less than three years.
May 03, 2013 - MARIE DAGHLIAN - Finance - Deals - Capital Royalty Raises $805 Million Fund
Firm says investible capital to exceed $1 billion in fund.
May 03, 2013 - DANIEL S. LEVINE - Finance - Investment Funds - New Hormone Holds Promise for Diabetics
Academic-industry partnership advances method for increasing body’s insulin production.
May 03, 2013 - SHERYL P. DENKER - Tech/Innovation - Diabetes - The May 2013 Issue of
The Burrill Report
May 03, 2013 - The Burrill Report - Monthly - Natera Lands $54.6 Million to Tranform Pre-Natal Testing
Company will use funds to advance roll-out of low-risk genetic test.
May 03, 2013 - SHERYL P. DENKER - Finance - Venture Capital - Atlas Ventures Closes $265 Million Fund
Latest in a string of venture funds focused on seed and early-stage biotechs.
May 03, 2013 - DANIEL S. LEVINE - Finance - Investment Funds - Merck and Pfizer Collaborate on Diabetes Drug
Global agreement ties partners together in march toward late-stage trials.
May 03, 2013 - MICHAEL FITZHUGH - Business - Drug Development - Regulus CEO Praises JOBS Act
Despite weak debut, Xanthopoulos sees big benefits in new law.
May 03, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Bill Would Require Labels for Genetically Engineered Foods
First such legislation introduced in Senate in more than a dozen years.
April 26, 2013 - DANIEL S. LEVINE - Law/Policy - Legislation - Global Biotech Survey Highlights Romania, United Arab Emirates
Scientific American Worldview scores national progress on biotech innovation.
April 26, 2013 - SHERYL P. DENKER - Tech/Innovation - Global - AstraZeneca Makes a String of Early-Stage Deals
Patent losses took a toll on the company’s first quarter earnings.
April 26, 2013 - DANIEL S. LEVINE - Business - Dealmaking - Vaccine Makers Face Global Challenges
In race to meet public health goals, much is left to resolve.
April 26, 2013 - MICHAEL FITZHUGH - Health - Vaccines - Novartis Faces Federal Claims of Kickbacks in Civil Court
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 26, 2013 - Business - Trials and Tribulations - Theravance Splitting in Two
Intention is to maximize value by separating its drug discovery and late-stage partnered pipeline.
April 26, 2013 - MARIE DAGHLIAN - Business - Business Strategy - Ocera Therapeutics Going Public in Merger with Tranzyme
Deal includes $20 million PIPE financing from Ocera’s backers.
April 26, 2013 - MARIE DAGHLIAN - Finance - Deals - GSK Teams with Avalon to Fund San Diego Biotechs
Pharma partners with venture capital to launch up to ten early-stage life companies.
April 26, 2013 - MARIE DAGHLIAN - Finance - Early-Stage Finance - Doctors Worldwide Call for Lower Cancer Drug Prices
Costs topping $100,000 for chronic myeloid leukemia called unsustainable, profiteering charged.
April 25, 2013 - MICHAEL FITZHUGH - Law/Policy - Drug Prices - Why Biotechs Need to Adapt to the Value-Based World
Podcast: April 29, 2013
April 23, 2013 - Business - Drug Development - FDA Won’t Approve Generic Oxycontin
Decision signals agency’s intention to insist on abuse-resistant forms of drug.
April 19, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Thermo Fisher Acquires Life Tech for $13.6B
Strategic buyer beats out private equity consortium to become leading life sciences tools and technology provider.
April 19, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Supreme Court Hears Oral Arguments in Myriad case
Justices search for balance.
April 19, 2013 - DANIEL S. LEVINE - Law/Policy - Patents - Royalty Pharma Moves to Acquire Elan
Deal in jeopardy as drugmaker goes ahead with $1 billion return to shareholders.
April 19, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Incentives Reward Surgical Complications
Hospitals and patients have conflicting interests when it comes to avoiding surgical complications.
April 19, 2013 - SHERYL P. DENKER - Health - Healthcare Economics - Allecra Debuts with $19.5 Million in Funding
New company is focused on antibiotics for multi-drug-resistant infections.
April 19, 2013 - MARIE DAGHLIAN - Finance - Deals - Back to that Same Old Place
Podcast: April 22, 2013
April 18, 2013 - Business - BIO International Convention - U.S. Regulators Lag European Counterparts in Protecting Patients, Report Says
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 18, 2013 - Business - Trials and Tribulations - Celltrion Drops Late-Stage Trial of Roche Rituxan Drug Copy
Founder seeks to sell his holdings.
April 18, 2013 - DANIEL S. LEVINE - Business - Biosimilars - Chimerix and Omthera Go Public in Upsized Offerings
One company prices in its target range, the other at a significant discount.
April 12, 2013 - MARIE DAGHLIAN - Finance - Deals - Obama Budget Raises Ire of PhRMA, BIO
Trade groups blast proposal as harmful to innovation, job growth, and patients.
April 11, 2013 - DANIEL S. LEVINE - Law/Policy - Legislation - Seeking Drug Savings, But Risking Safety
Study illuminates ways in which Americans are trimming their prescription drug costs.
April 11, 2013 - MICHAEL FITZHUGH - Health - Public Health - Precision Medicine Meets Antibiotics
Podcast: April 15, 2013
April 11, 2013 - Health - Infectious Disease - GSK Offers $1 Million Prize for Brain Breakthroughs
Competition seeks to uncover new techniques and device-based brain therapies.
April 11, 2013 - SHERYL P. DENKER - Health - Innovation - VistaGen Secures $36 Million
European investor provides funds to accelerate drug rescue programs.
April 10, 2013 - DANIEL S. LEVINE - Finance - Research and Development - Gene Mutation Could Direct Prostate Cancer Care
Carrying a BRCA2 mutation indicates poor survival for men with prostate cancer.
April 10, 2013 - SHERYL P. DENKER - Tech/Innovation - Personalized Medicine - Inovio and U.S. Army Receive $3.5 Million Biodefense Grant
Money will be used to advance electroporation delivery platform for multiple vaccines.
April 10, 2013 - MARIE DAGHLIAN - Health - Drug Delivery - Practice Makes Perfect
Surgeons use personalized organ model to improve patient outcomes.
April 10, 2013 - SHERYL P. DENKER - Tech/Innovation - Technology - GSK Trial Shows Encouraging Results for Duchenne MD
Exon-skipping technology moves ahead after mid-stage study validation.
April 10, 2013 - MICHAEL FITZHUGH - Business - Drug Development - Lilly Seeks Savings in Salesforce Cuts
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 10, 2013 - Business - Trials and Tribulations - GSK Strikes Emerging Markets Deal with A*STAR
Singapore-based institute looks to sharpen scientific edge with partnership.
April 09, 2013 - MICHAEL FITZHUGH - Business - Emerging Markets - The JOBS Act One Year Later
Podcast: April 8, 2013
April 08, 2013 - Law/Policy - Capital Markets - Bristol-Myers Replacing R&D; Chief
Fighting patent expirations, Inhibitex loss, challenges await new chief.
April 08, 2013 - MICHAEL FITZHUGH - Business - On the Move - Tumor Resistance Genes Can Be Detected Early
The ability to identify rare mutations in blood samples from cancer patients can direct future treatments.
April 08, 2013 - SHERYL P. DENKER - Tech/Innovation - Personalized Medicine - Gene Therapy Startup Raises $41 Million
GenSight Biologics is advancing a replacement therapy for hereditary blinding disease.
April 08, 2013 - MARIE DAGHLIAN - Finance - Venture Capital - Roche and Isis in $392M Antisense deal for Huntington’s Disease
Deal marries gene-inhibiting drugs with delivery technology.
April 08, 2013 - DANIEL S. LEVINE - Business - Dealmaking - Teva and Lonza Review Biosimilars Joint Venture
Barriers to progress temper companies’ enthusiasm for biosimilars opportunity.
April 05, 2013 - MICHAEL FITZHUGH - Business - Biosimilars - Scientists Find New Application for Cholesterol Drug
Could provide an alternative to use of injectable biologics for the disease.
April 05, 2013 - SHERYL P. DENKER - Tech/Innovation - Drug Development - Exits Scarce for Venture Backed Companies in Q1
Three-year low for IPO exits, 18 year-low for M&A; exits.
April 05, 2013 - DANIEL S. LEVINE - Finance - Initial Public Offerings - NICE Branches into Social Care Standards
Long-time chair turns over reins to David Haslam.
April 05, 2013 - MICHAEL FITZHUGH - Health - Public Health - U.S. Trade Representative Reviewing India’s Denial of Glivec Patent
Industry groups say it will hinder innovation and investment in the country.
April 05, 2013 - MARIE DAGHLIAN - Law/Policy - Patents - Appeals Court Rules Against Pfizer in Neurontin Case
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 05, 2013 - Business - Trials and Tribulations - Astellas Enters into $300M Cancer Collaboration with Ambrx
Deal focused on biotech’s next generation antibody drug conjugate technology.
April 04, 2013 - MARIE DAGHLIAN - Finance - Deals - NIH Launches Brain Research Initiative
New funding for brain research imaging and computational tools are on the horizon.
April 04, 2013 - SHERYL P. DENKER - Tech/Innovation - Neurodegeneration - RARE Webinar: Understanding Drug Development
Opportunities for Rare Disease Patients and Advocates to Speed Development of New Therapies.
March 30, 2013 - Tech/Innovation - Research - Lundbeck Enters Potential $825 Million Deal for Alzheimer’s Drug
Agreement extends collaboration with Otsuka in difficult area to meet growing market.
March 29, 2013 - MICHAEL FITZHUGH - Finance - Deals - Medical Residents Can’t Win
Study finds that limiting hours for medical residents offers uncertain value.
March 29, 2013 - MICHAEL FITZHUGH - Health - Medical Practice - Ziopharm Shares Tank on Trial Failure
Company shifts to focus on synthetic biology program with partner, Intrexon.
March 29, 2013 - MICHAEL FITZHUGH - Business - Drug Development - Health Insurers Seeking More for Their Dollars
Nationwide survey indicates little progress in promoting value-based care.
March 29, 2013 - SHERYL P. DENKER - Health - Healthcare Reform - Hundreds of clinical trials abandoned after CRO files for bankruptcy
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 29, 2013 - Business - Trials and Tribulations - Third Rock Ventures Raises $516 Million for New Biotech Fund
Firm says it will start 16 new companies over next few years.
March 29, 2013 - MARIE DAGHLIAN - Finance - Venture Capital - Edison Pharma Signs $545M Deal with Dainippon Sumitomo
Agreement focuses on inherited mitochondrial diseases and their application for adult CNS disorders.
March 29, 2013 - MARIE DAGHLIAN - Finance - Deals - SCOTUS Weighs Pay-for-Delay
Podcast: April 1, 2013
March 28, 2013 - Law/Policy - Regulatory - The April 2013 Issue of
The Burrill Report
March 28, 2013 - The Burrill Report - Monthly - Expanding Research on Highly Toxic Agents Concerns Government Accounting Office
No consensus exists on which federal agency, if any, should regulate research labs possessing dangerous pathogens.
March 28, 2013 - SHERYL P. DENKER - Law/Policy - Biodefense - Will Regulation Dampen Digital Health Innovation
Podcast: March 25, 2013
March 23, 2013 - Law/Policy - Regulatory - Spanish Researchers Identify Key Mutation in CLL
New discovery has broad implications for cancers characterized by telomere abnormalities.
March 22, 2013 - SHERYL P. DENKER - Tech/Innovation - Cancer - AstraZeneca Slashes R&D;, Sales Jobs in Consolidation
Global headquarters will move from London to Cambridge
March 22, 2013 - MICHAEL FITZHUGH - Business - Business Strategy - Sanofi and Biogen get EU Nod on MS Drugs
European regulator recommends approval for oral therapies.
March 22, 2013 - MICHAEL FITZHUGH - Business - Drug Development - Affymax Eliminates 75 Percent of Staff, Considers Sale or Bankruptcy
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 22, 2013 - Business - Trials and Tribulations - Two Life Sciences IPOs Debut
Tetraphase Pharmaceuticals and Enanta, both infectious disease companies, complete offerings.
March 22, 2013 - DANIEL S. LEVINE - Finance - Deals - President Obama Outlines $2B Energy Security Trust
Blueprint to “shift our cars and trucks off oil for good.”
March 22, 2013 - MARIE DAGHLIAN - Law/Policy - Regulatory - Feds Ponder Role of Kids in Biodefense Trials
Presidential Commission for the Study of Bioethical Issues delivers guidelines for medical testing in children.
March 22, 2013 - SHERYL P. DENKER - Law/Policy - Biodefense - One in Three U.S. Seniors Die with Dementia
Alzheimer’s group calls on NIH and Congress to take action.
March 22, 2013 - DANIEL S. LEVINE - Health - Aging - PhRMA Cheers Progress in Biotech
Report cites more than 900 biologic therapies and vaccines in development.
March 15, 2013 - MICHAEL FITZHUGH - Business - Drug Development - Drug Companies Sue EMA over Trials Data
AbbVie and InteMune seek to head off release of proprietary data by regulator.
March 15, 2013 - MICHAEL FITZHUGH - Law/Policy - Legal Application of Nanoparticles Moves From Lab to Field
Rapid detection of deadly food-borne bacteria is made possible with a modified glucose monitoring device.
March 15, 2013 - SHERYL P. DENKER - Tech/Innovation - Nanotechnology- Initiative Expanded to Advance Translational Research
Clinicians and researchers team up to bring novel therapies to patients faster.
March 15, 2013 - SHERYL P. DENKER - Business - Drug Development - U.K. Regulator Finds Man Guilty of Falsifying Preclinical Data
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 15, 2013 - Business - Trials and Tribulations - FDA Proposes to Lower Bar for New Alzheimer’s Drugs
Proposed rules could speed approval of drugs that might slow or prevent the disease.
March 15, 2013 - MARIE DAGHLIAN - Law/Policy - Regulatory - High Profile Pay Cuts Reflect Move to Pay-For Performance
Private company CEOs see compensation rise as war for talent heats up.
March 15, 2013 - DANIEL S. LEVINE - Business - Business Strategy - Why VC Investment in Emerging Markets Is a Demand Problem
Podcast: March 18, 2013
March 14, 2013 - Finance - Venture Capital - Shire Acquires Premacure
Deal adds to Shire’s late stage rare disease drug pipeline.
March 14, 2013 - MARIE DAGHLIAN - Finance - Deals - The March 2013 Issue of
The Burrill Report
March 12, 2013 - The Burrill Report - Monthly - A Proof-of-Concept for Fast Exit Strategy
Podcast: March 11, 2013
March 08, 2013 - Business - Business Strategy - New Initiative Takes on Multiple Sclerosis with Big Data
Orion Bionetworks will pool data for analysis by GNS Healthcare.
March 08, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Drug Development - U.S. Spending on Traditional Prescription Drugs Fell in 2012
Despite drop, overall spending rose.
March 08, 2013 - DANIEL S. LEVINE - Health - Healthcare Economics - Aggressive Treatment Halts HIV Infection in Newborn
Toddler's status has electrified researchers searching for cure.
March 08, 2013 - SHERYL P. DENKER - Health - HIV/AIDS - Study Finds Potential Risk in EHR Adoption
To realize a positive return, further changes are required, practices need to implement additional changes.
March 08, 2013 - Business - Digital Health - Device Tax Concerns Expand to Smartphones
As number of medical applications grows, questions arise over FDA’s plans.
March 08, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Basis Science Raises $11.5 M for Health-Tracking Wristwatch
Company hopes its suggestions will help you get healthy.
March 08, 2013 - MARIE DAGHLIAN - Finance - Deals - China to Reform Food and Drug Safety Oversight
Three bodies will be tasked with regulating industries in an effort to reduce overlapping jurisdictions.
March 08, 2013 - MARIE DAGHLIAN - Law/Policy - Regulatory - Jury Orders J&J; to Pay Plaintiff $8.3 Million for Defective Hip Implant
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 08, 2013 - Business - Trials and Tribulations - India Weighs Price Controls versus Compulsory Licensing
The new draft policy on patented drug pricing puts more emphasis on government regulation.
March 01, 2013 - SHERYL P. DENKER - Law/Policy - Drug Prices - Practice Fusion Buys Startup App Developer
100Plus offers tools to lure iPhone users to practice healthy behaviors.
March 01, 2013 - MICHAEL FITZHUGH - Business - Digital Health - OECD Calls for Harmonized Governance of Clinical Trials
Researchers hope that tailoring trials to the risks involved could help tackle complexity.
March 01, 2013 - MICHAEL FITZHUGH - Law/Policy - Research - Research Advocates Sound Alarm on NIH Sequestration Hit
$1.6 billion in cuts will slow research and reverberate through economy.
March 01, 2013 - DANIEL S. LEVINE - Law/Policy - Legislation - Mylan to Pay $1.6 Billion for Strides Injectables Business
Deal Expands the generic pharma’s geographic reach and product portfolio.
March 01, 2013 - MARIE DAGHLIAN - Finance - Deals - Affymax and Takeda Recall Anemia Drug After Three Patients Died
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 01, 2013 - Business - Trials and Tribulations - Royalty Pharma Offers to Acquire Elan for $6.55 Billion
Investor in pharmaceutical revenue streams goes directly to shareholders after management doesn’t respond to proposal.
March 01, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - FDA Approves New Breast Cancer Therapy
Antibody-drug conjugate offers targeted therapy for HER2-positive cancers.
March 01, 2013 - MICHAEL FITZHUGH - Law/Policy - Innovation - Supreme Court Hears Monsanto
Patent Case
Podcast: March 4, 2013
February 28, 2013 - Law/Policy - Patents - Lab-grown Ear Matches the Real Thing
Testing still needed, but implants could offer children born with deformities new options.
February 22, 2013 - Tech/Innovation - Research - New $3 Million Breakthrough Prize Seeks to Elevate Scientists
Trio of Internet billionaires hopes generate public recognition and interest in the life sciences.
February 22, 2013 - DANIEL S. LEVINE - Tech/Innovation - Research - Merck and Samsung Bioepis to Develop Biosimilars Together
Agreement will help position Korean company to become powerhouse in emerging area.
February 22, 2013 - DANIEL S. LEVINE - Business - Biosimilars - Personal Information May Be Released from U.K. Sequencing Effort
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 22, 2013 - Business - Trials and Tribulations - Roche and Chiasma Collaborate on Rare Disease Drug
Deal could deliver up to $600 million for the startup.
February 22, 2013 - MARIE DAGHLIAN - Finance - Deals - Supreme Court Hears Monsanto Seed Case
Farmer argues that patent rights on GM seed are exhausted after the first generation of seed.
February 22, 2013 - MARIE DAGHLIAN - Law/Policy - Litigation - Forever Young
Podcast: February 25, 2013
February 21, 2013 - Health - Aging - New U.K. Grant Program Taps Wisdom of Crowds
Government council seeks new solutions to tackle complex life sciences questions.
February 21, 2013 - Tech/Innovation - Global - Fox Chase Partners to Personalize Cancer Care
Innovations in sequencing and bioinformatics bring personal treatment solutions to advanced stage cancer patients.
February 21, 2013 - SHERYL P. DENKER - Health - Personalized Medicine - Disruptive Delivery
Podcast: February 18, 2013
February 15, 2013 - Health - Innovation - StemCells Reports Encouraging Trial Results
Early-stage test is first to restore some sensation in patient with complete spinal cord injury.
February 15, 2013 - DANIEL S. LEVINE - Health - Regenerative Medicine - BMS Licenses Over-the-Counter Brands to Reckitt for Latin America
U.K. consumer healthcare company will pay $482 million to sell products in Mexico and Brazil.
February 15, 2013 - MARIE DAGHLIAN - Business - Emerging Markets - IOM Calls for Reckoning on Cancer Costs
Drugs in U.S. can cost twice the price in Europe due to lack of price controls and negotiating authority.
February 15, 2013 - MICHAEL FITZHUGH - Law/Policy - Drug Prices - Industry Braces for Sequestration
Concerns grow about the impact of forced cuts on FDA, NIH.
February 15, 2013 - DANIEL S. LEVINE - Law/Policy - Legislation - Cardinal Health to Buy AssuraMed for $2 Billion
Deal extends Cardinal’s reach into home health products and services.
February 15, 2013 - MARIE DAGHLIAN - Finance - Deals - U.S. Government Recovers Record $4.2 Billion Lost to Fraud
Collaboration among federal, state, and local governments proves key.
February 15, 2013 - SHERYL P. DENKER - Law/Policy - Legal - The Computer Will See You Now
Computer simulations accurately diagnose and treat, all while saving money, researchers say.
February 15, 2013 - SHERYL P. DENKER - Tech/Innovation - Digital Health - Speedy Approval May Await Breakthrough Therapies
We expect many of these would come available very quickly with phase 1 data.
February 15, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Teva Faces $2.1 Billion in Damages For Jumping Gun on Protonix
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 15, 2013 - Business - Finance - Pharma's Growing Talent Gap
Podcast: February 11, 2013
February 08, 2013 - Business - Business Strategy - Early Communications Fueling Success at FDA
Agency finds that early conversations with drug developers are reducing drug development and approval times.
February 08, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Biogen Buys Tysabri Rights for $3.25 Billion
Elan opts for cash and royalties instead of original half interest in MS drug.
February 08, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Senators Reignite Fight to Block Pay-for-Delay
As Supreme Court review approaches, number of deals has climbed.
February 08, 2013 - MICHAEL FITZHUGH - Law/Policy - Legislation - GSK Plans European Cuts
With profits falling, drug giant looks for savings.
February 08, 2013 - MICHAEL FITZHUGH - Business - Business Strategy - Public-Private Partnership to Spur EU Innovation
$261.9 million (€196 million) platform expected to accelerate translational research.
February 08, 2013 - DANIEL S. LEVINE - Tech/Innovation - Global - Protalix Biotherapeutics, an Acquisition Target, Retains Citigroup
Israeli biotech has reportedly drawn the interest of Pfizer and other Big Pharma suitors.
February 08, 2013 - Daniel S. Levine - Finance - Mergers and Acquisitions - FDA Upgrades Ventilator Recall
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 08, 2013 - Business - Trials and Tribulations - The Medicines Company Acquires Rights to Alnylam Cholesterol Drug
Biotech to get up to $205 million for promising RNAi therapeutic.
February 08, 2013 - MARIE DAGHLIAN - Finance - Deals - Proteomics Research Gets a Boost
Academic partnership program aims to transform personalized medicine.
February 08, 2013 - SHERYL P. DENKER - Tech/Innovation - Research - Seeking a New Approach to Migraines
Podcast: February 4, 2013
February 01, 2013 - Business - Drug Development - Takeda Wins Diabetes Approvals
Three new drugs for type 2 form of the disease crucial for drugmaker’s bottom line.
February 01, 2013 - MICHAEL FITZHUGH - Business - Drug Development - GlaxoSmithKine to Create New Vaccine with Indian Partner
Companies will collaborate on polio eradication efforts in developing countries.
February 01, 2013 - SHERYL P. DENKER - Health - Vaccines - The February 2013 Issue of The Burrill Report
February 01, 2013 - The Burrill Report - Monthly - Zoetis IPO Raises $2.24 Billion
Deal caps strong month for U.S. life sciences company public financings.
February 01, 2013 - MARIE DAGHLIAN - Finance - Deals - Europe to Invest $1.4 Billion To Create Detailed Brain Model
Bold super-computing effort gains funding to speed understanding of cognition and disease.
February 01, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Funding Innovation - Ben Venue Laboratories Ordered to Stop Operations
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 01, 2013 - Business - Trials and Tribulations - The Lean Biotech Startup
What the life sciences entrepreneurs industry can learn from others.
February 01, 2013 - Mike Koeris, James Taylor, and Euan Ramsay - Business - Guest Column - Partnerships Moves Canadian Innovation Forward
The University of Manitoba takes a new approach to managing its intellectual property.
January 31, 2013 - SHERYL P. DENKER - Tech/Innovation - Tech Transfer - Trial Results Boost Keryx
Experimental drug offers alternative for common dialysis complication.
January 31, 2013 - MICHAEL FITZHUGH - Business - Drug Development - California’s Stem Cell Agency Seeks to Quell Criticism on Conflicts
CIRM moves to institute changes based on IOM recommendations.
January 25, 2013 - DANIEL S. LEVINE - Law/Policy - Regenerative Medicine - Deep Brain Stimulation Trial Gets Underway
Ohio State University team implants a brain pacemaker to treat Alzheimer’s disease.
January 25, 2013 - SHERYL P. DENKER - Health - Neurodegeneration - Brazil Places $294 Million Bet on Next-Gen Biofuels
State development bank’s venture arm takes 15 percent stake in GraalBio.
January 25, 2013 - MARIE DAGHLIAN - Finance - Government Funding - Allergan to Buy MAP Pharmaceuticals for Nearly $1 billion
Inhalation treatment for migraines would provide new alternative to treat migraine pain if approved.
January 25, 2013 - MICHAEL FITZHUGH - Business - Dealmaking - LipoScience Raises $45 Million in IPO
First life sciences IPO of 2013 prices 36 percent below the midpoint of original range.
January 25, 2013 - MARIE DAGHLIAN - Finance - Deals - Repairing What's Broken
Podcast: January 28, 2013
January 24, 2013 - Tech/Innovation - Drug Development - Translational Research Goes Global
Drug development could get a boost from previously unconnected organizations.
January 24, 2013 - SHERYL P. DENKER - Business - Drug Development - Reviews Measure Impact of Mobile Health Tech
Despite signs of promise, researchers say more work needed to establish the usefulness of mobile phones in care.
January 24, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Smartphones Not Smart in Catching Melanomas
Man beats machine when it comes to diagnosing skin lesions.
January 24, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Novartis Under Investigation on Multiple Fronts
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 24, 2013 - Business - Trials and Tribulations - Just What the Doctor Ordered
January 21, 2013
January 18, 2013 - Health - Innovation - Optum Labs Research Center Open for Business
UnitedHealth Group and Mayo Clinic form an open, collaborative research and development program.
January 18, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Information Technology - AstraZeneca and Vanderbilt Collaborate on Brain Disorders
Partnership opens new front in company’s effort to develop promising external neuroscience research.
January 18, 2013 - MICHAEL FITZHUGH - Business - Partnering - Generic HIV Treatment Could Save $1 Billion Annually
Despite cutting costs, generics switch may leave patients with less effective treatments.
January 18, 2013 - MICHAEL FITZHUGH - Health - Healthcare Economics - Boosting Venture Capital in Canada
Government plans to deploy $400 million toward the creation of large-scale VC funds led by private sector.
January 18, 2013 - MARIE DAGHLIAN - Finance - Government Funding - Big Pharma’s Reputation Sinks with Patient Groups
Annual survey finds a big drop in scores from advocates.
January 18, 2013 - SHERYL P. DENKER - Business - Marketing - U.S. Public Biotechs Raise $1.2 Billion in Equity and Debt
Improved outlook for biotech spurs opportunity to raise money.
January 18, 2013 - MARIE DAGHLIAN - Finance - Deals - Court Ruling Creates Liability for Branded Drugmakers
Alabama Supreme Court finds innovator can be sued for disclosures relating to competitors products.
January 18, 2013 - DANIEL S. LEVINE - Law/Policy - Court Rulings - FDA Green-lights Neuralstem Trial
Early-stage study will use company’s lead cell therapy in patients with chronic spinal cord injury.
January 18, 2013 - DANIEL S. LEVINE - Business - Regenerative Medicine / Stem Cells - BMS Moves to Wrap Up Litigation Over Failed Trial
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 18, 2013 - Business - Trials and Tribulations - California's Biomedical Industry Shows Resilience
Podcast: January 14, 2013
January 11, 2013 - Business - Economic Development - Tufts Sees Promise in Open Innovation
Drug developers need to more fully identify and address root causes of R&D; inefficiency, according to Tufts.
January 11, 2013 - DANIEL S. LEVINE - Tech/Innovation - Drug Development - BioTime Picks Up Geron’s Stem Cell Assets
Newly formed public company will be co-owned by Geron, BioTime, and private investor.
January 11, 2013 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - FDA Awards Vertex Breakthrough Designations
Program to speed the development and review of lifesaving drugs for cystic fibrosis.
January 11, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Illumina Acquires Verinata for $450 Million
Deal Adds to Genomics Powerhouse’s Non-invasive Genetic Testing Capabilities
January 11, 2013 - SHERYL P. DENKER - Business - Diagnostics - Cancer Deaths and Rates in the U.S. Continue to Decline
Broader access to early detection and treatment recommended for high-risk populations.
January 11, 2013 - SHERYL P. DENKER - Health - Cancer - MacroGenics Signs Potential $1 Billion Deal with Gilead Sciences
Biotech will develop bi-specific antibodies against four targets.
January 11, 2013 - MARIE DAGHLIAN - Finance - Deals - FCC Lines Up $400 Million Annually for Telehealth
New fund expands healthcare broadband pilot, seeks to bolster high-speed connectivity for hospitals.
January 11, 2013 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Agbiotech Startup Gets Funding
NewLeaf Symbiotics get $7 million to puruse beneficial bacteria for improving crop yields.
January 11, 2013 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Flu Bug Putting Strain on Tamiflu Supply
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 11, 2013 - Business - Trials and Tribulations - Regenerating Excitement
Podcast: January 7, 2013
January 04, 2013 - Tech/Innovation - Regenerative Medicine - A Banner Year for New Drugs
Best performance since 1996 as orphan drugs step into the spotlight.
January 04, 2013 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Life Sciences M&A; Sees Fewer Billion Dollar Deals
Average therapeutic deal values fall but premiums for biotech rise.
January 04, 2013 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Discovery and Research Deals Lead Partnering
Pharmaceutical companies collaborate on novel drug discovery, sharing risk.
January 04, 2013 - MARIE DAGHLIAN - Business - Partnering - Sarepta Adored While Anthera Suffers
The biggest gainers and decliners for 2012.
January 04, 2013 - MICHAEL FITZHUGH - Business - Capital Markets - Life Sciences Companies Raise $92.5 Billion in Financings in 2012
Sector ends year flat compared to 2011, as equities are up and debt is down.
January 03, 2013 - MARIE DAGHLIAN - Finance - Capital Markets - Biogen’s ALS Drug Fails Late-Stage Trial
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 03, 2013 - Business - Trials and Tribulations - IPOs Keep Pace
Companies find the financings they seek, but have to sell shares for less than hoped.
January 03, 2013 - MICHAEL FITZHUGH - Finance - Initial Public Offerings - San Francisco Adds Three Biotech Startups in New Year
Migraines, cancer metabolism, and a novel RNA drug delivery platform attract initial funding.
January 03, 2013 - Finance - Deals - Taking Stock: 2012, the JPMorgan Healthcare Conferece, and Beyond
Podcast: December 31, 2012
December 28, 2012 - Business - Review / Preview - Biotech Visionary G. Steven Burrill
Offers Predictions for 2013
Sees improvements to the sector in the new year despite continued global economic concerns
December 28, 2012 - Business - Review / Preview - Blindness in Type 2 Diabetes Patients Might Be Preventable
Researchers developing therapy to quell side effect of long-term insulin use.
December 21, 2012 - SHERYL P. DENKER - Health - Diabetes - Biogen Enlists Cell Biologists to Unlock ALS
Research could lead to new therapies for the deadly neurodegenerative disease.
December 21, 2012 - SHERYL P. DENKER - Business - Drug Development - Research Spending Creeps Upward
Despite cuts to budgets, Battelle forecasts modest R&D; gain.
December 21, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Research - Sanofi Lays Foundation for new Industrial Facility in Saudi Arabia
Site will be the first with 100 percent foreign direct investment in Kingdom.
December 21, 2012 - VINAY SINGH - Business - Emerging Markets - The January 2013 Issue of
The Burrill Report
December 21, 2012 - The Burrill Report - Monthly - Sutro Biopharma Enters into $500M Deal with Celgene
Biotech says its technology can produce ADCs and bi-specific antibodies much faster than others.
December 21, 2012 - MARIE DAGHLIAN - Business - Partnering - Amgen Settles Biggest Ever Biotech Off-Label Case
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 21, 2012 - Business - Trials and Tribulations - Tapping Diverse Pools of Capital
Life Sciences companies raise more than $500 million before the holidays.
December 21, 2012 - MARIE DAGHLIAN - Finance - Deals - Removing IP Barriers to Innovation
Podcast: December 24, 2012
December 20, 2012 - Law/Policy - Regulatory - FDA Guides Industry on How to Tailor Trials
Draft offers agency's thinking on ways to test targeted therapies.
December 20, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - FDA Approves Ariad’s Cancer Drug Iclusig
Treatment for rare leukemias gets early OK through accelerated approval program.
December 14, 2012 - MICHAEL FITZHUGH - Health - Personalized Medicine - Gilead to Buy YM BioSciences for $510 Million
Deal strengthens Gilead's cancer pipeline.
December 14, 2012 - MARIE DAGHLIAN - Finance - Deals - National Health Service to Map DNA of Up to 100,000 Patients
Effort to focus on cancer in hopes of accelerating diagnosis, improving treatment, and sparking innovation.
December 14, 2012 - SHERYL P. DENKER - Tech/Innovation - Genomics - “Pay-for-Delay” Goes to U.S. Supreme Court
Seeking clarity amid conflicting lower-court decisions, broad range of stakeholders sought review.
December 13, 2012 - MICHAEL FITZHUGH - Law/Policy - Legal - Antisense Gets Respect
Biogen Idec takes a third option to license Isis’ antisense candidates, this time in neurology.
December 13, 2012 - MARIE DAGHLIAN - Finance - Research and Development - Measuring Returns from Innovation
Podcast: December 17, 2012
December 13, 2012 - Business - Drug Development - Teva Looks for $2 Billion in Savings
Generic drug giant's long-term strategy will include manufacturing revamp, move toward higher-value medicines.
December 13, 2012 - MICHAEL FITZHUGH - Business - Business Strategy - India’s Patent Office Revocations Continue
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 13, 2012 - Business - Trials and Tribulations - Amgen to Acquire deCODE Genetics for $415 Million
Biotech giant hopes to use pioneering genetics work to drive drug development.
December 13, 2012 - DANIEL S. LEVINE - Business - Dealmaking - EU Leaders Agree on Patent Package
By streamlining system, Parliament hopes to cut costs and encourage filings.
December 13, 2012 - SHERYL P. DENKER - Law/Policy - Patents - Podcast Series: The Virtual Scientific Workplace
Sponsored Podcast
December 13, 2012 - Business - Business Strategy - FDA Touts Its Record on Approvals
Podcast: December 10, 2012
December 07, 2012 - Law/Policy - Regulatory - AliveCor Launches iPhone Heart Monitor
With FDA approval in hand, company begins taking orders for smartphone-linked device.
December 07, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Device Makers Partner with FDA to Speed Reviews
New public-private partnership focuses on developing regulatory science to assess new technologies.
December 07, 2012 - MICHAEL FITZHUGH - Health - Medical Devices - Geron Favors Telomerase Target over Blood-Brain-Barrier in Company Restructuring
Limited results from a mid-stage clinical trial again force tough decisions in Menlo Park.
December 07, 2012 - SHERYL P. DENKER - Business - Business Development - Baxter to Acquire Gambro for $4 Billion
Deal will enhance the drugmaker’s dialysis portfolio and global reach.
December 07, 2012 - MARIE DAGHLIAN - Finance - Deals - Drugmakers and Academia Unite to Create iPS Stem Cell Bank
Biorepository will accelerate the use of the technology to enhance drug development.
December 07, 2012 - MARIE DAGHLIAN - Tech/Innovation - Global - New Estimate of Drug Development Costs Pegs Total at $1.5 Billion
Office of Health Economics suggest more flexibility and better alignment needed between stakeholders and innovators is needed.
December 07, 2012 - DANIEL S. LEVINE - Business - Drug Development - The Virtual Scientific Workplace
The Burrill Report
December 07, 2012 - Business - Business Strategy - $700,000 in Gold Dust Goes Missing from Pfizer Lab
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 06, 2012 - Business - Trials and Tribulations - Congressman Sees Jobs in Health Tech Boom
Proposed act would create new Office of Wireless Health Technology within the FDA.
December 06, 2012 - MICHAEL FITZHUGH - Law/Policy - Legislation - Big Pharma Expands Access to Medicines
Despite progress, oversight of clinical trials outsourcing leaves room for improvement, says non-profit's review.
November 30, 2012 - MICHAEL FITZHUGH - Business - Emerging Markets - Selecta Biosciences Strikes Vaccine Partnership with Sanofi
Russian nanotech fund will invest up to $25 million as Selecta sets up Russian research center.
November 30, 2012 - MICHAEL FITZHUGH - Finance - Deals - Drugmakers Go Prospecting in Québec
With academic researchers and VCs in open collaboration, new institute strives to advance translational research.
November 30, 2012 - MICHAEL FITZHUGH - Business - Drug Development - Branded Drug Prices Rise Sharply in U.S.
Generic prices continue to drop.
November 30, 2012 - Vinay Singh - Health - Medical Practice - Smith & Nephew Makes $782 Million Push into Wound Care
Medical device maker looks to drug sector to grow sales.
November 30, 2012 - MARIE DAGHLIAN - Finance - Deals - Collaboration Critical to Address Global Health Challenges
Depspite obstacles, increased cooperation and growing flow of capital to international life science and healthcare initiatives seen.
November 30, 2012 - Östen Johansson - Partner Content - Partner Content - Roche and the Broad Institute Collaborate to Find New Uses for Abandoned Compounds
Latest agreement, among a growing list of repurposing collaborations, looks at more than 300 failed drugs.
November 30, 2012 - DANIEL S. LEVINE - Business - Drug Development - GSK Announces $1Billion Expansion in Emerging Market Nutritionals
Pharma plans to increase stake in its consumer healthcare brands in India and Nigeria
November 30, 2012 - MARIE DAGHLIAN - Business - Emerging Markets - Fiscal Cliff Threatens
Life Sciences Industry
Podcast: December 3, 2012
November 29, 2012 - Law/Policy - Legislation - Stem Cells Ready for Prime Time in Drug Discovery
Survival, growth, and storage conditions fine-tuned for screening assays.
November 29, 2012 - SHERYL P. DENKER - Tech/Innovation - Stem Cells - Novartis Threatens to Pull R&D; from the U.K.
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 29, 2012 - Business - Trials and Tribulations - 2020: The New World of Work
November 29, 2012 - Business - Business Strategy - Questioning Values
Podcast: November 26, 2012
November 21, 2012 - Business - Business Strategy - Tiny Bio-bots Show Promise
Applications including drug screening, toxin cleanup, and medical sensing could benefits from new technology.
November 21, 2012 - SHERYL P. DENKER - Tech/Innovation - Nanotechnology - Regular Check-Ups Fail to Extend Life
Long list of possible risk come with well visits to the doctor.
November 21, 2012 - MICHAEL FITZHUGH - Health - Wellness - TauRx Lands $112 Million to Fund Alzheimer’s Trial
Biotech’s late-stage study targets the tau tangles as a driver of the disease.
November 21, 2012 - MARIE DAGHLIAN - Finance - Deals - Diabetes Cases Soar in the United States
CDC reports the number of people with the disease at least doubles in 18 states.
November 21, 2012 - DANIEL S. LEVINE - Health - Drug Delivery - Teams Seek Answers in Genomic Data
Competitors model disease to speed translation.
November 21, 2012 - SHERYL P. DENKER - Tech/Innovation - Research - AMA Builds Out Policy Agenda at Meeting
Broad ranges of topics reflects period of transition within healthcare.
November 21, 2012 - DANIEL S. LEVINE - Law/Policy - Medical Practice - Startup Will Map Funders' Microbiomes
Launching from QB3, uBiome put high-throughput sequencing to work for backers.
November 21, 2012 - MARIE DAGHLIAN - Tech/Innovation - Genomics - Fund Manager Targeted for Insider Trades
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 21, 2012 - Business - Trials and Tribulations - The December 2012 Issue of
The Burrill Report
November 21, 2012 - The Burrill Report - Monthly - Progress Slow in Combating Fake Drugs
Property disputes muddy effort to save lives, say healthcare policy experts.
November 20, 2012 - MICHAEL FITZHUGH - Law/Policy - Public Health - No Longer a Working Experiment
Sponsored podcast
November 20, 2012 - Business - Business Strategy - Compounding Crisis Highlights Gaps in FDA Jurisdiction
FDA Commissioner Hamburg argues for expanded authority to monitor compounding pharmacies.
November 16, 2012 - SHERYL P. DENKER - Law/Policy - Regulatory - Intarcia Raises $210 Million to Fund Late Stage Trial
Financing is the largest for a private biotech in the past 25 years.
November 16, 2012 - MARIE DAGHLIAN - Finance - Deals - Researcher Calls for Roche Boycott
Long-running dispute over Tamiflu data rekindled.
November 16, 2012 - MICHAEL FITZHUGH - Health - Treatments - FDA Achieves Small Win as Whistleblower Law Passed
Agency’s right to withhold documents upheld.
November 15, 2012 - MICHAEL FITZHUGH - Law/Policy - Litigation - QB3's Grandest Experiment Pays Off
Podcast: November 19, 2012
November 13, 2012 - Business - Economic Development - Roche Seeks Insurance Policy for the Chinese Market
Drugmaker enters an alliance with Swiss Re to assure patients in China can afford its drugs.
November 13, 2012 - DANIEL S. LEVINE - Business - Business Strategy - Drugmakers Team Up to Form Clinical Trial Site Database
Global databank expected to improve efficiencies of industry-sponsored drug trials.
November 13, 2012 - MARIE DAGHLIAN - Business - Drug Development - Croatia Arrests Pharma Staff and Doctors in Anti-Corruption Sting
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 13, 2012 - Business - Trials and Tribulations - A Step Closer to Diagnostic Makers Getting Paid for Value
November 09, 2012 - Law/Policy - Reimbursement - Wearable Tech Market Has Rich Future
Smart glasses and other wearable devices will be worth more than $1.5B by 2014, finds Juniper.
November 09, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Sanofi Slashes Price of New Cancer Drug to Respond to Critics
Action reflects new realities for drugmakers.
November 09, 2012 - DANIEL S. LEVINE - Business - Drug Development - Takeda Acquires Envoy Therapeutics for $140 Million
Pharma gains access to biotech’s novel technology and preclinical CNS assets.
November 09, 2012 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - India Strikes Down Roche Patent
Decision adds to drugmakers’ concerns about protecting sales of patented medicines in the country.
November 09, 2012 - MICHAEL FITZHUGH - Law/Policy - Patents - AbbVie Approaches Launch with $14.7 Billion Debt Offering
Startups also enrich their coffers in active week for fundraising.
November 09, 2012 - MARIE DAGHLIAN - Finance - Deals - Pluristem Denies Bloomberg Report that it Hid Patient Death from Investors, Wants Correction
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 09, 2012 - Business - Trials and Tribulations - New Combinations to Fight Cancer
Data from experiments using 5,000 different pairings of approved drugs will be made available.
November 09, 2012 - SHERYL P. DENKER - Health - Cancer - Pfizer Wins Approval for Rheumatoid Arthritis Medicine
Xeljanz becomes first RA drug from new class of JAK inhibitors.
November 09, 2012 - VINAY SINGH - Business - Drug Development - Trials Highlight Progress on Cholesterol Drugs
Amgen scores positive data in mid-stage trials, while Roche illuminates a miss.
November 09, 2012 - MICHAEL FITZHUGH - Business - Drug Development - Researchers Get $11M to Find New Uses for Shelved AZ Drugs
Medical Research Council awards grants to fund 15 projects.
November 02, 2012 - DANIEL S. LEVINE - Business - Drug Development - Vertex Partners with Janssen and GSK on Hepatitis C Combos
Independent collaborations aim to study new all-oral therapies for the disease.
November 02, 2012 - VINAY SINGH - Business - Business Strategy - Sandy Wipes Out NYU Lab Full of Genetically Altered Mice
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 02, 2012 - Business - Trials and Tribulations - Menarini Bets Big on Antibody-Based Drugs
Deal with Oxford BioTherapeutics could mean up to $1 billion for U.K. biotech.
November 02, 2012 - MARIE DAGHLIAN - Finance - Deals - Shionogi Takes 10 Percent Stake in ViiV Healthcare
Deal gives GSK global rights to HIV integrase inhibitor portfolio.
November 02, 2012 - MARIE DAGHLIAN - Business - Dealmaking - Outlook for U.S. Research Funding Grows Grim
Podcast: November 5, 2012
November 01, 2012 - Law/Policy - Research - Policy, Specialization Key to Innovation in Emerging Economies
Study highlights the need for consistency and leveraging of local resources.
November 01, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Stomach Surgery Takes Top Honor in Innovation Ranking
Cleveland Clinic list projects technologies likely to have big impacts ahead.
November 01, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Healthcare - European Commission Approves First Gene Therapy
UniQure’s treatment will be used for rare metabolic disorder lipoprotein lipase deficiency.
November 01, 2012 - DANIEL S. LEVINE - Tech/Innovation - Gene Therapy - Take Two Stats Courses and Call Me in the Morning
Studies that show big effects of treatments likely to be small in size.
November 01, 2012 - SHERYL P. DENKER - Tech/Innovation - Clinical Trials - IMS Study Identifies Strategies to Improve Medicine Use
Report calls on industry and other stakeholders to take action to improve health outcomes and lower costs.
October 26, 2012 - MICHAEL FITZHUGH - Health - Drug Delivery - Pfizer’s Next Wave in ADHD
Drug giant will pay up to $680 million for specialty pharma focused on CNS disorders.
October 26, 2012 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Seattle Genetics Expands Collaboration with Abbott
Pharma will pay $25 million to use antibody-drug conjugate technology against additional cancer targets.
October 26, 2012 - MARIE DAGHLIAN - Finance - Deals - European Researchers Call for New Institute
Councils say better and more relevant research needed to improve clinical practice in Europe.
October 25, 2012 - DANIEL S. LEVINE - Law/Policy - Research - Swapping out DNA to Fight Disease
Scientists replace defective DNA with equivalent healthy DNA in battle against mitochondrial disease.
October 25, 2012 - Tech/Innovation - Research - EMA Investigates Roche over Safety Reporting
Agency will assess public health impact and share findings with European Commission.
October 25, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - How A Troubled Drugmaker
Reinvented Itself
Podcast: October 29, 2012
October 24, 2012 - Business - Business Strategy - The November 2012 Issue of
The Burrill Report
October 24, 2012 - The Burrill Report - Monthly - Alnylam and Genzyme Form RNAi Alliance
Companies will develop and commercialize RNAi therapeutics for Asia.
October 24, 2012 - MICHAEL FITZHUGH - Business - Partnering - United Therapeutics Runs into Roadblock
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 24, 2012 - Business - Trials and Tribulations - AstraZeneca Partners with Ironwood in China
Companies will share profits and losses while leveraging each other’s strengths.
October 24, 2012 - Business - Emerging Markets - Russia’s PM Backs Smoking Ban
Government pursues broad measures to improve Russians’ health.
October 19, 2012 - DANIEL S. LEVINE - Law/Policy - Legislation - Abbott Stumbles Ahead of Spinoff
Partner Reata halts trial of late-stage drug, expected to be a potential blockbuster.
October 19, 2012 - MICHAEL FITZHUGH - Business - Drug Development - FDA Advisors Back Genzyme-Isis Cholesterol Drug
Isis stands to claim $25 million milestone if U.S. regulator approves new drug.
October 19, 2012 - MICHAEL FITZHUGH - Business - Drug Development - Multivitamins Reduce Men’s Cancer Risk
Long-term study shows value of supplements.
October 19, 2012 - MICHAEL FITZHUGH - Health - Cancer - Samsung Halts Trials of Biosimilar
Company cites 'internal reasons' for action, says report.
October 19, 2012 - VINAY SINGH - Business - Drug Development - Six Biotechs Price Secondary Offerings
Companies take advantage of improved public markets and their own progress to raise money.
October 19, 2012 - DANIEL S. LEVINE - Finance - Capital Markets - AiCuris Strikes $571 Million Deal with Merck
Bayer spin-off gets $144 million upfront for its anti-viral program.
October 19, 2012 - MARIE DAGHLIAN - Business - Business Strategy - Three Early-Stage Biotechs Launch
Creative business models, innovative compounds, and proven management teams attract capital.
October 19, 2012 - MARIE DAGHLIAN - Finance - Deals - Harnessing Data to Improve Care
Podcast: October 22, 2012
October 18, 2012 - Tech/Innovation - Personalized Medicine - Vivus Drug Hits a Roadblock in Europe
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 18, 2012 - Business - Trials and Tribulations - Commission Calls for Genome Privacy Protections
Lack of rules could hurt promised medical advances, report says.
October 12, 2012 - DANIEL S. LEVINE - Law/Policy - Regulatory - Lilly, Roche Drugs Chosen for Alzheimer’s Trial
Study aims to slow disease development in high-risk patients.
October 12, 2012 - VINAY SINGH - Business - Drug Development - India and China Heighten Scrutiny of Medical Devices
Recalls raise recognition of need for consistent quality.
October 12, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Scripps Creates Digital Medicine Program with Qualcomm
New funding will help validate promising technologies faster, tackle best practice.
October 12, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Johnson & Johnson Seeks a Secure Line to Patients
Drugmaker sees mobile messaging as a path to better heart health and clinical trials communication.
October 12, 2012 - MICHAEL FITZHUGH - Health - Digital Health - OVP Venture Partners Calling It Quits
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 12, 2012 - Business - Trials and Tribulations - Two Biotech IPOs Raise $145 million
Kythera and Intercept price at the top of their target range, upsize their offering.
October 12, 2012 - MARIE DAGHLIAN - Finance - Deals - Outlook for Small Biotech Remains Difficult
Taking on risk is getting more difficult to reward, capital is available but expensive.
October 12, 2012 - MARIE DAGHLIAN - Finance - Capital Markets - Open Science and Reinventing Discovery
Podcast: October 15, 2012
October 11, 2012 - Tech/Innovation - Drug Development - UnitedHealth Group to Acquire Brazil’s Largest Health Insurer
U.S. giant to buy 90 percent stake in Amil Participações for $4.9 billion.
October 11, 2012 - DANIEL S. LEVINE - Business - Emerging Markets Medtech Ready to Outshine Pharma
Podcast: October 8, 2012
October 05, 2012 - Business - MedTech- J&J; Snags Rights to Astellas Drug for up to $945 Million
Deal for oral JAK inhibitor gives J&J; a shot at a potential blockbuster.
October 05, 2012 - MARIE DAGHLIAN - Business - Dealmaking - Breast Cancer Study Points to Personalized Treatments
Whole genome scanning tested for clinical decision making.
October 05, 2012 - DANIEL S. LEVINE - Tech/Innovation - Genomics - FDA Says Teva Generic Antidepressant Falls Short
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 05, 2012 - Business - Trials and Tribulations - Economist Pitches Megafund to Fight Cancer
Diversified investments and massive scale could mitigate risks, fund innovation, suggests proposal.
October 04, 2012 - MICHAEL FITZHUGH - Finance - Early-Stage Finance - Roche’s T-DM1 Shines in Breast Cancer Trial
Late-stage study adds details to positive picture for new antibody-drug conjugate.
October 04, 2012 - MICHAEL FITZHUGH - Business - Drug Development - NantWorks Delivers High-Speed Genomics Platform
With the right data at the right time, personalized treatments become possible, says Soon-Shiong.
October 04, 2012 - MICHAEL FITZHUGH - Health - Innovation - FDA Defibrillator Approval Triggers Payday
Post-market study will track patients to assess long-term safety.
October 04, 2012 - MICHAEL FITZHUGH - Health - Medical Devices - UPMC Promotes Personalized Medicine with Big Data Initiative
Medical Center will invest $100 million to improve patient outcomes, reduce costs.
October 04, 2012 - MARIE DAGHLIAN - Health - Information Technology - Regulus IPO: Slash Price, Offer More Shares
San Diego biotech does what it takes to get the deal done.
October 04, 2012 - MARIE DAGHLIAN - Finance - Deals - Aetna Enlists GNS Healthcare in Metabolic Syndrome Fight
Insurance giant hopes to improve prevention and treatment through modeling and analytics.
September 28, 2012 - DANIEL S. LEVINE - Business - Personalized Medicine - Peregrine Shares Plunge on Data Discrepancies
Company loses nearly 80 percent of value in single day.
September 28, 2012 - VINAY SINGH - Business - Drug Development - FDA Launches Antibacterial Drugs Task Force
As need for innovative antibiotics grow, challenges remain to be met.
September 28, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - FDA Gets New Authority over Trials Data
HHS hands off responsibility for integrity and completeness of database.
September 28, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Presidential Science Advisor Plan Seeks to Double New Drug Approvals
Recommendations cover ways to improve collaborations between industry, academia, and government.
September 28, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Drugmakers Paid Feds and States $6.6 Billion in First Half of 2012
Report says pharmaceutical companies paid more than $30 billion over misdeeds during past 20 years.
September 28, 2012 - MARIE DAGHLIAN - Law/Policy - Legal - Medtronic Agrees to Pay $816M for China Kanghui Holdings
Deal expands medical device maker’s reach in fast growing Chinese market.
September 28, 2012 - MARIE DAGHLIAN - Finance - Deals - Sanofi Cuts Staff in R&D; Reshuffle
The weekly round-up of failed trials, missed targets, and other business mishaps.
September 28, 2012 - Business - Trials and Tribulations - MD Anderson Launches $3 Billion Moon Shots Program Against Cancer
Podcast: October 1, 2012
September 27, 2012 - Tech/Innovation - Cancer - Vivus Launches U.S. Sales of Obesity Drug
Vivus hopes to gain early traction with doctors.
September 21, 2012 - VINAY SINGH - Health - Obesity - Drugmakers Band Together on Challenges
Collaborators attract FDA praise as they seek to knock out R&D; inefficiencies.
September 21, 2012 - MICHAEL FITZHUGH - Business - Business Strategy - The October 2012 Issue of
The Burrill Report
September 21, 2012 - The Burrill Report - Monthly - Life Technologies to Make Companion Diagnostics for Bristol-Myers Squibb
Long-term partnership affirms Life’s personalized medicine ambitions.
September 20, 2012 - MARIE DAGHLIAN - Business - Partnering - BGI-Shenzhen to Acquire Complete Genomics for $117.6M
China’s genomics giant captures struggling next-generation sequencing company.
September 20, 2012 - DANIEL S. LEVINE - Finance - Mergers and Acquisitions - China to Mandate Lower Prices on Select Drugs
Government plan expands price controls to improve affordability of medicines.
September 20, 2012 - MICHAEL FITZHUGH - Law/Policy - Drug Prices - Johnson & Johnson Plans New Global Innovation Centers
Forging tighter ties with entrepreneurs in biotech hubs is expected to fuel business.
September 20, 2012 - MICHAEL FITZHUGH - Business - Business Development - Threshold Pharmaceuticals’ Cancer Drug Misses Target
The weekly round-up of failed trials, missed targets, and other business mishaps.
September 20, 2012 - Business - Trials and Tribulations - Syngenta Pushes into Biologic Pest Control
Agbiotech taps into the power of microbes and RNAi with two acquisitions.
September 20, 2012 - MARIE DAGHLIAN - Finance - Deals - Will Biotech Double Life Expectancy?
Podcast: September 24, 2012
September 18, 2012 - Tech/Innovation - Aging - Opexa's Personalized MS Immunotherapy Returns to Clinic
Podcast: September 17, 2012
September 15, 2012 - Business - Business Strategy - Tobira Therapeutics Completes Senior Management Team
Experienced team in place to drive late-stage development of novel single-tablet anti-HIV regimen.
September 14, 2012 - MARIE DAGHLIAN - Business - Business Strategy - Geron’s Course Correction Hits Rocky Road
After quitting stem cell therapy, company hits trouble with cancer drug.
September 14, 2012 - MICHAEL FITZHUGH - Business - Drug Development - Venture Financings on the Rebound
Most life sciences sectors on track to surpass previous funding levels.
September 14, 2012 - MARIE DAGHLIAN - Finance - Deals - J&J; Terminates Trial of Investigational Skin Disorder Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
September 14, 2012 - J&J; Terminates Trial of Investigational Skin Disorder Drug - Business - Trials and Tribulations - MedImmune and WuXi Team Up
Joint venture will develop novel biologics in China.
September 14, 2012 - MARIE DAGHLIAN - Finance - Deals - Drug Pipelines Show Waning Progress, Analysis Says
Benchmarking data on pipelines shows slowdown, but its limits leaves room for hope.
September 14, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Drug Development - AstraZeneca Strikes Partnership with Broad Institute
Academic-Big Pharma collaboration intended to advance antibacterial and antiviral agents.
September 14, 2012 - VINAY SINGH - Health - Infectious Disease - Indian High Court Upholds Right to Copy Roche Drug
In battle with Cipla, Roche loses ability to block Tarceva generics, for now.
September 14, 2012 - MICHAEL FITZHUGH - Law/Policy - Court Rulings - Illumina and Partners Healthcare Ally to Help Docs Interpret Genetic Data
Agreement helps advance next-generation sequencing in the clinic.
September 13, 2012 - DANIEL S. LEVINE - Business - Personalized Medicine - Creating Personalized Medicine Bit by Bit
September 07, 2012 - Tech/Innovation - Personalized Medicine - BioMotiv Aims to Accelerate Therapeutic Innovation
Startup secures $21 million from founding investors University Hospitals and the Harrington family.
September 07, 2012 - MARIE DAGHLIAN - Finance - Early-Stage Finance - Valeant to Acquire Medicis for $2.6 Billion
Deal would shuffle top ranks in the dermatology market.
September 07, 2012 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - India Expanding Drug Price Controls
India’s pricing of imported, patented drugs is now under scrutiny.
September 07, 2012 - VINAY SINGH - Law/Policy - Drug Prices - IOM Slams Waste and Dysfunction in U.S. Healthcare
Institute says $750 billion lost to bad practices calling on docs and others to better use and share health information.
September 07, 2012 - MICHAEL FITZHUGH - Health - Medical Practice - Drugmakers Jockey to Lead Prostate Cancer Market
With FDA approval of Medivation’s Xtandi, rivalry heats up.
September 07, 2012 - MICHAEL FITZHUGH - Business - Drug Sales - Symphogen Licenses Lead Cancer Drug to Merck KGaA
Danish biotech will get $25 million upfront in a deal worth up to $625 million.
September 07, 2012 - MARIE DAGHLIAN - Finance - Deals - ENCODE Decodes Junk DNA
Non-gene DNA shown to regulate genes and play critical role in disease.
September 07, 2012 - DANIEL S. LEVINE - Tech/Innovation - Research - Eli Lilly Suffers another Late-Stage Drug Failure
The weekly round-up of failed trials, missed targets, and other business mishaps.
September 06, 2012 - Business - Trials and Tribulations - Industry Group Turns to Crowdfunding for Biotech Startups
U.K.’s BioIndustry Association proposes engaging public to fund homegrown innovation.
September 06, 2012 - MARIE DAGHLIAN - Finance - Investment Funds - Alnylam Plants Its RNAi Technology with Monsanto
August 31, 2012 - Business - Partnering - Delaying Tumors
Research points to potential path for cancer therapy.
August 31, 2012 - MICHAEL FITZHUGH - Health - Cancer - Federal Funding of Stem Cell Research Stands
Judges find NIH interpretation of Dickey-Wicker is reasonable.
August 31, 2012 - DANIEL S. LEVINE - Law/Policy - Court Rulings - HHS Finalizes New Electronic Health Records Rule
Second stage of federal incentives program focuses on health data exchange.
August 31, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Information Technology - FDA Halts Idenix’s Second Hepatitis C Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
August 31, 2012 - Business - Trials and Tribulations - Genmab Scores in $1.1 Billion Licensing Deal with J&J;
Biotech will get $135 million upfront for its anti-cancer antibody.
August 31, 2012 - MARIE DAGHLIAN - Finance - Deals - Roche Cancer Drug Meets Primary Trial Endpoint
Trial results add to promising reputation for antibody-drug conjugates.
August 30, 2012 - VINAY SINGH - Business - Drug Development - FDA Approves Gilead’s 4-in-1 HIV Pill
Stribild provides a convenient treatment regimen in a tablet taken once daily.
August 30, 2012 - MARIE DAGHLIAN - Health - HIV/AIDS - AstraZeneca Appoints New CEO
Former Roche executive steered Genentech, sees ‘underlying strength’ in U.K. drugmaker.
August 30, 2012 - MICHAEL FITZHUGH - Business - On the Move - Feeling Love for Orphans
Podcast: August 27, 2012
August 24, 2012 - Business - Business Development - Trial Seeks to Use Stem Cells to Treat Autism
Focus will be on cases where faulty immune systems may underlie the disorder.
August 24, 2012 - DANIEL S. LEVINE - Health - Autism - NICE Appeals Process Overhaul in the Works
NHS could gain power over appeals board appointments.
August 24, 2012 - MICHAEL FITZHUGH - Law/Policy - Legislation - Sanofi Pulls Campath to Protect Value of New MS Drug
Company concerned that the drug could cannibalize Lemtrada sales.
August 24, 2012 - MICHAEL FITZHUGH - Business - Drug Sales - Stanford Teams with Intel on Diagnostics
Study details power of new chip to diagnose disease, analyze protein interactions.
August 24, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Diagnostics - Allergan and Molecular Partners Enter $1.4 Billion Alliance
Companies aim to develop eye disease treatments.
August 24, 2012 - VINAY SINGH - Finance - Deals - Partnering for Health
Two deals highlight the use of information technologies to address today's healthcare problems.
August 24, 2012 - MARIE DAGHLIAN - Finance - Deals - BMS Backs out of Crowded Hepatitis C Race
The weekly round-up of failed trials, missed targets, and other business mishaps.
August 24, 2012 - Business - Trials and Tribulations - China Clones Two GM Calves
Project’s aim is to eventually market tastier meat with more protein.
August 23, 2012 - MARIE DAGHLIAN - Tech/Innovation - Industrial Bio/Ag Bio - China Set to Increase Number of Drugs Subject to Price Controls
List of essential drugs may begin to include patented western medicines.
August 23, 2012 - MARIE DAGHLIAN - Law/Policy - Drug Prices - The September 2012 Issue of
The Burrill Report
August 22, 2012 - The Burrill Report - Monthly - PatientsLikeMe Collaborates with Merck
Patient based psoriasis research aims to produce new insights into most common autoimmune disease in U.S.
August 17, 2012 - MICHAEL FITZHUGH - Health - Healthcare Outcomes - Myriad Appeal Is DeJa Vu All Over Again
Court upholds gene patents, but says methods of comparing those genes are not patentable.
August 17, 2012 - DANIEL S. LEVINE - Law/Policy - Court Rulings - Putting Academic Research to the Test
Podcast: August 20, 2012
August 17, 2012 - Business - Drug Development - Inching Closer to a Pill for Men
Mouse study for cancer drug may provide direction to quest for male contraceptive.
August 17, 2012 - MARIE DAGHLIAN - Tech/Innovation - Fertility - Pfizer’s Animal Health Unit Zoetis Files IPO
Experts estimate IPO could bring in more than $2 billion.
August 17, 2012 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Tengion Fights to Survive
Nasdaq non-compliance letter may threaten remaining cash reserve.
August 16, 2012 - VINAY SINGH - Business - Business Development - Whistleblower Sues Genentech
Manager charges biotech harassed and fired her for complaining the company inappropriately rushed program through clinic.
August 16, 2012 - DANIEL S. LEVINE - Law/Policy - Legal - Idenix Hep C Drug Put on Hold over Safety Concerns
The weekly round-up of failed trials, missed targets, and other business mishaps.
August 16, 2012 - Business - Trials and Tribulations - RNA Therapeutics in the Dealmaking Spotlight
MicroRNA biotech Regulus enters into separate deals with AstraZeneca and Biogen Idec.
August 16, 2012 - MARIE DAGHLIAN - Finance - Deals - Pharma Heads Back to School
Podcast: August 13, 2012
August 10, 2012 - Business - Partnering - Nanobiotix teams up with PharmaEngine in Nanomedicine Deal
Partnership will accelerate clinical program and develop Asian market.
August 10, 2012 - MARIE DAGHLIAN - Finance - Deals - U.K. Drug Pricing Talks Approach
Value based pricing may stifle innovation, suggests industry.
August 09, 2012 - MICHAEL FITZHUGH - Law/Policy - Value Based Pricing - Novartis and UPenn Strike Strategic Partnership
Deal aims to bring new approach to fighting cancer.
August 09, 2012 - VINAY SINGH - Business - Partnering - Targeted Drugs Show Less Serious Side Effects
Study confirms validity of personalized medicine approach to treating cancer.
August 09, 2012 - MARIE DAGHLIAN - Health - Personalized Medicine - As Drugmakers Turn to Global Trials, Politicians Seek Greater Transparency
TEST Act would force broader trial data disclosure.
August 09, 2012 - MICHAEL FITZHUGH - Law/Policy - Legislation - Personalizing Pain Medications
NIH awards $18.5 million toward discovery of a genetic link underlying response to pain drugs.
August 09, 2012 - VINAY SINGH - Tech/Innovation - Personalized Medicine - Alzheimer’s Drug Bapineuzumab Fails in Second Trial
The weekly round-up of failed trials, missed targets, and other business mishaps.
August 09, 2012 - Business - Trials and Tribulations - China Invests in U.K. Diagnostics Startup
Non-dilutive investment based on successful commercialization of products in China.
August 09, 2012 - MARIE DAGHLIAN - Finance - Deals - Innovation Bank Proposed
Grant and loan awards would be used to move promising research to market.
August 09, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Funding Innovation - Globus Medical Prices IPO at $12 per Share
Medical device maker raises $100 million in initial public offering.
August 03, 2012 - VINAY SINGH - Finance - Initial Public Offerings - Customized Therapy
Innovative early-stage technology alliance aims to create a one-stop shop for pharma.
August 03, 2012 - MARIE DAGHLIAN - Business - Partnering - Dendreon Cuts Jobs as It Battles Weak Sales
Second quarter losses blamed on sales rep turnover.
August 02, 2012 - VINAY SINGH - Business - Business Strategy - Generics Saved $1 Trillion over Past 10 Years
Study sees growing use of biosimilars as accelerating savings.
August 02, 2012 - DANIEL S. LEVINE - Health - Healthcare Economics - Proteus Gains FDA Clearance for Ingestible Sensor
Digital pill and patch pack will launch in U.K. this fall.
August 02, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Regulate Me
Podcast: August 6, 2012
August 02, 2012 - Law/Policy - Personalized Medicine - Biorenewables Companies Make Headway
Two industrial biotechs raise fresh capital as Senate bill introduced to provide renewable chemicals tax credits.
August 02, 2012 - MARIE DAGHLIAN - Finance - Deals - Bioethics Commission Readies Privacy Advice
Implications of wide-spread genome sequencing reviewed for Obama.
August 02, 2012 - MICHAEL FITZHUGH - Law/Policy - Genetics - Roche CEO Bullish on China
Schwan anticipates adding 1,000 new jobs in fast-growing market.
August 01, 2012 - MICHAEL FITZHUGH - Business - Business Strategy - Bristol-Myers Bet on Hepatitis C Drug Takes Major Hit
The weekly round-up of failed trials, missed targets, and other business mishaps.
August 01, 2012 - Business - Trials and Tribulations - Building a Better Cancer Drug
Podcast: July 30, 2012
July 27, 2012 - Business - Drug Development - NEA Reveals $2.6 Billion Global Venture Fund
About one-third of capital will be invested in global healthcare businesses.
July 27, 2012 - VINAY SINGH - Finance - Early-Stage Finance - Blackstone invests $125 Million in NantPharma
Injectables venture addresses billionaire’s alarm over drug shortages.
July 27, 2012 - MICHAEL FITZHUGH - Finance - Venture Capital - Amarin Wins FDA Approval of Vascepa
New drug reduces triglyceride levels.
July 27, 2012 - MICHAEL FITZHUGH - Business - Drug Development - NIH and DARPA Fund Development of Organ-on-a-Chip Systems
Collaborative effort kicks off with $133 million in grants.
July 27, 2012 - MARIE DAGHLIAN - Tech/Innovation - Technology - California’s Stem Cell Agency Approves $150 Million Grants
Individual projects garner up to $20 million for research teams in industry and academia.
July 27, 2012 - DANIEL S. LEVINE - Law/Policy - Regenerative Medicine - Supreme Court Ruling on Healthcare Reform Will Lower Costs
Effort to repeal legislation carries hefty price, according to revised government estimates.
July 27, 2012 - Health - Healthcare Reform - Hyperion Therapeutics Goes Public
Second biotech IPO in a week comes in below target.
July 27, 2012 - MARIE DAGHLIAN - Finance - Deals - India Preparing to Introduce Price Controls
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 27, 2012 - Business - Trials and Tribulations - Alzheimer’s Drug Fails Late-Stage Trial
Drug missed trial endpoints in study of subset of Alzheimer’s patients.
July 26, 2012 - MICHAEL FITZHUGH - Health - Drug Development - Fresenius Kabi Plans to Acquire Fenwal
Deal pairs companies’ complimentary technologies.
July 26, 2012 - VINAY SINGH - Finance - Mergers and Acquisitions - The August 2012 Issue of The Burrill Report
July 24, 2012 - The Burrill Report - Monthly - Vivus’ Obesity Drug Gains FDA Approval
But specific restrictions placed on its use.
July 20, 2012 - VINAY SINGH - Business - Drug Development - Durata Therapeutics Becomes Second Completed IPO in Month
Markets still unwelcoming, but show glimmer of hope.
July 20, 2012 - VINAY SINGH - Finance - Initial Public Offerings - Confidence Shaken
Podcast: July 23, 2012
July 20, 2012 - Finance - Venture Capital - MedImmune to Cut 200 Jobs in California
The weekly round-up of failed trials, missed targets and other business mishaps.
July 20, 2012 - Business - Trials and Tribulations - First Gene Therapy Gets EU Backing
Regulators recommend approval of uniQure's gene therapy Glybera.
July 20, 2012 - MARIE DAGHLIAN - Tech/Innovation - Gene Therapy - FDA approves Onyx Multiple Myeloma Drug
Green light based on mid-stage results.
July 20, 2012 - MARIE DAGHLIAN - Health - Drug Development - Tools Companies Expand in Diagnostics
Thermo Fisher buys One Lambda and Life Technologies acquires Navigenics.
July 20, 2012 - MARIE DAGHLIAN - Finance - Deals - Human Genome Sciences and GlaxoSmithKline End Hostilities
GSK finalizes takeover of longtime partner HGS.
July 19, 2012 - VINAY SINGH - Finance - Mergers and Acquisitions - Senator Turns Heat Up on FDA in Spying Scandal
Grassley says FDA Counsel's office authorized monitoring of employees critical of the agency.
July 18, 2012 - DANIEL S. LEVINE - Law/Policy - Privacy - Janssen and Evotec Partner on Portfolio of Diabetes Drugs
Focus is on regeneration of insulin producing beta cells.
July 13, 2012 - DANIEL S. LEVINE - Business - Drug Development - 23andMe Acquires CureTogether
Treatment reviews paired with genetic data may create new insights.
July 13, 2012 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Clinical Trials Waste Billions of Dollars Through Unnecessary Procedures
As much as $5 billion a year could be saved by eliminating steps that don’t support safety or efficacy endpoints.
July 13, 2012 - DANIEL S. LEVINE - Business - Drug Development - Chelsea Therapeutics' CEO Steps Down
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 13, 2012 - Business - Trials and Tribulations - AstraZeneca Ramping up Virtual Neuroscience Effort
Two deals expand company’s brain science assets.
July 13, 2012 - VINAY SINGH - Finance - Deals - Complete Genomics Says Tech Sets Standard for Clinical Grade Genomes
New approach improves accuracy and reduces amount of DNA needed for testing.
July 12, 2012 - DANIEL S. LEVINE - Health - Genomics - Biolex Files for Bankruptcy
As hepatitis C therapy market heats up, interferon therapy left behind.
July 12, 2012 - MICHAEL FITZHUGH - Business - Finance - The Already-Approved Drug Researchers Think Can Combat Aging
July 12, 2012 - Tech/Innovation - Aging - Obama Signs User Fee Bill
Legislation expands the resources at FDA’s disposal and cuts review time for generics.
July 10, 2012 - MICHAEL FITZHUGH - Law/Policy - Legislation - Rare Disease Community Scores a
Big Victory
July 06, 2012 - Law/Policy - Regulatory - NIH Targets $275M for Rare Disease Research
Program aimed at achieving a high impact in a short time.
July 06, 2012 - DANIEL S. LEVINE - Health - Genomics - First Rapid Over-the-Counter HIV Test Approved in U.S.
At-home test detects presence of HIV antibodies in saliva.
July 06, 2012 - Vinay Singh - Tech/Innovation - HIV/AIDS - GSK to Pay $3 Billion to Settle Civil and Criminal Charges with U.S. and States
DOJ says it is the largest healthcare fraud settlement in U.S. history.
July 06, 2012 - DANIEL S. LEVINE - Business - Drug Sales - USPTO Official Attacks Compulsory License
Patent office's 'dismay' surfaces in House hearing on intellectual property issues.
July 06, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - FDA proposes ID system for medical devices
Identifiers could help improve device safety programs and patient recordkeeping.
July 06, 2012 - MICHAEL FITZHUGH - Law/Policy - Device Safety - BMS to Acquire Amylin for $5.3 Billion Plus Debt
Complex agreement includes expanded diabetes alliance with AstraZeneca to pay for the deal.
July 06, 2012 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Cells From Parkinson’s Patients Show Unique Drug Responses
Research illuminates new opportunities for tailoring clinical trials.
July 06, 2012 - MICHAEL FITZHUGH - Health - Drug Delivery - Sanofi May Slash 2,000 Jobs in France
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 05, 2012 - Business - Trials and Tribulations - Pfizer Grants Russia’s SatRx Rights to Diabetes Compound
License follows last year’s agreement to collaborate with Russian biotech center.
July 05, 2012 - MARIE DAGHLIAN - Finance - Deals - Overhauling R&D; with Nothing but Net
Podcast: July 1, 2012
June 29, 2012 - Business - Drug Development - Digital Health VC Financing Booms in Year’s First Half
Rock Health round-up says digital health funding is on track for a record year.
June 29, 2012 - MICHAEL FITZHUGH - Finance - Venture Capital - Supreme Court Upholds Healthcare Reform
Individual mandate ruled constitutional as a tax.
June 29, 2012 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform - Roche to Shed 1,000 Jobs in New Jersey
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 29, 2012 - Business - Trials and Tribulations - User Fee Bill Awaits President’s Signature
Expansive legislation provides funding, improves transparency, and addresses key safety issues.
June 29, 2012 - MICHAEL FITZHUGH - Law/Policy - Legislation - India Proposes Offering Generic Drugs for Free
Prime Minister backs a plan set to begin in public health centers in October.
June 29, 2012 - MARIE DAGHLIAN - Health - Healthcare Affordability - FDA Approves Arena’s Obesity Drug
Approval brings company a big step closer to a $60 million milestone payment.
June 29, 2012 - MICHAEL FITZHUGH - Business - Drug Development - Making NICE with Investors
U.K. medicines watchdog will provide advice to early-stage VC investors.
June 29, 2012 - VINAY SINGH - Finance - Early-Stage Finance - New Mobile Healthcare Survey Reveals Mixed Bag
mHealth may not yet be ready for recruitment in clinical trials.
June 29, 2012 - VINAY SINGH - Tech/Innovation - Digital Health - Idec and Isis Pharmaceuticals in Rare Disease Pact
New collaboration builds on similar deal struck in January.
June 29, 2012 - MARIE DAGHLIAN - Finance - Deals - Seeing a Silver Lining to Big Pharma's Patent Cliff
Podcast: June 25, 2012
June 23, 2012 - Business - Business Strategy - Drugmakers Pledge $1.8M to Advance Neuroscience Research
A pre-competitive collaboration will offer counsel, resources, and rigor.
June 23, 2012 - MICHAEL FITZHUGH - Business - Drug Development - Ambrx Lands $303M Deal to Make Improved Drugs
Biotech teams up with Merck to develop biologic drug conjugates.
June 22, 2012 - MARIE DAGHLIAN - Finance - Deals - Alzheimer’s Disease Fight Heats Up
AC Immune and Genentech enter into second antibody collaboration for neurodegenerative disorders.
June 22, 2012 - MARIE DAGHLIAN - Finance - Deals - India Unveils Plans for Reviewing Biosimilars
New details clarify approval process and goals.
June 22, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - User Fee Bill Passes the House
Bipartisan support propels $6.4 billion bill toward passage.
June 22, 2012 - MICHAEL FITZHUGH - Law/Policy - Legislation - BIO Study: Bayh-Dole Shows Big Returns
Industry-backed study quantifies economic contribution of university and non-profit inventions.
June 22, 2012 - DANIEL S. LEVINE - Law/Policy - Legislation - BGI and Hospital Plan to Sequence 1,000 Rare Diseases
Cross-cultural collaboration aims to bring greater genetic understanding of rare diseases.
June 22, 2012 - MARIE DAGHLIAN - Tech/Innovation - Genomics - Celgene Withdraws EU Application for Revlimid
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 22, 2012 - Business - Trials and Tribulations - Genentech's Big Bet on New Cancer Drugs
Podcast: June 18, 2012
June 15, 2012 - Business - Drug Development - Johnson & Johnson Reaches $2.2 Billion Settlement with Government over Marketing Probes
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 15, 2012 - Business - Trials and Tribulations - Children of Older Fathers May Live Longer Than Most
Longer telomeres may promote slower aging.
June 15, 2012 - VINAY SINGH - Health - Aging - Computer Model Predicts Drug Side Effects
Approach could improve safety, reduce drug development costs.
June 15, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Drug Development - BSN Medical Acquired by EQT in $2.5 Billion Deal
Private equity firm plans expansion in Asia and Latin America.
June 15, 2012 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - A Drug by Any Other Name
Battle over how to name biosimilars rolls onward.
June 15, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Startups raise $786 million in June’s First Half
Therapeutics and medical device companies rake in more than $300 million in new capital.
June 15, 2012 - MARIE DAGHLIAN - Finance - Deals - Mapping the Single Cell World
Researchers map the microbes of the healthy to better understand the sick.
June 15, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Research - The July 2012 Issue of The Burrill Report
June 15, 2012 - The Burrill Report - Monthly - A Pitch to Employees
Podcast: June 17, 2012
June 14, 2012 - Business - Economic Development - Why Dendreon May Have Felt Less Pain at ASCO than Expected
Podcast: June 11, 2012
June 08, 2012 - Business - Drug Development - HHS and West Wireless Partner to Kickstart Health App Development
Initial research fellow developing innovative uses of data in healthcare.
June 08, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Chelsea Execs Take Pay Cuts Amid Troubles
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 08, 2012 - Business - Trials and Tribulations - Dr. Reddy’s and Merck Serono Partner on Biosimilars
New partnership adds to a growing list of collaborations seeking fortune in biosimilars market.
June 08, 2012 - MICHAEL FITZHUGH - Business - Partnering - Astellas and Drais Partner to Launch Virtual Company
Seldar set up to develop and commercialize experimental IBS drug.
June 08, 2012 - MARIE DAGHLIAN - Finance - Deals - California Smoking Tax Vote Outcome Too Close to Call
State votes reflect nearly even split over $1 per pack cigarette tax.
June 08, 2012 - MICHAEL FITZHUGH - Law/Policy - Legislation - Phone Appointments Effective in Battling Depression
Despite conveniences, however, foregoing face-to-face counseling comes at a cost, study finds.
June 07, 2012 - MICHAEL FITZHUGH - Health - Depression - Complete Genomics Restructures, Seeks Strategic Alternatives
Total of 20 percent of workforce or 55 jobs being eliminated as it halts expansion plans.
June 07, 2012 - DANIEL S. LEVINE - Business - Business Development - Will Reimbursement Be the Next Major Policy Fight for BIO?
Podcast: June 4, 2012
June 01, 2012 - Law/Policy - BIO International Conference - Medical App Developers Sweat Potential Delay
Amendment to Senate user fee bill calls for outsiders to evaluate risk strategy.
June 01, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Life Sciences Venture Investment Up
Increases are going into medical tools and devices.
June 01, 2012 - MARIE DAGHLIAN - Finance - Deals - Medical Costs Still Rising, but Slowly
PwC analysis finds brakes on rising healthcare spending slowing growth.
June 01, 2012 - MICHAEL FITZHUGH - Health - Healthcare Economics - User Fee Packages Win Congressional Approval
After long negotiations, drug industry succeeds in gaining broad bi-partisan support.
June 01, 2012 - MICHAEL FITZHUGH - Law/Policy - Legislation - China Poised to Boost Biotech
Government considering five-year development plan for the sector as the country’s economy slows.
June 01, 2012 - MARIE DAGHLIAN - Tech/Innovation - Global - 23andMe Patent Creates Concerns with Customers
Company defends decision as vital to translating findings into patient benefits.
June 01, 2012 - DANIEL S. LEVINE - Business - Business Development - Bristol-Myers Squibb Forms the International Immuno-Oncology Network
Collaboration will focus on harnessing body’s own immune system to fight cancer.
May 31, 2012 - VINAY SINGH - Business - Partnering - Marina Biotech Slashes 90 Percent of Workforce
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 31, 2012 - Business - Trials and Tribulations - Wall Street Turns Its Eyes to ASCO
Podcast: May 29, 2012
May 25, 2012 - Business - Drug Development - Paying for Value
Drugmakers challenged to provide adequate data as payers move to reimburse for outcomes rather than drugs.
May 25, 2012 - DANIEL S. LEVINE - Business - Finance - PCORI Aims to Award $120 Million in 2012
Funding will support comparative clinical effectiveness research.
May 25, 2012 - VINAY SINGH - Law/Policy - Comparative Effectiveness - Death Rates among Americans with Diabetes Falls
Despite improvement, disease expected to afflict a greater proportion of people in the United States.
May 25, 2012 - Vinay Singh - Health - Diabetes - GSK Responds to Human Genome’s Poison Pill
To avoid dilution, HGS buyers would need board’s blessing.
May 25, 2012 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Homeland Security Warns of Mobile Health Risks
Increasing use of wireless technologies comes with increased threat to network security.
May 25, 2012 - Marie Daghlian - Tech/Innovation - Digital Health - Teva Cuts Forecasts over European Weakness
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 25, 2012 - Business - Trials and Tribulations - U.S. Could Lose its Competitive Edge in Biomedical Innovation
Two reports highlight challenges to U.S. leadership position.
May 25, 2012 - MARIE DAGHLIAN - Business - Markets - Public Private Partnership Aims to Combat Drug Resistant Microbes
Pharmaceutical companies join forces with European initiative to speed development of new antibiotics.
May 24, 2012 - MARIE DAGHLIAN - Finance - Deals - NIH Study Shows Fake and Poor Quality Malaria Drugs Pose Threat
Progress against the disease is hampered by growing array of problems.
May 24, 2012 - MICHAEL FITZHUGH - Health - Global Health - Osiris Wins Canadian Approval for World’s First Stem Cell Drug
Prochymal is only approved treatment for GvHD.
May 19, 2012 - DANIEL S. LEVINE - Business - Regenerative Medicine / Stem Cells - A Venture Investor Cries Mea Culpa
The Burrill Report: May 21, 2012
May 18, 2012 - Finance - Venture Capital - The June 2012 Issue of The Burrill Report
May 18, 2012 - The Burrill Report - Monthly - Approvals of Innovative Drugs by FDA Surpass EU, Canada
Yale study challenges notion that the FDA lags behind its peers.
May 18, 2012 - Vinay Singh - Law/Policy - Regulatory - Express Scripts Settles Employee Theft Charges
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 18, 2012 - Business - Trials and Tribulations - International Doctors' Group Criticizes Gates’ Global Vaccines Plan
Doctors Without Borders says strategy may fail to deliver.
May 18, 2012 - MICHAEL FITZHUGH - Health - Global Health - Agilent Acquires Dako for $2.2 Billion
Deal for Danish cancer diagnostic company is Agilent’s largest to date.
May 18, 2012 - MARIE DAGHLIAN - Finance - Deals - Trial Seeks to Stop Alzheimer’s before it Starts
International collaboration undertakes expansive effort funded by NIH and industry.
May 18, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Drug Development - Kythera Files to Go Public Under JOBS Act
California company is the first biotech to take advantage of new law designed to make financing more accessible.
May 18, 2012 - MICHAEL FITZHUGH - Finance - Initial Public Offerings - European Private Investment Fundraising Up 80 Percent
EVCA reports strong numbers despite economic turmoil in Europe.
May 18, 2012 - MARIE DAGHLIAN - Finance - Venture Capital - GSK Goes Hostile
Pharma keeps offer at $13 per share and goes directly to shareholders.
May 12, 2012 - MARIE DAGHLIAN - Finance - Deals - User Fee Deal Eased Some Burdens, Exacerbated Others, Report Says
Tufts Center for the Study of Drug Development says supplemental new drug and biologic licenses grew more onerous.
May 11, 2012 - DANIEL S. LEVINE - Law/Policy - Regulatory - Use of Avastin for Eye Disease Could Save NHS $136 Million Annually
Trial pitting Avastin against Lucentis finds they yield similar results for wet-AMD.
May 11, 2012 - MICHAEL FITZHUGH - Health - Healthcare Economics - Bayer Appeals Forced Licensing in India
Issue creates friction between government trade representatives.
May 11, 2012 - MICHAEL FITZHUGH - Law/Policy - Patents - Keeping Score at the FDA
Podcast: May 14, 2012
May 11, 2012 - Law/Policy - Regulatory - Vertex’s Cystic Fibrosis Considered ‘Game-Changer’
Interim mid-stage data on combination therapy impresses investors.
May 11, 2012 - VINAY SINGH - Business - Drug Development - Groups Weigh in on Biosimilars
Naming, interchangability key focus of discussions.
May 11, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Daiichi Sankyo Enters Biosimilars Arena with Coherus BioSciences
Newly launched biotech employs seasoned production team with a global perspective.
May 11, 2012 - MARIE DAGHLIAN - Finance - Deals - Gilead's Truvada Gains Support for HIV Prevention
Risk-reducing use would be a first.
May 11, 2012 - Tech/Innovation - HIV/AIDS - Blech, One-Time "King of Biotech," Pleaded Guilty to Manipulating Stock Prices
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 11, 2012 - Business - Trials and Tribulations - Protalix Approval a Win for Its Manufacturing Technology
Podcast: May 7, 2012
May 04, 2012 - Business - Business Strategy - How to Fix Life Sciences IPOs
The easy answer: offering companies that investors can get excited about.
May 04, 2012 - DANIEL S. LEVINE AND MARIE DAGHLIAN - Finance - Initial Public Offerings - Hedge Fund Attacks Savient Over Financials
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 04, 2012 - Business - Trials and Tribulations - Castlight Health Secures another $100 Million in a Series D Financing
New funding further establishes company’s place in healthcare transparency market.
May 04, 2012 - VINAY SINGH - Health - Healthcare Delivery - Friction for Pharma Abroad, But Progress Too
U.S. trade report cites trading partners’ wrongs.
May 04, 2012 - MICHAEL FITZHUGH - Law/Policy - Trade - Investor Groups to Help Laid-Off Merck KGaA Employees Form Spin-offs
VC offering strategic advice, not money, but company committed $40 million in seed money.
May 04, 2012 - VINAY SINGH - Finance - Spin-Outs - NIH Seeks to Find Uses for Shelved Compounds
Partnership with Big Pharmas will provide $20 million in research grants.
May 04, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Drug Development - Piecing Together the Proteome
Scientists seeking hidden proteins meet to strategize and share progress.
May 04, 2012 - Tech/Innovation - Genetics - VCs See Sharp Drop in Biotech Investment
Pressures push companies away from IPO market.
May 04, 2012 - MARIE DAGHLIAN - Finance - Deals - FDA’s Woodcock Argues for Clinical Research Makeover
Academia can and should play a greater role in bringing better drugs to market, says CDER director.
April 28, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - FDA Stretches to Go Global
With limited resources, agency targets trouble spots and seeks cooperation.
April 27, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - AstraZeneca Agrees to Buy Ardea Biosciences for $1.3 Billion
Similar acquisitions are likely as AstraZeneca tries to replenish its pipeline.
April 27, 2012 - Finance - Mergers and Acquisitions - NIH grants $10.5 Million for Genome Explorations
Grants will back work to illuminate genome function.
April 27, 2012 - MICHAEL FITZHUGH - Health - Genomics - Saying "No" to an IPO
Podcast: April 30, 2012
April 27, 2012 - Finance - Initial Public Offerings - AstraZeneca CEO to Step Down
Poor R&D; productivity and heightened generic drug competition hamper company.
April 27, 2012 - VINAY SINGH - Business - Business Strategy - Tackling Oral Cancer with a Smartphone
For a few dollars, camera phones can catch cancers and prevent deaths.
April 27, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Diagnostics - Takeda Fails to Win FDA Approval for Diabetes Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 26, 2012 - Business - Trials and Tribulations - Buyouts Catch Fire in Race for Global Market Share
April ends with $20.6 billion in M&A; against a somber outlook for life sciences IPOs.
April 26, 2012 - MARIE DAGHLIAN - Finance - Deals - Novartis Challenging Avastin Use for Eye Disease in the U.K.
Lawsuit claims patient safety is being compromised.
April 23, 2012 - VINAY SINGH - Law/Policy - Litigation - Funding Early-Stage Companies with Radical Technologies
Podcast: April 23, 2012
April 20, 2012 - Tech/Innovation - Funding Innovation - Roche Decides Against Extending Offer for Illumina
Illumina remains independent, but shares fall as offer expires.
April 20, 2012 - MICHAEL FITZHUGH - Business - Dealmaking - Endocyte Scores with Merck Partnership
Shares double on announcement of potential $1 billion deal.
April 20, 2012 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Generic Drugmakers Score Victory at Supreme Court
Caraco case hinged on semantics.
April 20, 2012 - DANIEL S. LEVINE - Law/Policy - Court Rulings - GlaxoSmithKline Steers toward Innovation
Strikes second drug discovery alliance with FivePrime Therapeutics, sells OTC brands to Aspen Pharmacare.
April 20, 2012 - MARIE DAGHLIAN - Finance - Deals - Survey: One in Four Americans Had a Gap in Healthcare Coverage in 2011
Buying coverage between jobs is not an option for many.
April 20, 2012 - MARIE DAGHLIAN - Health - Healthcare Reform - The May 2012 Issue of The Burrill Report
April 20, 2012 - The Burrill Report - Monthly - NICE Rejects Avastin for Breast Cancer
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 20, 2012 - Business - Trials and Tribulations - Race for All-Oral Treatment for Hep C Leaps Forward
Gilead’s and Bristol-Myers Squibb’s combination therapy shows new promise.
April 19, 2012 - VINAY SINGH - Business - Drug Development - Health IT Deals Hot in Q1
Record number of venture investments provided $184 million, mostly for health information companies.
April 19, 2012 - MICHAEL FITZHUGH - Finance - Venture Capital - Roche Hints at Negotiating Room in Illumina Bid
War of words heats up as Illumina annual meeting grows near.
April 14, 2012 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - What's Ahead for Biotech Stocks
Podcast: April 16, 2012
April 13, 2012 - Business - Markets - U.S. Should Tax Medical Services to Fund Public Health, Says IOM
Study says investing in wellness and prevention could close the healthcare gap between U.S. and other wealthy nations.
April 13, 2012 - Business - Drug Development - Berwick Says Billions Can Be Saved through Cutting Waste
Former CMS administrator supported Affordable Care Act, but sees more opportunity for savings.
April 13, 2012 - MICHAEL FITZHUGH - Law/Policy - Healthcare Reform - R&D; Spending for Drug Giants Drops to $49.5 Billion in 2011
Industry remains among the most research-intensive.
April 13, 2012 - MARIE DAGHLIAN - Business - Drug Development - Mayo Clinic launches whole genome breast cancer study
Researchers apply pharmacogenomics approach to tailor treatments.
April 13, 2012 - Tech/Innovation - Personalized Medicine - Takeda Acquires URL Pharma in $800 Million Deal
Deal expands pharma’s gout portfolio and U.S. presence.
April 13, 2012 - MARIE DAGHLIAN - Finance - Deals - Drug Shortages and the Role of the Middle Man
Group Purchasing Organizations are a little understood driver of the problem.
April 13, 2012 - Peter J. Pitts - Law/Policy - Generics and Biosimilars - Amgen to Buy KAI Pharmaceuticals
Deal gives big biotech access to chronic kidney disease treatment.
April 13, 2012 - VINAY SINGH - Finance - Mergers and Acquisitions - J&J; Fined $1.1 Billion For Deceptive Marketing
The weekly roundup of failed trials, missed targets, and other business mishaps.
April 13, 2012 - Business - Trials and Tribulations - Forging a Launch Pad for Emerging Growth IPOs
Podcast: April 9, 2012
April 06, 2012 - Law/Policy - Regulatory - GAO Sees Gloomy Fiscal Outlook without Health Reform
Long-term simulations show federal deficits and debt on the rise without reforms.
April 06, 2012 - MICHAEL FITZHUGH - Law/Policy - Healthcare Reform - Amgen and AstraZeneca to Collaborate on Inflammation Portfolio
Companies will develop and commercialize five monoclonal antibodies.
April 06, 2012 - MICHAEL FITZHUGH - Business - Dealmaking - Following Late-Stage Failure, Spectrum To Buy Allos
Deals could be worth as much as $206 million.
April 06, 2012 - VINAY SINGH - Finance - Mergers and Acquisitions - GE Expands Diagnostic Business with SeqWright Buy
Acquisition adds sequencing capabilities as company seeks to expand services.
April 06, 2012 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Predictive Value of Whole Genome Sequencing Questioned
Study of twins suggests testing would not provide adequate warning of disease risks in most cases.
April 06, 2012 - DANIEL S. LEVINE - Health - Genomics - US Unveils $200 Million Big Data Initiative
Money will be used to advance means of analyzing growing volume of digital data.
April 06, 2012 - MARIE DAGHLIAN - Tech/Innovation - Information Technology - BARDA Cuts Funding for Radiation Poisoning Treatment
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 06, 2012 - Business - Trials and Tribulations - Covidien Looks to Israel for Novel Medical Devices
Global respiratory specialist acquires two companies in less than a month as medical device deals heat up.
April 06, 2012 - MARIE DAGHLIAN - Finance - Deals - New Report Finds Prescription Drug Spending Flat
Move to generics big reason for drop off.
April 06, 2012 - VINAY SINGH - Business - Drug Sales Celtic Launches ADC Therapeutics with $50 Million
Private equity firm boosts development of antibody-drug conjugates.
March 31, 2012 - MARIE DAGHLIAN - Business - Drug Development- Bausch & Lomb to Buy Ista Pharmaceuticals
Heavily courted Ista finally agrees to acquisition terms.
March 31, 2012 - VINAY SINGH - Finance - Mergers and Acquisitions - Understanding the Shifting Patent Landscape
Podcast: April 2, 2012
March 30, 2012 - Law/Policy - Patents - Merrimack IPO Falls Out the Gate
Cancer drug developer struggles after debut, while rest of 2012 class is up.
March 30, 2012 - MARIE DAGHLIAN - Finance - Deals - New Guidelines on Taking Life’s Measure
Institute of Medicine draws best practices from current and past medical tests.
March 30, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Diagnostics - Nanotech Armor Guards Against Breast Cancer Remission
“Bed-of-nails” breast implant deters cancer cells.
March 30, 2012 - MARIE DAGHLIAN - Health - Cancer - FDA Approves Affymax Anemia Therapy
New drug will create added competition for Amgen.
March 30, 2012 - MICHAEL FITZHUGH - Business - Drug Development - US Protests India’s Compulsory License for Nexavar
India counters it has not broken any rules.
March 30, 2012 - MARIE DAGHLIAN - Business - Global Economy - Chelsea Therapeutics’ Falls on FDA Rejection of Northera
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 29, 2012 - Business - Trials and Tribulations - The April 2012 Issue of The Burrill Report
March 27, 2012 - The Burrill Report - Monthly - Roche and Illumina Duke It out Ahead of Annual Meeting
Hostile campaign heats up as companies court votes.
March 24, 2012 - MARIE DAGHLIAN - Business - Dealmaking - Supreme Court Ruling Creates Uncertainty for Diagnostics Companies
Rejection of Prometheus patents reverses lower court ruling.
March 23, 2012 - MICHAEL FITZHUGH - Law - Patents - Senate Passes IPO On-Ramp Bill
Legislation would ease restrictions on emerging growth companies.
March 23, 2012 - DANIEL S. LEVINE - Finance - Initial Public Offerings - JNJ Faces Flood of Lawsuits for Unauthorized Medical Device
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 23, 2012 - Business - Trials and Tribulations - AstraZeneca and Targacept Won’t Seek Approval for Depression Drug
Third failed trial spells end of compound.
March 23, 2012 - VINAY SINGH - Business - Drug Development - Daily Dose of Aspirin Reduces Risk of Cancer
Widely-used drug overlooked in the battle against the deadly disease.
March 23, 2012 - VINAY SINGH - Health - Cancer - MediVector Lands $138.5 Million Defense Contract
Award will boost clinical development of broad-spectrum anti-viral.
March 23, 2012 - MARIE DAGHLIAN - Finance - Deals - Groups Seek Congressional Action on Drug Shortages
Discounted generic drug application fees proposed as incentive to curb shortfalls.
March 23, 2012 - MICHAEL FITZHUGH - Law/Policy - Public Health - Healthcare Reform Gets Its Day in Court
Podcast: March 26, 2012
March 22, 2012 - Law/Policy - Healthcare Reform - Wellcome Trust Launches $317 Million Investment Fund
New business will back healthcare and life sciences companies.
March 22, 2012 - MICHAEL FITZHUGH - Finance - Investment Funds - How Free Agents are Reshaping the Life Sciences
Sponsored podcast
March 22, 2012 - Business - Business Strategy - California Cigarette Tax Could Ignite Cancer Research
Podcast: March 19, 2012
March 16, 2012 - Law/Policy - Research - India Orders Bayer to License Nexavar
Ruling raises concern that developing nations could cast aside drug patents.
March 16, 2012 - MICHAEL FITZHUGH - Business - Emerging Markets - Merck Commits $90 Million to Found Drug Discovery Center
Research support buys Merck an option to exclusively license any promising drug candidates.
March 16, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Research - Shire Buys FerroKin BioSciences for $325 Million
Attractive market opportunity and good strategic fit draw Shire’s interest.
March 16, 2012 - VINAY SINGH - Finance - Mergers and Acquisitions - An iPOPping Result
A Stanford researcher analyzing his own DNA and RNA uncovers and tracks the onset of his diabetes.
March 16, 2012 - DANIEL S. LEVINE - Health - Genomics - Boston Scientific Connects With Vodafone for Cardiac Monitoring
New partnership extends the reach of monitoring systems as landline use falls in developed nations.
March 16, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Medical Devices - Pfizer Ends $350 Million Insulin Pact
Major blow for India’s largest biotech company.
March 16, 2012 - VINAY SINGH - Business - Biosimilars - Asahi Kasei Expands in Healthcare with $2.2 Billion Zoll Medical Buy
Deal builds on existing relationship to drive growth in critical care sector.
March 16, 2012 - MARIE DAGHLIAN - Finance - Deals - Biogen Idec Looks Ahead on MS
Seeks novel therapies in deal with MAKScientific’s cannabis-based compounds.
March 16, 2012 - MARIE DAGHLIAN - Business - Drug Development - Shire Surprisingly Pulls Biologics License Application
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 16, 2012 - Business - Trials and Tribulations - Alzheimer’s Costs to Top $200 Billion a Year
New report paints grim picture.
March 10, 2012 - VINAY SINGH - Health - Public Health - The Single Biggest Opportunity to Improve Health Outcomes
Podcast: March 12, 2012
March 09, 2012 - Business - Business Strategy - Joint Venture Seeks to Bring Medical Innovation to Russia
Companies will get funding to develop their products in Russia.
March 09, 2012 - MARIE DAGHLIAN - Finance - Investment Funds - Boston Scientific to Acquire Cameron Health for Up to $1.4B
Deal could jumpstart Boston Scientific’s sluggish cardiac defibrillator business.
March 09, 2012 - MARIE DAGHLIAN - Finance - Deals - J&J; Impresses with Prostate Cancer Drug
Interim results on Zytiga show clinical benefit, dampening enthusiasm for Dendreon shares.
March 09, 2012 - VINAY SINGH - Business - Drug Development - Novartis Takes Glivec Arguments to India’s Supreme Court
Outcome of legal battle closely watched by innovators and generic companies alike.
March 09, 2012 - MICHAEL FITZHUGH - Law/Policy - Patents - Working Out at Starbucks
Researchers find caffeine alters DNA as much as exercise.
March 09, 2012 - DANIEL S. LEVINE - Health - Wellness - Hospital Quality Reporting Program Had Little Impact on Death Rates
Study questions utility of Hospital Compare in prompting hospitals to improve quality of care.
March 09, 2012 - MICHAEL FITZHUGH - Health - Public Health - Cost of Drugs Rockets Past Inflation, Says AARP
While use of generics reduces spending, AARP finds brand and specialty drugs offset savings.
March 09, 2012 - MICHAEL FITZHUGH - Health - Public Health - Gilead Falls on News of Additional Hep C Patients Relapsing
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 09, 2012 - Business - Trials and Tribulations - Court Rules New FDA Labels for Cigarettes Unconstitutional
Judge says agency can’t coerce industry to deliver strong anti-smoking message.
March 02, 2012 - DANIEL S. LEVINE - Law/Policy - Court Rulings - Dainippon Sumitomo to Acquire Boston Biomedical
Deal value could reach up to $2.6 billion for cancer stem cell company.
March 02, 2012 - VINAY SINGH - Finance - Mergers and Acquisitions - FDA Adds New Warnings to Statin Labels
Officials are concerned the drugs can lead to diabetes and memory loss.
March 02, 2012 - VINAY SINGH - Health - Drug Safety - CMS Tries Text Messaging to Improve Health for New Moms
Partnership with Text4Baby seeks to expand enrollment in Medicaid, CHIP programs.
March 02, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Technology - Shire Inks Antibody Discovery Alliance with arGEN-X
Human antibody product collaboration in rare diseases.
March 02, 2012 - MICHAEL FITZHUGH - Finance - Research and Development - The Long Journey from the Amazon to the FDA
Podcast: March 5, 2012
March 01, 2012 - Business - Business Strategy - NIH Takes Its Genetic Testing Registry Online
Website expected to help researchers, doctors, and public understand available genetic tests.
March 01, 2012 - DANIEL S. LEVINE - Health - Genomics - Biogen and Samsung Advance Biosimilars Venture
With Samsung taking the lead, partners seek dominance as market grows.
March 01, 2012 - MICHAEL FITZHUGH - Business - Biosimilars - Galapagos Scores with Abbott Deal
Pharma will pay up to nearly $1.4 billion for novel drug to treat autoimmune diseases.
March 01, 2012 - MARIE DAGHLIAN - Finance - Deals - Bribery a Growing Legal Liability for Big Pharma, says Reuters
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 01, 2012 - Business - Trials and Tribulations - Ceres IPO Brings in $65M
Agbiotech goes public amid difficult times for bioenergy companies.
February 24, 2012 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Myriad Case Heads to Court of Public Opinion
ACLU solicits stories from people who say they’ve been hurt by gene patents.
February 24, 2012 - DANIEL S. LEVINE - Tech/Innovation - Bioethics - FDA Panel Recommends Approval of New Obesity Drug
Vivus gets strong support in advisory review, awaits a decision in April.
February 24, 2012 - MICHAEL FITZHUGH - Health - Obesity - Pfizer and Hisun Near Joint Venture Pact
Partners anticipate branded generics opportunities while seeking to keep pace with the competition.
February 24, 2012 - MICHAEL FITZHUGH - Business - Emerging Markets - Patients Sue U.S. Agencies Over Drug Shortages
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 24, 2012 - Business - Trials and Tribulations - Borscht Belt
Russia seeks U.S. innovation to grow its healthcare industry
February 24, 2012 - MARIE DAGHLIAN - Finance - Deals - A Push for Accelerated Approvals
Podcast: February 27, 2012
February 23, 2012 - Law/Policy - Regulatory - Intent Dissent
February 23, 2012 - PETER J. PITTS - Law/Policy - Commentary - Hepatitis C Remains A Hot Play
Novartis joins the pack of companies developing therapies for the infectious disease.
February 23, 2012 - VINAY SINGH - Business - Dealmaking - The March 2012 Issue of The Burrill Report
February 22, 2012 - The Burrill Report - Monthly - Will Obama's Budget Hinder Innovation?
Podcast: February 20, 2012
February 17, 2012 - Law/Policy - Innovation - Biogen Idec Commits Up to $487.5M to Acquire Stromedix
Small company hits a home run with fibrosis-focused deal.
February 17, 2012 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Feds Recoup $4.1 Billion in Healthcare Fraud
Task forces employ data analysis to target suspect claims.
February 17, 2012 - VINAY SINGH - Health - Healthcare Economics - Amyris Scales Back
Shares tumble as company finds scaling up more difficult than expected.
February 17, 2012 - MARIE DAGHLIAN - Business - Biofuels - Proposed FDA Budget Leans on Industry
Obama seeks $4 billion in savings by trimming exclusivity period.
February 17, 2012 - MICHAEL FITZHUGH - Law/Policy - Legislation - Despite Cuts, Big Pharma Says It’s Still Overstaffed
Study finds companies plan reductions to sales groups of up to 15 percent in the year ahead.
February 17, 2012 - Business - Downsizing - Gilead Drops on Poor Clinical Trials Results of Pharmasset Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 17, 2012 - Business - Trials and Tribulations - Developing Countries Lead Adoption Rate of Biotech Crops
Spurned by Europe and Japan, genetically modified crops are being embraced by the world’s small resource-poor farmers.
February 10, 2012 - MARIE DAGHLIAN - Business - Industrial/Ag Bio - Obama Administration Boosts Alzheimer’s Research Spending
Increase comes as research advocates brace for difficult budget fights.
February 10, 2012 - DANIEL S. LEVINE - Health - Public Health - GSK Boast: Improving R&D; Productivity
Quarterly results, however, fall short of Wall Street’s expectations.
February 10, 2012 - DANIEL S. LEVINE - Finance - Research and Development - Yesterday’s Science Fiction, Tomorrow’s Reality
Israeli startup Check-Cap is developing an ingestible capsule that may help detect colorectal cancer.
February 10, 2012 - MARIE DAGHLIAN - Tech/Innovation - Digital Health - Siemens Seeks Growth in Companion Diagnostics
New partnerships with ViiV Healthcare and Tocagen are designed to strengthen Siemens’ competitive stance.
February 10, 2012 - MICHAEL FITZHUGH - Business - Business Strategy - Can the FDA Get California's Biotech Sector Growing Again?
Podcast: February 13, 2012
February 10, 2012 - Law/Policy - Economic Development - Astex Pharma Plummets after Advisory Panel Rejects the Use of Dacogen for Cancer
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 10, 2012 - Business - Trials and Tribulations - FDA Unveils Biosimilars Guidance
Draft guidelines reveal agency’s current thinking, solicit public comment.
February 10, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Medical Device Firms Bring In the Bucks
Medical Device Firms Bring In the Bucks
February 10, 2012 - MARIE DAGHLIAN - Finance - Deals - U.S. Lagging in Science and Technology Education
Study suggests a need to reform undergraduate science to add more STEM professionals.
February 09, 2012 - VINAY SINGH - Law/Policy - Healthcare Reform - Fixing Drug Development with the Wisdom of Crowds
Podcast: February 6, 2012
February 04, 2012 - Business - Business Strategy - AstraZeneca Axes 7,300 Jobs, 12 Percent of Workforce
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 03, 2012 - Business - Trials and Tribulations - FDA, Industry Urge Quick Passage of User Fee Renewal
First House hearing on PDUFA V skips fireworks, reflects general harmony.
February 03, 2012 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Federal Spending on Healthcare to Double by 2022
CBO warns policymakers will need to curb healthcare spending, grow revenue.
February 03, 2012 - DANIEL S. LEVINE - Health - Healthcare Economics - Medical Device Makers Trade Higher Fees Faster Review Times
Regulators and industry reach agreement in principle on reauthorization of MDUFA.
February 03, 2012 - MARIE DAGHLIAN - Law/Policy - Legislation - Big Pharma Declares War on Neglected Diseases
Partners pledge to coordinate efforts to accelerate progress.
February 03, 2012 - MICHAEL FITZHUGH - Health - Global Health - Two Life Sciences IPOs Debut Below Target
The arrival of Facebook’s long-awaited filing could encourage more companies to go public.
February 03, 2012 - MARIE DAGHLIAN - Finance - Deals - E-Prescriptions Could Improve Patient Adherence
New study shows potential to reduce healthcare expenditures by $240 billion.
February 03, 2012 - VINAY SINGH - Tech/Innovation - Information Technology - Americans Warming to Healthcare Reform Law
Survey finds Americans still divided over the legislation, but support for certain components slowly increasing.
February 02, 2012 - Health - Healthcare Reform - What's Driving Roche's $5.7 Billion Bid for Illumina
Podcast: January 30, 2012
January 27, 2012 - Business - Business Strategy - Strategic Outsourcing To Buoy European Drug Manufacturers
Shifting market dynamics will free, and then fill, capacity at facilities once kept busy by blockbusters, says consulting firm.
January 27, 2012 - MICHAEL FITZHUGH - Business - Business Strategy - Kaiser Connects Patients on the Go
New website and free app put lab results, prescription refill requests on mobile phones.
January 27, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Information Technology - Novo to Launch Type 1 Diabetes R&D; Center
Danish diabetes care giant hopes to leverage basic research to speed drug development.
January 27, 2012 - MICHAEL FITZHUGH - Business - Drug Development - Gates Gives Global Fund $750 Million Boost
Philanthropist says tough economic times are no excuse for cutting aid to the world’s poorest.
January 27, 2012 - Health - Public Health - Infinity Pharmaceuticals Tanks on Failed Cancer Drug Trial
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 27, 2012 - Business - Trials and Tribulations - Big Biotech Fuels M&A; Activity
Amgen and Celgene acquisitions add to growing list of biotech buys.
January 27, 2012 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Hitting the Target
Verastem goes public in an upsized IPO.
January 26, 2012 - MARIE DAGHLIAN - Finance - Deals - Can Pharma Cure its Social Anxiety Disorder?
Podcast: January 23, 2012
January 20, 2012 - Business - Direct-to-Consumer Advertising - Proteus Debuts Smart Pill in the United Kingdom
Partnership with pharmacy chain will be the first broad test of market demand for the company’s ingestible sensors.
January 20, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Technology - Russian Scientist Say Siberian Bacteria May Slow Aging
Frozen bug may prove to be a fountain of youth.
January 20, 2012 - MARIE DAGHLIAN - Tech/Innovation - Aging - Janssen’s San Diego Experiment
New labs provide a ‘no-strings-attached’ home for life sciences startups.
January 20, 2012 - MICHAEL FITZHUGH - Business - Business Strategy - Panel Drafts Audacious Plan to Combat Alzheimer’s Disease
Sets 2025 as a date to have effective treatment to prevent or treat the disease.
January 20, 2012 - DANIEL S. LEVINE - Law/Policy - Research - Renewable Energy Group IPO Prices Well Below Target Range
Biodiesel company raised $72 million in the first life sciences IPO of 2012.
January 20, 2012 - MARIE DAGHLIAN - Finance - Deals - Mobile Health App Revenue Perks Up
Despite regulatory and reimbursement questions, big opportunities remain.
January 20, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Pfizer, Medivation End Development of Alzheimer’s Drug
Dimebon, once highly touted, failed in a second late-stage trial.
January 20, 2012 - VINAY SINGH - Business - Drug Development - US Obesity Rates Hold Steady
New reports suggest that American’s might be adopting healthier lifestyles.
January 20, 2012 - Health - Obesity - Sanofi Scientist Pleads Guilty to Thefts
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 20, 2012 - Business - Trials and Tribulations - The February 2012 Issue of The Burrill Report
January 19, 2012 - The Burrill Report - Monthly - Biggest Market Movers
January 13, 2012 - Data Center - Data Center - Drugs in Bugs
With up to $125 million in committed funding, Warp Drive Bio will use genomics to discover and develop new drugs from natural products.
January 13, 2012 - MARIE DAGHLIAN - Finance - Deals - Genentech Partners with Xenon Pharmaceuticals in $646M Pain Pact
Deal highlights growing interest in personalized medicine approaches to drug development.
January 13, 2012 - MARIE DAGHLIAN - Finance - Deals - Forma Therapeutics Inks Alliance with Janssen Biotech
Tumor-focused deal expands Forma’s growing link with Big Pharma.
January 13, 2012 - MICHAEL FITZHUGH - Business - Dealmaking - Novartis to Ax 2,000 jobs after Tekturna Development Halted
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 13, 2012 - Business - Trials and Tribulations - Why Regenerative Medicine Might Fix Healthcare
Podcast: January 17, 2012
January 12, 2012 - Tech/Innovation - Regenerative Medicine - Flagship Ventures Launches $270 Million Fund
Life sciences companies see more venture capital coming their way.
January 12, 2012 - VINAY SINGH - Finance - Investment Funds - Bristol-Myers Squibb Buys Inhibitex for $2.5 Billion
Hepatitis C players remain hot targets
January 12, 2012 - VINAY SINGH - Finance - Mergers and Acquisitions - Life Sciences Venture Capital Financings Grew 9.3 Percent in 2011
Boston area and Minnesota see greatest gains, while San Diego and Seattle see a slowdown in funding.
January 11, 2012 - MARIE DAGHLIAN - Finance - Venture Capital - Biotech Investors Get Their War Face On for JPMorgan
Podcast: January 9, 2012
January 06, 2012 - Business - Markets - Teva Names A New CEO
Former BMS, Novartis exec moves into place with expectations for positive 2012.
January 06, 2012 - MICHAEL FITZHUGH - Business - Business Strategy - Biogen Idec and Isis Partner on Rare Spinal Disorder
Isis could gain as much as $299 million in the deal, plus royalties.
January 06, 2012 - VINAY SINGH - Business - Dealmaking - Costs of Off-label Marketing of Anti-Psychotic Grow for J&J;
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 06, 2012 - Business - Trials and Tribulations - Record Drug Shortages Plagued the Year Gone By
A new FDA rule and proposed legislation offer some hope for progress.
January 06, 2012 - MICHAEL FITZHUGH - Health - Healthcare Delivery - Medtronic Scores Digital Health Victory
Device giant joins movement toward greater convenience, better monitoring for diabetics.
January 06, 2012 - MICHAEL FITZHUGH - Tech/Innovation - Diabetes - Smith & Nephew and Essex Woodlands Form Joint Venture
New firm Bioventus will take over S&N;’s biologics business.
January 06, 2012 - MARIE DAGHLIAN - Finance - Deals - Forma Cuts $815 Million Deal with Boehringer to Discover New Cancer Drugs
Collaboration will focus on cancer-related protein-protein interactions.
January 05, 2012 - MARIE DAGHLIAN - Finance - Deals - Genentech: The Beginnings of Biotech
Podcast: January 3, 2012
December 30, 2011 - Business - Business Strategy - Fundraising in 2011
A visual breakdown of where the money went.
December 30, 2011 - Finance - Capital Markets - Deals for the Week Ending December 30, 2011
Table of announced transactions.
December 30, 2011 - Finance - Deals - Amgen and Watson Enter Biosimilars Collaboration
The $400 million deal focuses on oncology.
December 23, 2011 - VINAY SINGH - Business - Biosimilars - Ranbaxy will pay $500 million to settle issues with FDA
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 23, 2011 - Business - Trials and Tribulations - Even the Insured Forgo Care
Rising costs, stagnant wages maintain number of families struggling with medical bills.
December 23, 2011 - MICHAEL FITZHUGH - Health - Healthcare Affordability - Pharma's Incredibly Shrinking R&D; Budget
Podcast: December 27, 2011
December 22, 2011 - Tech/Innovation - Drug Development - Filling the Funding Gap
New VC firm set up to focus on early-stage therapeutic opportunities.
December 22, 2011 - MARIE DAGHLIAN - Finance - Early-Stage Finance - Widely-Used Estimate of Costs to Develop Drug May Be Conservative
Harvard study defends oft-cited number from Tufts.
December 22, 2011 - DANIEL S. LEVINE - Tech/Innovation - Global - DOJ Recovers Billions in Fraudulent Healthcare Charges
Whistleblowers are helping the agency expand its pursuit of false claims and police the pharmaceutical industry.
December 22, 2011 - MICHAEL FITZHUGH - Law/Policy - Legal - Metamark and Janssen Partner on Cancer
Hitting every milestone, Metamark would capture $365 million plus royalties.
December 22, 2011 - MICHAEL FITZHUGH - Business - Dealmaking - Takeda acquires Intellikine for $310M
Japanese drugmaker pursues drugs targeting red-hot cell signaling pathway.
December 22, 2011 - MARIE DAGHLIAN - Finance - Deals - The January 2012 Issue of The Burrill Report
Focus on: Aging
December 20, 2011 - The Burrill Report - Monthly - Venture Investors Grow Grim
Podcast: December 19, 2011
December 16, 2011 - Finance - Venture Capital - Congress Axes Rule that Restricted Innovation Funding
Change opens the door to new money for VC-backed companies.
December 16, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Funding Innovation - BioSante’s "Female Viagra" Fails Late-Stage Trials
Trial shows that placebo performs as well as LibiGel.
December 16, 2011 - VINAY SINGH - Health - Sex - Healthcare Reform Extends Coverage to 2.5M Young Adults
Affordable Care Act paying dividends.
December 16, 2011 - VINAY SINGH - Law/Policy - Healthcare Reform - AstraZeneca Strikes Pact with UK Medical Research Council
New collaboration gives academic community access to drug candidates.
December 16, 2011 - VINAY SINGH - Business - Drug Development - SEC Charges Stiefel Labs and its Former CEO with Fraud
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 16, 2011 - Business - Trials and Tribulations - Abbott Licenses Reata Pipeline for $400M
Even the partnering agreements are big in Texas.
December 16, 2011 - MICHAEL FITZHUGH - Business - Dealmaking - Amgen CEO and Research Chief to Step Down
California biotech promotes from within to fill leadership roles.
December 16, 2011 - MICHAEL FITZHUGH - Business - On the Move - Combining Talents to Fund Early Stage Companies
Venture firm and biopharma join together to invest in early-stage rare disease therapies.
December 16, 2011 - MARIE DAGHLIAN - Finance - Deals - Quintiles Launches China CRO
Kun Tuo to be a one-stop shop for biopharma R&D.;
December 16, 2011 - MARIE DAGHLIAN - Business - Business Strategy - Diagnostics Deals Heat Up
Podcast: December 12, 2011
December 09, 2011 - Finance - Mergers and Acquisitions - Sebelius Blocks OTC Sales of Morning After Pill to Adolescents
Unprecedented move overrides FDA’s finding the drug is safe and effective for girls 16 and younger.
December 09, 2011 - DANIEL S. LEVINE - Law/Policy - Regulatory - Pharmacyclics Scores Big with Janssen Biotech Deal
Drugmaker’s pharma tie-up could get it up to $975 for lead midstage blood cancer drug.
December 09, 2011 - MARIE DAGHLIAN - Finance - Deals - Samsung and Biogen Idec Form $300 Million Joint Venture
Agreement serves to promote the development, manufacturing, and marketing of biosimilars.
December 09, 2011 - VINAY SINGH - Business - Biosimilars - Qualcomm Formalizes Wireless Health Fund
Influx of tech heavyweights highlights anticipated opportunities.
December 09, 2011 - MICHAEL FITZHUGH - Finance - Venture Capital - UK Government Touts Plans for Boosting Drug Development
New funding and early access to experimental drugs could help industry and patients.
December 09, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Funding Innovation - Nursing Workforce Sees Surge in Young Aged Entrants
Trend helps ease worry about shortages in the United States.
December 09, 2011 - VINAY SINGH - Health - Healthcare Delivery - Merck Outlines $1.5 Billion Commitment to Expand R&D; in China
Pharma profiles blueprint for new R&D; facility in Beijing.
December 09, 2011 - MARIE DAGHLIAN - Business - Emerging Markets - Why Pfizer Might Have Been Better Off Without Lipitor
Podcast: December 5, 2011
December 02, 2011 - Business - Business Strategy AstraZeneca Adds $100 Million to MedImmune Ventures
Corporate venture capital for life sciences industry is a growing resource.
December 02, 2011 - VINAY SINGH - Finance - Venture Capital- UK’s NICE Nixes Novartis’ Lucentis for Diabetic Macular Edema
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 02, 2011 - Business - Trials and Tribulations - Supreme Court Takes On Drug Rep Pay Case
Liability for overtime could cost billions, say industry group.
December 02, 2011 - MICHAEL FITZHUGH - Law/Policy - Court Rulings - Obama Appoints New CMS Chief
Following Berwick resignation, White House picks his deputy to move ahead.
December 02, 2011 - Health - Healthcare Reform - Affymetrix Will Pay $330 Million to Acquire eBioscience
Deal boosts tools firm’s business in molecular diagnostics.
December 02, 2011 - MARIE DAGHLIAN - Finance - Deals - Amgen Issued New Patent on RA Drug Enbrel
Extension of exclusivity period could deal a blow to developers of biosimilars.
December 01, 2011 - MARIE DAGHLIAN - Business - Business Strategy Senators Question Pfizer’s Lipitor Deals
Pharma giant’s generic drug defense spurs request for explanation and documents.
December 01, 2011 - VINAY SINGH - Law/Policy - Generics and Biosimilars- New Bill Designed to Make IPOs Welcoming to Emerging Growth Companies
Senators say legislation would stimulate creation of jobs, but not at the expense of investor protections.
December 01, 2011 - DANIEL S. LEVINE - Law/Policy - Legislation - CVS Strikes Back at Co-Pay Coupons
Pharmacy benefit business tells its customers to stop covering certain drugs.
November 23, 2011 - VINAY SINGH - Health - Healthcare Economics - Will Alnylam's Results Reignite Fervor for RNAi
Podcast: November 28, 2011
November 23, 2011 - Business - Drug Development - Merck pays $950M to Settle Vioxx Criminal and Civil Settlement
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 23, 2011 - Business - Trials and Tribulations - Regeneron Challenges Genentech’s Lucentis
Newly approved Eylea offers more convenience at a better price.
November 23, 2011 - VINAY SINGH - Business - Business Strategy - Healthcare Companies Lobby To Avoid Cuts
Worried industry leads spending to minimize potential pain inflicted by deficit-cutting Supercommittee.
November 22, 2011 - DANIEL S. LEVINE - Law/Policy - Regulatory - Talking Turkey About Access to Medicines
Index of social responsibility is deeply flawed.
November 22, 2011 - PETER J. PITTS - Law/Policy - Commentary - Gilead Agrees to Buy Pharmasset for $11 Billion
Acquisition serves antiviral drug developer’s long-term aspiration to dominate untapped hepatitis C market.
November 22, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Pharma’s R&D; Costs Soar as Returns Fall
Study says industry will collaborate more in non-competitive areas to save money.
November 22, 2011 - DANIEL S. LEVINE - Tech/Innovation - Drug Development - Health Network Kicks Into High Gear
Cisco expands its role with next-generation health network.
November 22, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Rich Market Unfolds for Mobile Health in Asia
Mobile phone operators could realize $7 billion from monitoring and diagnostics by 2017.
November 22, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Portola Brings in Cash to Advance Anticoagulant
Program dumped by Merck, gets backing of Asian investors.
November 22, 2011 - MARIE DAGHLIAN - Finance - Deals - Where have all the VC's Gone?
Podcast: November 21, 2011
November 18, 2011 - Finance - Venture Capital - Canada Commits $58 Million to Genomics
Fifth phase of country’s initiative will focus on interdisciplinary projects.
November 18, 2011 - DANIEL S. LEVINE - Tech/Innovation - Genomics - FDA Revokes Avastin Approval in Breast Cancer
Drug not shown to be safe and effective in breast cancer patients.
November 18, 2011 - DANIEL S. LEVINE - Law/Policy - Regulatory - New Survey Finds Care is Often Poorly Coordinated
Sicker adults need better coordination of care, especially in the United States.
November 17, 2011 - VINAY SINGH - Health - Healthcare Delivery - The Need for Speed
Industry advocates seeking new support for rare disease drug developers.
November 17, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Pfizer Cuts Lipitor Deals to Fight Generics
Plan would result in some payers being unable to realize savings from the drug’s new competition for six months.
November 17, 2011 - MICHAEL FITZHUGH - Business - Business Strategy - Doctor Who Faked Drug Research Permanently Debarred
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 17, 2011 - Business - Trials and Tribulations - Biotechs Rake in the Cash in Mid-Stage Rounds
Three financings raise $200 million to advance technologies.
November 17, 2011 - MARIE DAGHLIAN - Finance - Deals - Clovis Oncology Raises $130 Million in IPO
Drug developer avoids a discount to complete offering.
November 16, 2011 - MARIE DAGHLIAN - Finance - Initial Public Offerings - WuXi Forms $50 Million Venture Fund
China’s largest CRO seeks window on innovation to ramp up its R&D.;
November 16, 2011 - MARIE DAGHLIAN - Business - Business Strategy - Supreme Court to Review Healthcare Law
Arguments slated for March 2012 with a June 2012 decision date set.
November 16, 2011 - VINAY SINGH - Law/Policy - Healthcare Reform - Geron Dumps Stem Cells for Cancer Focus
Trailblazer seeks shelter from tough economic environment, faster payoff for shareholders.
November 16, 2011 - MICHAEL FITZHUGH - Business - Business Strategy - The December 2011 Issue of The Burrill Report
Focus: Digital Health
November 14, 2011 - The Burrill Report - Monthly - The Ultimate Exit Strategy
Scale Venture Partners Stops Investing in Life Sciences to focus on technology investments.
November 11, 2011 - Vinay Singh - Business - Business Strategy - China’s Largest Biotech Plans IPO
Offering in Hong Kong could raise up to $2 billion.
November 11, 2011 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Suicide Switch
Inserted gene may improve safety of cell therapies by halting potentially deadly reactions.
November 11, 2011 - DANIEL S. LEVINE - Tech/Innovation - Stem Cells - NewLink Genetics Goes Public
Company completes offering during wild week on Wall Street.
November 11, 2011 - MARIE DAGHLIAN - Finance - Deals - Former Shanghai Pharmaceutical Exec Gets Suspended Death Sentence
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 11, 2011 - Business - Trials and Tribulations - Amylin and Lilly Part Ways on Byetta
Companies resolve legal dispute and terminate long-standing alliance on type-2 diabetes drug.
November 11, 2011 - MARIE DAGHLIAN - Business - Dealmaking - A Mississippi Victory as the Battle Over Stem Cell Research Rages on
Podcast: November 14, 2011
November 10, 2011 - Law/Policy - Regenerative Medicine - Embracing Risk as We Embrace Benefit
New strategies are needed for the 21st century.
November 10, 2011 - PETER J. PITTS - Law/Policy - Regulatory - Obama’s Healthcare Legislation Ruled Constitutional
District of Columbia Circuit Court of Appeals panel upholds measure in a 2-1 vote.
November 10, 2011 - VINAY SINGH - Law/Policy - Healthcare Reform - Antibiotic Prescriptions for Kids Extremely Common and Frequently Inappropriate
Study finds 10 million prescriptions a year written for conditions where the drugs are not indicated.
November 10, 2011 - DANIEL S. LEVINE - Health - Public Health - What a Growing and Aging World Mean for Healthcare
Podcast: November 7, 2011
November 04, 2011 - Health - Global Health - Pfizer's and Teva's Results Point to Shifting Demand
November 04, 2011 - VINAY SINGH - Finance - Drug Sales - Payment Disclosure Rules Still Unclear
Senators, companies criticize lack of direction on reporting potential conflicts.
November 04, 2011 - MICHAEL FITZHUGH - Law/Policy - Conflicts of Interest - Seeking to End Drug Shortages
Obama orders FDA and DOJ to act to reduce shortages of critical medicines.
November 04, 2011 - MICHAEL FITZHUGH - Law/Policy - Public Health - Encouraging Data Sends Medivation Soaring
Late-stage interim results for experimental prostate cancer drug promising, cast cloud over competitors.
November 04, 2011 - VINAY SINGH - Business - Drug Development - Mayo Researchers Look to Exploit Measles to Treat Cancer
Modified virus may offer a less toxic alternative to chemotherapy and radiation.
November 04, 2011 - DANIEL S. LEVINE - Tech/Innovation - Cancer - Sanofi Set to Pass Pfizer as Biggest Drug Company
Pfizer will fall to third place behind Novartis as best seller Lipitor loses patent protection.
November 04, 2011 - DANIEL S. LEVINE - Business - Drug Sales - Proposed Indian Pricing Scheme Could Slash Prices on Foreign Drugs
Drugmakers ready to oppose policy that some say could cut prices by as much as 90 percent.
November 04, 2011 - Business - Emerging Markets - GSK Reaches $3 Billion Settlement with U.S. over Criminal and Civil Investigations
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 04, 2011 - Business - Trials and Tribulations - A Novel Approach to Funding a Startup
Versant Ventures builds in a potential exit for its Quanticel investment by teaming up with Celgene
November 04, 2011 - MARIE DAGHLIAN - Finance - Deals - Roche Makes Germans an Offer It Hopes They Can’t Refuse
With a money-back guarantee, Roche moves to unburden payers worried about cancer drug’s efficacy.
October 28, 2011 - MICHAEL FITZHUGH - Business - Business Strategy - Cigna Agrees to Acquire HealthSpring for $3.8 Billion
Deal adds Medicare and senior care coverage to healthcare insurer’s business.
October 28, 2011 - VINAY SINGH - Finance - Mergers and Acquisitions - Targeted Therapeutics Get a Russian Boost
Rusnano invests in two biotechs using nanotechnology to develop highly selective drugs.
October 28, 2011 - MARIE DAGHLIAN - Finance - Deals - Biotie Therapeutics Breaks Off Plans to Buy Newron Pharmaceuticals
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 28, 2011 - Business - Trials and Tribulations - Biotech’s Access to Capital Difficult in Volatile Economic Times
Panelists debate changing business and venture models at BIO Investor Forum in San Francisco.
October 28, 2011 - MARIE DAGHLIAN - Finance - Business Models - BGI Establishes West Coast Beachhead with UC Davis Deal
Chinese genomics giant plans a joint genome center with the university.
October 27, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Research Common Asthma Drugs May Boost Health Risk for Children
FDA study shows higher hospitalization rates for children using LABAs.
October 27, 2011 - VINAY SINGH - Health - Drug Safety- Molecular Diagnostics Makers Face Tougher Standards for Payment
Podcast: October 31, 2011
October 26, 2011 - Law/Policy - Reimbursement - Novartis Trims Workforce to Fit a Changing World
High-cost workers to go as new jobs open in low-cost centers.
October 26, 2011 - MICHAEL FITZHUGH - Business - Business Development - Same Fight, New Ring
The FTC is taking its war against pay-for-delay agreements to the Senate’s super committee.
October 26, 2011 - MICHAEL FITZHUGH - Law/Policy - Legislation - Looking for Reassurance at the BIO Investor Forum
Podcast: October 24, 2011
October 21, 2011 - Finance - Capital Markets - Virtual Care Center, Venture Funds Support Telehealth Efforts
Efforts to lower healthcare costs and provide better care to Californians find new legal backing.
October 21, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Global - U.S. Health Care System Scores Poorly on National Scorecard
American system lags other developed countries in quality, access to care.
October 21, 2011 - VINAY SINGH - Health - Healthcare Reform - Abbott to Split into Two Independent Public Companies
Separation recognizes different businesses and opportunities.
October 21, 2011 - MARIE DAGHLIAN - Business - Business Strategy - Roche Buys Anadys for $230M
Deal brings Roche two hepatitis C candidates.
October 21, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Amgen to Cut 380 R&D; Jobs
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 21, 2011 - Business - Trials and Tribulations - EU High Court Bans Embryonic Stem Cell Patents
Critics of the decision say it will dull Europe’s competitive edge.
October 21, 2011 - MICHAEL FITZHUGH - Law/Policy - Court Rulings - AMAG Shareholders Reject Acquisition of Allos
Despite enthusiasm by executives, investors saw a different picture.
October 21, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Chinese National Pleads Guilty to Espionage
Scientist is indicted for theft of U.S. trade secrets.
October 21, 2011 - VINAY SINGH - Law/Policy - Legal - Zeltiq’s Debut Breaks Life Science IPO Doldrums
Financings also stage a comeback with several sizeable early-stage venture deals.
October 20, 2011 - MARIE DAGHLIAN - Finance - Deals - DNAnexus Nails $15M Venture Investment from Google and TPG
Bioinformatics company and its investors see big opportunity in helping manage big data sets.
October 16, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Genetics - Can California Protect a Bright Source of Job Growth
Podcast: October 17, 2011
October 14, 2011 - Law/Policy - Economic Development - Bayer Launches $860 Million Joint Venture with Russia’s Yunona Holdings
Russian government continues push to revamp its pharmaceutical and medical industries.
October 14, 2011 - VINAY SINGH - Business - Emerging Markets - The November 2011 Issue of The Burrill Report
Focus: Management
October 14, 2011 - The Burrill Report - Monthly - Researchers Correct Sickle Cell Disease in Mice
Protein therapy shows promise for eliminating symptoms of the blood disorder.
October 14, 2011 - VINAY SINGH - Health - Treatments - Medical Device Developers Attract Cash
Venture capital increases its funding of medical technology.
October 14, 2011 - MARIE DAGHLIAN - Finance - Venture Capital - Planning for Wild Success
Feds turn to the public seeking ideas for building biotech’s role in the economy.
October 13, 2011 - MICHAEL FITZHUGH - Law/Policy - Economic Development - Europe Warned on Slow Pace of GM Crop Approvals
Industry organization says backlog will impact EU food security.
October 13, 2011 - MARIE DAGHLIAN - Law/Policy - AgBio - NICE Says Cost of Bristol-Myers Melanoma Drug Too High
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 13, 2011 - Business - Trials and Tribulations - GlycoMimetics Inks Deal with Pfizer for Rare Disease Drug
Treatment for complication of sickle cell disease could net biotech up to $340 million.
October 13, 2011 - MARIE DAGHLIAN - Finance - Deals - Sing for Your Supper
NIH chief tries to inspire a chorus.
October 07, 2011 - DANIEL S. LEVINE - Tech/Innovation - Research - Former Cougar Biotechnology CEO Seeks to Repeat Success with Puma
With $55 million from former investors, Auerbach licenses Pfizer cancer drug.
October 07, 2011 - VINAY SINGH - Finance - Early-Stage Finance - Thriving in the Data Deluge
New infrastructure, standardization, and technical literacy key elements for finding meaning in genomics revolution.
October 07, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Personalized Medicine - German Law Has Companies Weighing Whether to Sell New Drugs in Europe's Largest Market
Podcast: October 10, 2011
October 06, 2011 - Business - Business Strategy - Avastin Loses Insurer Support in California
Blue Shield of California follows FDA’s lead in questioning drug’s value.
October 06, 2011 - MICHAEL FITZHUGH - Health - Cancer - FDA Outlines Innovation Plan
Agency seeks to accelerate personalized medicine drive, improve service to small business.
October 06, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Illumina Falls on Disappointing Sales
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 06, 2011 - Business - Trials and Tribulations - Contract Researcher PPD Goes Private
The $3.9 billion deal is one of the largest private equity buyouts of 2011.
October 06, 2011 - MARIE DAGHLIAN - Finance - Deals - Blame it on the FDA
VCs attribute decreased investment in medical innovation to regulatory hurdles.
October 06, 2011 - MARIE DAGHLIAN - Law/Policy - Regulatory - Pressures on Medtech Forcing New Approaches
Podcast: October 3, 2011
September 30, 2011 - Business - Business Strategy - A Tough Road for Health IT Innovators
With big opportunities, tech entrepreneurs need to push ahead.
September 30, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Drug Shortage Clipping Clinical Trials
Multiple problems and few clear solutions are hampering cancer drug testing.
September 30, 2011 - MICHAEL FITZHUGH - Law/Policy - Cancer - Boehringer Jumps Into Biosimilars
Growing clarity in U.S. creates a new opportunity.
September 30, 2011 - MICHAEL FITZHUGH - Business - Biosimilars - Death Panels, Talk Radio, and Unplugging Grandma
Study finds end-of-life discussions don’t affect survival rates.
September 30, 2011 - DANIEL S. LEVINE - Health - Healthcare Reform - DOJ asks Supreme Court Review of the Affordable Care Act
Administration seeks declaration that the law is constitutional.
September 30, 2011 - MICHAEL FITZHUGH - Law/Policy - Healthcare Reform - BARDA Steps Up Awards for Radiation Countermeasures
Five biotechs receive separate contracts to support drug development activities.
September 30, 2011 - MARIE DAGHLIAN - Finance - Deals - Teva Acquires Control of Teva-Kowa Joint Venture
Move gives the Israeli pharma a broader platform in Japan’s fast-growing generics market.
September 30, 2011 - MARIE DAGHLIAN - Business - Generics and Biosimilars - Oxygen Biotherapeutics Says Former CEO Allegedly Falsified Resume, Abused Post
The weekly round-up of failed trials, missed targets, and other business mishaps.
September 30, 2011 - Business - Trials and Tribulations - Cleveland BioLabs Enters Into a Joint Venture with Rusnano
Panacela will develop new drugs for cancer and infectious disease to commercialize in Russia.
September 30, 2011 - MARIE DAGHLIAN - Business - Emerging Markets - GE Establishes Joint Venture in Russia
Move is part of tech firm’s global expansion strategy.
September 23, 2011 - MARIE DAGHLIAN - Business - Emerging Markets - Hua Medicine Lands $50 Million to Finance Its Biotech Activities
Startup plans to be at the center of Chinese biopharmaceutical innovation and drug development.
September 23, 2011 - MARIE DAGHLIAN - Finance - Venture Capital - Biorenewables Makers File to Go Public
Biofuels and biochemicals companies look to public markets to finance scale-up activities.
September 23, 2011 - MARIE DAGHLIAN - Finance - Deals - Pac Bio Slashes Staff Fearing Slower-Than Expected Adoption Because of the Bad Economy
The weekly round-up of failed trials, missed targets, and other business mishaps.
September 23, 2011 - Business - Trials and Tribulations - Obesity Drugmakers Gain New Traction with FDA
Talks lead to a new trial for Orexigen and a slimmer indication for Vivus.
September 23, 2011 - MICHAEL FITZHUGH - Business - Drug Development - What Patent Reform Means for Biotech
Podcast: September 26, 2011
September 22, 2011 - Law/Policy - Legislation - Deficit Reduction Could Pain Biotech
President proposes trimming data exclusivity and nixing pay-for-delay.
September 22, 2011 - MICHAEL FITZHUGH - Law/Policy - Healthcare Reform - Report Says Non-communicable Diseases Pose Threat to Economic Health
As burden of heart disease, cancer, and diabetes spreads to low- and middle-income countries, the cost extends beyond lives.
September 22, 2011 - DANIEL S. LEVINE - Health - Global Health - VA Stops Using Avastin for Eyes, Boosting Prospects for Regeneron Drug
Eyela expected to win approval by mid-November.
September 22, 2011 - MICHAEL FITZHUGH - Business - Drug Development - Playing a Video Game Like Life is on the Line
Determined gamers put their heads together for science and win.
September 21, 2011 - MICHAEL FITZHUGH - Tech/Innovation - HIV/AIDS - NIH Initiatives Boost Biotech
Programs aim to ease licensing for startups, improve drug development.
September 21, 2011 - DANIEL S. LEVINE - Law/Policy - Research - Express Scripts-Medco Deal Gets Another Going-Over
House hearing adds to inquiry, but doesn’t derail companies’ confidence in a H1 2012 close.
September 16, 2011 - MICHAEL FITZHUGH - Business - Dealmaking - Pro Bono Bio Melds East and West
Anglo/Russian partnership will have humanitarian objective from the start.
September 16, 2011 - MARIE DAGHLIAN - Finance - Deals - New $100M Challenge Fund Seeks to Spark Cancer Innovation
GE partners with VCs to draw fresh ideas and new collaborations.
September 16, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Research - Genzyme Must Ration Cerezyme--Again
The weekly round-up of failed trials, missed targets, and other business mishaps.
September 16, 2011 - Business - Trials and Tribulations - Pushing Policies in a Changed Washington
Podcast: September 19, 2011
September 15, 2011 - Law/Policy - Legislation - Sharing the Responsibility
Partnerships, not partisanship, is the key to combating non-communicable diseases.
September 15, 2011 - PETER J. PITTS - Law/Policy - Commentary - A Sweet Sponge Becomes a Familiar Villain
Researchers say fast-paced and fantastical cartoons impair the minds of the young. I say, "Don't have a cow."
September 15, 2011 - DANIEL S. LEVINE - Health - Public Health - Patient, Know Thyself
HHS aims to improve individuals' access to their own data, while safeguarding it too.
September 15, 2011 - MICHAEL FITZHUGH - Law/Policy - Privacy - Global Diabetes Epidemic Continues to Rise
New numbers released by the International Diabetes Federation confirm growing incidence of the disease.
September 15, 2011 - MARIE DAGHLIAN - Health - Global Health - Public Misreads the Meaning of FDA Approval
Study suggests agency could do a better job of making public aware of what it knows and doesn’t know about new drugs.
September 15, 2011 - DANIEL S. LEVINE - Health - Drug Safety - Teva Pharmaceuticals Strengthens Its Innovation Pipeline
Generic drugmaker continues its push into branded products.
September 15, 2011 - MARIE DAGHLIAN - Finance - Deals - The October 2011 Issue of The Burrill Report
Focus: Personalized Medicine
September 14, 2011 - The Burrill Report - Monthly - Eisai Taps Outside Funding
New partnership adds to expanding SFJ Pharma portfolio
September 09, 2011 - MICHAEL FITZHUGH - Finance - Business Models - BARDA Funds Bioterror Countermeasures
Funding comes on eve of 10-year anniversary of 9-11 attacks.
September 09, 2011 - MARIE DAGHLIAN - Finance - Deals - GPhA's New CEO Faces a Range of Challenges
Podcast: September 12, 2011
September 08, 2011 - Law/Policy - Generics and Biosimilars - U.S. Investment in Health Research Remains Stagnant
Research advocacy group calls for sustained, strong investment in research.
September 08, 2011 - DANIEL S. LEVINE - Tech/Innovation - Research - Sanofi Projects Growth Despite Challenges
Emerging markets opportunities and Genzyme cost-cutting to provide breathing room.
September 08, 2011 - MICHAEL FITZHUGH - Business - Business Strategy - Merck Serono Raises Bet on F-Star
Pair agree to collaborate to discover and develop targeted biologics.
September 08, 2011 - MICHAEL FITZHUGH - Finance - Deals - Excess Weight as Young Adult Predicts Earlier Death
The extra pounds many people carry at age 25 may shorten their lives, even if they slim down when they’re older.
September 08, 2011 - Health - Obesity - Dendreon to Slash 500 Jobs as Part of Restructuring
The weekly round-up of failed trials, missed targets, and other business mishaps.
September 08, 2011 - Business - Trials and Tribulations - Roche and Evotec Enter Alzheimer’s Licensing Pact
Pharma regains rights to compound it had originally licensed in 2006.
September 08, 2011 - MARIE DAGHLIAN - Finance - Deals - Aurobindo Pharma Expands into Russia
Joint Venture with Diod will make and market generics and OTC drugs.
September 08, 2011 - MARIE DAGHLIAN - Business - Emerging Markets - Wild Swings of Market in August Rough Up Life Sciences IPOs
New issues turn from positive to negative as the class of 2011 now underperforming major market and biotech indices.
September 02, 2011 - - Finance - Initial Public Offerings - A Look at the Surge in FDA Approvals
Podcast: September 6, 2011
September 02, 2011 - Law/Policy - Regulatory - Dirty Laundry at the Hospital
Deadly pathogens frequently hitch a ride on the uniforms of doctors and nurses.
September 02, 2011 - MICHAEL FITZHUGH - Health - Infectious Disease - Taking Cancer Detection Where It’s Needed Most
Mobile device could deliver genetic analysis to developing nations.
September 02, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - Indian Pharma in the Spotlight
India’s Piramal looks for overseas biotechs at the same time that Takeda eyes Indian pharma companies.
September 02, 2011 - MARIE DAGHLIAN - Business - Business Strategy - FDA and Industry Find Common Ground on New Rules
Higher fees for drugmakers and plans to embrace new trends and technology define updated PDUFA agreement.
September 02, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - NuPathe Loses Half Its Market Cap after FDA Rejects Pain Patch
The weekly round-up of failed trials, missed targets, and other business mishaps.
September 02, 2011 - Business - Trials and Tribulations - GI Dynamics completes IPO in Australia
U.S. obesity device maker raises $85.3 million
September 02, 2011 - MARIE DAGHLIAN - Finance - Initial Public Offerings - FTC Reviews Impact of Authorized Generics
Commission sees deals between branded and generic drugmakers costly for consumers.
September 02, 2011 - MICHAEL FITZHUGH - Law/Policy - Generics and Biosimilars - Secondary Financings Dry Up
Public market deals slow to a trickle.
September 02, 2011 - MARIE DAGHLIAN - Finance - Deals - What the Market's Turmoil Means for Biotech Stocks
Podcast: August 29, 2011
August 26, 2011 - Finance - Capital Markets - Digital Health Startups Attract Venture Bucks
Companies merge healthcare and digital technology in transformative devices.
August 26, 2011 - MARIE DAGHLIAN - Finance - Deals - Pulling Together to Cut Costs
CMS pilot program seeks to get doctors and hospitals to keep the big picture in mind.
August 26, 2011 - MICHAEL FITZHUGH - Law/Policy - Healthcare Reform - Pfizer Wins Approval for New Lung Cancer Drug
FDA moving quickly on new approvals, paying special attention to targeted therapies.
August 26, 2011 - MICHAEL FITZHUGH - Business - Drug Development - Personalized Cancer Center Gets $30 Million Kick Start
New Johns Hopkins effort will speed development of targeted therapies.
August 25, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Personalized Medicine - Doctors May Need Extra Convincing on Biosimilars
Potential need for trials to support individual indications could drive up costs and stymie smaller companies.
August 25, 2011 - MICHAEL FITZHUGH - Health - Medical Practice - Sanofi Ventures into Nutraceuticals in India
Deal will facilitate creation of a consumer healthcare and wellness platform.
August 25, 2011 - MARIE DAGHLIAN - Business - Emerging Markets - Sequencing Tumors to Target Treatments
Complete Genomics will sequence pediatric cancer genomes in effort to find new therapies.
August 25, 2011 - MARIE DAGHLIAN - Business - Personalized Medicine - NIH Awards $25 Million to Leverage Genetics with EHRs
Researchers hope to turn electronic medical records into powerful tool to understand role of genes in disease and drug metabolism.
August 25, 2011 - DANIEL S. LEVINE - Tech/Innovation - Personalized Medicine - MedImmune Sues Abbott Alleging Breach of Contract
The weekly round-up of failed trials, missed targets, and other business mishaps.
August 25, 2011 - Business - Trials and Tribulations - Inventive Cancer Drugs Gain Approval
Roche and Seattle Genetics show innovation in battle against cancer.
August 20, 2011 - MICHAEL FITZHUGH - Business - Drug Development - Smoothing Personalized Medicine's Ragged Edge
Podcast: August 22, 2011
August 19, 2011 - Health - Personalized Medicine - Cytos Biotechnology Slashes 80 Percent of Workforce
The weekly round-up of failed trials, missed targets, and other business mishaps.
August 19, 2011 - Business - Trials and Tribulations - Drug Shortages Need Addressing Now
FDA requires funding and authority to address the problem.
August 18, 2011 - PETER J. PITTS - Law/Policy - Regulatory - FDA Nears Fee Agreement for Generics
Funding stability from fees could be good for both the agency and industry.
August 18, 2011 - MICHAEL FITZHUGH - Law/Policy - Generics and Biosimilars - FDA Issues Guidance on Biomarkers
Agency seeks to harmonize applications and reduce the burden on drugmakers.
August 18, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Shanghai Pharma Goes Shopping
Chinese drug distributor and manufacturer targets branded drugmaker in United States or Europe.
August 18, 2011 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Obama Announces $510 Billion for Advanced Biofuels
Initiative calls for partnership with private sector to fuel military and commercial transportation.
August 18, 2011 - MARIE DAGHLIAN - Tech/Innovation - Biofuels - Pharma and Biotech M&A; Activity Advances in First Half of 2011
Exits produce good returns to venture investors.
August 18, 2011 - MARIE DAGHLIAN - Finance - Deals - IPO Class of 2011 Takes Drubbing
Market turmoil takes its toil on biotechs that went public this year.
August 13, 2011 - DANIEL S. LEVINE - Finance - Initial Public Offerings - Startups Continue to Attract Venture Backing
Volatile week in capital markets sees little public deal flow.
August 12, 2011 - MARIE DAGHLIAN - Finance - Deals - The August 2011 Issue of
The Burrill Report
Focus: Bio-Renewables
August 11, 2011 - The Burrill Report - Monthly - Russia Gets Innovative
SynBio joint venture set up to create novel medicines
August 11, 2011 - MARIE DAGHLIAN - Business - Emerging Markets - Study Finds 29 New Genetic Variants Tied to MS
Many of the newly implicated genes are linked to other autoimmune diseases as well.
August 11, 2011 - DANIEL S. LEVINE - Health - Neurodegeneration - Med Device Industry Balks at IOM Advice to FDA
Podcast: August 15, 2011
August 11, 2011 - Law/Policy - Regulatory - Adventrx Tumbles on FDA’s Rejection of Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
August 11, 2011 - Business - Trials and Tribulations - Two Shots Are Better Than One
Long time partners collaborate to develop their cancer drugs in combination.
August 10, 2011 - MARIE DAGHLIAN - Business - Drug Development - Fraud and Errors Fuel Research Journal Retractions
The Wall Street Journal finds a 15-fold increase in the number of peer-reviewed studies withdrawn.
August 10, 2011 - DANIEL S. LEVINE - Tech/Innovation - Research - Government Backs Off Pursuit of Forest CEO
Looming war with industry over enforcement powers calmed, for now.
August 08, 2011 - MICHAEL FITZHUGH - Law/Policy - Legal - Pfizer Expands Academic Alliances in California
University of California, San Diego lands new research funding and closer industry tie.
August 08, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Research - Covance CEO Sees Integration Challenges for Competition
Pharmas’ desire to streamline pressures CRO consolidation.
August 05, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - WellDoc Rings Up Success with Diabetes Management App
Trial of WellDoc system shows positive results, but potential barriers remain.
August 05, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Digital Health - M&A; Spells Disaster for R&D;
Former global head of research & development for Pfizer bemoans cuts at Big Pharma, but broader innovation could benefit.
August 05, 2011 - DANIEL S. LEVINE - Finance - Research and Development - Smoking, Eating, and Drinking Beyond Their Years
Study suggests genes, not lifestyle, may be key to longevity.
August 05, 2011 - DANIEL S. LEVINE - Health - Aging - Celgene and Acceleron Expand Their Collaboration
New drug development deal adds program to treat anemia.
August 05, 2011 - MARIE DAGHLIAN - Finance - Deals - New Tax Credits for Biotechs Proposed
Bill aims to stimulate R&D; investments, job growth.
August 05, 2011 - MICHAEL FITZHUGH - Law/Policy - Economic Development - Dendreon Shares Plummet on Weak Provenge Sales
Doctors hesitate to adopt new cancer vaccine, slowing sales.
August 04, 2011 - MICHAEL FITZHUGH - Business - Drug Sales - Doctors Say They Are Ill-Prepared for Personalized Medicine
Podcast: August 8, 2011
August 04, 2011 - Business - Personalized Medicine - Shionogi Moves into China
Japanese pharma sees Chinese presence as necessary to achieve its long term goals.
August 04, 2011 - MARIE DAGHLIAN - Business - Emerging Markets - NICE Rejects Novartis Oral MS Drug in Draft Guidance
The weekly round-up of failed trials, missed targets, and other business mishaps.
August 04, 2011 - Business - Trials and Tribulations - Getting the Prevent Defense to Pay Off
Podcast: August 1, 2011
July 29, 2011 - Business - Personalized Medicine - Government Wins Stem Cell Victory
Federal judge rules Dickey-Wicker does not prohibit federal funding of human embryonic stem cell research.
July 29, 2011 - DANIEL S. LEVINE - Law/Policy - Regenerative Medicine - Big Pharma’s Falling R&D; Investment Helps Small Biotechs
As pharmaceutical giants cut their budgets for discovery, external partners picking up the slack.
July 29, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Research - U.S. Healthcare Spending to Hit $4.6 Trillion by 2020
Sector expected to account for nearly 20 percent of GDP.
July 29, 2011 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform - Different Take on Cancer Suggests Early Chance for Prevention
Unique chromosomal fingerprint, autonomy, suggests tumors are individual species.
July 29, 2011 - MICHAEL FITZHUGH - Health - Cancer - Gene Patents Upheld in Myriad Appeal
Court allows intellectual protections for isolated DNA to stand.
July 29, 2011 - MICHAEL FITZHUGH - Law/Policy - Legal - Boston Scientific Plans China Expansion
Medical device maker will boost its presence in rapidly expanding healthcare market.
July 29, 2011 - MARIE DAGHLIAN - Business - Emerging Markets - Cloud Control
BGI taps the power of networked computers and new sequencing techniques to analyze genomic data.
July 29, 2011 - MARIE DAGHLIAN - Tech/Innovation - Global - Horizon Pharma Goes Public
Company manages to debut just below its target price during a volatile week in the capital markets.
July 29, 2011 - MARIE DAGHLIAN - Finance - Deals - Merck to Cut Up to 13,000 Jobs by 2015
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 29, 2011 - Business - Business Development - Venture Investment Surges in Life Sciences
Increased exits spur more financings.
July 23, 2011 - MARIE DAGHLIAN - Finance - Venture Capital - Study Finds Disease Modifying MS Drug Too Costly
Analysis says modest benefits are delivered for more than eight times their value.
July 22, 2011 - DANIEL S. LEVINE - Health - Healthcare Economics - Halting a Brain Drain
Study suggests that lifestyle changes, preventative treatment could prevent half of Alzheimer’s cases.
July 22, 2011 - DANIEL S. LEVINE - Health - Neurodegeneration - M&A; in a Risk-Sharing Environment
Three startups are acquired for upfront cash and performance-based payments.
July 22, 2011 - MARIE DAGHLIAN - Finance - Deals - Merck Establishes Joint Venture with Simcere Pharmaceuticals
Partners seek to take on cardiovascular diseases and diabetes.
July 22, 2011 - MICHAEL FITZHUGH - Business - Emerging Markets - Sanofi Halts Trial of Key Drug as Regulators Examine Adverse Events
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 22, 2011 - Business - Trials and Tribulations - Express Scripts finds a match in $29.1 Billion deal to buy Medco
Companies confident they will be able to convince regulators the deal won’t wreck competition in the pharmacy benefit management market.
July 22, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Defining When a Medical App is a Regulated App
Podcast: July 25, 2011
July 21, 2011 - Law/Policy - Regulatory - What I Did on My Summer Vacation
New study finds family caregivers play a critical and growing role in providing healthcare.
July 21, 2011 - DANIEL S. LEVINE - Health - Healthcare Delivery - Project Runway
Companies lined up in the IPO Queue.
July 20, 2011 - Data Center - Data Center - FDA Issues Draft Guidance on Mobile Medical Apps
Agency is now soliciting public comment on whether the guidance is on target.
July 20, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - The July 2011 Issue of The Burrill Report
Half-Year Review
July 20, 2011 - The Burrill Report - Monthly - Novartis Eyes Potential Chinese IPO
Drugmaker may list on Shanghai’s planned international board.
July 16, 2011 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Expanding Personalized Medicine in Psychiatry
July 15, 2011 - Business - Personalized Medicine - FDA Wants Companion Diagnostics Approved with Paired Drugs
Draft guidance intended to facilitate the development of personalized medicines.
July 15, 2011 - DANIEL S. LEVINE - Law/Policy - Regulatory - Unlocking Health Trends in 140 Characters
Health researchers find way to tap Twitter to monitor the public.
July 15, 2011 - DANIEL S. LEVINE - Tech/Innovation - Digital Health - Supply of Essential Medicines Falls Short in U.S. Hospitals
Trouble getting medicines leading to rationing and higher drug costs.
July 15, 2011 - MICHAEL FITZHUGH - Health - Public Health - FDA Delivers Blow to Transcept Over Insomnia Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 15, 2011 - Business - Trials and Tribulations - Astellas Bets $35M on Vical Vaccine
Global exclusive makes room for co-promotion and potential $130M payout.
July 15, 2011 - MICHAEL FITZHUGH - Business - Dealmaking - Amgen Tries Micromet’s BiTE
Companies will collaborate on solid tumor targets.
July 15, 2011 - MARIE DAGHLIAN - Finance - Deals - Debt Fight Snares Pharmaceutical Pricing
PhRMA says proposals to cut government spending on drugs would threaten jobs.
July 14, 2011 - DANIEL S. LEVINE - Law/Policy - Legislation - Hot Tea and Coffee Could Fight MRSA
People who consumed the beverages were half as likely to have the antibiotic-resistant bacterial infection in their nasal passages.
July 14, 2011 - DANIEL S. LEVINE - Health - Wellness - Vigilance Pays Off
Colorectal cancer rates are falling with increased screening.
July 08, 2011 - MICHAEL FITZHUGH - Health - Cancer - Better Together
Pharmasset inks collaboration with Tibotec on hepatitis C combination therapy.
July 08, 2011 - MICHAEL FITZHUGH - Business - Drug Development - E-prescribing Is Not Error Free
Outpatient electronic prescribing systems don't cut out common mistakes.
July 08, 2011 - MARIE DAGHLIAN - Health - Drug Delivery - Innate Pharma Lands Major Collaboration with BMS
Early-stage deal will advance the pharma’s immune-oncology pipeline.
July 08, 2011 - MICHAEL FITZHUGH - Finance - Deals - Heart Failure Drug Natrecor Found To Be Ineffective
The weekly round-up of failed trials, missed targets, and other business mishaps.
July 08, 2011 - Business - Trials and Tribulations - TPG Capital Takes Immucor Private for $1.97B
Blood testing firm is bought out at 30 percent premium.
July 08, 2011 - MARIE DAGHLIAN - Finance - Deals - Nearing the Home Stretch
FDA, industry, and patient advocates have their say in Congressional hearing.
July 07, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Ensuring QB3 Innovation Creates Jobs
July 07, 2011 - Tech/Innovation - Research - Gene Therapy Awaiting FDA Greenlight to Begin HIV Trial
Calimmune, backed with $20 million from California’s stem cell agency, hopes to enter clinic in early 2012.
July 01, 2011 - DANIEL S. LEVINE - Health - HIV/AIDS - Capital Flows to Massachusetts Startups
Boston area life sciences firms raised almost $90 million in early stage rounds.
July 01, 2011 - MARIE DAGHLIAN - Finance - Deals - A Billion-Dollar "No" Vote for Genentech
FDA advisory board votes to revoke Avastin’s use to treat breast cancer.
June 30, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Comparative Effectiveness Research Brings Industry to a Defining Moment
Podcast: July 4, 2011
June 30, 2011 - Law/Policy - Comparative Effectiveness - China Renews Commitment to Biotechnology
Government will spend more than $300 billion to boost science and technology over the next five years.
June 29, 2011 - MARIE DAGHLIAN - Tech/Innovation - Global - Google Shutters Health Records Site
Despite high hopes, site fails to gain critical mass.
June 28, 2011 - MICHAEL FITZHUGH - Business - Digital Health - Genentech Options Forma’s Preclinical Cancer Program
Structured as a collaboration, the Roche subsidiary has an option to acquire the entire program.
June 28, 2011 - MARIE DAGHLIAN - Business - Finance - Stormy Weather
Declining R&D; and falling success rates cast cloud over pharma.
June 27, 2011 - DANIEL S. LEVINE - Tech/Innovation - Drug Development - Study Raises Concerns About New Risks From Actos and Avandia
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 27, 2011 - The Burrill Report - Business - Trials and Tribulations - Mutually Beneficial
Gilead and J&J;’s Tibotec strike a deal to develop once-daily HIV combination medicines.
June 27, 2011 - MICHAEL FITZHUGH - Business - Business Strategy - A Rare Disease Pioneer Scores $45 Million for New Company
Podcast: June 27, 2011
June 23, 2011 - Finance - Early-Stage Finance - Venture Capitalists Say IPO Activity Levels Too Low
Survey finds VCs around the globe still look to U.S. exchanges to provide healthy markets.
June 23, 2011 - DANIEL S. LEVINE - Finance - Initial Public Offerings - Vermont Law Blocking Prescription Data Mining Overturned
Supreme Court finds state law violates companies’ First Amendment rights.
June 23, 2011 - MICHAEL FITZHUGH - Law/Policy - Court Rulings - FDA Surveys Import Risks
Globalization and growing complexity demand a new model, agency says.
June 23, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Analysis of FDA Data Shows Average Review Time Up
Study finds 37 percent increase in days to days to premarket notification clearance since 2006.
June 23, 2011 - DANIEL S. LEVINE - Law/Policy - Regulatory - Abbott makes $85 Million Bet on Biotest
Deal adds depth to Abbott’s anti-inflammatory pipeline.
June 23, 2011 - MICHAEL FITZHUGH - Business - Business Development - Tesaro Secures $101 Million in Venture Capital
Investors bet on experienced team focused on promising later stage cancer drugs.
June 23, 2011 - MARIE DAGHLIAN - Finance - Early-Stage Finance - Doing What It Takes—Or Not
Allozyme enters reverse merger with Poniard to go public while Agendia withdraws its IPO.
June 23, 2011 - MARIE DAGHLIAN - Finance - Deals - GSK to Pay $40.8 Million to Settle Case Over Puerto Rico Plant
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 22, 2011 - Business - Trials and Tribulations - Drug Approvals
June 22, 2011 - Data Center - Data Center - Drug Approvals
June 22, 2011 - Data Center - Data Center - Tout Tweets
A feed of all the traffic relating to the BIO International Convention.
June 22, 2011 - Business - BIO International Convention - The June 2011 Issue of The Burrill Report
June 20, 2011 - The Burrill Report - Monthly - Why $25 Billion Just Doesn't Seem to Go That Far Anymore
Podcast: June 20, 2011
June 17, 2011 - Finance - Capital Markets - NIH Expands Support for Translational Research
New grants totaling $200M help move research discoveries to patients more quickly.
June 17, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Research - AstraZeneca Finding Its Footing in Russia
Research and manufacturing investments grow to match opportunities.
June 17, 2011 - MICHAEL FITZHUGH - Business - Emerging Markets - Glaxo Expands Presence in China
Pharma takes full control of its Chinese vaccine joint venture.
June 17, 2011 - MARIE DAGHLIAN - Business - Emerging Markets - Startup Snags Big Biotech Partner
Alios BioPharma could earn up to $1.5 billion in Vertex deal.
June 17, 2011 - MARIE DAGHLIAN - Finance - Deals - Merck Strikes Biosimilars Deal with Hanhwa
Companies will collaborate to commercialize generic version of Amgen’s Enbrel.
June 17, 2011 - MARIE DAGHLIAN - Business - Emerging Markets - Should FDA Stand for Fast Drug Approvals?
Study finds agency is quicker at approving cancer drugs than European counterpart.
June 17, 2011 - DANIEL S. LEVINE - Law/Policy - Regulatory - WHO Knows
Taking cues from international essential medicines list could improve Medicaid.
June 17, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - J&J; Exiting Drug-Eluting Stent Market
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 17, 2011 - Business - Trials and Tribulations - Losing Ground
Life expectancy in most U.S. counties falls behind the world’s healthiest nations.
June 16, 2011 - DANIEL S. LEVINE - Health - Public Health - Knowing is Half the Battle
Merck and Roche extend diagnostic collaboration.
June 10, 2011 - MICHAEL FITZHUGH - Business - Personalized Medicine - The ASCO Effect
Annual meeting of clinical oncologists is closely watched by Wall Street.
June 10, 2011 - MARIE DAGHLIAN - Finance - Capital Markets - Report Says Pfizer Plans to Cut Another $1 Billion in Annual Spending
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 10, 2011 - Business - Trials and Tribulations - Pfizer Launches Electronically Tracked Trial
Overactive bladder study allows patients to report in by phone, web.
June 10, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Clinical Trials - Ambit Puts Off Public Offering
Biotech ditches planned IPO and raises $30 million from venture investors.
June 10, 2011 - MARIE DAGHLIAN - Finance - Deals - NIH Backs Portable Brain Scanner with $5.7 Million Grant
GE and Mayo Clinic aim to bring down cost, expand availability of MRIs.
June 10, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Neurodegeneration - Supreme Court Ruling Delivers Lesson to Universities on IP Agreements
Podcast: June 13, 2011
June 09, 2011 - Law/Policy - Patents - Stick It!
Proteus Biomedical teams with Avery Dennison for patch-based wearable sensors.
June 09, 2011 - MARIE DAGHLIAN - Tech/Innovation - Digital Health - Square Peg in a Round Hole
Researchers make a promising step toward a male oral contraceptive, but would you trust a man to use it?
June 09, 2011 - DANIEL S. LEVINE - Health - Sex - UNICEF Promotes Vaccine Pricing Transparency
Several major pharmaceutical companies take steps to cut prices.
June 09, 2011 - DANIEL S. LEVINE - Health - Global Health - CBO Says Advertising Moratorium on New Drugs Will Have Little Effect
Proponents tout safety and cost benefits, but ads alert patients to availability of new drugs.
June 03, 2011 - DANIEL S. LEVINE - Law/Policy - Regulatory - Consult Your Physician
European geneticists give DTC gene test the cold shoulder.
June 03, 2011 - MICHAEL FITZHUGH - Health - Genomics P&G; Teams Up With ZeaChem For Bio-based Chemicals
Multi-year agreement aims to boost P&G;’s commitment to sustainable consumer products.
June 03, 2011 - MARIE DAGHLIAN - Business - Dealmaking- BMS and Roche Come Together to Treat Metastatic Melanoma
Pharmas will conduct combination studies with their respective cancer drugs.
June 03, 2011 - MARIE DAGHLIAN - Business - Dealmaking - Aveo Lines Up $15M Upfront in Deal With Centocor
Deal could yield $540M in milestone payments.
June 03, 2011 - MICHAEL FITZHUGH - Finance - Deals - GSK Searches Out Bright Ideas in Canada
Partners will advance selected projects during partnership.
June 03, 2011 - DANIEL S. LEVINE - Business - Drug Development - Synthetic Biology and Biofuels Collect the Cash
Intrexon and Enerkem get strong backing from investors.
June 03, 2011 - MARIE DAGHLIAN - Finance - Deals - Orexigen Halts Obesity Programs in the U.S. While Awaiting Regulatory Clarity
The weekly round-up of failed trials, missed targets, and other business mishaps.
June 03, 2011 - Business - Trials and Tribulations - Play It Again, Sam
Bill seeks to extend Therapeutic Discovery Project Grants
June 03, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Funding Innovation - Industry Says FDA is Forcing MedTech Innovation Overseas
June 02, 2011 - Law/Policy - Regulatory - Cutting Up Pfizer May Just Make A Big Mess
Report questions the wisdom of splitting the company in two.
May 27, 2011 - MICHAEL FITZHUGH - Business - Business Strategy - Rigel Refuels in $130M Offering
New funding will support R&D; for asthma and arthritis drugs.
May 27, 2011 - MICHAEL FITZHUGH - Finance - Deals - NIH Halts Trial of Abbott’s Niaspan Early
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 27, 2011 - Business - Trials and Tribulations - Solazyme IPO Prices Above Range
Industrial biotech firm rakes in $198 million to advance its renewable oil technology.
May 27, 2011 - MARIE DAGHLIAN - Finance - Deals - Facebook to Pharma: Comments Allowed
Social networking site says its pages must be an open forum for conversation.
May 27, 2011 - MARIE DAGHLIAN - Tech/Innovation - Social Media - Industry Readies to Descend on Washington for BIO Convention
Podcast: May 31, 2011
May 26, 2011 - Law/Policy - BIO International Conference - “Overwarning” May Obscure, Not Highlight, Drug Dangers
Study finds average of 70 adverse drug events listed on package inserts.
May 26, 2011 - DANIEL S. LEVINE - Health - Drug Safety - J&J; Unveils “Revitalized” Pharma Pipeline
Ambitious plans charted for expansions and approvals.
May 26, 2011 - MICHAEL FITZHUGH - Business - Drug Development - BIO Says It’s Reached Agreement with FDA on User Fees
Major hurdle is cleared for PDUFA renewal, which must still get sign-off from White House and move through the legislative process.
May 25, 2011 - DANIEL S. LEVINE - Law/Policy - Regulatory - Senate Panel Criticizes Sanofi Tactics to Delay Competition
Associations and doctor questioned alternatives to generic Lovenox following payments.
May 25, 2011 - MICHAEL FITZHUGH - Law/Policy - Generics and Biosimilars - Merck and Roche Strike Hepatitis C Pact
Partners will promote Victrelis together and research new treatments.
May 20, 2011 - MICHAEL FITZHUGH - Business - Marketing - Wall Street Looks for Signs of Life at ASCO
Podcast: May 23, 2011
May 20, 2011 - Finance - Research and Development - Stem Cell Setback
Immune system attacks cells expected to be well-tolerated
May 20, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Regenerative Medicine - Amylin Sues Lilly Over Boehringer Deal
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 20, 2011 - Business - Trials and Tribulations - Questioning Assumptions About Biotech Investing
Report finds biotech exits come faster and smaller than device exits in recent years.
May 20, 2011 - DANIEL S. LEVINE - Finance - Venture Capital - Cancer Drug Costs Rising Fast
Biosimilars years away from tempering trend.
May 20, 2011 - MICHAEL FITZHUGH - Health - Healthcare Economics - Takeda Expands Global Reach with $13.7 Billion Nycomed Buy
Deal tops strong week of life sciences M&A; activity.
May 20, 2011 - MARIE DAGHLIAN - Finance - Deals - FDA Approvals of Biologics Nearly Doubled in Past Decade
Study says it will be challenging to maintain that pace.
May 19, 2011 - MARIE DAGHLIAN - Law/Policy - Regulatory - Growth in Drug Sales Slow with Loss of Patents
Emerging markets strong areas of growth, but 80 percent of spending will be for generics.
May 19, 2011 - Health - Healthcare Economics - Cornering Japan's Generics Market
Teva paying $460 for Taiyo stake
May 16, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - An $800 Billion Genomics Payoff
Podcast: May 16, 2011
May 13, 2011 - Law/Policy - Genetics - Elan Sells Drug Unit to Alkermes for $960M
Sale lightens company’s debt load, sharpens focus.
May 13, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Nursing Homes Use of Antipsychotics on Elderly Raises Concerns
Potentially lethal off-label use costs taxpayers millions.
May 13, 2011 - DANIEL S. LEVINE - Health - Aging - Can You Hear Me Now? I’ve Fallen and I Can’t Get Up
Verizon Strikes Health Monitoring Deal
May 13, 2011 - MICHAEL FITZHUGH - Business - Digital Health - Placebo Hocus Pocus
Study suggests physicians see benefits in placebos, but are uneasy over their use.
May 13, 2011 - DANIEL S. LEVINE - Tech/Innovation - Healthcare - FDA to Issue Guidance on Biosimilars by Year End
Agency preparing review process and fee structure for reviews.
May 13, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Feds Seek $1 Billion from J&J; to Settle Risperdal Case
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 13, 2011 - Business - Finance - Collaborating with Non-Profits for Clinical Trials
Three companies partner to advance development of their drugs.
May 13, 2011 - MARIE DAGHLIAN - Finance - Deals - Panel Recommends Large-scale Study to Assess Alzheimer's Risk
Current evidence insufficient for associating behaviors with risk, panel says.
May 12, 2011 - MARIE DAGHLIAN - Health - Neurodegeneration - Venture Capitalist, Heal Thy Self
Firms explore new ways to fund startups.
May 11, 2011 - MARIE DAGHLIAN - Finance - Venture Capital - Teva Swoops in to Snag Cephalon for $6.8 Billion
Deal strengthens generic powerhouse’s branded business.
May 06, 2011 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Getting that R&D; Mojo Working
Pfizer CEO: Improving the company’s “innovative core” remains top priority.
May 06, 2011 - DANIEL S. LEVINE - Business - Business Strategy - If At First You Don't Succeed
Vivus seeks more limited approval for stymied obesity drug.
May 06, 2011 - MICHAEL FITZHUGH - Business - Drug Development - FTC: Pay-for-Delay Costing Taxpayers Billions
Agency report finds 60 percent increase in deals where pharma companies pay generic drugmakers to hold off entering the market.
May 06, 2011 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform - Report: Ranbaxy Could Pay More Than $1 Billion to Settle with U.S. Regulators
The weekly round-up of failed trials, missed targets, and other business mishaps.
May 06, 2011 - Business - Trials and Tribulations - Losing Biobucks as Pharma Reshuffles its Deck
Returning of rights becomes an unintended consequence of partners restructuring their R&D; budgets.
May 06, 2011 - MARIE DAGHLIAN - Finance - Deals - Room for Improvement
Studies comparing new drugs to existing ones are often not performed.
May 06, 2011 - MICHAEL FITZHUGH - Health - Healthcare Reform - Slick Trick
New biosensor uses antibodies to detect marine pollutants.
May 06, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Environment - Stem Cell Injunction Lifted, but Fight Remains
Podcast: May 9, 2011
May 05, 2011 - Law/Policy - Regenerative Medicine - J&J; Acquires Synthes for $21.3 Billion
Combination expands J&J; orthopedics portfolio.
April 29, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Making a Case for Biofuels
Report says they can contribute to significant greenhouse gas reductions.
April 29, 2011 - MARIE DAGHLIAN - Law/Policy - Biofuel - A Near-Tie
Study shows two Genentech drugs almost equally effective for eye disease.
April 29, 2011 - MICHAEL FITZHUGH - Law/Policy - Comparative Effectiveness - Intrexon Raises $66.9 Million to Advance Synthetic Biology
Venture capital flows to private companies as IPO exits are scarce.
April 29, 2011 - MARIE DAGHLIAN - Finance - Deals - Changing Medical Research through Social Media
Podcast: May 2, 2011
April 28, 2011 - Tech/Innovation - Digital Health - Fighting Parkinson's From Within
Lilly and Medtronic team up on implantable drug delivery device.
April 28, 2011 - MICHAEL FITZHUGH - Business - Business Development - Feds Turning up the Heat on Off-Label Marketing Violators
HHS Office of Inspector General considers excluding Forest Lab’s CEO from doing business with the government.
April 28, 2011 - DANIEL S. LEVINE - Law/Policy - Legislation - Aging and Lifestyle Take Global Toll
New WHO report finds deaths from noncommunicable diseases on the rise, with developing world hit hardest.
April 28, 2011 - DANIEL S. LEVINE - Health - Public Health - Par Pharmaceutical Settles Drug-Pricing Lawsuit for $153 Million
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 28, 2011 - Business - Trials and Tribulations - Answering an Epidemic in Russia
Sequella could get up to $50 million in licensing deal that benefits both parties.
April 27, 2011 - MARIE DAGHLIAN - Finance - Deals - Upcoming PDUFA Dates
April 25, 2011 - Data Center - Data Center - Upcoming PDUFA Dates
April 25, 2011 - Data Center - Data Center - SciClone Ramps Up in China with NovaMed Buy
Bigger portfolio, bigger sales force may cushion threats to earnings.
April 23, 2011 - MICHAEL FITZHUGH - Finance - Initial Public Offerings - BIO Sours on Patent Reform Legislation
Industry wants to kill amendment before floor vote.
April 22, 2011 - DANIEL S. LEVINE - Law/Policy - Patents - Study of Gilead HIV Drug to Prevent Infection Halted
Results disappoint, but company said it will still seek expanded approval in U.S. for use by gay men.
April 22, 2011 - DANIEL S. LEVINE - Business - Drug Development - Parents See Benefits to Testing Kids’ Genes
Study says pediatricians need to facilitate informed decision making.
April 22, 2011 - MICHAEL FITZHUGH - Health - Personalized Medicine - T-Cell Vaccine Developer Circassia Scores $98 Million
Deal is the second largest fundraising by a private European biopharmaceutical company this year.
April 22, 2011 - MARIE DAGHLIAN - Finance - Deals - Pfizer Says Patient Died from Experimental RA Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 22, 2011 - Business - Trials and Tribulations - Growth in Drug Sales Slows
Rate drops to 2.3 percent increase in 2010 as people make fewer visits to doctors and turn to generics.
April 21, 2011 - MARIE DAGHLIAN - Business - Drug Sales - VA Awards $1.4 Billion in Telehealth Contracts
Six companies selected to help deploy technology to improve care to vets.
April 21, 2011 - MARIE DAGHLIAN - Tech/Innovation - Digital Health - Pfizer Inks Agreement with Shanghai Pharma
Partners plan to launch “innovative product.”
April 21, 2011 - MICHAEL FITZHUGH - Business - Emerging Markets - Fighting Off Pharma's Demise
Podcast: April 25, 2011
April 21, 2011 - Business - Business Strategy - Capital Scorecard
April 18, 2011 - Data Center - Data Center - Avoiding a Medical Meltdown
Podcast: April 18, 2011
April 15, 2011 - Law/Policy - Healthcare Reform Endo Makes $2.9B Device Play
Acquisition of American Medical Systems diversifies urology offering.
April 15, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions- Viehbacher Wants to Buy Not Build
Sanofi CEO reiterates his plans to look outside the company for sources of innovation.
April 15, 2011 - DANIEL S. LEVINE - Business - Business Strategy - Obama’s Deficit Reduction Plan Includes Cuts in Health Care
Claims of $500 million in savings by 2023, more than $1 trillion by 2033.
April 15, 2011 - MARIE DAGHLIAN - Law/Policy - Healthcare Reform - A Plan for Cash
Personalized medicine startup, Blueprint Medicines, closes on $40 million round.
April 15, 2011 - MARIE DAGHLIAN - Finance - Deals - Dimebon Fails in Late Stage Huntington's Disease Trial
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 15, 2011 - Business - Trials and Tribulations - Pieris’ Anticalins Gain Traction
Deal is the German biotech’s third in seven months.
April 13, 2011 - MARIE DAGHLIAN - Finance - Deals - Drinking to Remember
Study sheds new light on addiction.
April 13, 2011 - Health - Public Health - GSK to Invest $84M in Egypt
Investment to expand local manufacture of consumer products.
April 13, 2011 - MICHAEL FITZHUGH - Business - Business Strategy - Larry Smarr Talks Digital Health
Mindshare's Fred Davis interviews the founding director of the California Institute for Telecommunications and Information Technology.
April 12, 2011 - Tech/Innovation - Digital Health - Amgen Doubles Down in Brazil
With $215M Bergamo buy, rights buyback, biopharma giant chasing growth.
April 09, 2011 - MICHAEL FITZHUGH - Business - Emerging Markets - Financing and Dealmaking Activity Soar in China
Podcast: April 11, 2011
April 08, 2011 - Business - Global Economy - Fine Dining
An unusual cross-border start-up wins $100 million in backing.
April 08, 2011 - DANIEL S. LEVINE - Finance - Business Models - StemCell Discontinues Batten Disease Trial for Lack of Enrollment
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 08, 2011 - Business - Trials and Tribulations - No Love for Biopharma IPOs
Tranzyme completes offering well below its hoped for price.
April 08, 2011 - MARIE DAGHLIAN - Finance - Deals - ASCO and CollabRx Team Up for Personalized Care
Partnership will develop online apps for planning cancer treatment.
April 07, 2011 - MARIE DAGHLIAN - Tech/Innovation - Cancer - Damned If You Do, Damned If You Don’t
Two studies look at the effects on mortality of working too hard or not working at all.
April 06, 2011 - DANIEL S. LEVINE - Health - Drug Delivery - Cephalon Rejects Hostile Bid
Company says Valeant undervalues assets and prospects.
April 06, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Pfizer Sells Capsugel to KKR for $2.4B
Focus on drug discovery and development drives portfolio review.
April 06, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Getting Back on Track
Podcast: April 4, 2011
April 02, 2011 - Business - Business Strategy - Valeant goes hostile with $5.7B bid for Cephalon
Canadian company pressures Cephalon for faster decision.
April 01, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Gilead Sciences Partners with Yale University
Multi-year deal to discover new cancer therapies.
April 01, 2011 - MARIE DAGHLIAN - Business - Business Strategy - Omeros Knee Surgery Drug Fails in Late-Stage Trial
The weekly round-up of failed trials, missed targets, and other business mishaps.
April 01, 2011 - Business - Trials and Tribulations - Pharma Companies Disclose Millions Paid to U.S. Doctors
Voluntary reporting accelerates ahead of new requirements
April 01, 2011 - MICHAEL FITZHUGH - Law/Policy - Conflicts of Interest - Biota Lands Major BARDA Contract
U.S. government sees promise in Aussie flu drug.
April 01, 2011 - MARIE DAGHLIAN - Finance - Deals - Think It, Do It
California team is developing brain-machine interfaces.
March 31, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Neurodegeneration - Obama Outlines U.S. Energy Security Plan
President pledges support for development of advanced biofuels.
March 31, 2011 - MARIE DAGHLIAN - Law/Policy - Biofuel - Biosimilars Present Opportunities and Challenges to Russia
If country hopes to export these medicines, a 21st century, state of the art, internationally recognized and harmonized regulatory system will be a fundamental requirement.
March 28, 2011 - PETER J. PITTS - Law/Policy - Commentary - BioConference Live Interview with G. Steven Burrill
A discussion about Biotech 2011-Life Sciences: Looking Back to See Ahead
March 25, 2011 - Business - Business Strategy - Why Big Pharma's Got Executive Compensation All Wrong
Podcast: March 28, 2011
March 25, 2011 - Finance - Executive Compensation - California Joins Whistleblower Lawsuit against BMS over Alleged Kickbacks to Docs
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 25, 2011 - Business - Trials and Tribulations - U.S. and Brazil Expand Agreement to Include Aviation Biofuels
Brazillian industry group calls development an encouraging step toward the end of tariff that keeps corn-derived ethanol competitive with sugar-cane derived fuel.
March 25, 2011 - MARIE DAGHLIAN - Law/Policy - Biofuel - NIH Announces New Strategic Plan to Combat Diabetes
Stakeholders tapped to develop roadmap for preventing, treating and finding a cure.
March 25, 2011 - MARIE DAGHLIAN - Tech/Innovation - Diabetes - Religious Groups Tell Pharma to Reel in Prices
Shareholder activists call on companies to tie pricing increases to inflation.
March 25, 2011 - MICHAEL FITZHUGH - Business - Drug Sales - Uncovering Healthcare’s Hidden Costs
A year after reform becomes law, study finds consumers spend billions not captured in government reporting.
March 25, 2011 - DANIEL S. LEVINE - Health - Healthcare Reform - Cephalon Beefs Up its Cancer Pipeline
Acquisition of Gemin X will add experimental treatment for lung cancer.
March 25, 2011 - MARIE DAGHLIAN - Finance - Deals - Procter & Gamble and Teva Forming OTC Drug Venture
Companies seek growth from emerging markets, brand recognition.
March 25, 2011 - MICHAEL FITZHUGH - Business - Business Strategy - BMS Wins FDA Approval for Melanoma Drug
Treatment is first shown to extend life for people with deadliest form of skin cancer.
March 25, 2011 - MICHAEL FITZHUGH - Business - Business Development - Gene Therapy Shows Promise in Treating Parkinson’s Disease
Neurologix’ novel drug improves patients’ symptoms in mid-stage study.
March 19, 2011 - MARIE DAGHLIAN - Tech/Innovation - Gene Therapy - Alzheimer's Fuels a Healthcare Crisis
Podcast: March 21, 2011
March 18, 2011 - Health - Neurodegeneration - Pfizer Recalls Pain Drug Acquired Through King Deal
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 18, 2011 - Business - Trials and Tribulations - Unrealized Savings
Use of $4 generic drug programs could collectively spare patients nearly $6 billion a year in costs, study finds.
March 18, 2011 - Health - Healthcare Affordability - Betting on Results
Cigna and EMD Serono sign first outcomes-based multiple sclerosis medication contract.
March 18, 2011 - MARIE DAGHLIAN - Business - Business Strategy - Limiting Payoffs
Changing face of industry threatens hubs.
March 18, 2011 - MICHAEL FITZHUGH - Business - Economic Development - Human Genome Sciences on the Prowl
Enters licensing deal with FivePrime for novel anti-cancer biologic following its lupus drug success.
March 18, 2011 - MARIE DAGHLIAN - Finance - Deals - Startups Rake in the Cash
Converting waste to renewables heats up.
March 18, 2011 - MARIE DAGHLIAN - Finance - Deals - Brand Name Drug Prices Rise Faster than Medical Inflation
Generic drugs fall at an annual rate of 2.6 percent since 2006.
March 16, 2011 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform - Alzheimer’s Toll Grows
Incidence of the disease could triple by 2050 without new medical breakthroughs.
March 16, 2011 - DANIEL S. LEVINE AND MICHAEL FITZHUGH - Health - Neurodegeneration - Heretical Mathematics: Why R&D; Cost May Be Overstated
Podcast: March 14, 2011
March 11, 2011 - Business - Drug Development - Healthy Eating for Two
A poor maternal diet during pregnancy can have lasting impact.
March 11, 2011 - MICHAEL FITZHUGH - Health - Diabetes - Gates Foundation Pours $10 million into Liquidia
Charitable support funds next-generation vaccine technology.
March 11, 2011 - MICHAEL FITZHUGH - Finance - Venture Capital - AstraZeneca Enters into $68.5 Million Multi-State Pharmaceutical Settlement
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 11, 2011 - Business - Trials and Tribulations - Lupus Drug Wins FDA Approval
Human Genome and Glaxo could capture up to $1B in annual sales.
March 11, 2011 - MICHAEL FITZHUGH - Business - Drug Development - A Finger Prick Test to Measure Cardiovascular Risk
Deal flow dominated by medical technology developers.
March 11, 2011 - MARIE DAGHLIAN - Finance - Deals - A Step Closer to Regulation
FDA advisory panel calls for physician supervision of direct-to-consumer genetic tests.
March 11, 2011 - MARIE DAGHLIAN - Law/Policy - Regulatory - Obscuring Financial Ties
Studies of studies can hide conflicts-of-interest with drugmakers.
March 11, 2011 - Tech/Innovation - Research - Relatively Worse
Americans have higher rates of most chronic diseases than English
March 11, 2011 - Health - Public Health - Smoothing Fine Lines and Wrinkles
biofuels developer Solazyme will sell its anti-aging creams on QVC.
March 11, 2011 - MARIE DAGHLIAN - Business - Business Strategy - Not Tonight, I Had a Headache
Non-steroidal anti-inflammatory drugs linked to risk of erectile dysfunction.
March 04, 2011 - Health - Sex - Getting Rewarded to Stay Well
HHS announces $100 million in Affordable Care Act grants to prevent disease.
March 04, 2011 - MARIE DAGHLIAN - Law/Policy - Healthcare Reform - Daiichi Sankyo Acquires Plexxikon
Japanese pharma gains cancer drugs in potential $935 million deal.
March 04, 2011 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Communicating Cost-Think
Everything that reduces short-term costs is defined as a benefit to the patient.
March 04, 2011 - PETER J. PITTS - Law/Policy - Commentary - Looking Back to See Ahead
Podcast: March 7, 2011
March 04, 2011 - Business - Business Strategy - Enhancing the Truth
Plastic surgery group suggested spin for implant-related cancer.
March 04, 2011 - MICHAEL FITZHUGH - Health - Public Health - Diabetics Die Earlier than Non-Diabetics
Disease is associated with premature death from various causes.
March 04, 2011 - MICHAEL FITZHUGH - Health - Diabetes - Don Jones Talks Digital Health
Mindshare's Fred Davis interview the Qualcomm executive.
March 04, 2011 - Tech/Innovation - Digital Health - Amylin’s Bydureon Fails in Head-to-Head Match with Victoza
The weekly round-up of failed trials, missed targets, and other business mishaps.
March 03, 2011 - Business - Trials and Tribulations - Takeda Enters Schizophrenia Partnership
Pharma joins its Japanese compatriots seeking outside innovation.
March 03, 2011 - MARIE DAGHLIAN - Finance - Deals - A Supply Chain Reaction
Podcast: February 28, 2011
February 25, 2011 - Business - Business Strategy - Gilead makes $600 million play for Calistoga
Promising mid-stage cancer drug draws interest.
February 25, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Comparison Shopping
Bipartisan group of senators pushes to allow drug reimportation.
February 25, 2011 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform - FDA Not Ready to Approve Protalix’s Gaucher Disease Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 25, 2011 - Business - Trials and Tribulations - Samsung and Quintiles Team Up to Make Biosimilars
Electronics powerhouse forges into biosimilars.
February 25, 2011 - MARIE DAGHLIAN - Finance - Deals - Cell Phone Use Affects Brain Metabolism
Health consequences are unknown though.
February 25, 2011 - MARIE DAGHLIAN - Health - Cancer - Out of School
Firm closes $100 million venture fund focused on startups based on university technology.
February 25, 2011 - DANIEL S. LEVINE - Tech/Innovation - Funding Innovation - Forest Nabs Clinical Data for $1.2 Billion
Appetite for new acquisitions still strong, Forest says.
February 24, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Astellas strikes $1.3B Cancer Deal with Aveo
Stronger ties support both partners’ ambitions.
February 18, 2011 - MICHAEL FITZHUGH - Finance - Deals - It's a Deal
Sanofi-Aventis will make Genzyme its rare disease center of excellence.
February 18, 2011 - MARIE DAGHLIAN - Finance - Deals - Failure is the Norm
Study sheds new light on U.S. drug approval rates.
February 18, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Drug Development - Why Pharma's Future Will Be Selling Results
Podcast: February 21, 2011
February 17, 2011 - Business - Business Strategy - Hard Hit to Soft Drinks
Caramel coloring in colas and other dark beverages may contain carcinogens.
February 17, 2011 - MARIE DAGHLIAN - Health - Wellness - Paying Attention to Neglected Diseases
Greater investment being made, but funding shifts away from products to basic research as public sector plays a greater role.
February 17, 2011 - DANIEL S. LEVINE - Health - Global Health - A Generic Argument
Obama budget seeks to speed the entry to market for generic drugs and biosimilars.
February 17, 2011 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform - Budget Increases Proposed for Health Agencies
FDA, NIH, NSF budgets grow in Obama proposal.
February 17, 2011 - MICHAEL FITZHUGH - Law/Policy - Innovation - Merck Serono Withdraws EMEA Application to Market Oral MS Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 17, 2011 - Business - Trials and Tribulations - Biotech back in the positive column
For the week ending February 11, 2011
February 14, 2011 - Finance - Initial Public Offerings - Gevo Goes Public
Renewable chemicals and fuels maker raises $107 million.
February 11, 2011 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Lilly CEO criticizes pace of R&D;
New bonuses will reward drug approvals.
February 11, 2011 - MICHAEL FITZHUGH - Business - Business Strategy - Quest for savings hits FDA, NIH
Research and regulation budgets face cuts in budget proposal.
February 11, 2011 - MICHAEL FITZHUGH - Law/Policy - Legislation - Biotech IPOs Flow
Four life sciences companies make their market debut.
February 11, 2011 - MARIE DAGHLIAN - Finance - Deals - Mannkind Slashes Staff
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 11, 2011 - Business - Trials and Tribulations - Props for the Public-Sector
Biotech tools and policy changes turn federal labs and universities into engines of drug discovery.
February 10, 2011 - DANIEL S. LEVINE - Tech/Innovation - Drug Development - Transforming Healthcare Bit by Bit
Podcast: February 14, 2011
February 10, 2011 - Health - Digital Health - Diet Soda—Risks Could Outweigh Rewards
Studies link artificially sweetened drinks and salt to increased risk of vascular events, including stroke.
February 10, 2011 - MARIE DAGHLIAN - Health - Cardiovascular - Danaher bids $6.8 billion for Beckman Coulter
Acquisition could yield efficiencies in competitive diagnostics market.
February 09, 2011 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Tufts seeks cash, recognition from drugmakers
School launches new partnering institute and website
February 09, 2011 - MICHAEL FITZHUGH - Business - Drug Development - Searching for a Faster Exit
Podcast: February 7, 2011
February 04, 2011 - Finance - Business Models - U.K. Could Save $324 Million with Generic Heart Drug
National Health System faces mandate to do more with less.
February 04, 2011 - MICHAEL FITZHUGH - Health - Healthcare Reform - Epocrates’ IPO Has Strong Market Reception
Digital health firm is one of five life sciences companies out the gate this week.
February 04, 2011 - MARIE DAGHLIAN - Finance - Deals - Biotech Billionaire Buys Digital Health Company Vitality
Startup’s device reminds patients to take their medications.
February 03, 2011 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - What A Dog’s Nose Knows
Cancer-sniffing canines may point the way to new means of early detection.
February 03, 2011 - DANIEL S. LEVINE - Tech/Innovation - Diagnostics - AstraZeneca Makes Foray into Comparative Effectiveness
Deal with WellPoint subsidiary fleshes out real-world evidence on drugs.
February 03, 2011 - DANIEL S. LEVINE - Business - Comparative Effectiveness - Pfizer Slashes R&D; Spending
Company looks to partners as it narrows therapeutic focus.
February 03, 2011 - MICHAEL FITZHUGH - Business - Drug Development - Jury Nails J&J; with $482 Million Patent Infringement Verdict
The weekly round-up of failed trials, missed targets, and other business mishaps.
February 03, 2011 - Business - Trials and Tribulations - New Hurdle for Orexigen
FDA rejects diet pill and calls for additional, expensive study.
February 02, 2011 - MICHAEL FITZHUGH - Business - Drug Development - Stem Cells for Cash, Jobs
California agency touts 25k new jobs, $200M in tax revenue.
January 28, 2011 - MICHAEL FITZHUGH - Business - Economic Development - Amgen Buys Cancer Vaccine maker BioVex
Deal worth $1 billion with milestones.
January 28, 2011 - MICHAEL FITZHUGH - Finance - Deals - Biofuels and Biochemicals Companies Rake in the Cash
Investments support renewable fuels and chemicals projects.
January 28, 2011 - MARIE DAGHLIAN - Finance - Deals - Pfizer Embraces New Model for Drug Development
Leading medical research centers in New York join Pfizer’s Center for Therapeutic Innovation.
January 27, 2011 - DANIEL S. LEVINE - Business - Drug Development - Feds Recover $4 Billion in Healthcare Fraud
DOJ and HHS boast record year of recoveries.
January 27, 2011 - DANIEL S. LEVINE - Law/Policy - Legal - Brawl Over Exclusivity Heats Up
Senators push FDA to avoid delays in bringing biosimilars to market.
January 27, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Smoking and Overeating Are Bad for You—Later
Improvements in lifespans in the United States fall behind their peers.
January 27, 2011 - MARIE DAGHLIAN - Health - Public Health - The (Medical) Revolution Will Be Televised
Podcast: January 31, 2011
January 27, 2011 - Tech/Innovation - Digital Health - Arena Pharmaceuticals Slashes Workforce by 25 Percent
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 27, 2011 - Business - Trials and Tribulations - FDA Rejects MannKind's Inhaled Insulin
Agency wants additional trials before approving company's Afrezza.
January 21, 2011 - MICHAEL FITZHUGH - Business - Business Development - States Failing to Curb Smoking-Related Illness
FDA and new healthcare reform act praised for tough stance on tobacco.
January 21, 2011 - MICHAEL FITZHUGH - Health - Cancer - Medical Technology Innovation Shifting to Emerging Markets
Podcast: January 24, 2011
January 21, 2011 - Tech/Innovation - Global - Going Global
Harbor BioSciences will have its drugs developed by a large Chinese government-owned pharmaceutical.
January 21, 2011 - MARIE DAGHLIAN - Finance - Deals - GSK Sets Aside $3.4 Billion Over Avandia Liabilities
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 21, 2011 - Business - Trials and Tribulations - Biodefense Investments Shift to Detection
Pentagon shifts focus from treatment of bad bugs to identifying them.
January 20, 2011 - MICHAEL FITZHUGH - Tech/Innovation - Biodefense - Sanford-Burnham Pushes New Role in J&J; Collaboration
Institute will work with drug giant to develop new drugs for Alzheimer’s and psychiatric disorders.
January 20, 2011 - DANIEL S. LEVINE - Tech/Innovation - Drug Development - Pfizer Taps Theraclone on Cancer, Infectious Disease R&D;
Potential for $632 million in milestones, plus royalties
January 19, 2011 - MICHAEL FITZHUGH - Finance - Deals - Dying to Go to Switzerland
Some in the country want changes to liberal assisted suicide law that they fear is making the country a haven for those seeking to die.
January 19, 2011 - DANIEL S. LEVINE - Law/Policy - Public Health - DuPont to Acquire Danisco
for $6.3 Billion
Combination would create industrial biotech powerhouse.
January 15, 2011 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Lilly, Boehringer Collaborate on Diabetes
Drugmakers’ pact covers up to five therapeutics.
January 15, 2011 - MICHAEL FITZHUGH - Business - Dealmaking - Merck Discontinues One Study of Experimental Anticlotting Drug, Narrows a Second
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 14, 2011 - Business - Trials and Tribulations - Epizyme and GSK to Pursue Cancer, Other Diseases
Alliance tied to $630 million in milestone payments.
January 14, 2011 - MICHAEL FITZHUGH - Finance - Deals - U.S. Cancer Cost Could Exceed $200 Billion by 2020
NIH projects annual tab to hit at least $158 billion.
January 14, 2011 - DANIEL S. LEVINE - Law/Policy - Regulatory - Building a Better Bird
Researchers genetically modify chickens to prevent spread of avian flu.
January 14, 2011 - DANIEL S. LEVINE - Tech/Innovation - Infectious Disease - Life Science Companies Exude Confidence at Annual Confab
Deal flows boost positive mood.
January 14, 2011 - MARIE DAGHLIAN - Finance - Deals - Making Cancer Research Personalized and Actionable
Podcast: January 17, 2011
January 13, 2011 - Health - Digital Health - Sanofi Enters Collaboration with UCSF
French pharmaceutical giant hopes to capture innovation from biomedical powerhouse.
January 13, 2011 - DANIEL S. LEVINE - Tech/Innovation - Research - Merck BioVentures Enlists Parexel
Dedicated Parexel unit will support development and strategy.
January 12, 2011 - MICHAEL FITZHUGH - Business - Biosimilars - JPMorgan Raises the Curtain on 2011
Podcast: January 10, 2011
January 07, 2011 - Finance - Capital Markets - Europeans Rein in the Cash
Life sciences companies begin the New Year with stronger financial positions.
January 07, 2011 - MARIE DAGHLIAN - Finance - Deals - Xoma Lands Deep-Pocketed French Partner
Servier to pay up to $505 million for experimental antibody to treat diabetes and other conditions.
January 06, 2011 - MICHAEL FITZHUGH - Business - Dealmaking - Life Sciences Venture Capital Flows in 2010
Regional breakdown shows most money goes to San Francisco Bay Area, but Boston area sees greatest gains.
January 06, 2011 - MARIE DAGHLIAN - Finance - Venture Capital - A Shock to the Heart
Study says many defibrillator implants are unnecessary.
January 06, 2011 - MICHAEL FITZHUGH - Health - Medical Devices - A Stalled Revolution
An outdated reimbursement system hampers the promise of personalized medicine.
January 06, 2011 - DANIEL S. LEVINE - Tech/Innovation - Diagnostics - Indian Patent Office Allows Generic Versions of Abbott’s Kaletra to Be Sold
The weekly round-up of failed trials, missed targets, and other business mishaps.
January 06, 2011 - Business - Trials and Tribulations - When NICE News Isn’t So Nice for Roche
UK advisory body will consider whether to allow the use of Avastin to treat wet age-related macular degeneration.
January 05, 2011 - DANIEL S. LEVINE - Law/Policy - Regulatory - FDA Deputy Commissioner Sharfstein Resigns
Takes job as Maryland’s top public health official.
January 05, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Hard Slog for Drugmakers
The number of 2010 approvals drops compared to 2009.
January 04, 2011 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Policy Victories of 2010 and the Battles Ahead in the New Year
Podcast: January 3, 2011
December 31, 2010 - Law/Policy - Legislation - Life Sciences Companies Raise Record Amounts of Capital
Venture financings more than double while public companies go for debt.
December 31, 2010 - MARIE DAGHLIAN - Finance - Deals - Gazing into his Crystal Ball
G. Steven Burrill offers his predictions for 2011.
December 30, 2010 - Business - Business Strategy - Sanofi-Aventis Signs $800 Million Cancer Drug Deal
Avila Therapeutics' targeted drug technology adds another arrow to Sanofi’s quiver for targeting cancer.
December 23, 2010 - MARIE DAGHLIAN - Finance - Deals - Novartis Invests $500 million in Russia’s Healthcare Industry
Pharma will build a new manufacturing plant and expand its R&D; efforts in the country.
December 23, 2010 - MARIE DAGHLIAN - Business - Finance - REVA Medical Debuts—in Australia
Outlook for IPOs next year is hopeful.
December 23, 2010 - MARIE DAGHLIAN - Finance - Deals - Prometheus Ruling Boosts Patents on Diagnostics
Podcast: December 27, 2010
December 22, 2010 - Law/Policy - Patents - Chronic Fatigue Alleged Culprit Questioned
New research shows virus linked to the disease is a lab contaminant.
December 22, 2010 - Health - Chronic Fatigue Syndrome - Brave Combo
Sanofi and Merck Serono to jointly study paired experimental cancer therapies as the FDA issues new guidance for codevelopment of two or more experimental drugs for use in combination.
December 22, 2010 - DANIEL S. LEVINE - Law/Policy - Regulatory - Pfizer and Adolor End Collaboration to Develop Pain Meds
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 22, 2010 - Business - Trials and Tribulations - Queensland’s Next Smart Move
Further growth of the industry will be facilitated by the establishment of a life sciences industry organization.
December 21, 2010 - MARIO PENNISI - Partner Content - Partner Content - Pondering Synthetic Biology's Future
Commission finds much work ahead to define boundaries, debate.
December 21, 2010 - MICHAEL FITZHUGH - Tech/Innovation - Bioethics - Why You Will Soon Spit on Your Blackberry
The Burrill Report's Publisher G. Steven Burrill discusses the transformation of medicine.
December 21, 2010 - Tech/Innovation - Digital Health - Sanofi Taps Former NIH Head to Lead R&D;
Retooling aligns leadership with new development model.
December 17, 2010 - MICHAEL FITZHUGH - Business - Drug Development - What a Judge's Ruling Means to Healthcare Reform
Podcast: December 20, 2010
December 17, 2010 - Law/Policy - Healthcare Reform - Soda Taxes Fall Flat
Modest impacts predicted for the middle class waistline.
December 17, 2010 - MICHAEL FITZHUGH - Health - Obesity - FDA to Revoke Avastin’s Approval as Breast Cancer Treatment
Off label use will be allowed, but insurance companies likely won’t pay for it.
December 17, 2010 - DANIEL S. LEVINE - Law/Policy - Regulatory - Outgoing EMEA Chief Criticizes Pharma’s R&D;
European Medicines Agency’s Lonngren says research and development efforts yield inadequate results and often fail to target areas of greatest need.
December 17, 2010 - DANIEL S. LEVINE - Tech/Innovation - Drug Development - Ramius’ Persistence Pays Off
Cypress Biosciences finally says yes to a many times spurned suitor.
December 17, 2010 - MARIE DAGHLIAN - Finance - Deals - Intercell Slashes R&D; After Vaccine Failure
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 17, 2010 - Business - Trials and Tribulations - Worries Freeze Lilly Melanoma Trial
Trials of tasisulam for other cancers will continue.
December 16, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Charles River Makes Additional Cuts
Investor pressure inspires planned asset sale.
December 15, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Amgen Drug Slows Cancer’s Spread to Bones
Expanded use could significantly boost market.
December 14, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Kindler Out, Read In at Pfizer
Podcast: December 13, 2010
December 10, 2010 - Business - Business Strategy - Putin Strengthens Russian Drug Industry
Prime Minister promises $3.9 billion to modernize Russia’s pharmaceutical and medical sector.
December 10, 2010 - MARIE DAGHLIAN - Law/Policy - Emerging Markets - OMG UR SO FAT
Mobile phones and social networks could be just what the doctor ordered.
December 10, 2010 - DANIEL S. LEVINE - Health - Digital Health - Cephalon Makes Big Bet on Stem Cells
Company enters global licensing agreement and takes equity stake in Mesoblast in deal worth up to $1.7 billion.
December 10, 2010 - MICHAEL FITZHUGH - Finance - Deals - States Now Fund Majority of Human Embryonic Stem Cell Research
Most of $1.3 billion spent went to fund projects that were eligible under federal rules.
December 10, 2010 - DANIEL S. LEVINE - Law/Policy - Regenerative Medicine - Contrave Wins Backing of FDA Panel
Victory for Orexigen and Takeda bring obesity drug a step closer to market.
December 10, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Reaching Out to China’s Sick
Ideal Life and Novatech launch massive health monitoring program.
December 10, 2010 - MICHAEL FITZHUGH - Health - Digital Health - Drug Discovery Center Wins NIH Approval
Goal is to better link basic research to drug discoveries.
December 10, 2010 - MICHAEL FITZHUGH - Tech/Innovation - Drug Development - DOJ Reaches $421 Million False Claims Act Settlement with Three Companies
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 10, 2010 - Business - Trials and Tribulations - Ramius Offers to Acquire Cypress Bioscience—Again
Cypress shares rise 20 percent on the possibility of a sale.
December 10, 2010 - MARIE DAGHLIAN - Finance - Deals - China Forces Drug Price Cuts
Facing runaway inflation, maximum prices are set.
December 03, 2010 - MICHAEL FITZHUGH - Business - Emerging Markets - GSK Adds $129 million to Theravance Stake
New investment could provide extra boost for Relovair.
December 03, 2010 - MICHAEL FITZHUGH - Finance - Deals - Merck’s Makes Insulin Play
Pharma acquires MIT spinout in a deal potentially worth more than $500 million.
December 03, 2010 - MARIE DAGHLIAN - Finance - Deals - J&J; and GE Enter Alzheimer’s Collaboration
Two companies seek to develop new means of detecting the neurodegenerative disease at its earliest stages.
December 03, 2010 - Business - Diagnostics - Pushing for Prevention
Government announces its new health promotion and disease prevention agenda.
December 02, 2010 - MARIE DAGHLIAN - Health - Wellness - As Battle Readies, Industry, Public Question User Fees
Podcast: December 6, 2011
December 02, 2010 - Law/Policy - Regulatory - Life Built with Arsenic
New microbe expands our understanding of biology.
December 02, 2010 - MICHAEL FITZHUGH - Tech/Innovation - Research - Advisory Votes Against Expanding Use of GSK’s, Merck’s Prostate Drugs
The weekly round-up of failed trials, missed targets, and other business mishaps.
December 02, 2010 - Business - Trials and Tribulations - Survey Points to Fight Ahead over FDA User Fees
Life Sciences companies and consumers show opposing concerns and shared distrust for the FDA as renewal of legislation moves to center stage in the policy ring.
December 01, 2010 - DANIEL S. LEVINE - Law/Policy - Regulatory - Court Orders Destruction of GM Sugar Beets
Judge finds government and Monsanto rushed to illegally plant genetically engineered crop before a final Environmental Impact Statement was completed.
December 01, 2010 - MARIE DAGHLIAN - Law/Policy - Litigation - Stem Cell Trial Gets FDA Go-Ahead
Advance Cell Technology to test safety of eye disease treatment.
November 24, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Eternal Sunshine of the Tetris Mind
Playing Tetris may diminish post-traumatic flashbacks.
November 24, 2010 - MICHAEL FITZHUGH - Tech/Innovation - Research - U.S. Diabetes Cost Could Hit $3.4 trillion by 2020
Massive intervention, better patient compliance needed says insurer.
November 24, 2010 - MICHAEL FITZHUGH - Health - Diabetes - Preventing HIV Infection with a Pill
Results of a new study could potentially change strategies to slow the global epidemic.
November 24, 2010 - MARIE DAGHLIAN - Health - HIV/AIDS - Hey Now, You're a Rock Star
Podcast: November 29, 2010
November 24, 2010 - Law/Policy - Regulatory - A Global Healthcare Crisis
WHO report says 100 million are pushed into poverty each year by medical bills.
November 24, 2010 - Law/Policy - Global Health - November Biotech IPOs Fizzle
Offerings debut with little fanfare.
November 24, 2010 - MICHAEL FITZHUGH - Finance - Initial Public Offerings - Roche Terminates Metabasis HCV Alliance
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 24, 2010 - Business - Trials and Tribulations - Med Device Giants Snap Up a Pair of Start-Ups
The acquisitions will augment the cardiovascular offerings of Medtronic and Boston Scientific.
November 24, 2010 - MARIE DAGHLIAN - Finance - Deals - Making an Omelette
As negotiations over PDUFA V heat up, the divide between the agency and industry takes center stage.
November 24, 2010 - PETER J. PITTS - Law/Policy - Commentary - Roche Drops Alnylam Alliance
Major reorganization will cut or transfer 6,300 jobs.
November 19, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Two Biotechs Fail to IPO
GM’s offering dwarfs all others during a busy week for initial offerings.
November 19, 2010 - MARIE DAGHLIAN - Finance - Deals - StemCells Seeks Human Clinical Trials in Spinal Cord Injury
Podcast: November 22, 2010
November 18, 2010 - Business - Drug Development - When Fat is Good for Heart Attack Patients
Adipose-derived stem cells may be safe to boost cardiac function after acute attack.
November 18, 2010 - Business - Drug Development - Bayer to Cut 4,500 Jobs
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 18, 2010 - Business - Trials and Tribulations - Pfizer Seeks to Accelerate Drug Development
Partnership with UCSF aims to speed the translation of discoveries into therapies.
November 17, 2010 - MARIE DAGHLIAN - Tech/Innovation - Drug Development Medicare Committee Supports Provenge Coverage
Outside experts back effectiveness in controversial review.
November 17, 2010 - MICHAEL FITZHUGH - Law/Policy - Reimbursement- Take That Back
Study finds U.S. scientists significantly more likely to publish fake research.
November 17, 2010 - Tech/Innovation - Research - Medical Errors Hurt 1 in 7 Medicare Patients
Consumer group says report points to an “alarming rate” and calls for mandatory reporting requirements.
November 17, 2010 - Health - Medical Errors - Lupus Drug Wins FDA Panel Backing
Vote lends new hope to lupus sufferers, investors.
November 16, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Complete Genomics Slashes Price to Go Public
Lukewarm reception carries over into early trading.
November 12, 2010 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Obesity Spreading in Emerging Economies
Governments need to take immediate action, warns the OECD.
November 12, 2010 - MARIE DAGHLIAN - Health - Obesity - FDA Gets Graphic with Smokers
FDA wants to require cigarette packages to carry harsh images of the effects of smoking.
November 12, 2010 - DANIEL S. LEVINE - Law/Policy - Public Health - HGS Lupus Drug Nears Review
FDA staff flags concerns, dents value of Human Genome Sciences shares.
November 12, 2010 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Japan’s Otsuka Plans IPO
The $2.8 billion offering would make it the world’s largest initial public offering in the biopharmaceutical sector.
November 12, 2010 - MARIE DAGHLIAN - Finance - Deals - Bioenergy Companies Looking to Big Oil and BRIC
Partnerships seen as key to success in a tough environment.
November 11, 2010 - MARIE DAGHLIAN - Tech/Innovation - Biofuels - Moody’s Downgrades Eli Lilly
Ratings slip adds to a growing burden.
November 11, 2010 - MICHAEL FITZHUGH - Business - Capital Markets - Republicans Get Ready to Play Healthcare Reform Jenga
Podcast: November 15, 2010
November 11, 2010 - Law/Policy - Healthcare Reform - Provenge Review Brightens Dendreon’s Outlook
Government assessment shows vaccine to be moderately effective.
November 11, 2010 - MICHAEL FITZHUGH - Law/Policy - Reimbursement - Novartis Pulls the Plug on Antisoma Drug Trial
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 11, 2010 - Business - Trials and Tribulations - Therapeutic Discovery Project Grants Begin to Flow
More than $32 million has been awarded in the first two days of announcements.
November 05, 2010 - MARIE DAGHLIAN - Finance - Government Funding - Lilly Makes Diabetes Beachhead on the Mainland
Drugmaker opens new research center that puts focus on China.
November 05, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Inside Job
Protein tags viruses for destruction.
November 05, 2010 - MICHAEL FITZHUGH - Health - Infectious Disease - Gutting Healthcare Reform
Senate Republican leader lays out strategy to cripple healthcare reform.
November 05, 2010 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform - Hearing Aid
With Republicans in control of the House, get ready for a long list of hearings on healthcare reform and the FDA.
November 05, 2010 - PETER J. PITTS - Law/Policy - Commentary - FDA rejects Biodel’s Diabetes Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
November 05, 2010 - Business - Trials and Tribulations - Pushing into China
Swiss biopharma Nycomed buys major stake in Chinese firm.
November 05, 2010 - MARIE DAGHLIAN - Finance - Deals - A U.S. Policy Reversal on Gene Patents
Podcast: November 8, 2010
November 04, 2010 - Law/Policy - Patents - Data Fraud Allegation Decks Mannkind
Lawsuit trims share price as FDA decision approaches.
November 04, 2010 - MICHAEL FITZHUGH - Law - Litigation - Moving Regulatory Science Forward
FDA partners with University of Rochester to streamline the development of pain-reducing drugs.
November 04, 2010 - MARIE DAGHLIAN - Tech/Innovation - Drug Development - Pacific Biosciences Goes Public
DNA sequencing company debuts in the middle of its expected range.
October 29, 2010 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Sanofi Makes a Big Push in China
October closes with almost $1 billion in IPOs, $3 billion in M&A; activity, and potentially $3 billion in partnering deals.
October 29, 2010 - MARIE DAGHLIAN - Finance - Deals - Changing role for NICE
Value-based pricing gains favor in the UK.
October 28, 2010 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Yanking Pharma's Supply Chain
Podcast: November 1, 2010
October 28, 2010 - Business - Business Strategy - Report: Biogen Idec Planning Cost Cutting Measures
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 28, 2010 - Business - Trials and Tribulations - With the Elections Almost Over, BIO Gets Ready to Launch Its Campaign
Trade group gets ready to make its case to Congress for extension and expansion of the Therapeutic Discovery Project Credit.
October 28, 2010 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform - Crash (and Burn) Diet
FDA seeks more data on safety as it denies Vivus’ request for marketing approval of Qnexa.
October 28, 2010 - MARIE DAGHLIAN - Business - Drug Development - What Does Pharma Want From Social Media?
Rather than wishing for FDA guidance, we need to burn the midnight oil and work harder to make healthcare communications via social media a reality.
October 28, 2010 - PETER J. PITTS - Law/Policy - Commentary - Wage Gap Among Docs Needs Closing
Study finds specialists earn as much as 52 percent more than primary care docs, a disparity that could exacerbate shortage of GPs.
October 27, 2010 - DANIEL S. LEVINE - Health - Healthcare Reform - The Original Wonder Drug Strikes Again
The lowly aspirin may cut the risk of death for men with prostate cancer.
October 27, 2010 - DANIEL S. LEVINE - Tech/Innovation - Cancer - Laurels for MacroGenics
Pfizer and Boehringer separately provide fresh funds.
October 27, 2010 - MICHAEL FITZHUGH - Finance - Deals - Slim Hopes
Lorcaserin failure points to heavy regulatory scrutiny obesity drugs face.
October 26, 2010 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Sanofi-Aventis Enters Collaboration with Harvard
Move represents ongoing strategy to externalize R&D; for the French pharmaceutical.
October 22, 2010 - DANIEL S. LEVINE - Business - Business Strategy - Amylin Diabetes drug disappoints
FDA tells the company it won’t approve Bydureon without further study of cardiovasular risks.
October 22, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Aegerion Pharmaceuticals Goes Public
Development-stage biotech prices well below expectations to get its offering done.
October 22, 2010 - MARIE DAGHLIAN - Finance - Deals - MacroGenics and Lilly Antibody Fails in Late-Stage Diabetes Trial
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 22, 2010 - Business - Trials and Tribulations - Biofuels Can Revive Rural Economy
Series of measures will promote production of renewable fuels and create jobs.
October 22, 2010 - MARIE DAGHLIAN - Law/Policy - Biofuel - Why Medtech Needs to Reinvent Itself
Podcast: October 25, 2010
October 21, 2010 - Business - Business Strategy - Pfizer’s Big Generics Bet
Biosimilars look like an opportunity in a crisis.
October 21, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Bundling Cancer Care Costs
UnitedHealthcare pilots a new approach to cost-cutting.
October 21, 2010 - MICHAEL FITZHUGH - Health - Healthcare Reform Placebo Effected
Researcher says it’s tough to know the effect of controls on clinical trials because their ingredients are usually not disclosed.
October 21, 2010 - DANIEL S. LEVINE - Tech/Innovation - Clinical Trials- Reversing Depression with Gene Therapy
Study finds the restoration of a single gene in a small area of the brain in mice points to promise of the therapy in man.
October 21, 2010 - DANIEL S. LEVINE - Tech/Innovation - Gene Therapy - Pfizer Pinches King for $3.6 Billion
Expansion of pain franchise, strategic alignment drive deal.
October 15, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Doctors More Likely to Report Drug Side Effects with EHRs
Incorporating adverse event reporting into electronic health records provides easy way to report problems to FDA.
October 15, 2010 - Health - Information Technology - Synosia Therapeutics in Potential $745 Million Alliance with UCB
Pharma continues to tap biotech for innovation.
October 15, 2010 - MARIE DAGHLIAN - Finance - Deals - Lilly Obeys Its Thirst for Exploration
Sprite may aid effectiveness of anticancer drug.
October 14, 2010 - MICHAEL FITZHUGH - Tech/Innovation - Cancer - Exelixis Deepens Ties to BMS
New agreements land $60 million for Exelixis, with potential for $505 million more.
October 14, 2010 - MICHAEL FITZHUGH - Business - Dealmaking - FDA Threatens Prosecution of Drug Executives
Agency looks to harsher measures to dissuade off-label promotion of drugs.
October 14, 2010 - DANIEL S. LEVINE - Law/Policy - Legal - A Call to Arms for Personalized Healthcare
Podcast: October 18, 2010
October 14, 2010 - Law/Policy - Personalized Medicine - Eli Lilly Scraps Late-Stage Head and Neck Cancer Drug
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 14, 2010 - Business - Trials and Tribulations - Biotechs Move To Be Lean and Mean
Money in the bank is no guarantee against job cuts.
October 14, 2010 - DANIEL S. LEVINE - Business - Business Strategy - Behind the Magic 8-Ball
Can biotech companies learn to be disciplined in the face of success?
October 08, 2010 - DANIEL S. LEVINE - Business - Finance - Emerging Markets Bright Spot of Growth for Pharmaceuticals
China, the world’s third-largest market, to grow at least 25 percent in 2011.
October 08, 2010 - DANIEL S. LEVINE - Business - Drug Sales - A Potential Fountain of Youth
Amino acid supplement makes mice live longer.
October 08, 2010 - MARIE DAGHLIAN - Tech/Innovation - Aging - Emerging Biotechs Grapple with Financing Challenges
Podcast: October 11, 2010
October 08, 2010 - Finance - Capital Markets - Short lives, Big Bills
Poor health care is trimming longevity, study finds.
October 08, 2010 - MICHAEL FITZHUGH - Health - Healthcare Reform - Novartis to Take $590 Million Charge as It Halts Development of Two Drugs
The weekly round-up of failed trials, missed targets, and other business mishaps.
October 08, 2010 - Business - Trials and Tribulations - Hostile Could Become the Name of the Game
Sanofi goes hostile while major Crucell shareholders express displeasure.
October 08, 2010 - MARIE DAGHLIAN - Finance - Deals - Shareholders Fire at Crucell
Management rejects criticism that Johnson & Johnson takeover bid too low.
October 08, 2010 - MICHAEL FITZHUGH - Finance - Deals - Fast-forward for flu vaccine
Novartis taps Venter to speed flu vaccine production.
October 08, 2010 - MICHAEL FITZHUGH - Business - Dealmaking - Getting Specific on Safety
New FDA rule aims to sharpen reports for better signal to noise ratio.
October 07, 2010 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Amyris completes IPO
Company prices below expectations but rises in aftermarket trading.
October 01, 2010 - MARIE DAGHLIAN - Finance - Deals - Court Ruling Increases Pressure on Sanofi
Generic competition adds pressure to buy Genzyme.
September 30, 2010 - MICHAEL FITZHUGH - Business - Dealmaking - Embryonic Stem Cell Research Funding Gets a Reprieve
U.S. appeals court overturns lower court’s injunction on federally funded research.
September 30, 2010 - MARIE DAGHLIAN - Law/Policy - Litigation - Finding Biomarkers for Drug-Induced Serious Adverse Events
Public-private partnership enters the second stage of effort to identify predictive genetic markers of rare adverse reactions to existing medications.
September 30, 2010 - Health - Drug Safety - Seeing an Opportunity in Biosimilars
Podcast: October 4, 2010
September 30, 2010 - Business - Business Strategy - Endo snaps up Qualitest for $1.2 billion
Acquisition builds out pain franchise and generics lineup.
September 30, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Cypress and Ramius Renew Battle
Biotech and hedge fund lock horns over control.
September 30, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Sanofi Forges Agreement with Covance Worth Up to $2.2 Billion
The French pharmaceutical giant continues to look beyond its own walls to fill the void from drugs going off-patent.
September 30, 2010 - DANIEL S LEVINE - Business - Business Strategy - Novartis to Pay $422.5 Million to Settle Criminal and Civil Allegations with U.S. Attorney’s Office
The weekly round-up of failed trials, missed targets and other business mishaps.
September 30, 2010 - Business - Trials and Tribulations Barcoding Life
International initiative aims to build a digital identification system of biodiversity.
September 29, 2010 - Tech/Innovation - Environment- How Will the FDA Decide A Biosimilar is Enough Like the Real Thing
Podcast: September 27, 2010
September 24, 2010 - Law/Policy - Regulatory - Dementia’s Devastating Global Economic Toll Hits $604 Billion
The number of people with cognitive loss will double by 2030, and more than triple by 2050.
September 24, 2010 - Health - Aging - Genetically Engineered Salmon on the Dinner Plate?
FDA approval could pave the way for human consumption of other engineered species.
September 24, 2010 - MARIE DAGHLIAN - Law/Policy - AgBio - Translating Research into Outcomes in Queensland
Queensland-based biomedical research institutes have well-developed commercialization units ready to explore different financial arrangements and risk models.
September 24, 2010 - MARIO PENNISI - Partner Content - Partner Content - Reata Strikes Lucrative Deal with Abbott Rakes in the Cash
Private biotechs take different avenues to rake in the cash.
September 24, 2010 - MARIE DAGHLAIN - Finance - Deals - Another Avastin Setback
Chemotherapy alone proves more effective for early-stage colon cancer.
September 23, 2010 - MICHAEL FITZHUGH - Business - Drug Development - European Regulators Remove GSK’s Avandia from Market, FDA Restricts Its Use
The weekly round-up of failed trials, missed targets and other business mishaps.
September 23, 2010 - Business - Trials and Tribulations - Gilenya is a Go
FDA approves first oral MS pill.
September 22, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Missing DNA in Boys Linked to Autism
Canadian researchers find clues to why the disorder disproportionately affects males.
September 22, 2010 - MARIE DAGHLIAN - Tech/Innovation - Global - Vivus Shows Positive Qnexa Results
Obesity drug helps patients drop pounds.
September 21, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Deep Recession Fuels Rise in Uninsured
The number of people without health insurance in the United States rose to nearly 51 million.
September 17, 2010 - Health - Healthcare Reform - Crafting an Innovation Agenda
Podcast: September 20, 2010
September 16, 2010 - Law/Policy - Innovation - Liquid Fuel Directly from Sunlight
Joule awarded patent on renewable diesel production from sunlight and CO2.
September 16, 2010 - MARIE DAGHLIAN - Tech/Innovation - Biofuels - FDA Panel Rejects Obesity Drug
Arena’s shares plunge as panel says risks outweigh the benefits.
September 16, 2010 - MICHAEL FITZHUGH and MARIE DAGHLIAN - Business - Finance - Ramius Gets Hostile
Hedge fund manager takes its case directly to Cypress shareholders.
September 16, 2010 - MICAEL FITZHUGH - Finance - Mergers and Acquisitions - Genmab Recalibrates
Strategic partnerships, cost-cutting key to strategy.
September 16, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Johnson & Johnson to Buy Dutch Vaccine Maker Crucell for $2.3 Billion
Deal will expand biopharma’s position in growing vaccine market.
September 16, 2010 - MARIE DAGHLIAN - Finance - Deals - Forest Settles Criminal Investigation over Illegal Drug Marketing
The weekly round-up of failed trials, missed targets and other business mishaps.
September 15, 2010 - Business - Trials and Tribulations - Investors Discount Arena’s Obesity Drug on FDA Briefing
Lorcaserin stumbles near finish line in race to bring new weight loss drug to market.
September 14, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Genzyme sells lab test unit to LabCorp
Troubled biotech looks to lighten its load.
September 13, 2010 - MICHAEL FITZHUGH - Business - Dealmaking - Roche Bets $635 Million on Parkinson's, Alzheimer's Programs
New partnership with Belgium's reMynd targets toxicity.
September 10, 2010 - MICHAEL FITZHUGH - Finance - Deals - What's in Store for the 2010 Home Stretch
Podcast: September 13, 2010
September 10, 2010 - Business - Markets - Obama Calls for a Permanent Extension of the R&D; Tax Credit
Life sciences industry groups want it, but venture investors do not.
September 09, 2010 - DANIEL S. LEVINE - Law/Policy - Legislation - Healthcare Reform Expected to Have Moderate Impact on Spending
Cost projected to reach nearly $4.6 trillion by 2019.
September 09, 2010 - Law/Policy - Regulatory - FDA Stays Idenix Hepatitis C Study
Idenix hopes to be back on track by year's end.
September 09, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Bristol Courts ZymoGenetics with $885 Million
Acquisition delivers potential hepatitis C blockbuster.
September 09, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Super Bugs May Hold Key to Fighting Superbugs
Cockroach brains could be rich stores of new antibiotics.
September 09, 2010 - MARIE DAGHLIAN - Tech/Innovation - Infectious Disease - Ghost in the Machine
Study looks at how Wyeth paid writers to insert marketing messages into journal articles.
September 09, 2010 - Health - Public Health - Pharma Looks to Biotech for Innovation
Clinical failures drive need to license new drug candidates.
September 09, 2010 - MARIE DAGHLIAN - Finance - Deals - GSK’s Diabetes Drug Avandia Continues to Face Scrutiny
The weekly round-up of failed trials, missed targets and other business mishaps.
September 09, 2010 - Business - Trials and Tribulations - Boon for Biodefense
Cellerant and Achaogen rack up millions in new contracts.
September 04, 2010 - MICHAEL FITZHUGH - Finance - Government Funding - USDA and DOE Fund Biofuel Genomics Research
Grants aim to accelerate development of plants better suited for bioenergy production.
September 03, 2010 - MARIE DAGHLIAN - Business - Biofuels - Roche Plans Cost-Cutting as It Feels Pressure from Reform, Delays, and Failures
The weekly round-up of failed trials, missed targets and other business mishaps.
September 03, 2010 - Business - Trials and Tribulations - Takeda Signs On to Back Contrave
Summer's second major obesity deal puts Orexigen on sound footing.
September 03, 2010 - MICHAEL FITZHUGH - Business - Dealmaking - Genzyme Rejects Sanofi’s $18.5 Billion Takeover Offer
CEO Termeer says it’s possible the two sides can eventually come to terms.
September 03, 2010 - MARIE DAGHLIAN - Finance - Deals - Another Specialty Buy for Pfizer
FoldRx acquisiton adds to neuroscience portfolio.
September 02, 2010 - MICHAEL FITZHUGH - Finance - Deals - A Crossword A Day Does Not Keep Mental Decline Away
Brain exercises may slow loss of cognitive abilities, but speed up dementia later.
September 02, 2010 - MARIE DAGHLIAN - Health - Neurodegeneration - DOJ Seeks Stay in Stem Cell Ruling
Podcast: September 7, 2010
September 02, 2010 - Law/Policy - Regulatory - Scientists Find Protein Behind Alzheimer's Plaques
Research suggests new treatments modeled on the cancer drug Gleevec.
September 02, 2010 - Tech/Innovation - Neurodegeneration - A Big Bet on Biofuels
Shell and Cosan joint venture moves closer to reality.
August 26, 2010 - MARIE DAGHLIAN - Finance - Deals - Remarkable Result in Melanoma Drug Trial
Study drug shrinks tumors in 81 percent of melanoma patients.
August 26, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Roche Bets Big on Aileron
Partners see promise in peptides for tackling tough diseases.
August 26, 2010 - MICHAEL FITZHUGH - Finance - Deals - Actos and Avandia pose similar risks
New study contrasts with earlier findings on top diabetes drugs.
August 26, 2010 - MICHAEL FITZHUGH - Health - Drug Safety - Legislators Weigh Goals of Personalized Medicine Bill
Podcast: August 30, 2010
August 26, 2010 - Law/Policy - Regulatory - Retrovirus Linked to Chronic Fatigue Syndrome
Study could open new avenues of treating a debilitating disease.
August 26, 2010 - Health - Chronic Fatigue Syndrome - Costs of Scientific Misconduct
Case study sheds light on underappreciated consequences of research misconduct.
August 26, 2010 - MARIE DAGHLIAN - Law/Policy - Research - Abuse Concerns Lead FDA Committee to Reject Expanded Use of Jazz Pharmaceuticals’ Drug
The weekly round-up of failed trials, missed targets and other business mishaps.
August 25, 2010 - Business - Trials and Tribulations - Roche Dominates the Deal Flow
The Swiss biopharma announces a new acquisition and a drug discovery partnership.
August 25, 2010 - MARIE DAGHLIAN - Finance - Deals - Researchers Find Key Proteins for Drought Tolerance
Study could aid in the development of crops capable of thriving in a hotter and dryer world.
August 24, 2010 - MARIE DAGHLIAN - Tech/Innovation - Industrial Bio/Ag Bio - Judge Blocks Funding for Stem Cell Research
Court overturns Obama Administration guidelines.
August 23, 2010 - MICHAEL FITZHUGH - Law/Policy - Regenerative Medicine - Breaking Resistance
Studies pinpoint key targets for MRSA vaccine.
August 20, 2010 - Tech/Innovation - Vaccines - Drug Recalls Soar
Podcast: August 23, 2010
August 20, 2010 - Law/Policy - Regulatory - What’s in a Name?
Study suggests Lou Gehrig may not have died of Lou Gehrig’s disease.
August 20, 2010 - DANIEL S. LEVINE - Health - Neurodegeneration - Life Technologies to Buy Ion Torrent for $375 Million
Deal, which could grow to $725 million if milestones are reached, heats up competition in low-cost sequencing.
August 20, 2010 - MICHAEL FITZHUGH - Finance - Deals - Lilly's Rocky Road
FDA panel on Cymbalta offers some needed good news.
August 20, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Genzyme Shareholder Files Suit to Block Sanofi Deal
The weekly round-up of failed trials, missed targets and other business mishaps.
August 20, 2010 - Business - Trials and Tribulations - Federal Court Revokes Approval of GM Sugarbeets
Planting ban will stay in place until USDA completes an environmental impact statement.
August 20, 2010 - MARIE DAGHLIAN - Law/Policy - AgBio - Deals on a Roll
Aspen’s acquisition leads a busy week of deals worth up to $4.5 billion to life sciences companies.
August 20, 2010 - MARIE DAGHLIAN - Finance - Deals - Aspen Unburdens Sigma with Pharmaceutical Division Buy
Deals gives South African generic drugmaker foothold in Australia.
August 19, 2010 - MICHAEL FITZHUGH - Finance - Deals Renewables Fuel IPO Queue
Two companies developing alternatives to petroleum file to go public.
August 14, 2010 - MARIE DAGHLIAN - Finance - Initial Public Offerings- Deal Making Takes a Vacation
Slow week is stirred by a few smaller deals.
August 13, 2010 - MARIE DAGHLIAN - Finance - Deals - FDA Overhauling Key Medical Device Regs
Podcast: August 16, 2010
August 13, 2010 - Law/Policy - Regulatory - Sanofi Funds Personalized Medicine Research
Company establishes research alliance with Scripps Genomic Medicine.
August 12, 2010 - Business - Personalized Medicine - Elan Delays Spin-off
Drugmaker pays debt, holds tight on selling drug tech unit.
August 12, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Vertex Boast of Trial Results
Hepatitis C drug telaprevir can treat patients in half the time.
August 12, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Court Rules Against Lilly in Strattera Patent Litigation
The weekly round-up of failed trials, missed targets and other business mishaps.
August 12, 2010 - Business - Trials and Tribulations - The Brain on a Microchip
Neurochip technology opens the brain to deeper inspection.
August 11, 2010 - MARIE DAGHLIAN - Tech/Innovation - Global - Merck, SciClone Tapped in Fed's Pharma Probe
Investigation by DOJ and SEC looking at several life sciences companies.
August 10, 2010 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Endo to Buy Penwest for $168 million
Deal frees Endo from royalty payments and gives it access to two experimental drugs for rare diseases.
August 10, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions Rough Haircut
Trius slashes offering to get out the door.
August 06, 2010 - MICHAEL FITZHUGH - Finance - Initial Public Offerings- GE and Intel to Form Digital Healthcare Joint Venture
Efforts seek to capitalize on aging population and rise in chronic diseases.
August 06, 2010 - Business - Digital Health - FDA Tells Novartis It Doesn’t Like Its Facebook Page
The weekly round-up of failed trials, missed targets and other business mishaps.
August 06, 2010 - Business - Trials and Tribulations - Two Companies Complete IPOs; Two Enter the Queue
Trius and NuPathe scale back their offering price to complete their deals.
August 06, 2010 - MARIE DAGHLIAN - Finance - Deals - Shire moves to acquire Movetis
The $560 million deal bolsters the specialty pharma’s gastrointestinal business.
August 05, 2010 - MICHAEL FITZHUGH - Finance - Deals - Seeking Clarity and Predictability
FDA to revise medical device regulations.
August 05, 2010 - MICHAEL FITZHUGH - Law/Policy - Regulatory - FDA Gives Geron Green Light for Stem Cell Trial
Podcast: August 9, 2010
August 05, 2010 - Law/Policy - Regulatory - Pancreatic Cancers Use Fructose to Fuel Growth
Study’s findings challenge general notions about sugars.
August 04, 2010 - Tech/Innovation - Cancer - Obesity Rates Growing Faster Than Expected
More than 72 million U.S. adults are obese.
August 04, 2010 - Health - Obesity - Favorable Outcomes
Drug trials funded by industry are more likely to publish positive results.
August 04, 2010 - Tech/Innovation - Clinical Trials - Looking East
Merck charts China expansion with Sinopharm.
July 31, 2010 - MICHAEL FITZHUGH - Business - Dealmaking - IPO Market Sizzles - In China
Podcast: August 2, 2010
July 30, 2010 - Finance - Initial Public Offerings - Charles River Calls off WuXi Deal
Investors kill the $1.6 billion acquisition.
July 30, 2010 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Pay-for-Delay May Go Away
FTC pushes Congress to pass legislation to ban such patent settlement between branded and generic drugmakers.
July 30, 2010 - Law/Policy - Regulatory - NEJM Editorial Raises Questions About Dendreon’s Cancer Vaccine Study
The weekly round-up of failed trials, missed targets and other business mishaps.
July 30, 2010 - Business - Trials and Tribulations - The Deals That Didn’t Get Done
Charles River’s WuXi acquisition is axed and Trius fails to debut.
July 30, 2010 - MARIE DAGHLAIN - Finance - Deals - An Urging for Emerging
Teva looks to Latin America for growth.
July 30, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Game on
Sanofi preps a bid for Genzyme
July 29, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Painless Protection
Researchers develop a dissolvable needle-free nanopatch for vaccine delivery.
July 29, 2010 - MARIE DAGHLIAN - Tech/Innovation - Nanotechnology - Playing Together
FDA and FCC issue joint statement on wireless health.
July 29, 2010 - Law/Policy - Regulatory - Friends for Life
Relationships improve your odds of survival by 50 percent.
July 28, 2010 - Health - Aging - One Size Does Not Fit All
Why fad diets work well for some, but not others.
July 28, 2010 - MARIE DAGHLIAN - Health - Genomics - Investors Weigh Biotech Results
Podcast: July 26, 2010
July 23, 2010 - Finance - Capital Markets - Reckitt Gets Its Mojo Rising
Life sciences deals and financings take a summer break.
July 23, 2010 - MARIE DAGHLIAN - Finance - Deals - Pfizer Halts Trial of Pain Drug
The weekly round-up of failed trials, missed targets and other business mishaps.
July 23, 2010 - Business - Trials and Tribulations - Gel is Promising in Preventing HIV Infections
South Africa may put it into use before regulators review it.
July 23, 2010 - MICHAEL FITZHUGH - Health - HIV/AIDS - Clean Living
Cash rewards with counseling could help prevent STIs.
July 22, 2010 - Health - Global Health - GAO Study Slams Direct-to-Consumer Genetic Test Companies
Stinging report comes as FDA interest in their products reaches a boil.
July 22, 2010 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Recommendation Reversal
FDA panel says Avastin shouldn’t be marketed for breast cancer.
July 21, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Mannkind Tries Again
Biopharma resubmits application for inhaled insulin to FDA.
July 21, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Holding on to the Past
Reprogrammed adult stem cells may not be as versatile as first thought.
July 21, 2010 - MARIE DAGHLIAN - Tech/Innovation - Stem Cells - European Union Invests in Research and Innovation
Biggest ever funding package aims to stimulate smart growth and jobs.
July 21, 2010 - MARIE DAGHLIAN - Law/Policy - Research - FDA Panel Rejects Vivus Fat Pill
Reviewers vote 10-6 against recommending approval of obesity drug because of safety concerns.
July 16, 2010 - MICHAEL FITZHUGH - Business - Business Development - Can PhRMA's New CEO Repair the Industry's Image?
Podcast: July 19, 2010
July 16, 2010 - Law/Policy - Legislation - Scientists Develop First Malaria-Proof Mosquito
Approach seeks way around problems of development, manufacturing, and distributing drug to treat the disease.
July 16, 2010 - Tech/Innovation - Infectious Disease - Common Class of Meds Can Impair Aging Brain
Researchers find widely used drugs cause long-term cognitive harm.
July 16, 2010 - Health - Drug Safety - Companies Give Back First Quarter Gains
M&A; remains robust as public markets become restrained.
July 16, 2010 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Private Equity Looks to Vitamins for Strength
Acquisitions, venture financings, and government contracts in the week’s news.
July 16, 2010 - MARIE DAGHLIAN - Finance - Deals - GSK To Take $2.36 Billion Charge for Legal Settlements
The weekly round-up of failed trials, missed targets and other business mishaps.
July 16, 2010 - Business - Trials and Tribulations - Genyme Expands Manufacturing Plans Amid Troubles
Meanwhile, investors and company are placing bets on its prospects.
July 14, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Merck Wins Approval for MS drug in Russia
First oral drug for multiple sclerosis expected to launch in early 2011.
July 14, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Will Investors Hang on to Biotech
Podcast: July 12, 2010
July 09, 2010 - Finance - Capital Markets - Takeda Looking for Products
Japanese pharma adds $569 million to acquisition kitty
July 09, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Genentech Seeks FDA Approval for New Breast Cancer Drug
Drug aimed at patients with recurrent cancer when Herceptin and other drugs have already been used.
July 09, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Commission Tackles Man-Made Life
Scientists air their views on bioethical implications of synthetic biology.
July 09, 2010 - MARIE DAGHLIAN - Law/Policy - Regulatory - Staying Ahead of the Cheats
Pharmaceutical industry joins with anti-doping agency to develop new detection methods for drugs in development.
July 09, 2010 - Health - Public Health - U.S. and European Regulators Examine Safety of GSK’s Avandia
The weekly round-up of failed trials, missed targets and other business mishaps.
July 09, 2010 - Business - Trials and Tribulations - Prevent, Detect, and Treat
Study finds continuing drop in death rate from cancer.
July 09, 2010 - Health - Cancer - Giving HIV the Finger
Sangamo’s ZFN technology generates HIV-resistant human stem cells.
July 09, 2010 - Tech/Innovation - HIV/AIDS - Lilly Seeks Replacement Therapy
Drugmaker buys into new market with Alnara.
July 09, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Money Flows to Start-Ups
Venture-backed companies have a busy week.
July 09, 2010 - MARIE DAGHLIAN - Finance - Deals - Court Decision Allows Diagnostics Makers to Dodge a Bullet
Podcast: July 5, 2010
July 02, 2010 - Law/Policy - Regulatory - Regulatory Flexibility
Patient advocates call on FDA to develop policy that would speed development of new therapies for rare disease.
July 02, 2010 - Law/Policy - Regulatory - Chasing a Fat Opportunity
Big dollars and promising results heat up the race to bring new obesity therapies to market.
July 02, 2010 - Business - Drug Development - Sanofi on the Prowl
Rumors around a potential $20 billion acquisition in the U.S. fan the flames.
July 02, 2010 - MARIE DAGHLIAN - Finance - Deals - Two Studies Add to Concerns Over GSK's Avandia
The weekly round-up of failed trials, missed targets and other business mishaps.
July 02, 2010 - Business - Trials and Tribulations - Do They Make A Pill That Can Fix This?
Global pharmaceutical R&D; productivity is declining.
July 01, 2010 - Tech/Innovation - Drug Development - A Reason to Pass on Dessert
Adult obesity increases in 28 states.
July 01, 2010 - MARIE DAGHLIAN - Health - Obesity - Taking a Giant Leap
Exelixis CEO George Scangos named new CEO of Biogen Idec.
July 01, 2010 - MARIE DAGHLIAN - Business - On the Move - Staying Ahead of the Game
Celgene expands its oncology focus into solid tumors with acquisition of Abraxis BioScience.
July 01, 2010 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Rising Health Costs a Global Problem
Growing health spending puts pressure on government budgets, according to OECD Health Data 2010
July 01, 2010 - Health - Healthcare Reform - A Search for Equilibrium
Pharma faces a tricky balancing act in Europe says GSK’s Witty
June 26, 2010 - MICHAEL FITZHUGH - Law/Policy - Healthcare Reform - Under the Radar
Podcast: June 28, 2010
June 25, 2010 - Law/Policy - Regulatory - Researchers Find an Easier Way to Synthesize New Drug Candidates
Scientists say their method could have a big impact on pharmaceutical business.
June 25, 2010 - Tech/Innovation - Drug Development - Beefing Up
Amyris seems to want to reassure wary investors by adding muscle prior to going public.
June 25, 2010 - MARIE DAGHLIAN - Business - Business Strategy - J&J; Subsidiary Joins the Diabetes Fray
Ortho-McNeil-Janssen enters into agreements worth up to $1 billion total with Diamyd and Metabolex to build pipeline.
June 25, 2010 - MICHAEL FITZHUGH - Finance - Deals - Improving Access
Global ranking shows more transparency and more programs for making drugs available to people in developing nations.
June 25, 2010 - Health - Global Health - Good Things Come in Pairs
From big pharma to industrial biotech, the deals keep flowing.
June 25, 2010 - MARIE DAGHLIAN - Finance - Deals - Back to the Courthouse
U.S. Supreme Court reverses district court ban on planting Monsanto’s genetically modified alfalfa.
June 24, 2010 - MARIE DAGHLIAN - Law/Policy - Regulatory - Despite Positive Results, Affymax Tanks as Investors Worry About Safety of Anemia Drug
The weekly round-up of failed trials, missed targets and other business mishaps.
June 24, 2010 - Business - Trials and Tribulations - Valeant and Biovail Agree to Merge
The $3.2 billion deal creates a new specialty pharma with a global presence.
June 23, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Sanofi Bets Big on a Tiny Regulator
Regulus Therapeutics could score as much as $750 million on deal to develop microRNA therapies for fibrosis.
June 22, 2010 - MICHAEL FITZHUGH - Finance - Deals - Forest Diabetes Deal
Pharma company gains access to Transtech's new class of compounds in deal that could total $1.1 billion.
June 18, 2010 - MICHAEL FITZHUGH - Finance - Deals - Not Tonight
Boehringer Ingelheim’s female libido booster fails to excite FDA reviewers.
June 17, 2010 - MICHAEL FITZHUGH - Business - Business Development - FDA Moves Toward Regulating Direct-to-Consumer Genetic Tests
Podcast: June 21, 2010
June 17, 2010 - Law/Policy - Regulatory - Crafting a Personalized Medicine Pathway
FDA and NIH heads seek to connect the steps between discovery through the approval of a therapy for clinical use.
June 17, 2010 - Tech/Innovation - Personalized Medicine - Posting Market Surveillance
FDA will make safety monitoring information on recently approved drugs available on the web.
June 17, 2010 - Law/Policy - Regulatory - A Global Threat
Report finds diseases common for children in developing countries are no longer curable by many older antibiotics.
June 17, 2010 - MICHAEL FITZHUGH - Health - Public Health - Curis Tumbles on Failure of Drug in Mid-Stage Colorectal Cancer Trial
The weekly round-up of failed trials, missed targets and other business mishaps.
June 17, 2010 - Business - Trials and Tribulations - Patent Protection for Medical Technology
Supreme Court’s ruling may well impact the bounds of protection available for medical diagnostics and even methods of medical treatment.
June 17, 2010 - JASON R. KRAUS AND BRIAN W. OBERST - Partner Content - Partner Content - Life Sciences Companies Capture the Cash
Hot week for opportunistic dealmaking and venture capital fundraising.
June 17, 2010 - Finance - Deals - Pfizer Targets Rare Diseases
Drug giant forms new unit to pursue uncommon, but lucrative, patients.
June 15, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Pfizer cuts Trubion program loose
Drug giant dumps one of the biotech's experimental rheumatoid arthritis drugs after mid-stage trial results fail to excite.
June 15, 2010 - MICHAEL FITZHUGH - Business - Business Development - Blaming Genes
Adults are more likely to give too much importance to genetic causes of disease rather than addressing lifestyle, study finds.
June 11, 2010 - Health - Wellness - Grifols' Taste for Blood
Spanish company offers $3.4 billion for Talecris.
June 11, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - FDA Panel Gives Novartis MS Drug Thumbs Up
Positions Swiss drugmaker in the lead to bring an oral multiple sclerosis treatment to the market.
June 11, 2010 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Watching Where You Eat
Video study finds risky food-safety behavior more common than thought.
June 11, 2010 - Law/Policy - Public Health - Talecris Offers Private Equity Backers a Big Payday
Grifols $4 billion package leads a hot week for life sciences deals.
June 11, 2010 - MARIE DAGHLIAN - Finance - Deals - Amgen's 15-Year Effort to Build a Blockbuster
Podcast: June 14, 2010
June 10, 2010 - Business - Drug Development - A Cheap Fix
Forty-year-old gout drug Allopurinol could be used to treat angina.
June 10, 2010 - Health - Drug Delivery - Genzyme and Icahn Reach a Truce
Genzyme says it will appoint two of the activist investor's nominees, and a third endorsed by the company and shareholder.
June 09, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Congressional Committee Chair Says J&J; Uncooperative
The weekly round-up of failed trials, missed targets and other business mishaps.
June 09, 2010 - Business - Trials and Tribulations - And the Winners Are...
As the much-watched cancer conference ASCO ends, few stocks get a lift from news at the event.
June 08, 2010 - PETER WINTER - Tech/Innovation - Cancer - Developing Cancer
Poorest nation's face a heavier burden from the disease, new global resources shows
June 04, 2010 - Law/Policy - Global Health - Bridging the Gap on Discovery and Development
Podcast: June 7, 2010
June 04, 2010 - Business - Business Development - Tropical Health – Finding Solutions from Within
By looking inward, Queensland researchers are finding health solutions to tropical disease.
June 04, 2010 - ANNA BLIGH - Partner Content - Partner Content - A Coffee Jolt
Study finds no real alertness gained from that morning cup o’ joe.
June 04, 2010 - Health - Wellness - Amgen’s Bonne Chance
Biotech giant wins earlier-than-expected approval for potential osteoporosis blockbuster.
June 04, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Mining a New Vein
Coviden to acquire medical device maker ev3 for $2.6 billion.
June 04, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Insuring Innovation
Maryland governor wants the state to give the insurance industry tax credits for helping fund biotech.
June 04, 2010 - Law/Policy - Economic Development - Advisory Committee Says Agency Should Reject MedImmune RSV Drug
The weekly round-up of failed trials, missed targets and other business mishaps.
June 04, 2010 - Business - Trials and Tribulations - Attacking Tumors Before They Develop
Prototype vaccine prevents breast cancer formation in mice.
June 04, 2010 - Tech/Innovation - Cancer - Market Turmoil Roils Public Markets
Slow week for public financings, deals.
June 04, 2010 - Finance - Deals - Put Your Money Where Your Metastases Are
Only 5 percent of cancer research funding in Europe is spent on the spread of cancer cells in the body, yet it kills 90 percent of all cancer patients.
June 03, 2010 - Tech/Innovation - Cancer - Does the Industry Get its Money's Worth From Drug Review Fees
Podcast: June 1, 2010
May 28, 2010 - Law/Policy - Regulatory - Sanofi Ups Its Bet on Generics
French biopharma establishes joint venture with Japanese generics leader.
May 28, 2010 - MARIE DAGHLIAN - Finance - Mergers and Acquisitions - Teva Targets Rituxan
Israeli generics giant begins testing of biosimilar of Roche blockbuster.
May 28, 2010 - MICHAEL FITZHUGH - Business - Drug Development - NIH Proposes Tougher Conflicts of Interest Rules
Agency proposes substantial changes in the way in which it seeks to oversee potential financial conflicts of interest.
May 28, 2010 - Law/Policy - Research - U.K.’s NICE Gives Thumbs Down to Nexavar
Bayer liver cancer drug seen as too pricey for what it delivers.
May 28, 2010 - Law/Policy - Comparative Effectiveness - Vertex Leaps Ahead
Late-stage hepatitis C drug produces encouraging results.
May 28, 2010 - MICHAEL FITZHUGH - Business - Business Development - Economics Drive Obesity
Seattle study finds cost, not distance, underlies food shopping decisions.
May 28, 2010 - Health - Drug Delivery - FDA Investigates Complications, Deaths That May Be Tied to Recalled J&J; Children's Medicines
The weekly round-up of failed trials, missed targets and other business mishaps.
May 28, 2010 - Business - Business Development - An Unfolding Natural Disaster
Cumulative costs of Alzheimer’s in the United States will top $20 trillion over the next 40 years.
May 28, 2010 - MARIE DAGHLIAN - Tech/Innovation - Neurodegeneration - Start-Ups Get Fresh Cash
Several VC-backed life sciences companies raise capital.
May 28, 2010 - MARIE DAGHLIAN - Finance - Deals - Transforming the Life Sciences Labor Force
Podcast: May 24, 2010
May 21, 2010 - Business - Business Strategy - Medco Gets Personal
Benefits manager expands its push to better match patients to drugs with genetic testing.
May 21, 2010 - MICHAEL FITZHUGH - Business - Personalized Medicine - DIY Life
J. Craig Venter Institute Researchers make first self-replicating synthetic bacterial cell.
May 21, 2010 - MARIE DAGHLIAN - Tech/Innovation - Industrial Bio/Ag Bio - U.C. Berkeley Sparks a DNA Debate
School asks incoming freshmen to provide a DNA sample and some thoughtful interaction.
May 21, 2010 - MICHAEL FITZHUGH - Law/Policy - Genetics - Astellas Grabs OSI
Japanese drugmaker ups its bid to $4 billion to close the deal.
May 21, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - The Repurpose Driven Life
Pfizer and Washington University collaborate to find new uses for old drugs.
May 21, 2010 - Tech/Innovation - Research - Kids Are the Fastest Growing Segment for Pharma
More than one-in-four children in the United States take medications to treat ongoing health conditions.
May 21, 2010 - Health - Public Health - A Crack at Transparency
FDA task force recommends the agency explain to the public the reasons when it decides not to approve a drug or device.
May 21, 2010 - Law/Policy - Regulatory - Emerging Market Fever
Abbott aims to become leading Indian pharmaceutical company.
May 21, 2010 - MARIE DAGHLIAN - Finance - Deals - Medical Devices Powered by a Sugar High
Researchers successfully implant glucose biofuel cells in living rats.
May 20, 2010 - Tech/Innovation - Medical Devices - Roche and Biogen Idec Scrap Devleopment of Ocrelizumab in RA
The weekly round-up of failed trials, missed targets and other business mishaps.
May 20, 2010 - Business - Finance - DNA Robots Take a Step Closer to Reality
Scientists create molecules to perform in specific ways.
May 15, 2010 - MARIE DAGHLIAN - Tech/Innovation - Global - Sanofi Looks Beyond Its Own Walls
Podcast May 17, 2010
May 14, 2010 - Business - Drug Development - Stressed? Call Your Mother
The sound of Mom’s voice can trigger hormones that reduce stress and calm the body.
May 14, 2010 - Health - Wellness - Not So Fast
FDA puts brakes on Pathway Genomics’ drugstore ambitions.
May 14, 2010 - Law/Policy - Regulatory - A Search for Accuracy
Google Flu Trends not as accurate as CDC national surveillance programs.
May 14, 2010 - Tech/Innovation - Information Technology - Protecting Your Investment
Patent strategy tips for emerging companies
May 14, 2010 - SEAN D. SOLBERG - Partner Content - Partner Content - Killer Infections
More than two-thirds of deaths in children under five caused by infectious disease.
May 14, 2010 - Health - Global Health - Seoul Mates
GSK expands its emerging markets reach with Dong-A investment.
May 14, 2010 - MICHAEL FITZHUGH - Finance - Deals - Merck's road ahead
Five new drugs to be submitted for regulatory approval.
May 14, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Regeneron’s Not Mousy About Antibody Results
New York biotech offers positive news on rich pipeline.
May 14, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Pharma’s Emerging Market Drive
Pharmaceutical companies continue their headlong rush into branded generics.
May 14, 2010 - MARIE DAGHLIAN - Finance - Deals - Unable to Find a Partner, Avexa Tumbles As It Pulls the Plug on HIV Drug
The weekly round-up of failed trials, missed targets and other business mishaps.
May 14, 2010 - Business - Trials and Tribulations - Let's Make a Deal
Podcast May 10, 2010
May 07, 2010 - Business - Dealmaking - Sanofi Complains About Canada's Bias for Generics As It Cuts Jobs
Company takes issue with lack of sufficient intellectual property protection.
May 07, 2010 - MARIE DAGHLIAN - Law/Policy - Regulatory - InterMune's Terrible, Horrible, No Good, Very Bad Day
FDA says it wants another trial before it will approve experimental drug for fatal lung disease.
May 07, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Wondering About A Potential Wonder Drug
GSK suspends trial of Sirtris’ experimental therapy.
May 07, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Ariad’s New Deal
Revised agreement with Merck refills biotech’s coffers.
May 07, 2010 - MICHAEL FITZHUGH - Finance - Deals - J&J; Unit Announces Voluntary Recall of Over-the Counter Kid's Drugs
The weekly round-up of failed trials, missed targets and other business mishaps.
May 07, 2010 - Business - Trials and Tribulations - A Bright Spot in the Economy
Bioscience jobs show some growth despite recession.
May 07, 2010 - Business - Economic Development - A Caregiver’s Toll
The stress of taking care of a partner with dementia boosts likelihood of a spouse developing the same condition.
May 07, 2010 - Health - Neurodegeneration - A New Super Detective
New technology identifies bacteria, viruses, other organisms within 24 hours.
May 07, 2010 - Tech/Innovation - Diagnostics - Medtech Brings in Life Sciences Venture Dollars
The weekly wrap-up of financings and deals.
May 07, 2010 - MARIE DAGHLIAN - Finance - Deals - Surviving in a Changing Environment
Podcast: May 3, 2010
April 30, 2010 - Business - Business Strategy - Do That Thing You Do
Venture capitalists funding more early-stage deals.
April 30, 2010 - MARIE DAGHLIAN - Finance - Venture Capital - Going Global
Charles River expands in Asia with $1.6 billion WuXi acquisition.
April 30, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Dendreon’s Personalized Therapy
FDA approves cancer vaccine Provenge.
April 30, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Proxy Fight
Icahn seeks more Genzyme control.
April 30, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Living Cell Gets Boost
New Zealand biotech wins support for trial of its encapsulated pig islet cells from the Juvenile Diabetes Research Foundation.
April 30, 2010 - Tech/Innovation - Diabetes - Measure for Measure
Obese children metabolize drugs differently than healthy weight children.
April 30, 2010 - Health - Obesity - Alzheimer’s Quandary
NIH panel says there's no proven means of preventing or slowing onset of the neurodegenerative disease.
April 30, 2010 - Health - Neurodegeneration - AstraZeneca Settles Seroquel Case for $520 million
The weekly round-up of failed trials, missed targets and other business mishaps.
April 30, 2010 - Business - Trials and Tribulations - CROs Take Center Stage
The weekly wrap-up of financings and deals.
April 30, 2010 - MARIE DAGHLIAN - Finance - Deals - Stemming a Crisis in Cancer Clinical Trials
Podcast: April 26, 2010
April 23, 2010 - Health - Cancer - Drug Demand Remains Robust
Despite rise of generics, global pharmaceutical sales to grow to reach $1.1 trillion by 2014.
April 23, 2010 - Business - Drug Sales - Shining a Light on FDA Advisors
The agency’s proposed guidance would expand disclosure, transparency in conflict of interest waivers, agency says.
April 23, 2010 - Law/Policy - Regulatory - Done Deals
Three life sciences companies complete their initial public offerings.
April 23, 2010 - MARIE DAGHLIAN - Finance - Initial Public Offerings - An Obesity Gene's Hidden Danger
A gene variant carried by more than a third of the U.S. population could lead to brain tissue loss.
April 23, 2010 - Tech/Innovation - Neurodegeneration - Elan Renews Spinoff Hopes
Irish drugmaker considered creating two separate, publicly traded companies.
April 23, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - Another Hit to Genzyme
The FDA proposes a $175 million settlement with the company over contaminated plant.
April 23, 2010 - MICHAEL FITZHUGH - Law/Policy - Regulatory - Boehringer looks for fresh inspiration
German drugmaker looks to build profits in the face of competition from generics.
April 23, 2010 - MICHAEL FITZHUGH - Business - Business Strategy - FDA Tells Pfizer It Failed To Properly Monitor Trial of Antipsychotic in Kids
The weekly round-up of failed trials, missed targets and other business mishaps.
April 23, 2010 - Business - Trials and Tribulations - Three Life Sciences Companies Go Public
A busy week for small company financings
April 23, 2010 - MARIE DAGHLIAN - Finance - Deals - Healthcare Reform Delivers a Bonanza for Biotechs
Podcast: April 19, 2010
April 16, 2010 - Law/Policy - Research - A Preventable Tragedy
Simple interventions could prevent the deaths of millions of delivering mothers, newborns, and children.
April 16, 2010 - Health - Global Health - New Insight to Arousal, But No Plans for a Female Viagra
Pfizer research points the way to possible treatments for sexual arousal disorder for women.
April 16, 2010 - Tech/Innovation - Sex - Novartis Racing To Be First with Oral MS Drug
The company reveals additional encouraging data on its experimental treatment for multiple sclerosis.
April 16, 2010 - Business - Drug Development - Javelin Bolts from Myriad for Hospira
Hospira sweeps in with richer offer for company with post operative pain drug pending regulatory approval.
April 16, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - A Growing Controversy
Patents block competition, slow innovation in gene testing, researchers say.
April 16, 2010 - Law/Policy - Patents - Astellas Unchallenged
With time running out on the Japanese company’s hostile bid, no counterbid is in sight.
April 16, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Abbott Must Turn Over CEO Emails to Prosecutors
The weekly round-up of failed trials, missed targets and other business mishaps.
April 16, 2010 - Business - Trials and Tribulations - Convergence of Technology and Healthcare
Oracle acquires clinical trials data management company.
April 16, 2010 - MARIE DAGHLIAN - Finance - Deals - BIO Readies to Address Big Issues in the City of Big Shoulders
Podcast: April 12, 2010
April 09, 2010 - Law/Policy - BIO International Conference - A Simple Twist of Fate
Stem cell therapeutics company buys Canada’s Verio Therapeutics.
April 09, 2010 - MICHAEL FITZHUGH - Finance - Mergers and Acquisitions - Celgene Looks Beyond Revlimid
Biotech giant paints a bright future in its R&D; update.
April 09, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Fighting Words
Generex files $250 million libel suit against TheStreet.com and columnist.
April 09, 2010 - MICHAEL FITZHUGH - Law/Policy - Litigation - An Autoimmune Strategy
Nanovaccine reverses autoimmunity without general immunosuppression.
April 09, 2010 - Tech/Innovation - Vaccines - The Unkindest Cut of All
Doctors with ownership stake in a surgery center operate twice as often those without.
April 09, 2010 - Health - Medical Practice - FDA Staff Expresses Concerns About Forest Labs’ Daxas
The weekly round-up of failed trials, missed targets and other business mishaps.
April 09, 2010 - Business - Trials and Tribulations - Exercising Your Demons
Mental health providers should prescribe workouts more often for depression, anxiety, researchers say.
April 09, 2010 - Health - Mental Health - Getting It Done At Any Price
Tengion’s IPO comes in well below its initial range.
April 09, 2010 - MARIE DAGHLIAN - Finance - Deals - An Open Window
Life Sciences companies that have gone public since August 2009.
April 08, 2010 - Finance - Initial Public Offerings - Project Runway
Life Sciences companies in the IPO queue.
April 08, 2010 - Finance - Initial Public Offerings - An Open Window
Life Sciences companies that have gone public since August 2009.
April 08, 2010 - Finance - Initial Public Offerings - Boosting Anemic Growth
IMS Health Reports U.S. Prescription Sales Rose 5.1 Percent in 2009, to $300.3 Billion.
April 03, 2010 - Finance - Drug Sales - Biotech Companies Weigh Implications of Judge's Gene Patents Ruling
Podcast: April 5, 2010
April 02, 2010 - Law/Policy - Patents - GenVec Pulls Plug on Trial
Disappointing results leads the company to end test of pancreatic cancer drug as stock tumbles.
April 02, 2010 - MICHAEL FITZHUGH - Business - Drug Development - Antisoma tumbles after halting of late-stage cancer trial
The weekly round-up of failed trials, missed targets and other business mishaps.
April 02, 2010 - Business - Trials and Tribulations - Myriad Ruling Unsettles the Industry
Judge’s decision to invalidate set of gene patents has companies worried.
April 02, 2010 - MICHAEL FITZHUGH - Law/Policy - Patents - GSK Embraces Isis
Drug giant enters into potential $1.5 billion deal to use antisense discovery platform to discover new drugs for rare diseases.
April 02, 2010 - Finance - Deals - Put That in Your Bonnet
Study shows chocolate reduces blood pressure and risk of heart disease.
April 02, 2010 - Health - Drug Delivery - Boehringer Joins the Club
German pharmaceutical launches $135 million venture capital fund.
April 02, 2010 - MICHAEL FITZHUGH - Law/Policy - Regulatory - RNA in the Spotlight
March goes out like a lamb as deal activity takes a breather.
April 02, 2010 - Finance - Deals - An Exit Strategy
Capstone gives investors puts in case they want out after mid-stage trial results.
March 27, 2010 - Finance - Capital Markets - Healthcare Reform Opens the Door to Copycat Biologics
Podcast: March 29, 2010
March 26, 2010 - Law/Policy - Healthcare Reform - Yes We Can
Healthcare reform will carry a staggering tab, but the good news is we can fix that with innovation.
March 26, 2010 - PETER J. PITTS - Law/Policy - Commentary - A Blow to Cell Therapeutics
FDA advisory panel unanimously finds clinical trial data inadequate to approve Seattle company's cancer drug.
March 26, 2010 - Business - Drug Development - Getting Personal
Pfizer leads $15.5 million round for diagnostics maker Nodality.
March 26, 2010 - Finance - Venture Capital - Positive Results, Negative Consequences
Stopping clinical trials early often exaggerates treatment effects.
March 26, 2010 - Tech/Innovation - Research - Avoiding Death
Four preventable risk factors reduce U.S. life expectancy and lead to health disparities.
March 26, 2010 - Health - Public Health - Another biotech IPO in the offing
CorMedix prices its initial public offering.
March 26, 2010 - MARIE DAGHLIAN - Finance - Deals - Jury Hits Pfizer with a $142.1 Million Verdict in Neurontin Racketeering Case
The weekly round-up of failed trials, missed targets and other business mishaps.
March 25, 2010 - Business - Trials and Tribulations - Practice, Not Theory
Federal appeals court ruling could be blow to universities' ability to win patents for ideas.
March 25, 2010 - Law/Policy - Patents - Inadequate Coverage
Media reports may paint overly optimistic view of cancer.
March 19, 2010 - Health - Cancer - An Urging for Emerging
AstraZeneca expands its interest in emerging markets.
March 19, 2010 - Business - Business Strategy - OSI Seeks a Better Offer
The biotech balks at Astellas' advances
March 19, 2010 - Finance - Mergers and Acquisitions - A New Model for Clinical Trials
Innovative trial could lead to personalized cancer treatments.
March 19, 2010 - Tech/Innovation - Global - Waiting to Inhale
Mannkind faces delay with FDA approval for inhaled insulin Afrezza.
March 19, 2010 - Business - Drug Development - Human Genome Sciences Antibody Fails in Mid-Stage Trial
The weekly round-up of failed trials, missed targets and other business mishaps.
March 19, 2010 - Business - Trials and Tribulations - Appraising Progress in the War on Cancer
Podcast: March 22, 2010
March 19, 2010 - Law/Policy - Research - Teva buys Ratiopharm
The Week's Deals and Financings
March 19, 2010 - MARIE DAGHLIAN - Finance - Deals - Sweet News for Monsanto
U.S. District judge refuses to grant ban on planting genetically-modified seeds.
March 18, 2010 - Law/Policy - AgBio - Teva Triumphs
Generics giants beats out Pfizer in $5 billion bid to buy Ratiopharm.
March 18, 2010 - Finance - Mergers and Acquisitions - Why 4 Billion Cell Phones Are Forever Changing Healthcare
Podcast: March 15, 2010
March 12, 2010 - Tech/Innovation - Convergence - To the Spender Go the Spoils
Abbott buys Facet Biotechnology for $722 million.
March 12, 2010 - Finance - Deals - Targeting Patients Who are Sick As A Dog
Sanofi-Aventis and Merck join forces in the animal healthcare market.
March 12, 2010 - Business - Dealmaking - Intermune rounds the final corner
Shares soars as FDA panel recommends approval of company’s drug for scarring of lung tissue.
March 12, 2010 - Business - Drug Development - Good Health Has Its Rewards
Staying healthy associated with more frequent and better quality sex in later life.
March 12, 2010 - Health - Sex - A Cure for Doctors’ Handwriting
Physicians use of e-prescribing dramatically cut medication errors.
March 12, 2010 - Law/Policy - Healthcare Reform - An Assortment of Deals
A lukewarm IPO and a white knight spice up the week’s deals.
March 12, 2010 - MARIE DAGHLIAN - Finance - Deals - Roche and Biogen Suspend Experimental RA Treatment
The weekly round-up of failed trials, missed targets and other business mishaps.
March 12, 2010 - Business - Trials and Tribulations - Consumer Group Sues Over Health Insurance Increases
Podcast: March 8, 2010
March 05, 2010 - Law/Policy - Healthcare Reform - Archimedes Does Some Math
Biopharma’s funding round is the largest private European financing in 15 years.
March 05, 2010 - Finance - Venture Capital - A Humble Start for Anthera
Anthera Pharmaceuticals IPO gets done, but at just more than half of its $70 million target.
March 05, 2010 - Finance - Initial Public Offerings - Astellas Turns Up the Heat
Suitor sues OSI, adding pressure to its hostile bid.
March 05, 2010 - Business - Dealmaking - Keeping a Beat
Coffee associated with reduced risk of hospitalization for heart rhythm disturbances.
March 05, 2010 - Health - Cardiovascular - Can’t Read You
Parkinson's disease makes it harder to figure out how other people feel. Deep brain stimulation seems to make it worse.
March 05, 2010 - Tech/Innovation - Neurodegeneration - Merck KgaA Outbids Thermo
German pharmaceutical and chemical giant snaps up Millipore for $7.2 billion in a bid to diversify its revenue stream.
March 05, 2010 - Finance - Mergers and Acquisitions - Surprise and Disappointment for Medivation and Pfizer over Alzheimer’s Drug Failure
The weekly round-up of failed trials, missed targets and other business mishaps.
March 05, 2010 - Business - Trials and Tribulations - The World’s Tropical Zone – Rich Beauty, Rare Opportunity
Growth in wealth and population in the tropics is driving demand for solutions that are economical, environmentally sustainable and directly improve health and living conditions.
March 05, 2010 - PETER BEATTIE - Partner Content - Partner Content - March Roars in for Life Sciences
Something for everyone—a big acquisition, an attempt at a hostile takeover, and an anemic IPO.
March 05, 2010 - MARIE DAGHLIAN - Finance - Deals - A Battle Brews for Control of Genzyme
Podcast: March 1, 2010
February 26, 2010 - Business - Business Strategy - Divine Medicine
Study finds belief in a caring God improves response to medical treatment for depression.
February 26, 2010 - Health - Personalized Medicine - Fast-tracking regulatory science
NIH and FDA collaborate to speed new treatments to patients.
February 26, 2010 - Law/Policy - Regulatory - Biotech IPO a No-Go
Slow deal week ends slow month for life sciences dealmaking.
February 26, 2010 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Anthera IPO Put On Hold
The weekly round-up of failed trials, missed targets and other business mishaps.
February 26, 2010 - Business - Trials and Tribulations - Put That in Your Pipe
New technology to manufacture vaccines in tobacco plants.
February 26, 2010 - Tech/Innovation - Vaccines - No Place Like Home
GE Healthcare, Intel and Mayo Clinic explore new models of healthcare delivery through remote montioring.
February 26, 2010 - Tech/Innovation - Convergence - Booster Shot
Pfizer Prevnar 13 vaccine wins FDA approval.
February 26, 2010 - Business - Drug Development - R&D; is better with three
Lilly, Merck and Pfizer collaborate to accelerate cancer research in Asia.
February 26, 2010 - Business - Business Strategy - Freezing Fertility
Woman becomes the first to give birth to two children after ovarian tissue transplant following cancer treatment.
February 26, 2010 - Tech/Innovation - Regenerative Medicine - Millipore in play
Thermo Fisher Scientific sets it eyes on $6 billion takeover of the toolmaker.
February 25, 2010 - Business - Dealmaking - Fighting Cancer Gets Personal
Next generation sequencing opens the door to new ways to track cancer and indentify personalized biomarkers from tumor DNA.
February 20, 2010 - Tech/Innovation - Personalized Medicine - A Potential Blockbuster
Astra nets global rights to Rigel’s RA treatment in deal worth up to $1.25 billion.
February 20, 2010 - Finance - Deals - Why Biotech Is Worried About The Fight Over Gene Patents
Podcast: February 22, 2010
February 19, 2010 - Law/Policy - Patents - Action from Europe
Rigel’s $1.2 billion deal shines in an otherwise dull week, but investors less than enthusiastic about agreement.
February 19, 2010 - MARIE DAGHLIAN - Finance - Deals - Bad Medicine
Medical shows on TV often don’t depict proper first aid for seizures.
February 19, 2010 - Health - Public Health - Biotech, Je t'adore
Sanofi-Aventis enters $67 public-private partnership with leading academic researchers in France.
February 19, 2010 - Business - Business Strategy - No Sweat
New method makes vaccines stable at tropical temperatures.
February 19, 2010 - Tech/Innovation - Vaccines - Formalizing Warnings
FDA places new requirement on makers of anemia drugs.
February 19, 2010 - Law/Policy - Regulatory - Basilea Gets Rights to Antibiotic Back from J&J; after European Regulators Reject Application
The weekly round-up of failed trials, missed targets and other business mishaps.
February 19, 2010 - Business - Trials and Tribulations - Targeting Delivery
Netherlands research groups form $38 million personalized medicine partnership.
February 19, 2010 - Tech/Innovation - Research - Why Drugmakers Need to Rethink Their Business Models
Podcast: February 15, 2010
February 13, 2010 - Business - Business Strategy - Crucell Beefing Up R&D;
Vaccine maker funnels new cash into research and development.
February 13, 2010 - Finance - Research and Development - Boston Scientific to Cut up to 1,300 Employees
The weekly round-up of failed trials, missed targets and other business mishaps.
February 12, 2010 - Business - Trials and Tribulations - Crestor's Expanded Role
Heart attack prevention role for AstraZeneca’s cholesterol drug.
February 12, 2010 - Business - Business Strategy - Bone Weakness? It’s Miller Time
Study finds beer is a rich source of silicon and may help prevent osteoporosis.
February 12, 2010 - Health - Wellness - A Near Perfect Storm
HHS Advisory committee calls for exemptions to liability for infringement of patents on genes.
February 12, 2010 - Law/Policy - Patents - Snow day for Cell Therapeutics
Bad weather gives Seattle company a momentary reprieve from FDA, but investors don’t have high hopes for cancer drug passing muster.
February 12, 2010 - Business - Drug Development - Are Your Genes Making You Older Than You Are?
Scientists identify first genetic variant linked to biological aging in humans.
February 12, 2010 - Tech/Innovation - Aging - Simple and Safe
Virus-free technique enables scientists to easily make stem cells pluripotent.
February 12, 2010 - Tech/Innovation - Regenerative Medicine - Dealmaking Takes a Breather
Biotech stocks follow general market’s see-saw during the week.
February 12, 2010 - MARIE DAGHLIAN - Finance - Deals - Why GINA Can Be Problematic in the Workplace
Podcast: February 8, 2010
February 05, 2010 - Law/Policy - Privacy - Ironwood Tests Its Mettle
Company’s offering sets the mood for biotech IPOs.
February 05, 2010 - Finance - Initial Public Offerings - Sweet Venture
Shell-Cosan enter $12 billion venture to ramp up production and distribution.
February 05, 2010 - Business - Biofuels - Unlocking the Genetics of Child Killers
Top pediatric hospital teams up with leading genomics center for $65 million.
February 05, 2010 - Tech/Innovation - Genetics - Another Autism Link
Study confirms link between older moms and the disorder.
February 05, 2010 - Health - Autism - Budget Boost
Obama's fiscal 2011 budget calls for more money for NIH, FDA.
February 04, 2010 - Law/Policy - Regulatory - When Less Means More
New research finds some morbidly obese people are missing genes.
February 04, 2010 - Tech/Innovation - Obesity - GSK to Slash 4,000 Jobs
The weekly round-up of failed trials, missed targets and other business mishaps.
February 04, 2010 - Business - Trials and Tribulations - Biotech has its first IPO this year
Capital markets slide and dealmaking crosses borders.
February 04, 2010 - MARIE DAGHLIAN - Finance - Deals - Novo Hopes for a Diabetes Blockbuster
Danish pharma secures approval for Victoza.
January 30, 2010 - Business - Drug Development - With Healthcare Reform Uncertain, BIO's Policy Fights Remain
Podcast: February 1, 2010
January 29, 2010 - Law/Policy - Regulatory - Pfizer Overhauls Pipeline
Drug giant to cut 100 programs following purchase of Wyeth.
January 29, 2010 - Business - Business Strategy - Skin in the Game
Quintiles expands strategy, branding.
January 29, 2010 - Business - Business Strategy - Jimenez Takes Reigns at Novartis
Swiss drugmaker shuffles its top leadership.
January 29, 2010 - Business - On the Move - A Big Fat “F”
Commission gives the government a failing grade for its preparation to prevent and counter biological attacks.
January 29, 2010 - Law/Policy - Biodefense - Geron Looks at Alzheimer’s
Stem Cell company teams with UC Irvine to explore new application for hampered drug.
January 29, 2010 - Tech/Innovation - Regenerative Medicine - Gates Foundation committs $10 billion to vaccines
Venture financing and philanthropy deliver during an otherwise slow week.
January 29, 2010 - MARIE DAGHLIAN - Finance - Deals - Pay Now or Later
Increased co-payments for doctor visits boost healthcare costs for seniors.
January 29, 2010 - Health - Healthcare Reform - AstraZeneca to Ax 8,000 more employees
The weekly round-up of failed trials, missed targets and other business mishaps.
January 29, 2010 - Business - Trials and Tribulations - Ulcer Causer Not All Bad
Common stomach pathogen may protect against tuberculosis.
January 22, 2010 - Tech/Innovation - Research - Seeing Value
Struggling DeCode Genetics picked up by its investors.
January 22, 2010 - Finance - Deals - Doubly Dangerous
Counterfeit internet drugs pose significant risks and discourage vital health checks, report says.
January 22, 2010 - Health - Drug Safety - Not Seeing Eye to Eye
Alcon's independent directors still blocking Novartis bid.
January 22, 2010 - Business - Dealmaking - Abbott to Stop Selling Diet Drug in Europe
The weekly round-up of failed trials, missed targets and other business mishaps.
January 22, 2010 - Business - Trials and Tribulations - Where Healthcare Goes After Massachusetts
Podcast: January 25, 2010
January 22, 2010 - Law/Policy - Healthcare Reform - Can you catch appendicitis?
Appendicitis may be related to viral infections.
January 22, 2010 - Tech/Innovation - Research - By Any Measure
Degree of obesity raises risk of stroke, regardless of gender, race.
January 21, 2010 - Health - Obesity - Say What?
Novartis to invest as much as $213.6 in GenVec program for hearing loss.
January 21, 2010 - Finance - Deals - Money Magnet
Biotech is top sector for venture investment in 2009.
January 21, 2010 - MARIE DAGHLIAN - Finance - Deals - Price Break
New Illumina sequencer dramatically cuts costs.
January 15, 2010 - Finance - Deals - Up, Up and Away
GAO blames lack of competition for extraordinary increases in drug prices.
January 15, 2010 - Law/Policy - Healthcare Reform - Strike a Pose
Yoga reduces cytokine levels known to promote inflammation.
January 15, 2010 - Health - Wellness - Vegas Genes
Why people play the longshot and buy insurance?
January 15, 2010 - Tech/Innovation - Genetics - Busy week of handshakes and financings
Conservative optimism at JPMorgan Healthcare Conference.
January 15, 2010 - Finance - Deals - Biotechs Adjust to the New Normal
Podcast: January 18, 2010
January 14, 2010 - Business - Business Strategy - EU's Antitrust Probe Includes Pfizer
The weekly round-up of failed trials, missed targets and other business mishaps.
January 14, 2010 - Business - Trials and Tribulations - Smart Pill
Novartis banks $24 million on Proteus Biomedical and its ingestible sensors for monitoring drugs and patients.
January 14, 2010 - Business - Business Strategy - Unheeded Warnings
Monitoring of high-risk medications unchanged despite FDA warnings.
January 14, 2010 - Law/Policy - Regulatory - Making Strides
Pfizer expands portfolio with partnership with Indian generics company.
January 09, 2010 - Business - Business Strategy - Worse than Walking in Heels
Running shoes may cause damage to knees, hips and ankles.
January 08, 2010 - Health - Wellness - Eyeing an Opportunity
Novartis pursues vision of owning Alcon.
January 08, 2010 - Finance - Deals - Rising Star
China emerges as leader in regenerative medicine despite world skepticism of stem cell therapies offered at clinics.
January 08, 2010 - Tech/Innovation - Regenerative Medicine - Anemia Drugs Raise Renewed Safety Concerns
The weekly round-up of failed trials, missed targets and other business mishaps.
January 08, 2010 - Business - Trials and Tribulations - Stepping Down
Biogen Idec CEO Mullen to call it quits.
January 08, 2010 - Business - On the Move - A Strong Start for the New Year
A flurry of financings kick off 2010.
January 08, 2010 - Finance - Deals - New drug approvals improve in 2009 as more biologics get the green light
Podcast: January 11, 2010
January 07, 2010 - Law/Policy - Regulatory - Gazing Into the Crystal Ball
G. Steven Burrill's Predictions for 2010
December 31, 2009 - Business - Business Strategy - Will the Biotech Industry See Its Own Shadow at JPMorgan?
Podcast: January 4, 2010
December 31, 2009 - Finance - Capital Markets - Darlings and Dogs
The biggest winners and losers in 2009 among publicly traded life sciences companies.
December 31, 2009 - Finance - Capital Markets - Big Bucks
A list of the largest life sciences financings of 2009
December 31, 2009 - Finance - Deals - Big Deals
A list of the top M&A; and partnering deals of 2009.
December 31, 2009 - Finance - Deals - Not with a Bang but a Whimper
Slow holiday week marked by one important deal outside biotech's normal range.
December 30, 2009 - MARIE DAGHLIAN - Finance - Deals - Pfizer Will Discontinue Late-Stage Cancer Drug
The weekly round-up of failed trials, missed targets and other business mishaps.
December 30, 2009 - Business - Trials and Tribulations - IPO Queue is Growing
Biotech Companies lining up to go public in 2010.
December 30, 2009 - MARIE DAGHLIAN - Finance - Initial Public Offerings - Part II: Life Sciences Companies Brace For Big Changes
Podcast: December 28, 2009
December 23, 2009 - Finance - Deals - Sanofi Looks Over the Counter
French Pharma spends $1.9 billion to deepen its reach in consumer healthcare.
December 23, 2009 - Business - Business Strategy - Sanofi Pulls the Plug on Two Drugs in Development
The weekly round-up of failed trials, missed targets and other business mishaps.
December 23, 2009 - Business - Trials and Tribulations - Lilly Goes Christmas Shopping
Drugmaker to pay up to $775 million for Incyte arthritis drug rights.
December 23, 2009 - Business - Dealmaking - Fast and Cheap
Researchers say they have developed a quicker and less expensive DNA sequencing method.
December 23, 2009 - Tech/Innovation - Global - Resistant Bacteria? Blame Lawyers
Fear of lawsuits may prompt some doctors to overprescribe antibiotics.
December 23, 2009 - Health - Drug Delivery - Pharma wishes Biotech a Very Merry Christmas
A bevy of deals announced in a what was supposed to be a slow holiday week.
December 23, 2009 - MARIE DAGHLIAN - Finance - Deals - Graduating from Coverage
Survey of young adults, often without coverage, finds wide majority support health reform.
December 22, 2009 - Health - Healthcare Reform - No Deal
Facet rejects Biogen’s $493 million offer, looks for new buyer
December 19, 2009 - Business - Dealmaking - Making Sense of a Tumultuous Year
Podcast: December 18, 2009
December 18, 2009 - Finance - Deals - A Vote of Confidence
Seattle Genetics nails $365 million cancer drug deal with Takeda
December 18, 2009 - Business - Dealmaking - Curbing the Appetite
Controlling a key enzyme in the brain may lay the groundwork for treating obesity.
December 18, 2009 - Tech/Innovation - Obesity - Beta Islet Cell Phones
Mobile phones could help parents monitor blood sugar of their diabetic children.
December 18, 2009 - Health - Diabetes - After failure, Gilead Likely to Discontinue Development of Hypertension Drug
The weekly round-up of failed trials, missed targets and other business mishaps.
December 18, 2009 - Business - Trials and Tribulations - A Victory for Big Pharma
U.S. Senate rejects amendment that would have permitted drug reimportation.
December 18, 2009 - Law/Policy - Healthcare Reform - Astellas' Ambit Gambit
Japanese Pharma enters into a $390 million oncology deal with San Diego biotech.
December 18, 2009 - MARIE DAGHLIAN - Finance - Deals - Imitating Life
Synthetic red blood cells carry drugs, diagnostic agents.
December 17, 2009 - Tech/Innovation - Drug Delivery - Life Sciences Execs Enjoy Rising Pay Despite Economic Downturn
Podcast: December 11, 2009
December 11, 2009 - Finance - Executive Compensation - Embracing Biotech
Lilly says it plans an innovation strategy to insulate it from lost revenue when key patents expire.
December 11, 2009 - Business - Business Strategy - Fueling Innovation
Feds invest $564 million to advance biorefineries.
December 11, 2009 - Law/Policy - Biofuel - Is Cleanliness Overrated?
To protect against heart attacks as adults, it may be good to expose babies to germs.
December 11, 2009 - Health - Public Health - Extra Large Genes
Type 2 diabetes gene predisposes children to obesity.
December 11, 2009 - Tech/Innovation - Diabetes - Seems Like Old Times
Respiratory damage from H1N1 flu familiar say researchers.
December 11, 2009 - Health - Influenza - Cytokinetics and GSK End Collaboration
The weekly round-up of failed trials, missed targets and other business mishaps.
December 11, 2009 - Business - Trials and Tribulations - Opportunities and Challenges
The U.S. market for personalized medicine will reach $452 Billion by 2015.
December 11, 2009 - Business - Personalized Medicine - Making and Breaking Deals
Pharma companies make and break alliances, plus two Chinese IPOs on American exchanges.
December 11, 2009 - MARIE DAGHLIAN - Finance - Deals - Making Progress
Cancer death and diagnosis rates decline.
December 10, 2009 - Health - Cancer - Pfizer Takes Aim at Genzyme
Drug Giant taps Protalix for Gaucher's Disease treatment produced in genetically altered carrot cells.
December 05, 2009 - Business - Dealmaking - Life Science Companies Face A Taxing Problem
Podcast: December 4, 2009
December 04, 2009 - Finance - Taxes - Ready to Pounce
Teva seeking U.S. approval for copycat of Amgen's Neupogen
December 04, 2009 - Law/Policy - Regulatory - Taking a Best Shot
Availability of a vaccine is no guarantee the public will want it.
December 04, 2009 - Health - Vaccines - Consumer Group Wants FDA to Pull Abbott Weight-Loss Drug from Market
The weekly round-up of failed trials, missed targets and other business mishaps.
December 04, 2009 - Business - Trials and Tribulations - Novartis' Bolsters Cancer Pipeline
Swiss drugmaker enters into $1.1 billion deal with Incyte for two cancer compounds.
December 04, 2009 - Business - Dealmaking - Controlling the Means of Production
Scientists find a hormonal on-and-off switch for male fertility that could lead to a birth control pill for men.
December 04, 2009 - Tech/Innovation - Fertility - Opening Europe's IPO Window
Movetis raises $128 million in successful IPO on Euronext Brussels ending drought of VC-backed IPOs.
December 04, 2009 - Finance - Initial Public Offerings - Bright Signs Highlight End of the Year
Financing drought appears to be ending.
December 04, 2009 - MARIE DAGHLIAN - Finance - Deals - A Mental Illness Gene
Researchers identify a possible genetic cause for schizophrenia, depression, and other disorders.
December 03, 2009 - Tech/Innovation - Mental Illness - A Research Institute Seeks to Ignite Interest in Personalized Medicine
Podcast: November 27, 2009
November 27, 2009 - Tech/Innovation - Personalized Medicine - Clavis and Clovis Click
Norwegian biotech inks $380 million cancer deal with newly formed private pharma.
November 26, 2009 - MARIE DAGHLIAN - Finance - Deals - Culture Shift
Novartis and HHS partner for faster flu vaccine manufacturing.
November 25, 2009 - Business - Drug Development - A Bone of Contention
Merck successful in Fosamax defense.
November 25, 2009 - Law/Policy - Litigation - Paying a Price for Ads
Drug ads ineffective for boosting sales, could cost taxpayers study finds.
November 25, 2009 - Business - Direct-to-Consumer Advertising - Superbug on the Rise
New study finds potentially lethal MRSA increased seven-fold in hospital outpatients.
November 25, 2009 - Health - Public Health - Financing Drug Discovery
A smattering of deals lead up to the Thanksgiving break.
November 24, 2009 - MARIE DAGHLIAN - Finance - Deals - The FDA Grapples with Rules for Social Media
Podcast: November 20, 2009
November 20, 2009 - Law/Policy - Regulatory - A Personalized Medicine Proving Ground
Ignite Institute receives key backing from Virginia.
November 20, 2009 - Tech/Innovation - Personalized Medicine - Divesting to Invest
Bristol-Myers Squibb divesting Mead Johnson stake before end of 2009.
November 20, 2009 - Finance - Spin-Outs - Breakfast of Champions
Promising pharmaceutical agents emerge as sports doping products.
November 20, 2009 - Health - Public Health - DeCode Defunct
The weekly round-up of failed trials, missed targets and other business mishaps.
November 20, 2009 - Business - Trials and Tribulations - Dealmaking takes a breather
While activity slows, GSK makes a potential $540 million vaccine alliance with Nabi Biopharmaceuticals.
November 20, 2009 - Finance - Deals - Unlocking the Genetics of IBD
Largest gene study of childhood inflammatory bowel disease identifies five new genes.
November 19, 2009 - Tech/Innovation - Global - Treating Down Syndrome
Early intervention with existing drugs that boost norepinephrine may counter effects of the disorder.
November 19, 2009 - Tech/Innovation - Neurodegeneration - Niacin Beats Zetia
Cholesterol study questions impact of Merck’s Statin.
November 19, 2009 - Health - Comparative Effectiveness - Diagnostics Makers Sweat Out A Supreme Court Ruling
Podcast: November 13, 2009
November 13, 2009 - Law/Policy - Regulatory - Biotech Innovation Gets the Cash
Big pharma appetite for therapeutic antibodies reaps rewards for biotech companies.
November 13, 2009 - MARIE DAGHLIAN - Finance - Deals - On the Prowl
Sanofi's Viehbacher says company will form VC unit to invest in biotech companies.
November 13, 2009 - MARIE DAGHLIAN - Business - Dealmaking - Geezer Boom
People entering their sixties may have more disabilities today than in prior generations.
November 12, 2009 - Law/Policy - Aging - Bundling to Save a Bundle
Trimming US health care spending will require new approaches, study finds.
November 12, 2009 - Law/Policy - Healthcare Reform - Halting Parkinson’s
Widely used cholesterol-lowering drug may prevent progression of the neurodegenerative disease.
November 12, 2009 - Tech/Innovation - Neurodegeneration - Weighing Benefits and Risks
Drugs to treat anemia in cancer patients linked to clots.
November 12, 2009 - Health - Drug Safety - Lilly Reaches $24 Million Settlement with Utah in Off-Label Marketing Case
The weekly round-up of failed trials, missed targets and other business mishaps.
November 12, 2009 - Business - Trials and Tribulations - A Tumor-Forming Interaction
Discovery in worms points to more targeted cancer treatment.
November 11, 2009 - Tech/Innovation - Personalized Medicine - Living Longer, but Not Healthier
Despite progress, societies continue to fail women’s healthcare needs at key times.
November 11, 2009 - Health - Global Health - A Sequencing Revolution Ushers in a New Era
Podcast: November 6, 2009
November 06, 2009 - Tech/Innovation - Genetics - A Growth Market
Novartis to invest $1 billion in China over the next five years.
November 06, 2009 - Business - Business Strategy - Omnicare, Ivax to Pay $112 Million to Settle Kickback Charges
The weekly round-up of selected failed trials, missed targets and other business mishaps.
November 06, 2009 - Business - Trials and Tribulations - Feeling McDown
Processed foods may put people at greater risk of depression.
November 06, 2009 - Health - Wellness - Gene Lawsuit Proceeds
Court upholds right of scientists and patients to challenge BRCA patents.
November 06, 2009 - Law/Policy - Regulatory - A Desire to Acquire
Big Pharma reiterates its appetite for biotech.
November 06, 2009 - Marie Daghlian - Finance - Deals - Falling Short
Drug company-sponsored events for health professionals fail to disclose financial ties.
November 05, 2009 - Law/Policy - Medical Practice - A Performance Gap
International physician survey finds even though United States spends the most, it lags in access and quality of healthcare.
November 05, 2009 - Law/Policy - Healthcare Reform - Decision Day
Four companies awaiting FDA thumbs up or down in upcoming week.
November 05, 2009 - MARIE DAGHLIAN - Business - Drug Development - Biotech Blooms at Lilly
Drug giant opens biotech facility in San Diego with nearly 200 Scientists focusing on cancer, diabetes, and autoimmune diseases.
October 31, 2009 - Business - Business Strategy - Biotechs Expand Their Financial Arsenal
Podcast: October 30, 2009
October 30, 2009 - Finance - Government Funding - Pound Foolish
Waste spending in the U.S. healthcare system pegged at $700 billion in report.
October 30, 2009 - Law/Policy - Healthcare Reform - Clean Water, Clean Sex
WHO: Millions of premature deaths could be prevented by addressing a handful of factors.
October 30, 2009 - Health - Global Health - Lonza to Cut 450 Jobs
The weekly round-up of selected failed trials, missed targets and other business mishaps.
October 30, 2009 - Business - Trials and Tribulations - Seed Money
Fund seeks to invest in University of California discoveries.
October 30, 2009 - Finance - Early-Stage Finance - Matching Your Shade of Blue
Researchers hunt for genetic 'Prozac markers' to find a test for treating depression.
October 30, 2009 - Tech/Innovation - Personalized Medicine - More Treats than Tricks
A week’s worth of deals and financings, an IPO filing, and the inauguration of a new technology stock market exchange.
October 30, 2009 - Finance - Deals - Biotech Investors Charging Ahead
Podcast: October 23, 2009
October 24, 2009 - Finance - Capital Markets - The Boss’s Paradox
Job authority may contribute to health problems, research says.
October 24, 2009 - KRISTI EATON - Health - Wellness - Are We Not Men?
Scientists say natural selection is still at play today.
October 24, 2009 - KRISTI EATON - Tech/Innovation - Evolutionary Biology - VC Financing Grabs the Spotlight
Venture capital flows while public financing takes a breather
October 24, 2009 - MARIE DAGHLIAN - Finance - Deals - Electrifying Funds
GE launches $250 million equity fund to invest in healthcare technology companies.
October 23, 2009 - Finance - Investment Funds - Accelerating Reprogramming
Researchers improve speed and efficiency in creating stem cells.
October 23, 2009 - KRISTI EATON - Tech/Innovation - Stem Cells - Leave It to Gleevec
A cancer drug may help with the untreatable skin disease scleroderma.
October 23, 2009 - KRISTI EATON - Health - Drug Development - Cancer Killers
Two metals can help fight ovarian and colon cancer, scientists say.
October 23, 2009 - KRISTI EATON - Tech/Innovation - Cancer - Vessels of Wrath
Scientists look at Genetech’s Rituxan as an alternative treatment for vasculitis.
October 23, 2009 - KRISTI EATON - Health - Drug Development - Rare Find
Gaucher disease increases chance of the developing Parkinson’s disease, research says.
October 23, 2009 - KRISTI EATON - Tech/Innovation - Global - Redefining Fat
Scientists make the case for a new way to measure if someone is overweight.
October 23, 2009 - KRISTI EATON - Health - Obesity - Life-Saving Recycling
Study shows refurbished pacemakers work well in patients.
October 17, 2009 - KRISTI EATON - Health - Global Health - Biotech Readies for an Open IPO Window
Podcast: October 16, 2009
October 16, 2009 - Finance - Initial Public Offerings - Untangling Variations
Blood counts are clues to diseases, study says.
October 16, 2009 - KRISTI EATON - Tech/Innovation - Genetics - Fluid Findings
A metabolite in blood could determine rate of Parkinson’s progression, study finds.
October 16, 2009 - KRISTI EATON - Tech/Innovation - Neurodegeneration - Comparing Solutions
Two Genentech drugs show little difference in effectiveness for macular degeneration, research shows.
October 16, 2009 - KRISTI EATON - Law/Policy - Comparative Effectiveness - End in Sight
Poor vision can factor into lifespan, researchers say.
October 16, 2009 - KRISTI EATON - Health - Public Health - Young and Vulnerable
Study says healthy adolescents are more susceptible to swine flu.
October 16, 2009 - KRISTI EATON - Health - Public Health - Heart Breakthrough
Scientists recreate heart muscle using stem cells.
October 16, 2009 - KRISTI EATON - Tech/Innovation - Regenerative Medicine - Companies turn to capital markets
With growing investor confidence, biotechs complete secondary offerings.
October 16, 2009 - MARIE DAGHLIAN - Finance - Finance - Born Too Early
Premature births are global problem, report and advocacy groups say.
October 09, 2009 - KRISTI EATON - Health - Public Health - Biotech Does Its Recovery and Reinvestment Act
Podcast: October 9, 2009
October 09, 2009 - Business - Markets - Technology for Your Health
Medical providers using electronic health records offer better quality of care, study says.
October 09, 2009 - KRISTI EATON - Law/Policy - Healthcare Reform - A Genetic Misspelling
A single letter change in the genetic code is linked to autism.
October 09, 2009 - KRISTI EATON - Tech/Innovation - Autism - Untangling Genetics
Researchers uncover how DNA is packed so tightly in nuclei.
October 09, 2009 - KRISTI EATON - Tech/Innovation - Genetics - Deadly Misuse
Improper use of aspirin during 1918-1919 flu pandemic may have caused deaths, report says.
October 09, 2009 - KRISTI EATON - Health - Public Health - Making Safer Drugs
Researchers develop antidote for entire class of drugs.
October 09, 2009 - KRISTI EATON - Health - Drug Development - A New Route for Cancer Vaccines
Human stem cells show potential as vaccination for colon cancer.
October 09, 2009 - KRISTI EATON - Tech/Innovation - Stem Cells - A Venture-Backed Biotech Goes Public
Omeros’ debut receives mixed reactions
October 09, 2009 - MARIE DAGHLIAN - Finance - Finance - The Journal of Life Sciences
Fall 2009: The Personalized Medicine Issue
October 08, 2009 - Magazine - Magazine - Cord Plugs
Reprogrammed cells from umbilical cord blood found similar to embryonic stem cells, research says.
October 02, 2009 - KRISTI EATON - Tech/Innovation - Regenerative Medicine - Cancer Collaboration
California study will follow breast cancer patients for decades.
October 02, 2009 - KRISTI EATON - Tech/Innovation - Cancer - Why an Open IPO Window Won't Solve Biotech's Woes
Podcast: October 2, 2009
October 02, 2009 - Finance - Finance - Midriff Crisis
Weight gain as a young woman means shorter life span, study reports.
October 02, 2009 - KRISTI EATON - Health - Obesity - Round-Heeled and Happy
Women who have good sex lives report a positive well-being and vitality, study says.
October 02, 2009 - KRISTI EATON - Health - Drug Delivery - Paying for the Whole, Not the Parts
Study looks at benefits of paying set fee for ailments.
October 02, 2009 - KRISTI EATON - Law/Policy - Healthcare Reform - A Pathway to Overcome Resistance
Scientists discover a new compound to help slay bacteria able to withstand today’s arsenal of antibiotics.
October 02, 2009 - KRISTI EATON - Tech/Innovation - Vaccines - Predicting Abuse
Researchers say medical records could help identify likely victims of domestic violence.
October 02, 2009 - KRISTI EATON - Health - Information Technology - Immunization Fear
Despite swine flu concerns, most Americans wary about using experimental vaccines or adjuvants authorized for emergency use, according to study.
October 02, 2009 - KRISTI EATON - Law/Policy - Public Health - Capital Markets Gather Steam
A successful IPO and a steady rise in public financings could point to better times ahead.
October 02, 2009 - MARIE DAGHLIAN - Finance - Finance - Straight Shooter
Children may be protected from swine flu with one vaccination, study says.
September 25, 2009 - KRISTI EATON - Health - Vaccines - Stressed to Death
Report says distress can lead to medical mistakes.
September 25, 2009 - KRISTI EATON - Law/Policy - Medical Practice - Nothing to Sneeze At
Flu can induce heart attacks in people with heart disease, diabetes.
September 25, 2009 - KRISTI EATON - Health - Vaccines - More Than a Gut Feeling
New tests help detect GI cancers.
September 25, 2009 - KRISTI EATON - Tech/Innovation - Diagnostics - A New Path
Researchers develop a prototype vaccine for HIV.
September 25, 2009 - KRISTI EATON - Tech/Innovation - HIV/AIDS - A Deadly Deficiency
Elderly people not getting enough vitamin D are more susceptible to death, according to study.
September 25, 2009 - KRISTI EATON - Health - Aging - A Moving Discovery
Scientists discover a breakthrough that could help spinal cord injury patients.
September 25, 2009 - KRISTI EATON - Tech/Innovation - Regenerative Medicine - Environment Trumps Genetics
Researchers say how one lives may explain differing diabetes rates.
September 25, 2009 - KRISTI EATON - Law/Policy - Public Health - Stretching The Biodefense Dollar
Podcast: September 25, 2009
September 25, 2009 - Law/Policy - Biodefense - Hope for Sunnier Days Ahead
Financing activity heats up as summer turns into fall.
September 25, 2009 - MARIE DAGHLIAN - Finance - Finance - The Deadly Toll from Being Uninsured Rises
Podcast: September 18, 2009
September 18, 2009 - Law/Policy - Regulatory - Walking Wounded
Study says VA must ramp up efforts to deal with post-traumatic stress for Iraq War veterans.
September 18, 2009 - KRISTI EATON - Health - Public Health - Rising Risks
Excess weight, diabetes and hypertension is eroding progress aimed at improving heart health, study says.
September 18, 2009 - KRISTI EATON - Health - Cardiovascular - Diagnosing Alzheimer’s
Scientists discover a new protein associated with the neurodegenerative disease.
September 18, 2009 - KRISTI EATON - Tech/Innovation - Neurodegeneration - Immune Booster
Researchers create a new substance that could be used as a universal vaccine carrier.
September 18, 2009 - KRISTI EATON - Tech/Innovation - Vaccines - Premium Prices
Survey shows rising costs as Congress tries to pass reforms.
September 18, 2009 - KRISTI EATON - Law/Policy - Healthcare Reform - Stomach Turner
Popular acid-reducing drug can cause pneomonia, scientists say.
September 18, 2009 - KRISTI EATON - Health - Drug Safety - Fat Head
Research shows that the brain may send messages mixed messages about hunger.
September 18, 2009 - KRISTI EATON - Tech/Innovation - Obesity - Queuing Up
Three life sciences companies join the growing line for IPOs.
September 18, 2009 - Marie Daghlian - Finance - Finance - BIO's Greenwood Sees Healthcare Reform as Inevitable
Podcast: September 11, 2009
September 11, 2009 - Law/Policy - Regulatory - Fear of Rejection
Concerns about getting turned down by insurance companies keeps some people from participating in genetic testing, research says.
September 11, 2009 - KRISTI EATON - Law/Policy - Personalized Medicine - Perceptions Matter
When it comes to health, social classificiation can sometimes trump genetics, scientists say.
September 11, 2009 - KRISTI EATON - Health - Personalized Medicine - Causal Connection
Stem cell inside prostate may cause cancer, researchers say.
September 11, 2009 - KRISTI EATON - Tech/Innovation - Global - Unraveling Memories
Alzheimer’s patients could find help with memory loss in a class of cancer drugs.
September 11, 2009 - KRISTI EATON - Tech/Innovation - Neurodegeneration - Genes to Remember
Reserachers identify three new genetic risk factors for Alzheimer’s.
September 11, 2009 - KRISTI EATON - Tech/Innovation - Neurodegeneration - Dining Made Safe
Poll shows Americans want increased food safety regulations.
September 11, 2009 - KRISTI EATON - Law/Policy - Regulatory - Resistance Training
New gene helps researchers understand why muscle tissue grows resistant to insulin.
September 11, 2009 - KRISTI EATON - Health - Diabetes - Kids Go First
To mitigate possible swine flu cases, researchers recommend vaccinating children and young adults first.
September 11, 2009 - KRISTI EATON - Health - Vaccines - Getting Back to Work
Biotech companies busy with a bevy of smaller deals.
September 11, 2009 - Finance - Finance - New York Fights Fat
Podcast: September 4, 2009
September 04, 2009 - Law/Policy - Public Health - iPhone uSick
New mobile application tracks and maps infectious disease outbreaks.
September 04, 2009 - KRISTI EATON - Health - Information Technology - Test Your Metal
A new process of measuring zinc in cells could help treat certain diseases, researchers say.
September 04, 2009 - Tech/Innovation - Diagnostics - Junk (Food) Science
Lack of a certain gene may keep weight off despite poor diet, scientists say.
September 04, 2009 - KRISTI EATON - Health - Obesity - Community Affair
Local government can also play a role in fighting childhood obesity, report says.
September 04, 2009 - KRISTI EATON - Law/Policy - Regulatory - Daytime Doctors
Research says daytime orthopedic surgery may help prevent additional follow-up surgeries.
September 04, 2009 - KRISTI EATON - Health - Medical Practice - Spacing Out
Scientists have discovered the part of the brain responsible for the sense of personal space.
September 04, 2009 - KRISTI EATON - Tech/Innovation - Autism - Picking and Choosing
Race, gender, and insurance could effect whether someone receives a liver transplant, report says.
September 04, 2009 - KRISTI EATON - Law/Policy - Regulatory - Osteoclasts Warfare
New therapy for gum disease, rheumatoid arthritis, and osteoporosis could be in the future thanks to the discovery of protein.
September 04, 2009 - KRISTI EATON - Tech/Innovation - Global - Buying Spree
Summer ends with a spate of acquisitions.
September 04, 2009 - MARIE DAGHLIAN - Finance - Finance - Carb Lovers Rejoice
Low-carb diets might help the waistline but not the heart, research says.
August 28, 2009 - KRISTI EATON - Health - Obesity - A Hard Sell
No matter what party affiliation, Americans accept healthcare reform “myths” as true, researchers say.
August 28, 2009 - KRISTI EATON - Law/Policy - Healthcare Reform - Flu Frenzy
The scenarios are frightening, but a Federal advisory board says the U.S.’ preparations for swine flu are the “best ever.”
August 28, 2009 - KRISTI EATON - Health - Public Health - Halting Cancer
By blocking a critical biological pathway, colon cancer cells can be stopped, scientists say.
August 28, 2009 - KRISTI EATON - Tech/Innovation - Cancer - Fighting Fat
Scientists discover a molecule found to turn off the genes responsible for producing fatty tissue.
August 28, 2009 - KRISTI EATON - Tech/Innovation - Global - A Part D Payoff
More seniors receiving medication for a lower cost thanks to Medicare prescription drug program, report says.
August 28, 2009 - KRISTI EATON - Law/Policy - Regulatory - Deal Happy
The market was cautious but life sciences companies seemed to be in an agreeable mood.
August 28, 2009 - MARIE DAGHLIAN - Finance - Finance - Kennedy's Death Casts Shadow Over Healthcare Reform
Podcast: August 28, 2009
August 27, 2009 - Law/Policy - Healthcare Reform - A Depressed Housing Market
Widespread foreclosures are sparking a mental health crisis.
August 21, 2009 - KRISTI EATON - Law/Policy - Public Health - Faking It
With a little know-how, falsifying DNA is simple, research says.
August 21, 2009 - KRISTI EATON - Society - Crime - A Focused Strategy
Scientists approach to analyze gene variants in rare disease could provide a fast and cheap means of unlocking the genetics underlying common diseases.
August 21, 2009 - KRISTI EATON - Tech/Innovation - Genetics - Dying to Sleep
People with sleep apnea have an increased chance of death, research shows.
August 21, 2009 - KRISTI EATON - Health - Public Health - A Predictable Response
A single letter change in DNA could explain why some people respond better than others to hepatitis C treatments, a study says.
August 21, 2009 - KRISTI EATON - Tech/Innovation - Personalized Medicine - A Discovery to Toast
Compounds in red wine could reach the brain and help prevent Alzheimer’s, disease researchers say.
August 21, 2009 - KRISTI EATON - Health - Neurodegeneration - Light in August
Dealmakers take a break during the lazy days summer.
August 21, 2009 - MARIE DAGHLIAN - Finance - Finance - Investors Bullish on Biotech
Podcast: August 21, 2009
August 20, 2009 - Business - Markets - There Ought to Be a Law
Millions of young adults go without health insurance. Legislation could change that, report says.
August 14, 2009 - KRISTI EATON - Health - Healthcare Reform - Divided We Stand
Changing the stated role of government in health plans did little to change a plan’s appeal.
August 14, 2009 - KRISTI EATON - Health - Drug Delivery - Patient Profiling
Urine could be an indicator for a drug’s effectiveness in an individual, study finds.
August 14, 2009 - KRISTI EATON - Tech/Innovation - Personalized Medicine - When More Is Less
A comprehensive care approach for patients with chronic conditions reduces medical visits, study finds.
August 14, 2009 - KRISTI EATON - Tech/Innovation - Healthcare - Turning Hyde into Jekyll
By suppressing the immune system, scientists believe they may be able to reverse multiple sclerosis.
August 14, 2009 - KRISTI EATON - Tech/Innovation - Autoimmune Disease - Lazy and Stupid
High-fat diet impacts physical endurance and memory in rats, study shows.
August 14, 2009 - KRISTI EATON - Health - Wellness - An Infection Connection
Obsessive-compulsive disorder may stem from an incorrect response to bacteria found in throat infections, scientists say.
August 14, 2009 - KRISTI EATON - Tech/Innovation - Autoimmune Disease - Pesonalized Medicine Driving RX-DX Deals
Podcast: August 14, 2009
August 14, 2009 - Business - Dealmaking - Prying Open the Window
Two life sciences companies, neither biotechs, manage to debut this week.
August 14, 2009 - MARIE DAGHLIAN - Finance - Finance - Predetermined Diet
Consuming added sugars is associated with race and ethnicity, family income, and education, survey says.
August 07, 2009 - KRISTI EATON - Health - Public Health - Fat Target
Researchers say BMI misses the mark as an ineffective indicator for high cholesterol in children.
August 07, 2009 - KRISTI EATON - Law/Policy - Public Health - A Triple Whammy
Scientists are changing the way they think about how an aggressive form of breast cancer develops.
August 07, 2009 - KRISTI EATON - Tech/Innovation - Cancer - An Unhealthy Habit
Heavy drinking increases risk for some cancers, study says.
August 07, 2009 - KRISTI EATON - Tech/Innovation - Cancer - How Much Are Breakthroughs Worth?
Podcast: August 7, 2009
August 07, 2009 - Law/Policy - Healthcare Reform - Suspicious Symptoms
Flu drugs look promising, but researchers say studies supporting their use may be faulty.
August 07, 2009 - KRISTI EATON - Tech/Innovation - Research - Bugging Out Over Deet
Insect repellent inhibits a central nervous system enzyme, scientists say.
August 07, 2009 - KRISTI EATON - Health - Public Health - Eating Mindfully
Yoga can help control weight, researchers say.
August 07, 2009 - KRISTI EATON - Health - Obesity - Discounts Galore
Companies raising money in the capital markets offering, but selling shares at below-market prices to do so.
August 07, 2009 - MARIE DAGHLIAN - Finance - Finance - A Smoke Screen Detector
Podcast: August 3, 2009
July 31, 2009 - Law/Policy - Regulatory - Jumpin’ July
The month was a good one for biotech financing and dealmaking.
July 31, 2009 - MARIE DAGHLIAN - Finance - Finance - Saving Lives and Money
New genetic test identifies colon cancer patients who need lower doses of treatment drug.
July 30, 2009 - KRISTI EATON - Law/Policy - Personalized Medicine - No Longer Irresistible
A critical weapon in the fight against Malaria is growing less effective, study says.
July 30, 2009 - KRISTI EATON - Health - Global Health - Ready to Not Go
Pandemic flu will keep some health workers at home, survey says.
July 30, 2009 - KRISTI EATON - Health - Drug Delivery - The Crying Game
Researchers believe organism may unlock the key to the cause of colic in babies.
July 30, 2009 - KRISTI EATON - Tech/Innovation - Research - Turn Ons and Turn Offs
A new field of research is helping doctors and patients identify potential cancer cells and intervene before it’s too late.
July 30, 2009 - KRISTI EATON - Tech/Innovation - Cancer - Ready for Reform
Changes in healthcare are needed this year, industry leaders say.
July 30, 2009 - KRISTI EATON - Law/Policy - Healthcare Reform - Fat Chance
Researchers say over-the-counter meds may combat adult-onset diabetes and obesity.
July 30, 2009 - KRISTI EATON - Health - Obesity - Rare Disease Patient Advocates Series
July 24, 2009 - Tech/Innovation - Research - New Approaches to Treatment Needed in Pediatric Cancer
Podcast: July 24, 2009
July 24, 2009 - Tech/Innovation - Research - Evolve or Die
How the financial crisis is forcing biotech to change its traditional business models.
July 23, 2009 - PETER WINTER - Business - Business Strategy - A Step Toward A Diabetes Cure
Scientists find a key gene that determines whether an embryonic cell in mice becomes a pancreatic cell or biliary cell.
July 23, 2009 - KRISTI EATON - Tech/Innovation - Diabetes - Smog’s Brain Fog
Childrens’ IQs can be affected by a mother's exposure to urban air pollutants.
July 23, 2009 - KRISTI EATON - Health - Personalized Medicine - Oral Fixation
Scientists use human embryonic stem cells to engineer tissues mimicking human skin that could treat mouth and skin conditions.
July 23, 2009 - KRISTI EATON - Tech/Innovation - Regenerative Medicine - Career Compromise
Female surgeons are generally happy with their profession, but the job competes with family for women’s time, survey finds.
July 23, 2009 - Health - Medical Practice - When “Fingerprints” Are on the Inside
Researchers believe no two people have the same metabolism in a discovery that could boost medicine tailored to the individual.
July 23, 2009 - Health - Personalized Medicine - A Delicate Balance
A key manipulation performed when doctors screen for potential genetic diseases could actually interfere with healthy development.
July 23, 2009 - KRISTI EATON - Health - Diagnostics - A New Reason to Stop and Smell the flowers
Burning a lavender-scented candle not only gives the room a nice smell but could also alleviate stress, scientists say.
July 23, 2009 - Health - Wellness - Struggling for Coverage
High premiums keep uninsured adults from purchasing individualized health insurance, report says.
July 23, 2009 - KRISTI EATON - Health - Healthcare Reform - Biotech Takes Center Stage
Positive drug data and VC financings boost interest in the sector as big pharma gobbles another biotech company.
July 23, 2009 - MARIE DAGHLIAN - Finance - Finance - A New Model for Funding Research
Podcast: July 17, 2009
July 17, 2009 - Tech/Innovation - Research - “Biologic Residue”
Researchers say early-life experiences may make some more susceptible to chronic diseases of aging.
July 17, 2009 - Health - Public Health - Gluttons for Punishment
Many surgical residents say regulations that limit their work schedules to 80 hours per week are hurting their education.
July 17, 2009 - Health - Medical Practice - Liquid Memory Booster
Study suggests moderate alcohol consumption reduces risk of dementia in older adults.
July 17, 2009 - Tech/Innovation - Research - Otoscope, Stethoscope, and…Computer
Doctors who use electronic health records and electronic consultations are improving health of high-risk patients, study finds.
July 17, 2009 - Health - Information Technology - Back to the Bench
A new study challenges a basic assumption by finding that genes in the same individual’s blood cells and tissue cells have major differences.
July 17, 2009 - Tech/Innovation - Research - The Yogurt Effect
Taking the good bacteria found in yogurt called probiotics could help obese patients lose more weight after a certain type of gastric bypass surgery.
July 17, 2009 - Health - Obesity - Finding the Exit
Promising biotechs can still reward their employees and investors in these challenging times, but they’ll have to be more flexible and creative.
July 17, 2009 - ERIC WAHLGREN - Business - Dealmaking - Searching for a Cure
Podcast: July 10, 2009
July 10, 2009 - Tech/Innovation - Research - Nervous Reaction
Researchers close on the first artificial nerve cell that can communicate with nerve cells in the body using neurotransmitters.
July 10, 2009 - Tech/Innovation - Research - Gainful Gonads
Researchers say a unique culture method has enabled them to create a clearly defined cell type from the testis of adult mice and convert them into pluripotent stem cells.
July 10, 2009 - Tech/Innovation - Stem Cells - System Break Down
A new study says adverse work conditions may be to blame for the decrease in the number of primary care physicians.
July 10, 2009 - Health - Medical Practice - Don’t Forget Your Coffee
New research suggests caffeine significantly decreased abnormal levels of the protein linked to Alzheimer's disease in mice.
July 10, 2009 - Tech/Innovation - Research - Researchers Create Sperm from Stem Cells
The discovery could pave the way for future infertility treatments.
July 10, 2009 - Tech/Innovation - Stem Cells - Thigh Anxiety
Being stressed out can cause people to gain weight.
July 10, 2009 - Health - Public Health - A Bridge to Cross the Valley of Death
An innovative funding program at the National Cancer Institute could prove a model for other National Institutes of Health divisions to follow.
July 09, 2009 - DANIEL S. LEVINE - Finance - Finance - The Bulls Strike Back
Podcast: July 3, 2009
July 03, 2009 - Finance - Finance - A Complex Puzzle
Study shows that a combination of common genetic variations can lead to schizophrenia.
July 02, 2009 - Tech/Innovation - Genetics - Suppressing the Suppressor
Researchers pinpoint a new enemy for tumor-suppressor p53.
July 02, 2009 - Health - Cancer - Time for Hard Choices
Two top U.S. researchers say the medical community must address the dilemma of using expensive treatments that only extend life for a short while.
July 02, 2009 - Health - Healthcare Affordability - Summer Sizzle
A hot week for biotech dealmaking as Roche aligns itself with BIO.
July 02, 2009 - MARIE DAGHLIAN - Finance - Finance - Waging a War on Smoking
The U.S. government should take stronger steps to combat tobacco use in military, veteran populations, says report.
July 01, 2009 - Health - Wellness - A Signature Difference
UCLA researchers find molecular differences between embryonic stem cells and reprogrammed skin cells.
July 01, 2009 - Tech/Innovation - Stem Cells - More Pieces of the Autism Puzzle
Further gene mutations linked to risk of the disorder.
July 01, 2009 - Tech/Innovation - Autism - The Zest to Test
A new report finds that prostate screenings lead to more positive diagnoses but don’t necessarily lead to reduced risk of death or lower costs.
July 01, 2009 - Health - Cancer - Boning Up on the Heart
Scientists find that an extract derived from bone marrow cells improves cardiac function after an attack.
July 01, 2009 - Tech/Innovation - Regenerative Medicine - Why We Must Address The Primary Care Crisis for Healthcare Reform to Succeed
Podcast: June 26, 2009
June 25, 2009 - Health - Healthcare Reform - Ending Another Kind of Drug Trade
Regulators seek to end settlements that let brand-name pharmaceutical makers pay generic competitors to stay out of the market.
June 25, 2009 - Business - Generics and Biosimilars - Medicine’s Generation Gap
Baby Boomers and Gen Xers are 3.5 times more likely than older Americans to postpone treatments because of costs.
June 25, 2009 - Health - Healthcare Affordability - Test Anxiety
Patients beware: One of 14 American’s isn’t informed about abnormal results by their doctor, new research shows.
June 25, 2009 - Health - Medical Practice - Eradicating HIV
Researchers uncover approach to possibly destroy the virus that causes AIDS.
June 25, 2009 - Tech/Innovation - Influenza - Smoking Your Brain
New research discovers link between tobacco and neurological damage.
June 25, 2009 - Tech/Innovation - Neurodegeneration - Going Public
Report finds national savings and federal budget costs vary widely depending on alternative public plan options.
June 25, 2009 - Health - Healthcare Reform - Big Bonds and Small Deals
Merck’s raises $4.25 billion in debt, but it was mostly a quiet week for raising money.
June 25, 2009 - MARIE DAGHLIAN - Finance - Finance - Big Bonds and Small Deals
Merck’s raises $4.25 billion in debt, but it was mostly a quiet week for raising money.
June 25, 2009 - MARIE DAGHLIAN - Finance - Finance - Making Comparisons Effective
Any cost-versus-efficiency studies of healthcare should consider at least five elements, researchers say.
June 19, 2009 - Law/Policy - Healthcare Reform - No Recession in Medical Costs
Health spending is seen growing by 9 percent in 2010, according to a new report.
June 19, 2009 - Health - Healthcare Reform - The Downer of Getting High
Researchers find that pot smoke damages DNA in ways that could increase cancer risks.
June 19, 2009 - Health - Cancer - Redefining Pharma
Biotechnology products will dominate industry’s growth.
June 19, 2009 - Business - Global Economy - Power of Prayer
Novel social history of intercessory prayer studies reveals growing religious diversity and diminishing belief in science to measure the value of prayer.
June 19, 2009 - Society - Culture - An Inflammatory Study
Study finds popular Alzheimer's theory may be false trail.
June 19, 2009 - Tech/Innovation - Neurodegeneration - Preventing Blindness
Study suggests new approach to age-related macular degeneration.
June 19, 2009 - Tech/Innovation - Research - Blame Stress, Not Genes
Much touted “depression risk gene” may not add to risk after all.
June 19, 2009 - Tech/Innovation - Personalized Medicine - VCs Left to Their Own Devices
Since early June, there has been a marked increase in venture capital raised by medical device companies.
June 19, 2009 - MARIE DAGHLIAN - Finance - Finance - How to Fuel the BioEconomy
Podcast: June 19, 2009
June 18, 2009 - Business - Global Economy - How Personalized Medicine Is Transforming Healthcare
Podcast: June 12, 2009
June 12, 2009 - Law/Policy - Regulatory - Inheritance Tax
Individuals with family history of genetic disease are at risk of discrimination.
June 12, 2009 - Law/Policy - Personalized Medicine - Thinking EARLI
A new national network of researchers studies earliest possible causes of autism.
June 12, 2009 - Tech/Innovation - Autism - Sins of Omission
Women are underrepresented in cancer research.
June 12, 2009 - Tech/Innovation - Cancer - Saving Through Testing
Routine diabetes screenings could cut healthcare costs.
June 12, 2009 - Health - Diabetes - Something in the Water
The discharge of antibiotics into waterways may spread resistant bacteria and effect aquatic life.
June 12, 2009 - Health - Public Health - Ticking Time Bomb
Climate change could trigger a host of environmental disasters by 2050, setting off a wave of massive and disruptive migrations, a new report finds.
June 12, 2009 - Society - Global Warming - Knowing Your Ass from Your Elbow
Study reveals public’s ignorance of the human body.
June 12, 2009 - Health - Public Health - Robust Activity
Private capital is providing lifeblood for the life sciences industry.
June 12, 2009 - MARIE DAGHLIAN - Finance - Finance - Weeding Out Feedstocks
J. Craig Venter thinks jatropha, a weed that grows in areas unsuitable for agriculture, may be a promising source of fuel.
June 12, 2009 - MARIE DAGHLIAN - Business - Biofuels - What You Know About Funding Start-Ups Today Is Wrong
Podcast: June 5, 2009
June 05, 2009 - Finance - Finance - Profits Over Health
Health, life insurers hold billions in tobacco stocks.
June 05, 2009 - Finance - Finance - Keep It Simple
Medicare Part D is too complicated for seniors to identify lowest-cost plan, a study finds.
June 05, 2009 - Health - Healthcare Reform - Extreme Eating
Group says chain restaurants engaged in obesity-promoting “waist race” and calls on Congress to require menu labeling.
June 05, 2009 - Health - Obesity - Antibiotic Savoir-Faire
A French public health campaign about overuse of the bacteria-killing compounds is associated with a reduction in unnecessary use.
June 05, 2009 - Health - Public Health - The Bigger Picture
A study finds that pay-for-performance helps physicians identify the problems that present the most risk and deal with them effectively.
June 05, 2009 - Health - Medical Practice - Corn Scorned
Bankruptcies continue to plague ethanol companies.
June 05, 2009 - MARIE DAGHLIAN - Finance - Finance - Unintended Consequences
Federal regulator warnings lead to changes in depression diagnosis.
June 05, 2009 - Law/Policy - Regulatory - Hidden Health Tax
Undisclosed premium surcharge that pays for the uncompensated healthcare costs of the uninsured cost families more than $1,000 in 2008.
May 29, 2009 - Health - Healthcare Reform - Living Longer
Study finds dramatic increase in metastatic colon cancer survival.
May 29, 2009 - Tech/Innovation - Cancer - A Growing Burden
Type 1 diabetes cases in children under 5 to double across Europe by 2020.
May 29, 2009 - Law/Policy - Public Health - Flu Fighter
Study suggests arthritis drug might prove effective in fighting influenza.
May 29, 2009 - Tech/Innovation - Influenza - Identity Crisis
Cancer drug causes patient to lose fingerprints and be detained by U.S. immigration.
May 29, 2009 - Society - Culture - Location, Location, Location
Retail medical clinics appear to be situation in more well-to-do neighborhoods, flouting the notion that they primary serve the disadvantaged.
May 29, 2009 - Health - Healthcare Delivery - Why Biotech Business Models May No Longer Be Sustainable
Podcast: May 29, 2009
May 29, 2009 - Business - Business Strategy - Medical Turísmo
About 1 million Californians travel to Mexico for healthcare every year because of lower costs.
May 29, 2009 - Health - Medical Tourism - Comparing the Comparers
Podcast: May 22, 2009
May 22, 2009 - Law/Policy - Healthcare Reform - Hoping for a Reprise
The team behind Pharmion raise $145 million for a new venture.
May 22, 2009 - DANIEL S. LEVINE - Finance - Finance - The Clean Team
Advanced biofuel company LS9 partners with consumer products bigwig Procter and Gamble to advance its technology.
May 22, 2009 - MARIE DAGHLIAN - Business - Biofuels - Living to Fight Another Day
At a time when young biotechs face a hard time raising money, having a revenue-generating business can give them longevity.
May 21, 2009 - DANIEL S. LEVINE - Business - Business Strategy - Treasure Hunt
Biotech companies can still find investment in these tough times, but they’ll have to look a lot harder and get more creative.
May 21, 2009 - ERIC WAHLGREN - Finance - Finance - The Next Big Thing
Personalized medicine companies aren’t just making major scientific breakthroughs. They’re also starting to attract big money.
May 21, 2009 - PETER WINTER - Finance - Finance - Ten Technologies to Watch
Here are some of the key areas that will change biotechnology.
May 21, 2009 - DANIEL S. LEVINE - Tech/Innovation - Technology - Cluster Bluster
Boston retains its bragging rights as the top U.S. life sciences hub in a new study, but Greater Philadelphia topples Greater San Francisco in the No. 2 position.
May 21, 2009 - Business - Economic Development - Flight Risk
As the financial crisis throws the biotech job market into turmoil, here are some tips for retaining your A-players.
May 20, 2009 - ERIC WAHLGREN - Business - Business Strategy - Brave New Biotech World
With the global economic crisis and healthcare reform, life sciences companies must adapt to thrive. Here are five strategies for success.
May 19, 2009 - Peter Winter - Business - Business Strategy - Burrill Addresses State of the Industry
Podcast: May 15, 2009
May 15, 2009 - Business - Global Economy - Predicting Alzheimer’s
A 15-point risk index can help predict likelihood of an elderly person developing the neurodegenerative disease.
May 15, 2009 - Tech/Innovation - Neurodegeneration - Too Close for Comfort
Review finds conflicts of interest in many cancer studies.
May 15, 2009 - Tech/Innovation - Research - Building A Bigger Brain
Study shows that meditation may increase gray matter.
May 15, 2009 - Health - Wellness - Just Say “No”
Critics of widespread practice say providing free drug samples to patients risks harm to public health.
May 15, 2009 - Health - Public Health - Phoning It In
New reports suggest using videoconferencing to evaluate stroke patients can be just as effective as a bedside exam.
May 14, 2009 - Health - Technology - Access Matters
A new survey finds that Americans value their ability to get care from their physicians above many other healthcare services and products.
May 14, 2009 - Health - Healthcare Reform - Workout Knockout
Daily vitamin supplements may undermine the benefits of exercise.
May 14, 2009 - MARIE DAGHLIAN - Health - Wellness - Heading to Atlanta in Less Than Peachy Times
Podcast: May 8, 2009
May 08, 2009 - Business - Dealmaking - BIO 2009: Our Picks
Sessions recommended by the editors of The Burrill Report
May 08, 2009 - Business - Dealmaking - You Call This Living?
Women live longer, but not better, plagued by obesity and arthritis.
May 08, 2009 - Health - Aging - Picturing Austism
Imaging study finds evidence of brain abnormalities in toddlers with the disorder.
May 08, 2009 - Tech/Innovation - Autism - A Narcolepsy Awakening
Researchers say the sleep disorder is an autoimmune disease.
May 08, 2009 - Tech/Innovation - Autoimmune Disease - Pink Slips Hurt Health
Job loss can make you sick, a new study finds.
May 08, 2009 - Health - Public Health - A Cellulosic Biofuel Breakthrough
Company says consolidated bioprocessing paves the way to low cost cellulosic biofuels.
May 08, 2009 - MARIE DAGHLIAN - Business - Biofuels - Charged Up Over Bioelectricity
Researchers say converting biomass to electricity is more efficient and friendlier to the environment than converting to ethanol.
May 08, 2009 - Tech/Innovation - Biofuels - Largely Verboten
Direct-to-consumer genetic tests are restricted in Germany.
May 08, 2009 - Law/Policy - Regulatory - A Regulatory Problem
Less than half of adults surveyed believe the FDA is doing a good job.
May 02, 2009 - Law/Policy - Regulatory - Flu Forensics
Avian flu research sheds light on swine flu outbreak.
May 02, 2009 - Health - Public Health - Understanding Autism
Large study traces root causes of disorder to variations in central nervous system genes.
May 02, 2009 - Tech/Innovation - Personalized Medicine - Feeding the Planet
Researchers report significant advances in genetic modification of plants.
May 02, 2009 - MARIE DAGHLIAN - Business - Industrial/Ag Bio - Staying Effective
In a flu pandemic, first using small stockpile of secondary drug could delay resistance to primary stockpiled medication.
May 02, 2009 - Health - Public Health - Lessons From A Pandemic Past
Podcast: May 1, 2009
May 01, 2009 - Health - Public Health - Price Sensitive
Patients are far less likely to take recommended drugs in a timely manner after being diagnosed chronic conditions if they have high co-pays, a new study finds.
May 01, 2009 - Health - Drug Delivery - Stopping the Killers
Smoking and high blood pressure are responsible for the highest number of preventable deaths in the U.S. and could be greatly reduced.
May 01, 2009 - Health - Public Health - A Simple Solution
Bleach shows a remarkable ability to treat chronic, severe pediatric eczema, a study finds.
May 01, 2009 - Health - Treatments - Talking ‘Bout Regeneration
Collaboration between Pfizer regenerative medicine and UCL aims to develop treatment for macular degeneration.
May 01, 2009 - Business - Regenerative Medicine / Stem Cells - Scale up time for advanced biofuels
Attendees at the Advanced Biofuels Development Summit say there's no single solution for renewable fuels.
April 25, 2009 - MARIE DAGHLIAN - Tech/Innovation - Biofuels - Not So Great Expectations
U.S. drug sales to fall in 2009 as IMS Health revises its forecast downward to forecast record low sales growth.
April 24, 2009 - Business - Global Economy - Seeing Salad but Eating Fries
Healthful menus may backfire by allowing people to feel good about just thinking of ordering healthful foods.
April 24, 2009 - Health - Wellness - Increasing Survival
Molecular profiling can result in specific treatments for individual patients that significantly limit the growth and spread of tumors.
April 24, 2009 - Tech/Innovation - Global - Plaque Attack
Researchers find agents that speed up destruction of proteins linked to Alzheimer's.
April 24, 2009 - Tech/Innovation - Neurodegeneration - Closing the Health Gap
Offering universal coverage could reduce racial and socioeconomic disparities on several key measures, a study finds.
April 24, 2009 - Law/Policy - Healthcare Reform - A Disturbing Pattern
A web-based system could help doctors track complications in surgery but getting clinicians to enter the reports isn’t always easy.
April 24, 2009 - Health - Information Technology - Not To Be Continued
Elderly patients who are hospitalized are much less likely to experience continuity of care than they were ten years ago.
April 24, 2009 - Health - Public Health - Slow Ride
Raising money in the public markets remains extremely difficult with just $60.5 million recording during the past week.
April 24, 2009 - Finance - Finance - Rethinking University-Industry Relationships
Podcast: April 24, 2009
April 23, 2009 - Tech/Innovation - Research - A Carrot for Good Health
An unusual competition will award $10 million to the team that comes up with the best plan to reform U.S. healthcare.
April 22, 2009 - ERIC WAHLGREN - Law/Policy - Healthcare Reform - New Stem Cell Technology Gets Boost from Collaboration
Podcast: April 17, 2009
April 17, 2009 - Business - Business Development - Riding Roughage
Colon cancer shuts down receptor that could shut it down.
April 17, 2009 - Health - Cancer - Misperceptions Underlie Donor Crisis
A majority of Americans express interest in organ and tissue donation, but few register.
April 17, 2009 - Health - Organ Donation - Brain Drain
Study finds neurodegeneration targets the destruction of neural networks that support healthy functioning.
April 17, 2009 - Tech/Innovation - Neurodegeneration - Packing Protection
Cholesterol-fighting statins cut stroke risk by one fifth.
April 17, 2009 - Health - Cardiovascular - A Processing Problem
Insulin, not genes, are linked to obesity.
April 17, 2009 - Health - Obesity - Tracking a Killer
Researchers harness nanoparticles to peer inside tumor cells and monitor changes.
April 17, 2009 - Tech/Innovation - Nanotechnology - Reprogram Without Going Retro
Researchers say they are closer to creating safe embryonic-like stem cells.
April 17, 2009 - Tech/Innovation - Stem Cells - Biotech Survival Guide
Here are some key tips on how to stay the course during the global economic crisis.
April 13, 2009 - PETER WINTER - Business - Business Strategy - Making Sense of the First Quarter Numbers
Podcast: April 10, 2009
April 10, 2009 - Finance - Finance - Deadly Disconnect
Hospitals with higher self-reported safety scores don’t have a substantially lower rate of patient deaths.
April 09, 2009 - Health - Medical Practice - Double Whammy
The number of Americans with at least one chronic disease is rising, as is their problems with paying for care.
April 09, 2009 - Health - Public Health - Let’s Make a Steal
Global dealmaking among biotechs will remain active in 2009, but M&A; and licensing deal values could decline as buyers seek out bargains.
April 09, 2009 - ERIC WAHLGREN - Business - Dealmaking - Playing the Field
Rather than relying on any single source of financing, biotechnology companies need to call upon a toolbox of various instruments.
April 09, 2009 - DANIEL S. LEVINE - Finance - Finance - Universal Health Insurance, Olé!
Mexico’s program to provide coverage for 50 million uninsured succeeds in reducing catastrophic health expenditures, study says.
April 08, 2009 - Health - Healthcare Reform - Pink Is in Fashion
First quarter 2009 biotech company restructurings and layoffs reach a brisk pace.
April 03, 2009 - MARIE DAGHLIAN - Business - Downsizing - Downsizing and Job Searching in the Life Sciences
Podcast: April 3, 2009
April 03, 2009 - Business - Downsizing - Revolving Door
Nearly one in five Medicare patients is readmitted to the hospital within 30 days after being discharged.
April 03, 2009 - Health - Public Health - Creating Hawkeyes
Action video games improve vision with a 58 percent improvement in the ability to perceive changes in shades of gray.
April 03, 2009 - Tech/Innovation - Research - Seeds of Growth
Syngenta and Dow AgroSciences look to maximize the value of their technologies in cross licensing pact.
April 03, 2009 - MARIE DAGHLIAN - Business - Industrial/Ag Bio - Of Mice and Men
Rodents and humans should have more in common in clinical trials.
April 03, 2009 - Tech/Innovation - Research - The Fine Print
Researchers question effectiveness of warning labels on over-the-counter drugs.
April 03, 2009 - Health - Public Health - Something Fishy about Cows
Giving moo-moos omega 3 fatty acids reduces the bovine’s methane emissions.
April 03, 2009 - Tech/Innovation - Environment - Technophobic Hospitals
U.S. medical centers have a long way to go to achieve a healthcare system that is fully electronic.
March 30, 2009 - Health - Information Technology - Obama Administration Readies Comparative Effectiveness for Prime Time
Podcast: March 27, 2009
March 27, 2009 - Law/Policy - Healthcare Reform - A Sympathetic Approach
Ardian's $47 million financing reflects market's high hopes for its breakthrough treatment for hypertension aimed at quieting the sympathetic nervous system.
March 27, 2009 - DANIEL S. LEVINE - Business - MedTech - Off the Honor Roll
Some 80 percent of U.S. consumers give the U.S. health system a grade of “C” or lower, a new Deloitte study finds.
March 27, 2009 - Health - Healthcare Reform - Good as Gold
Special nanoparticles show promise for “cooking” cancer cells.
March 27, 2009 - Tech/Innovation - Nanotechnology - Hopes of Stabilizing Unstable Genes
Discovery may result in test to determine predisposition to cancer.
March 27, 2009 - Tech/Innovation - Cancer - Heal Thyself
Human adult testes cells can become embryonic-like.
March 27, 2009 - Tech/Innovation - Stem Cells - Predisposed to Depression
Thinning of the brain’s cortex implicated in inherited form of the disorder.
March 27, 2009 - Health - Personalized Medicine - Biotech Braces for a New FDA Chief
Podcast
March 20, 2009 - Law/Policy - Regulatory - Dutch Masters
The Netherlands is already known for many things, but the country’s recent health system overhaul could provide some pointers for U.S. reformers, a Dutch diplomat says.
March 20, 2009 - Law/Policy - Healthcare Reform - An Early Warning
Biomarker test predicts conversion from mild cognitive impairment to Alzheimer’s disease.
March 20, 2009 - Tech/Innovation - Neurodegeneration - A Boost for Biotech
Legislative approach by Virginia Biotechnology Association may offer roadmap for others.
March 20, 2009 - Business - Economic Development - Hoping To Breathe New Life Into Inhaled Insulin
MannKind submits application with FDA to market AFRESA, but may face bigger challenges than regulatory hurdles because of Pfizer’s past failure.
March 20, 2009 - Business - Business Strategy - A Smoothie Delivery
New generation of oral vaccines uses dairy probiotics to protect against disease.
March 20, 2009 - Tech/Innovation - Vaccines - Great White North Biotech Fading To Black
Canadian biotech industry’s R&D; engine is running out of gas.
March 20, 2009 - Finance - Finance - Building a Better Soybean
DuPont hopes to market healthful GM soy oil and enters a partnership to develop rice hybrids.
March 20, 2009 - MARIE DAGHLIAN - Business - Industrial/Ag Bio - A Dangerous Distance
A substantial number of U.S. residents live too far away from emergency departments, prompting researchers to call for a revamp of the country’s response network.
March 20, 2009 - Health - Public Health - Science Comes Back In Vogue
Podcast: March 13, 2009
March 13, 2009 - Law/Policy - Regenerative Medicine - BIO Simmering Over Biosimilars
Bipartisan bill more is viewed as more onerous than a previous version by limiting to five years market exclusivity for innovator products.
March 13, 2009 - DANIEL S. LEVINE - Law/Policy - Legislation - Betting on the Future
Despite U.S. economic woes, biopharmaceutical R&D; investment grows to $65.2 billion and shows no sign of slowing down.
March 13, 2009 - Business - Drug Development - Insurance Creep
An expert says President Obama’s health reform plan that includes increasing Medicare premiums for the wealthiest Americans could ultimately affect the less well off.
March 13, 2009 - Health - Healthcare Reform - It's Alive!
Harvard Scientists create synthetic ribosome.
March 13, 2009 - MARIE DAGHLIAN - Tech/Innovation - Industrial Bio/Ag Bio - Reversal of Fortune
The Ethanol industry hopes to stage a comeback.
March 13, 2009 - MARIE DAGHLIAN - Business - Biofuels - High Court Rejects Preemption
The U.S. Supreme Court upholds verdict of Vermont court in Wyeth v. Levine.
March 09, 2009 - MARIE DAGHLIAN - Law/Policy - Regulatory - Patent Reform Pending
Podcast: March 6, 2009
March 06, 2009 - Law/Policy - Patents - Stem Cell Therapy Trial Gets Greenlight
FDA clears Pluristem Therapeutics to begin first-in-human trial of placenta-derived stem cell therapy for limb disease.
March 06, 2009 - Tech/Innovation - Stem Cells - Getting Personal About Genitourinary Cancers
UCLA center will offer “one-stop shopping” to those fighting kidney, bladder, testicular, and prostate cancers.
March 06, 2009 - Health - Personalized Medicine - Eat Your Broccoli
Cruciferous vegetables may help protect against respiratory conditions like asthma.
March 06, 2009 - Health - Wellness - Instant Immunity
Scripps research scientists engineer new type of vaccination that provides protections against pathogens without delay.
March 06, 2009 - Tech/Innovation - Research - A Tax-Free Savings Plan for Disabilities
Legislation in Congress seeks to allow the disabled and their families to create tax-exempt savings accounts for future care-related expenses.
March 06, 2009 - MARIE DAGHLIAN - Law/Policy - Legislation - The Weekend Effect
Patients with gastrointestinal bleeding admitted to hospitals outside the workweek have a higher death rate.
March 05, 2009 - Health - Public Health
More than 1 million new farmers experience benefits associated with biotech crops, an industry-supported group says.
February 27, 2009 - MARIE DAGHLIAN - Business - Industrial/Ag Bio- It’s a Long Way to the Top
The U.S. ranks sixth in a new report on global competitiveness and innovation with Singapore the country to beat.
February 27, 2009 - Business - Global Economy - Genzyme Ready to Spend on Personalized Medicine
Podcast: February 27, 2009
February 27, 2009 - Health - Drug Delivery
The National Heart, Lung, and Blood Institute plans to put genetic-based warfarin dosing to the test.
February 27, 2009 - MARIE DAGHLIAN - Health - Public Health
Health experts urge supermarket pharmacies to get smart about free antibiotics.
February 27, 2009 - Health - Public Health
UCLA stem cells scientists make electrically active motor neurons from iPS cells to model and treat diseases.
February 26, 2009 - Tech/Innovation - Stem Cells
Researchers report hormone-disorder drug could help drinkers stay sober.
February 26, 2009 - Tech/Innovation - Alcoholism and Drug Addiction
Armed with information, patients influence cancer treatment
February 26, 2009 - Health - Cancer- Biotech Scores Black Ink
Podcast: February 20, 2009
February 20, 2009 - Finance - Finance - A Geographic Health Danger
The number of fast-food restaurants in a neighborhood is associated with increased risk of stroke.
February 20, 2009 - Health - Public Health
Researchers cast doubt on role of free radicals in aging.
February 20, 2009 - Tech/Innovation - Aging
Study finds statins are cost-effective and would save thousands of lives every year of doctors and patients closely followed guidelines for their use.
February 20, 2009 - Law/Policy - Healthcare Reform
Wellpoint teams up with customer-generated review service Zagat to provide ratings on doctors.
February 20, 2009 - MARIE DAGHLIAN - Health - Medical Practice- Underfunded, Understaffed, and No Oversight
“Badly fragmented” forensic science system needs overhaul.
February 20, 2009 - Society - Crime
States expand newborn screening for life-threatening disorders.
February 20, 2009 - Law/Policy - Regulatory
Now that Tom Daschle is out of the picture, a group of U.S. medical leaders proposes a new strategy for revamping the U.S. healthcare system.
February 20, 2009 - Law/Policy - Healthcare Reform- Roche Turns Up The Heat On Genentech
Podcast: February 13, 2009
February 13, 2009 - Business - Dealmaking - Nature’s Antibiotics
Surgical implants coated with one of naturally occurring peptides could prevent infection.
February 13, 2009 - Tech/Innovation - Technology - Restructuring and Refocusing
Three more companies announced reorganization plans as the economic condition continue to take their toll on the industry.
February 13, 2009 - Business - Business Strategy - Brain Drain
Study questions effectiveness of $80 million per year brain exercise products industry and say further study to assist elderly in making informed decisions.
February 13, 2009 - Tech/Innovation - Neurodegeneration
Study finds high level of adverse drug reactions in hospitals.
February 13, 2009 - Health - Public Health- Protecting Historic Treasures
Scientists team with curators to stem decay of world's art, cultural heritage.
February 13, 2009 - Society - Culture
New genomic test can personalize breast cancer treatment.
February 13, 2009 - Health - Personalized Medicine
Study finds Medicare Part D led to most seniors having drug benefit.
February 13, 2009 - Health - Healthcare Reform
Advanced Biofuel Production Looms Ahead.
February 13, 2009 - MARIE DAGHLIAN - Business - Biofuels- Cracking the Common Cold
Researchers decipher the genetics of all known strains of the human rhinovirus and gain insight into the suspected cause of asthma and acute asthma attacks.
February 12, 2009 - Tech/Innovation - Research - When a Doughnut Hole Is No Treat
An insurance coverage gap for prescriptions that arises when annual spending on drugs is neither too high nor too low is a serious problem for seniors.
February 10, 2009 - Health - Healthcare Reform - Advancing Healthcare Reform After Daschle
Podcast February 6, 2009
February 06, 2009 - Law/Policy - Healthcare Reform - Alzheimer’s: A Type 3 Diabetes
Research provides evidence insulin may shield against the neurodegenerative disease.
February 06, 2009 - MARIE DAGHLIAN - Tech/Innovation - Neurodegeneration - Twice the Risk
Researchers finds clear proof of hormone therapy causing breast cancer.
February 06, 2009 - Health - Cancer - Race Matters
Study finds African-Americans more distrusting of research than whites.
February 06, 2009 - Society - Research - FDA Embraces Genomics
Newly created post within the agency will focus on providing staff with access to high level analysis of complex genetic data.
February 06, 2009 - Law/Policy - Regulatory - Green for Green
Government agencies plan to pony up $25 million for new biofuel research and development grants.
February 06, 2009 - Business - Biofuels - Stimulating Research
Senators add amendment to stimulus package to boost NIH funding by $6.5 billion.
February 05, 2009 - Law/Policy - Research - Daschle Withdraws
Obama's pick to head HHS pulls out because of controversy over unpaid taxes.
February 03, 2009 - Law/Policy - Healthcare Reform - A Blockbuster Deal
Podcast: January 30, 2009
January 30, 2009 - Business - Dealmaking -
New study found transplantation of stem cells reverses paralysis in laboratory tests in animals.
January 30, 2009 - Tech/Innovation - Regenerative Medicine
Concussions in former athletes can affect mental and physical processes later in life.
January 30, 2009 - Society - Culture
A new study finds even modest increases in healthcare automation at hospitals can reduce death rates dramatically.
January 30, 2009 - Health - Information Technology
Six plants have shut their doors since the beginning of 2009 as ethanol producers struggle to cope with waning demand and poor profit margins.
January 30, 2009 - MARIE DAGHLIAN - Business - Biofuels
Personalized medicine is good for patients, but policy changes will be needed for drug companies and payers to realize its benefits.
January 30, 2009 - MARIE DAGHLIAN - Health - Personalized Medicine
Diabetes is an epidemic in the United States as some 40 percent of the population having the disease hasn’t yet been diagnosed.
January 30, 2009 - Health - Diabetes
Children who lack health insurance even for short periods are less likely to go to the doctor.
January 30, 2009 - Health - Healthcare Reform- A Call for Medical Diplomacy
Controlling neglected tropical diseases may be key to U.S. foreign policy, says former HHS Secretary Tommy Thompson.
January 29, 2009 - Law/Policy - Global Health
An experimental topical microbicide offered convenient, long-lasting protection against genital herpes in mouse study.
January 24, 2009 - MARIE DAGHLIAN - Tech/Innovation - Global- FDA Gives Geron A Green Light
Podcast: January 23, 2009
January 24, 2009 - Law/Policy - Regulatory
New research strengthens the link between water pollution and rising male fertility problems.
January 23, 2009 - Health - Personalized Medicine
Genetic testing is not cost-effective in guiding initial dosing of the common blood thinner warfarin.
January 23, 2009 - Health - Personalized Medicine
Study links smoking to most male cancer deaths, not just those from lung cancer.
January 23, 2009 - Health - Cancer
Psychology study shows that violence does not motivate video game players.
January 23, 2009 - Society - Culture
People who are socially active and calm may not develop dementia.
January 23, 2009 - Health - Neurodegeneration
Measles virus vaccine derivatives may prove to be an effective treatment for patients with advanced prostate cancer.
January 23, 2009 - Health - Cancer
Researchers genetically link Lou Gehrig’s disease in humans to canine disease, a discovery that could help identify therapy for humans and dogs.
January 23, 2009 - Tech/Innovation - Global- An Ad That Gnaws At You
Pfizer commercial sends stark warning about dangers of buying fake medicine.
January 23, 2009 - Society - Culture
Beaker's Beth Perry Interviews G. Steven Burrill, CEO of Burrill & Company and publisher of The Burrill Report, about the themes of his new book Biotech 2009-Life Sciences: Navigating the Sea Change.
January 23, 2009 - Finance - Finance
Pfizer is in talks to buy Wyeth in a deal potentially worth $60 billion.
January 23, 2009 - MARIE DAGHLIAN - Business - Dealmaking- A Small Regulatory Gap
Report warns that the U.S. Food and Drug Administration’s ability to regulate the safety of over-the-counter products containing nanomaterials is hampered by a lack of information.
January 21, 2009 - Law/Policy - Regulatory - Tin Ears
Cellulosic ethanol grows as corn ethanol withers.
January 17, 2009 - MARIE DAGHLIAN - Business - Industrial/Ag Bio - Brain Teaser
Study of a rare disease finds a mechanism that may underlie many neurodegenerative diseases.
January 17, 2009 - Tech/Innovation - Research - From Cage To Catwalk
Researchers find disabling an enzyme allows mice to gorge yet remain stylishly svelte.
January 16, 2009 - Health - Obesity - The Biotech Industry Braces For Obama
Podcast: January 16, 2009
January 16, 2009 - Law/Policy - Legislation - Shopping for a Stimulus
Leading U.S. biotechnology association warns government action is needed to save the development of new medicines.
January 16, 2009 - PETER WINTER - Finance - Finance - Ready For Reform
JPMorgan chairman calls for universal healthcare coverage.
January 16, 2009 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform - Why Brazilians Wear Skimpy Bathing Suits
The country’s fifth largest city offers free exercise classes in public places, making people who participate three times more likely to work out.
January 16, 2009 - Health - Wellness - A Growing Burden
Americans with diabetes had 3.6 times more hospital admissions than those without, accounting for nearly $171 billion in charges.
January 16, 2009 - Health - Diabetes - A Coffee Break
Study finds high caffeine intake is linked to a proneness to hallucination.
January 15, 2009 - Health - Public Health - Paging Dr. Walgreens
A new health offering for employers integrates worksite health centers and retail-store medical clinics run by the pharmacy chain with discounts on prescription drugs and merchandise.
January 15, 2009 - Health - Healthcare Delivery - Sensitivity Training
Researchers identify two FDA-approved drugs that heighten the brain’s response to the appetite-suppressing hormone leptin.
January 09, 2009 - MARIE DAGHLIAN - Health - Obesity - A Gut Feeling about an Old Drug
Clioquinol, an 80-year-old drug used to treat diarrhea, may alleviate Alzheimer’s disease.
January 09, 2009 - Health - Neurodegeneration - A Good Housekeeping Seal For Diagnostics
The Critical Path Institute readies to launch the United States Diagnostic Standards to provide voluntary certification for laboratory and pathology diagnostics.
January 09, 2009 - MARIE DAGHLIAN - Health - Personalized Medicine - A Resistance Movement
Excessive use of antiviral drugs could aid deadly flu.
January 09, 2009 - Health - Public Health - Viva Viagra
The erectile dysfunction drug sildenafil appears to help a signaling protein shield the heart from the damage of high blood pressure.
January 09, 2009 - Health - Cardiovascular - Kicking Off The New Year
Podcast: January 9, 2009
January 09, 2009 - Finance - Finance
Turns out, playing video games may actually be a good fitness program, but only if they make you move around a bit.
January 09, 2009 - Health - Wellness
Researchers say substance abuse services could help reduce the hundreds of millions of dollars that drug and alcohol disorders add to Medicaid healthcare spending.
January 09, 2009 - Law/Policy - Healthcare Reform
The Bill & Melinda Gates Foundation awards a $7.5-million grant to work on alleviating healthcare worker shortage in Tanzania.
January 09, 2009 - Health - Global Health- A Loaf of Bread, a Carton of Milk,…and a Diagnosis
Although they've been around for years, health clinics located in grocery stores and retail pharmacies have expanded dramatically in the last two years as consumers seek easier access to doctors. Worried about being left behind, large hospital systems are
January 07, 2009 - ERIC WAHLGREN - Health - Healthcare Delivery
Unlike other retail-based clinics, QuickHealth relies on actual doctors and doesn’t take insurance. Some of its service policies take inspiration from Starbucks.
January 07, 2009 - ERIC WAHLGREN - Health - Healthcare Delivery- Polishing The Crystal Ball
G. Steven Burrill predicts what's ahead for biotech in 2009
January 02, 2009 - - Finance - Finance
It's a wrap on 2008, a year that delivered a drubbing to the life sciences sector.
January 02, 2009 - Finance - Finance- Super Size Me
Even when their penises are of a normal size, men will go to great lengths to go to great lengths.
December 31, 2008 - DANIEL S. LEVINE - Society - Culture
Researchers identify common genetic variant linked to high blood pressure opening up the possibility of more tailored treatments for patients.
December 31, 2008 - Health - Personalized Medicine
Antifungal pills used to treat everyday infections could provide relief for many asthma sufferers.
December 31, 2008 - Health - Asthma
Scientists isolate genes that made the Spanish Flu of 1918 so lethal.
December 31, 2008 - Health - Genomics
Moderate consumption of alcohol can reduce risks of Alzheimer’s dementia and cognitive decline, researchers say.
December 31, 2008 - Health - Neurodegeneration
Podcast: January 2, 2009
December 31, 2008 - Finance - Finance- Stimulating the Appetite
The pharmaceutical industry is chasing dreams of sexual dysfunction treatments for women that could rival the success of Viagra, but finding such a wonder drug poses lots of challenges.
December 29, 2008 - DANIEL S. LEVINE - Business - Drug Development - Restructuring And Refocusing
BioPharma creates a spin-off of its drug-development business in just one example of the recent realignments, cost-cuttings, and layoffs.
December 20, 2008 - Business - Business Strategy - Improving The Odds
Mayo Clinic research on tamoxifen leads to recommendation for gene testing for postmenopausal women about to begin tamoxifen for breast cancer.
December 19, 2008 - Health - Personalized Medicine - A Test With Limits
Colonoscopy significantly reduces death from left-sided colon cancer but not from right-sided.
December 19, 2008 - Health - Diagnostics - More Testing Needed
FDA plays it safe, remaining unconvinced about retrospective analyses.
December 19, 2008 - MARIE DAGHLIAN - Health - Personalized Medicine - A Carrot To E-Prescribe
Medicare offers a cash incentive to get doctors to adopt information technology as part of its healthcare reform agenda.
December 19, 2008 - MARIE DAGHLIAN - Health - Information Technology - Seeds For Energy
Ceres launches seed sales for dedicated energy crops.
December 19, 2008 - MARIE DAGHLIAN - Business - Industrial/Ag Bio - EU Gets Ambitious On Alternative Fuels
Mandate includes 20 percent of power generation and 10 percent of transportation fuel to be derived from renewable sources by 2020.
December 19, 2008 - MARIE DAGHLIAN - Business - Industrial/Ag Bio - The Diet Drug
Eating meals high in vegetables and fruit and lower in fat reduces breast-cancer recurrence for a certain group of survivors by 31 percent.
December 18, 2008 - Health - Cancer - Boning up on Diabetes
Researchers find that many youths with the type 1 form of the disease are deficient in Vitamin D, putting them at risk for bone fragility.
December 18, 2008 - Health - Diabetes - As Real As Santa
Researchers bust medical myths in time for the holiday season.
December 18, 2008 - Society - Culture - Big Pharma To Eat Big Bio
Deutsche Bank sees acceleration of M&A; activity as industry races toward the “patent cliff.”
December 18, 2008 - Finance - Finance - Free Drugs Have A Cost
Study finds samples end up costing uninsured patients more than generics.
December 16, 2008 - DANIEL S. LEVINE - Business - Marketing - Going Dutch
The Netherlands' universal model requires everyone to pay for their own health insurance but, a researcher says the United States must learn from the system's mistakes before emulating it.
December 12, 2008 - Health - Healthcare Reform - Running In Place
U.S. health research funding hit $122 billion in 2007, but failed to grow relative to healthcare costs overall.
December 12, 2008 - Tech/Innovation - Research - The Treadmill vs. The Staple
A study finds that people have just as much success keeping the weight off through diet and exercise as they do through bariatric surgery.
December 12, 2008 - Health - Obesity - The Big, Teen-y Problem
Health services for Americans ages 10 to 18 aren't effectively meeting their needs, a report finds.
December 12, 2008 - Health - Healthcare Reform - What’s In A Name?
Medical terms worry people more than lay terms according to a recent study.
December 11, 2008 - Society - Culture - A Worldwide Pandemic
Cancer rates continue to fall in the United States and elsewhere, but the disease is expect to pass heart disease as the leading killer by 2010.
December 11, 2008 - MARIE DAGHLIAN - Health - Cancer - Sick Of You
Marital problems lead to poorer outcomes for breast cancer patients.
December 11, 2008 - Health - Cancer - A Big Copycat
Merck plans to dive into biogenerics as it looks for new sources of growth to offset expiring patents.
December 11, 2008 - MARIE DAGHLIAN - Business - Business Strategy - Estimating A Killer’s Costs
Study finds cancer deaths could represent a nearly $1.5-trillion loss to U.S. economy by 2020.
December 11, 2008 - Health - Cancer - Building For The Future
India plants seeds for future biotech growth as sector remains healthy during the current downturn.
December 11, 2008 - MARIE DAGHLIAN - Business - Global Economy - Magic Beans
The Joint Genome Institute cracks the genetic code for soybeans in the hopes of making it a better feedstock for biodiesel.
December 11, 2008 - MARIE DAGHLIAN - Business - Industrial/Ag Bio - A Dose Of Common Sense
A husband-and-wife team thinks its low-tech system will reduce medication mistakes.
December 08, 2008 - ERIC WAHLGREN - Health - Drug Safety - Is Ben & Jerry’s Healthier Than Beignets?
U.S. health stagnates for the fourth year in a row as obesity, smoking, and a lack of health insurance remain critical areas in need of improvement.
December 05, 2008 - Health - Public Health - Early Warning
Ontario researchers play key role in identifying new colorectal cancer genes that promise to indentify people at heightened risk of developing the disease.
December 05, 2008 - Tech/Innovation - Research - Tired of Sleep-deprived Residents
A leading medical policy group calls for revising work standards for doctors in training to reduce medical errors.
December 05, 2008 - Health - Medical Practice - A Code Blue For General Surgery
A new study projects there won’t be enough surgeons in U.S. hospitals by 2010.
December 04, 2008 - Health - Medical Practice - Putting Mascara On The Run
Regulators don’t seem to bat an eye at use of glaucoma treatment to grow lashes.
December 04, 2008 - MARIE DAGHLIAN - Society - Research - An Innovation Ecosystem
Presidential panel endorses university-industry partnerships and says steps need to be taken to improve them.
December 04, 2008 - MARIE DAGHLIAN - Society - Research - FDA 2.0
The FDA seeks to leverage information technologies to promote public health.
December 04, 2008 - MARIE DAGHLIAN - Health - Public Health - From Rags to Royalty
Paul Capital Healthcare offers companies an alternative to debt or equity as a way to raise capital at a time when markets may be unwelcoming to companies seeking cash to fuel growth.
December 03, 2008 - DANIEL S. LEVINE - Finance - Finance - Is Something in the Air Making Us Fat?
A ubiquitous pollutant has a potent effect on genes and may be helping to fuel obesity.
December 02, 2008 - Health - Obesity - Change We Can Tolerate
Any reform to the U.S. health system—or any system for that matter—is limited by the country’s history and traditions that have created the system.
December 01, 2008 - Health - Healthcare Reform - Off Label, But On The Radar
Researchers identify a list of 14 drugs in most urgent need of studies to justify their non-approved uses.
November 26, 2008 - Health - Public Health - Bacterial Booby-Traps
Microscopic spheres that trap harmful pathogens could help combat an estimated 1.4 million infection-related deaths caused by contaminated medical devices each year.
November 26, 2008 - Tech/Innovation - Technology - Bike Messengers
People with cancer raise awareness of the disease in "Breakaway Miles" that take place during the annual Amgen Tour of California, the country's premier cycling event.
November 25, 2008 - ERIC WAHLGREN - Society - Culture - Feeling Uninhibited
Researchers find a way to manipulate human endocannabinoids in the search for new treatments for chronic pain and other ills.
November 25, 2008 - Tech/Innovation - Research - A Real Buzz Kill
Researchers call for warning labels on energy drinks.
November 24, 2008 - DANIEL S. LEVINE - Health - Public Health - Shy in Public
The list of biotechs pulling their IPOs is growing, but companies are still finding alternatives.
November 21, 2008 - PETER WINTER
The Burrill Biotechnology Report - Finance - Finance - It's Real
An exhaustive, Congressionally-mandated report refutes common claims that Gulf War illness stemmed from combat or other stressors.
November 21, 2008 - Law/Policy - Research - Great White North Grows Cold
Venture capital in Canada continues to decline both in total number and size.
November 21, 2008 - PETER WINTER
The Burrill Biotechnology Report - Finance - Finance - A Green Light For Clean Energy
Obama puts “cap-and-trade” legislation at the top of his clean energy to-do list.
November 20, 2008 - MARIE DAGHLIAN
The Burrill Biotechnology Report - Business - Industrial/Ag Bio - Heal Thyself
Bone marrow cells may prove effective in regenerating heart muscle and improving function.
November 20, 2008 - Health - Regenerative Medicine - Finding When The Worm Has Turned
Research in nematodes could lead to tests that provide an objective means of evaluating anti-aging therapeutics ability to delay aging.
November 20, 2008 - Tech/Innovation - Aging - Sick Of Medicine
With mounting problems facing primary care doctors, a survey of physicians finds the shortage will only grow worse.
November 19, 2008 - Health - Medical Practice - Breathe Easy
Study finds that physicians in Canada may be over-diagnosing asthma.
November 19, 2008 - Health - Public Health - Playing It Safe
The U.S. Food and Drug Administration opens three offices in China.
November 19, 2008 - Law/Policy - Regulatory - Heal Thyself
Bone marrow cells may prove effective in regenerating heart muscle and improving function.
November 19, 2008 - Health - Regenerative Medicine - A Reform Agenda
Obama Taps Tom Daschle To Head HHS.
November 19, 2008 - Law/Policy - Healthcare Reform - Young At Brain
Elderly people with unusually sharp memory provide insight into what happens to people suffering from Alzheimer’s disease.
November 18, 2008 - Tech/Innovation - Research - Google's Big Record Deal
If the search giant is successful in its healthcare venture, it could spark a nationwide electronic medical records network.
November 17, 2008 - ERIC WAHLGREN - Health - Technology - It's In His DNA
Barack Obama may represent the first President who understands personalized medicine at more than a conceptual level.
November 13, 2008 - DANIEL S. LEVINE - Law/Policy - Healthcare Reform - Political Scientists
As Washington gets ready to overhaul the healthcare system, research advocates want to make sure innovation doesn't take a backseat to the bottom line.
November 11, 2008 - DANIEL S. LEVINE - Society - Politics - Thinning Pipelines
Pharma companies push away the plate on diet pills as concern grows over a risk averse regulatory environment.
November 06, 2008 - MARIE DAGHLIAN
Burrill Biotech Report - Business - Drug Development - Another Inconvenient Truth
Podcast: November 2008
November 04, 2008 - Law/Policy - Research - Getting Protection
San Diego biotech' results show DNA vaccine could work in humans.
October 28, 2008 - DANIEL S. LEVINE - Tech/Innovation - Research - A Stone Cold Truth
Rising temperatures in the United States mean increasing incidence of nephrolithiasis.
October 24, 2008 - DANIEL S. LEVINE - Health - Public Health - On the Frontline at Home
Treating psychiatric casualties of the wars in Iraq and Afghanistan at the Seattle VA, I am inspired by the determination and healing capacity of individuals, but disheartened by the profound damage inflicted on the nation.
October 21, 2008 - EVAN KANTER - Health - Medical Practice - Not Horsing Around
Scientist and racehorse owner Patrick Casey has developed a new way to treat injured horses. Bets are on as to whether the tissue transplantation therapy will have human applications.
October 14, 2008 - ERIC WAHLGREN - Health - Regenerative Medicine - Wheeled Away
Golf cart injuries surge along with the vehicles' use on and off the links.
October 09, 2008 - ERIC WAHLGREN - Society - Culture - I Want A New Drug
IDIS Pharmaceuticals has carved out a niche by connecting patients to drugs not yet approved in their countries. Now it's taking its services to the United States.
October 06, 2008 - DANIEL S. LEVINE - Business - Business Strategy - They Don't Call, They Don't Write
Ethicists says investigators should share results with research volunteers in their studies.
October 02, 2008 - DANIEL S. LEVINE - Law/Policy - Research - Guinea Pig Zero Speaks
Podcast: October 2008
October 01, 2008 - Society - Research - Avoiding Exposure
Google says information contained in its web-based personal health records is very secure, but some privacy experts say there are concerns about these types of services.
September 24, 2008 - ERIC WAHLGREN - Health - Technology - Missing Links
Creating a nationwide network of electronic medical record systems that talk to each other could be the most challenging information technology project in history. Potential price tag? $276 billion.
September 24, 2008 - ERIC WAHLGREN - Health - Technology - Gas Guzzlers
Scientists in New Zealand move closer to curbing global warming with a vaccine for sheep flatulence.
September 18, 2008 - ERIC WAHLGREN - Tech/Innovation - Industrial Bio/Ag Bio - Gimme Shelter
A lab building boom is underway in California thanks to money raised by the state's stem cell agency. The race is on as 12 institutions must complete building their state-of-the art research facilities in just two years.
September 15, 2008 - ERIC WAHLGREN - Tech/Innovation - Research - An Ounce Of Prevention
Biomedical research costs money, but it promises to fix the healthcare mess, save billions in the long run, and cure people even before they get sick.
September 05, 2008 - DANIEL S. LEVINE - Law/Policy - Research - The Journal Of Life Sciences
August/September 2008
September 04, 2008 - Magazine - Magazine - The Gene Poll
Researchers say heritability plays a role in voter turnout.
September 02, 2008 - ERIC WAHLGREN - Society - Politics - Tall Order
Can Singapore buy its way to the top of the biotech world with no background in entrepreneurship or science?
August 29, 2008 - JOEL MCCORMICK - Business - Global Economy - Love Stinks
Research finding that body odor influences attraction inspires a new dating site.
August 27, 2008 - JULIE CHAO - Society - Culture - Wait for Me
Consumers are embracing tests that aim to reveal genetic risk factors for disease. Problem is, the medical community doesn't seem ready to deal with all the data begging for interpretation.
August 22, 2008 - BRUCE GOLDMAN - Health - Medical Practice - Borders without Doctors
Efforts intensify to address health worker migration's toll on sub-Saharan Africa.
August 21, 2008 - ERIC WAHLGREN - Health - Global Health - Why Darwin May Be Wrong
Stanford's Joan Roughgarden takes issue with Darwinian theory of sexual selection, but she's no creationist. The evolutionary biologist believes it's time to look at sex in a new way.
August 19, 2008 - SANDYA VISWANATHAN - Tech/Innovation - Research - DNA Inside
Bio-based computers may help scientists overcome the limitations of silicon-powered machines, leading to new nano-scale products as well as smart drugs that adjust to the environment inside the body.
August 13, 2008 - LORI ANDREWS - Tech/Innovation - Convergence - A Magic Formula
Big Pharma may have finally figured out the secret recipie for preserving innovation in the biotechs it acquires.
August 01, 2008 - Business - Dealmaking - English, Gym, Algebra..Biotech
I've tried to inspire a new generation of scientists through an unusual curriculum and partnerships with industry.
July 31, 2008 - KIRK BROWN - Tech/Innovation - Education - Hits and Misses
An analysis of pharma deals shows certain types are better predictors of success than others.
July 22, 2008 - DANIEL S. LEVINE - Business - Dealmaking - When a Career Change Is in the Cards
Former pharmaceutical patent attorney Greg Raymer has found much greener pastures as a poker ace.
July 21, 2008 - CAROL HUANG - Society - Culture - Dishonor Roll
U.S. health system's grade knocked down to a D.
July 17, 2008 - ERIC WAHLGREN - Health - Drug Delivery - Whether The Couric Effect Is Real, It's Not Enough
CDC says despite improvements colorectal cancer screening rate remain too low.
July 16, 2008 - DANIEL S. LEVINE - Health - Wellness - Holy Heatstroke!
Study finds 80 percent of sunscreens don't really work.
July 11, 2008 - ERIC WAHLGREN - Health - Wellness - The Grain of Life
Biotech may have the solution to avert a rice crisis, but adoption is slow.
July 10, 2008 - ALEX GRONKE - Tech/Innovation - Industrial Bio/Ag Bio - From Information Superhighway to Mean Streets
Report finds anyone can obtain dangerous and addictive prescription drugs with the click of a mouse.
July 10, 2008 - DANIEL S. LEVINE - Society - Culture - Attack of the (Alzheimer's) Killer Tomatoes
Transgenic tomatoes expressing beta-amyloaid may serve as a vaccine against the dreaded neurodegenerative disease.
July 08, 2008 - DANIEL S. LEVINE - Tech/Innovation - Aging - Are You Ready For Flintstone Chewable Statins?
New American Academy of Pediatrics guidelines call for kids as young as 8 to get cholesterol-lowering drugs.
July 07, 2008 - Health - Wellness - Deep Yogurt
Technical innovation is imporant, but biopharma companies will need new operational innovation to thrive in the current environment.
July 06, 2008 - DANIEL S. LEVINE - Business - Drug Development - Biotech Gets A Flat
The life sciences sectors fails to muster a single IPO in the second quarter.
July 03, 2008 - DANIEL S. LEVINE - Finance - Finance
Study finds Weight Watchers participants lost more weight than fitness center users, but the wrong kind.
July 03, 2008 - DANIEL S. LEVINE - Health - Drug Delivery- Conversations From BIO 2008
Podcast: July 2008
June 26, 2008 - Law/Policy - Regulatory - The New Gene Pool
Scientists develop way to look into marine creatures and isolate promising new drug compounds.
June 19, 2008 - LISA SUMMERS - Tech/Innovation - Research - Now Available
June/July 2008 edition
June 12, 2008 - Magazine - Magazine - Odd Stories
A news round-up of the bizarre from the world of the life sciences
June 11, 2008 - TJOLS-TV - News - The Burrill Report
View Past Issues
June 02, 2008 - Magazine - Magazine - Critical Condition
A Conversation On Healthcare Reform and Income Security.
June 01, 2008 - Law/Policy - Healthcare Reform - A 20/20 Vision to 2020
Podcast: May 2008
April 28, 2008 - Health - Innovation - The Latest Ebola outbreak
The deadly virus is turning up across the U.S. - but thankfully only as a pattern in ties, scarves, and other fashions.
March 28, 2008 - JULIE CHAO - Society - Culture - PODCAST:
March 2008
Turn On, Tune In, and Research.
March 07, 2008 - Law/Policy - Research - Pumped About Polymers
Symphony Medical thinks it can tackle large cardiology markets with its seemingly simple approach to alter troubled hearts.
February 15, 2008 - DANIEL S. LEVINE - Health - Medical Devices - Pocket Protector
A wearable sensor system could help shed light on what really triggers asthma attacks.
February 13, 2008 - ERIC WAHLGREN - Health - Medical Devices - Fast Follower
Lead Therapeutics hopes to leverage its chemical expertise and low-cost talent in China to build better molecules cheaper.
February 05, 2008 - DANIEL S. LEVINE - Business - Business Strategy - PODCAST: February 2008
February 01, 2008 - Law/Policy - Regulatory - Blood Simple
Trellis Bioscience is pursuing several preclinical candidates, but its antibody discovery engine is where its star power lies.
January 25, 2008 - DANIEL S. LEVINE - Business - Drug Development
The latest news and numbers from Wall Street.
January 22, 2008 - Business - Markets
The latest news and numbers from Wall Street.
January 22, 2008 - Business - Markets- Some Food for Thought
A Colorado company takes a novel approach to treating Alzheimer's disease - and to getting its therapy to market.
January 16, 2008 - DANIEL S. LEVINE - Business - Business Strategy - Taking Pulses
Against a turbulent start for financial markets, the JPMorgan conference launches the new year for the biotechnology sector with optimism.
January 06, 2008 - DANIEL S. LEVINE - Finance - Finance - The Outlook for the Year Ahead
December 31, 2007 - Business - Global Economy - Scientists Rewrite Murder Mystery
DNA evidence raises new questions about a nearly 100-year-old conviction.
December 27, 2007 - ERIC WAHLGREN - Law/Policy - Legal - A Different Approach to Parkinson's
Two separate efforts could lead to a new class of drugs to treat the neurodegenerative condition.
December 21, 2007 - DANIEL S. LEVINE - Business - Dealmaking - An Ounce of Prevention
Changing reimbursement rules promise to create demand for product with a once dim future.
December 10, 2007 - DANIEL S. LEVINE - Business - Drug Development PODCAST
December 2007
December 01, 2007 - Health - Wellness- PODCAST
November 2007
October 31, 2007 - Health - Personalized Medicine - Safety Blitz
Special football helmets alert coaches when potential brain injuries occur.
October 24, 2007 - ERIC WAHLGREN - Health - Technology - RX For Stroke Victims: Irish Coffee - Iced
A San Diego company believes a mixture of caffeine and alcohol along with its cooling technology might minimize damage to the brain when the flow of blood becomes blocked.
October 22, 2007 - DANIEL S. LEVINE - Business - Drug Development - Suite Deal
Efforts to lure venture capitalists to San Diego are ramping up, but can America's self-proclaimed "finest city" become a VC center of its own?
October 19, 2007 - DANIEL S. LEVINE - Finance - Finance - Making Chemo Irresistible
A virtual biopharma has a late-stage cancer drug with an encouraging safety profile that may be able to turn chemo-resistant cancer cells vulnerable.
October 05, 2007 - DANIEL S. LEVINE - Business - Drug Development - A Big, Fat Irony
Researchers discover diners consume more calories at low-cal restaurants.
September 28, 2007 - ERIC WAHLGREN - Health - Public Health - Universities Mean Business
Merck and Harvard enter a collaboration that reflects the closer ties being forged between industry and academia, but it's a trend that is alarming to some.
September 18, 2007 - DANIEL S. LEVINE - Tech/Innovation - Research - Variations on a Theme
Crohn's discovery points to the power of a Canadian company's approach to unraveling genetic players in complex diseases.
September 12, 2007 - DANIEL S. LEVINE - Finance - Finance
NIH provides $25-million grant for interdisciplinary program in newly-dubbed field of geroscience at a California institute for age research.
September 07, 2007 - DANIEL S. LEVINE - Tech/Innovation - Research
As key products come off patent, the drug giant looks to biologics to help build its future.
August 29, 2007 - DANIEL S. LEVINE - Business - Drug Development- Money Changes Everything
Stem cell measure draws top researchers to California through promise of funding.
August 20, 2007 - DANIEL S. LEVINE - Health - Regenerative Medicine - Healthy Couture
Clothes that protect health professionals from bacteria and agricultural workers from pesticides may be coming soon.
August 17, 2007 - ERIC WAHLGREN - Health - Innovation - 1
Federal regulators hope computer modeling can identify drugs that damage the liver before they do harm.
August 13, 2007 - DANIEL S. LEVINE - Tech/Innovation - Technology - FDA Thinks Small
Agency task force wrestles with the regulatory challenges posed by nanotechnology, but critics say its business as usual.
July 27, 2007 - DANIEL S. LEVINE - Law/Policy - Regulatory - Bio: the New Chemistry
Codexis' says its super enzymes makes the production of pharmaceuticals faster, cheaper and cleaner and could help make biofuels a commercial reality.
July 25, 2007 - DANIEL S. LEVINE - Tech/Innovation - Industrial Bio/Ag Bio - Hatching Companies
Pfizer gets first tenant for its incubator as it hopes to tap new ideas from outside to help fill the evolving void from drugs going off patent.
July 20, 2007 - DANIEL S. LEVINE - Health - Drug Delivery - Delivering the Goods
$1 billion RNAi deal heats up sector, but hurdles for the technology remain.
July 12, 2007 - DANIEL S. LEVINE - Business - Drug Development - To Err is Human
A near-death experience for a little girl leads her father to develop medical diagnosis software company.
July 03, 2007 - DANIEL S. LEVINE - Health - Information Technology - Why Did the Chicken Cross the Road? To Make... Plastic.
The race to develop renewable plastics is picking up steam, and poultry feathers are among the materials under consideration.
June 29, 2007 - ERIC WAHLGREN - Tech/Innovation - Industrial Bio/Ag Bio - True Romance
Genentech shows it can attract a big pharma partner to take role traditionally played by smaller biotechs.
June 27, 2007 - DANIEL S. LEVINE - Business - Dealmaking - Breathing New Life
Eli Lilly launches public-private non-profit partnership to discover new drugs to treat tuberculosis.
June 25, 2007 - DANIEL S. LEVINE - Health - Global Health - A Shot In The Arm
A company developing a breakthrough approach to producing vaccines gets boost from US Government.
June 19, 2007 - DANIEL S. LEVINE - Health - Vaccines - Debating Evolution
PriceWaterhouseCoopers sees the global pharmaceutical market doubling to $1.3 trillion by 2020, but says industry will have to change to capitalize on opportunities.
June 14, 2007 - DANIEL S. LEVINE - Business - Business Strategy - Pharma's High-Mileage Hybrid
Wyeth hopes to drive up drug discoveries by blurring the lines between pharmaceutical and biotech.
June 11, 2007 - DANIEL S. LEVINE - Health - Drug Development - Tracking Killers
Northwestern professor's effort to identify adverse drug reactions proves faster than FDA and drug makers, but he says they all need to work together.
June 06, 2007 - DANIEL S. LEVINE - Health - Drug Safety - A New Kind of Life Insurance
California company offers personalized stem cells lines for patients of IVF clinics.
June 02, 2007 - DANIEL S. LEVINE - Health - Regenerative Medicine - Music To Their Ears
MP3-like device retrains brain to ignore tinnitus
May 30, 2007 - DANIEL S. LEVINE - Business - MedTech - The Early Bird
Canary Foundation funds Stanford center to identify new ways to detect cancer at its earliest stages.
May 25, 2007 - DANIEL S. LEVINE - Society - Philanthropy - Sherlock Meets The Other Dr. Watson
Applied Biosystems sees growth opportunities in databases of DNA samples from criminals.
May 23, 2007 - DANIEL S. LEVINE - Business - Business Strategy - Flu Bugged
A small Australian biotech takes on a drug giant over a soured influenza drug alliance.
May 22, 2007 - DANIEL S. LEVINE - Business - Dealmaking - Key Patent Ruling No Biotech Killer
U.S. Supreme Court refines what "obvious" means for patents, but doesn't scrap protection for innovators.
May 16, 2007 - COURTENAY C. BRINCKERHOFF - Law/Policy - Patents - How Do You Like Them Apples?
A new hybrid from New Zealand may change the way we think about fruit.
May 15, 2007 - DANIEL S. LEVINE - Tech/Innovation - Industrial Bio/Ag Bio - In A Pig's Islet
Australian company ready to enter clinic with encapsulated pig cells.
May 14, 2007 - DANIEL S. LEVINE - Health - Regenerative Medicine - Fill 'er Up With Corn or Algae?
A clean fuel ratings system could help identify the greenest alternatives to gasoline.
May 11, 2007 - ERIC WAHLGREN - Tech/Innovation - Industrial Bio/Ag Bio - Everything Old Is New Again
As the cost of drug development soars, entrepreneurs and investors are looking to repurpose off-patent drugs.
May 10, 2007 - DANIEL S. LEVINE - Health - Drug Development - Inventing the Future
Billionaire David Murdock is trying to turn Kannapolis, North Carolina, into a boom town for biotech.
May 08, 2007 - DANIEL S. LEVINE - Business - Economic Development
.gif)
